R128126,R128127,R128131,R129126,R129127,R129131,R130126,R130127,R130131,id,accession_number,geneSymbol,numColumnsProteinObserved,numSpectraProteinObserved,numPepsUnique,numPepsUniqueSubgroupSpecificCI,accession_numbers,species,protein_mw,percentCoverage,groupNum,subgroupNum,scoreUnique,scoreUniqueSubgroupSpecificCI,orfCategory,sequenceLength,entry_name,cellular_component,biological_process,molecular_function,Proteome.unique_peptides,Proteome.numSpectra,Proteome.totalIntensity,Proteome.pct_cov,adj.P.Val.XBirA.over.No_BirA,AveExpr.XBirA.over.No_BirA,Log.P.Value.XBirA.over.No_BirA,logFC.XBirA.over.No_BirA,P.Value.XBirA.over.No_BirA,t.XBirA.over.No_BirA,Proteome..126.126.127.128.129.130.131..No_BirA50.multimedian,Proteome..127.126.127.128.129.130.131..No_BirA51.multimedian,Proteome..131.126.127.128.129.130.131..No_BirA52.multimedian,Proteome..128.126.127.128.129.130.131..XBirA_48.multimedian,Proteome..129.126.127.128.129.130.131..XBirA_49.multimedian,Proteome..130.126.127.128.129.130.131..XBirA_47.multimedian,PCorNC,ES_score,signalP,TM
1.542,1.912,0.875,1.695,2.0775,0.9985,1.725,2.108,1.0315,Q8VDD5,Q8VDD5,Myh9,1,1767,290,234,Q8VDD5|F2Z494|Q02566|A2AQP0|P13541|P13542|E9Q264,MOUSE,227566.2,79.3,1,1.1,4186.95,3444.79,NA,1960,Myosin-9,stress fiber|ruffle|uropod|nucleus|cytoplasm|actomyosin contractile ring|cytosol|plasma membrane|brush border|cell-cell adherens junction|cell cortex|actin cytoskeleton|membrane|myosin complex|myosin II complex|cortical cytoskeleton|cell leading edge|cleavage furrow|actomyosin|protein complex|extracellular exosome|myosin II filament|immunological synapse|spindle|plasma membrane|focal adhesion|COP9 signalosome|integrin complex|neuromuscular junction|,"meiotic spindle organization|cell morphogenesis involved in differentiation|cytokinesis|angiogenesis|in utero embryonic development|establishment of T cell polarity|membrane protein ectodomain proteolysis|phagocytosis, engulfment|cell adhesion|myoblast fusion|regulation of cell shape|protein transport|single organismal cell-cell adhesion|actin filament-based movement|platelet formation|monocyte differentiation|actomyosin structure organization|actin cytoskeleton reorganization|uropod organization|blood vessel endothelial cell migration|establishment of meiotic spindle localization|platelet aggregation|negative regulation of actin filament severing|positive regulation of protein processing in phagocytic vesicle|actin filament polymerization|actin filament capping|",microfilament motor activity|actin binding|protein binding|calmodulin binding|ATP binding|ATPase activity|protein domain specific binding|actin-dependent ATPase activity|protein homodimerization activity|protein anchor|ADP binding|poly(A) RNA binding|actin filament binding|,291,1767,1.17E+13,0.793,0.001467873,-0.297333333,34.74618125,1.539666667,0.00033526,6.750718568,-1.1785,-1.489,-0.534,0.361,0.513,0.5435,NC,9,NA,NA
1.412,1.96,0.967,1.552,2.0675,1.0835,1.611,2.129,1.1215,Q3UH59,Q3UH59,Myh10,1,592,213,157,Q3UH59|Q61879|Q5SV64|Q8BXF2,MOUSE,234472.2,69.1,1,1.2,2936.96,2220.49,NA,2013,Myosin-10,stress fiber|nucleus|cytoplasm|mitochondrion|cell cortex|actin cytoskeleton|myosin complex|myosin II complex|axon|growth cone|midbody|cleavage furrow|actomyosin|neuron projection|neuronal cell body|dendritic spine|extracellular exosome|myosin II filament|spindle|plasma membrane|neuromuscular junction|,"mitotic cytokinesis|in utero embryonic development|neuron migration|plasma membrane repair|exocytosis|substrate-dependent cell migration, cell extension|nuclear migration|axonogenesis|axon guidance|brain development|adult heart development|metabolic process|cell proliferation|regulation of cell shape|fourth ventricle development|lateral ventricle development|third ventricle development|cerebellar Purkinje cell layer development|actin cytoskeleton organization|actin filament-based movement|myofibril assembly|actomyosin structure organization|neuron projection development|neuromuscular process controlling balance|cardiac myofibril assembly|ventricular cardiac muscle cell development|retina development in camera-type eye|",microfilament motor activity|protein binding|ATP binding|actin-dependent ATPase activity|ADP binding|actin filament binding|,157,592,1.32E+12,0.574,0.000824395,-0.259666667,37.59933536,1.549,0.000173807,7.538166528,-1.0275,-1.468,-0.607,0.387,0.556,0.6015,undefined,9,NA,NA
0.966,1.145,0.803,0.971,1.0975,0.7345,1.11,1.188,0.8775,Q6URW6,Q6URW6,Myh14,1,127,81,60,Q6URW6|Q6URW6-3|K3W4R2|Q6URW6-2,MOUSE,229494.5,39.6,1,1.5,1078.8,790.1,NA,2000,Myosin-14,stress fiber|cytoplasm|brush border|membrane|myosin complex|myosin II complex|axon|growth cone|actomyosin|myelin sheath|extracellular exosome|myosin II filament|,skeletal muscle contraction|skeletal muscle tissue development|sensory perception of sound|metabolic process|regulation of cell shape|neuronal action potential|actin filament-based movement|actomyosin structure organization|mitochondrion morphogenesis|vocalization behavior|,microfilament motor activity|calmodulin binding|ATP binding|actin-dependent ATPase activity|actin filament binding|actin-dependent ATPase activity|actin filament binding|,60,127,4.07E+10,0.328,0.000106306,-0.116166667,48.09655727,0.998,1.55E-05,11.1357476,-0.6345,-0.762,-0.449,0.353,0.347,0.4485,NC,9,NA,NA
2.156,2.243,2.459,1.744,1.9195,2.1085,2.244,2.394,2.5765,A2ARV4,A2ARV4,Lrp2,1,1202,242,242,A2ARV4|A2ARV5|Q3V346,MOUSE,537969.9,54.9,3,3.1,3572.42,3572.42,NA,4660,Low-density lipoprotein receptor-related protein 2,lysosomal membrane|endosome|endoplasmic reticulum|Golgi apparatus|brush border|coated pit|membrane|integral component of membrane|apical plasma membrane|endocytic vesicle|brush border membrane|receptor complex|apical part of cell|extracellular exosome|,vitamin metabolic process|receptor-mediated endocytosis|cell proliferation|forebrain development|Wnt signaling pathway involved in dorsal/ventral axis specification|canonical Wnt signaling pathway|,receptor activity|calcium ion binding|protein binding|SH3 domain binding|Wnt-protein binding|Wnt-activated receptor activity|,242,1202,3.67E+12,0.549,2.89E-05,-0.238833333,54.84306779,2.224,3.28E-06,14.19749123,-1.1675,-1.252,-1.633,0.926,0.631,1.0625,undefined,9,TRUE,TRUE
1.014,1.03,0.877,1.002,1.0345,0.8805,1.046,1.031,0.8995,P16546,P16546,Sptan1,1,331,139,139,A3KGU9|A3KGU7|P16546|E9Q447|A3KGU5|P16546-2|P08032,MOUSE,285391,55.8,5,5.1,1715.01,1715.01,NA,2472,"Spectrin alpha chain, non-erythrocytic 1",fascia adherens|microtubule cytoskeleton|membrane|lateral plasma membrane|Z disc|cortical cytoskeleton|cuticular plate|paranode region of axon|myelin sheath|intracellular membrane-bounded organelle|extracellular exosome|extracellular vesicle|,actin filament capping|,actin binding|calcium ion binding|protein binding|calmodulin binding|spectrin binding|protein heterodimerization activity|,140,331,1.34E+11,0.558,1.35E-05,-0.095,59.82850459,0.973666667,1.04E-06,16.70781813,-0.6245,-0.618,-0.503,0.384,0.406,0.3855,undefined,9,NA,NA
1.529,1.464,1.471,1.527,1.4805,1.4835,1.474,1.438,1.4245,V9GX76,V9GX76,Myo6,1,435,93,3,V9GX76|E9Q174|V9GXM4|E9Q3L1|Q64331,MOUSE,150710.4,67.3,12,12.1,1346.5,31.11,NA,1294,Unconventional myosin-VI,"ruffle|nucleus|nucleoplasm|cytoplasm|Golgi apparatus|plasma membrane|vesicle membrane|membrane|cytoplasmic membrane-bounded vesicle|myosin complex|DNA-directed RNA polymerase II, holoenzyme|axon|filamentous actin|nuclear membrane|neuronal cell body|synapse|perinuclear region of cytoplasm|extracellular exosome|clathrin-coated endocytic vesicle|","protein targeting|endocytosis|synaptic transmission|synapse assembly|sensory perception of sound|locomotory behavior|metabolic process|glutamate secretion|dendrite development|DNA damage response, signal transduction by p53 class mediator|inner ear morphogenesis|auditory receptor cell differentiation|positive regulation of transcription from RNA polymerase II promoter|regulation of synaptic plasticity|inner ear development|regulation of secretion|cellular response to electrical stimulus|",motor activity|protein binding|ATP binding|actin filament binding|,94,435,1.70E+12,0.673,2.52E-06,-0.1885,74.16393931,1.501333333,3.83E-08,27.53002663,-0.9595,-0.893,-0.965,0.548,0.6,0.5385,undefined,9,NA,NA
2.209,2.304,2.415,1.75,1.9175,1.9815,2.23,2.379,2.4235,Q9JLB4,Q9JLB4,Cubn,1,337,92,92,Q9JLB4,MOUSE,407932.7,29.5,14,14.1,1293.13,1293.13,NA,3623,Cubilin,cytoplasm|lysosomal membrane|endosome|endoplasmic reticulum|Golgi apparatus|brush border|coated pit|endosome membrane|apical plasma membrane|endocytic vesicle|apical part of cell|extracellular exosome|,receptor-mediated endocytosis|cholesterol metabolic process|lipoprotein transport|,receptor activity|calcium ion binding|protein binding|cobalamin binding|protein homodimerization activity|,92,337,3.91E+11,0.295,1.47E-05,-0.2185,59.21518287,2.202,1.20E-06,16.58679017,-1.2025,-1.254,-1.502,0.961,0.63,1.0565,undefined,9,TRUE,NA
0.733,0.814,0.6,0.666,0.7315,0.5405,0.79,0.834,0.5975,Q62261,Q62261,Sptbn1,1,262,101,94,Q62261|Q62261-2|Q3UGX2|E9Q397|P15508,MOUSE,275074,46.5,15,15.1,1248.73,1153.22,NA,2363,"Spectrin beta chain, non-erythrocytic 1",nucleus|nucleolus|cytoplasm|plasma membrane|spectrin|membrane|axolemma|cortical cytoskeleton|M band|cuticular plate|extracellular exosome|neuronal postsynaptic density|,mitotic cytokinesis|plasma membrane organization|common-partner SMAD protein phosphorylation|SMAD protein import into nucleus|Golgi to plasma membrane protein transport|actin filament capping|membrane assembly|protein targeting to plasma membrane|positive regulation of interleukin-2 secretion|regulation of protein localization to plasma membrane|positive regulation of protein localization to plasma membrane|,actin binding|structural constituent of cytoskeleton|protein binding|calmodulin binding|phospholipid binding|ankyrin binding|poly(A) RNA binding|GTPase binding|,103,262,1.10E+11,0.465,0.00014106,-0.073166667,46.62820675,0.709333333,2.17E-05,10.44595841,-0.4545,-0.512,-0.317,0.283,0.251,0.3105,NC,9,NA,NA
-0.522,-0.204,0.201,-0.611,-0.2825,0.0895,-0.469,-0.14,0.2375,Q9JIL4,Q9JIL4,Pdzk1,1,181,50,2,Q9JIL4,MOUSE,56897,84.9,55,55.1,713.25,30.82,NA,519,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,cytoplasm|plasma membrane|brush border membrane|extracellular exosome|,transport|carnitine transport|positive regulation of ion transmembrane transport|regulation of anion transport|establishment of protein localization to plasma membrane|positive regulation of protein targeting to membrane|,protein binding|PDZ domain binding|,50,181,2.44E+11,0.849,0.418465487,0.029333333,4.829165355,-0.175666667,0.328914837,-1.053615798,0.4455,0.154,-0.248,-0.047,-0.135,0.0065,undefined,6,NA,NA
0.374,1.636,0.735,0.138,1.2575,0.5095,0.375,1.418,0.7615,A0A0R4J1V0,A0A0R4J1V0,Pdzk1,1,10,50,3,A0A0R4J1V0,MOUSE,56896,84.9,55,55.2,712.96,40.63,NA,519,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,NA,NA,NA,3,10,1.20E+10,0.046,0.045487461,-0.19,16.801997,0.716333333,0.020883356,3.013056192,-0.0815,-1.097,-0.466,0.192,0.079,0.2335,undefined,6,NA,NA
0.616,0.784,0.234,0.799,0.9915,0.4525,0.72,0.907,0.3595,E9QAX2,E9QAX2,Myo18a,1,95,51,51,E9QAX2|Q9JMH9-6|Q9JMH9|B2RRE2|K3W4L0|Q9JMH9-1|Q9JMH9-4|A0A1C7ZN10|Q9JMH9-2|Q9JMH9-7|Q9JMH9-5|E9Q405|E9QA74,MOUSE,237125.2,27.9,77,77.1,628.15,628.15,NA,2083,Unconventional myosin-XVIIIa,Golgi membrane|trans-Golgi network|cytoskeleton|membrane|myosin complex|actomyosin|,Golgi organization|metabolic process|cell migration|actomyosin structure organization|negative regulation of apoptotic process|Golgi vesicle budding|positive regulation of protein secretion|Golgi ribbon formation|asymmetric Golgi ribbon formation|,motor activity|ATP binding|ADP binding|poly(A) RNA binding|actin filament binding|,51,95,1.76E+10,0.279,0.008341505,-0.124,25.93619919,0.660333333,0.00254906,4.700161811,-0.5185,-0.686,-0.158,0.09,0.322,0.2065,undefined,7,NA,NA
0.565,0.596,0.292,0.602,0.5775,0.3495,0.616,0.626,0.3515,P48678,P48678,Lmna,1,105,44,44,P48678|P48678-2|P48678-3,MOUSE,74521.5,63.6,103,103.1,557.25,557.25,NA,665,Prelamin-A/C,nucleus|nuclear envelope|lamin filament|nucleoplasm|cytoplasm|nuclear matrix|nuclear membrane|perinuclear region of cytoplasm|,nucleus organization|nuclear envelope organization|spermatogenesis|muscle organ development|establishment of cell polarity|regulation of cell migration|establishment or maintenance of microtubule cytoskeleton polarity|protein localization to nucleus|sterol regulatory element binding protein import into nucleus|ventricular cardiac muscle cell development|cellular response to hypoxia|negative regulation of release of cytochrome c from mitochondria|positive regulation of cell aging|regulation of protein localization to nucleus|negative regulation of extrinsic apoptotic signaling pathway|,structural molecule activity|protein binding|,44,105,6.04E+10,0.636,0.003278832,-0.0835,30.75958812,0.515333333,0.00083954,5.758377709,-0.4465,-0.421,-0.156,0.123,0.192,0.2075,undefined,6,NA,NA
2.556,2.823,2.882,2.423,2.6495,2.7725,2.539,2.903,2.9725,Q8CG71,Q8CG71,P3h2,1,134,40,40,Q8CG71,MOUSE,81008.7,59.3,106,106.1,552.53,552.53,NA,703,Prolyl 3-hydroxylase 2,basement membrane|endoplasmic reticulum|Golgi apparatus|,negative regulation of cell proliferation|peptidyl-proline hydroxylation|collagen metabolic process|oxidation-reduction process|,iron ion binding|procollagen-proline 3-dioxygenase activity|L-ascorbic acid binding|,40,134,2.32E+11,0.593,4.49E-06,-0.522,68.97967524,2.707,1.26E-07,23.40023007,-1.6885,-1.81,-2.128,0.807,0.792,0.8955,undefined,9,TRUE,NA
2.616,2.59,2.839,2.422,2.4795,2.6585,2.537,2.617,2.7525,Q61739,Q61739,Itga6,1,153,41,41,Q61739|Q61739-2,MOUSE,123297.6,41.5,118,118.1,533.22,533.22,NA,1091,Integrin alpha-6,basement membrane|plasma membrane|focal adhesion|integrin complex|external side of plasma membrane|basal plasma membrane|cell surface|basolateral plasma membrane|hemidesmosome|basal part of cell|plasma membrane|,cell-matrix adhesion|integrin-mediated signaling pathway|ectodermal cell differentiation|positive regulation of cell-cell adhesion|cell-substrate adhesion|cellular response to extracellular stimulus|cell adhesion mediated by integrin|nail development|positive regulation of phosphorylation|odontogenesis of dentin-containing tooth|positive regulation of apoptotic process|skin development|positive regulation of transcription from RNA polymerase II promoter|filopodium assembly|digestive tract development|brown fat cell differentiation|leukocyte migration|renal system development|amelogenesis|negative regulation of extrinsic apoptotic signaling pathway|,integrin binding|metal ion binding|,41,153,2.41E+11,0.415,1.32E-06,-0.459,85.24555621,2.567666667,2.99E-09,40.37868353,-1.7285,-1.682,-1.818,0.83,0.765,0.8795,undefined,9,TRUE,TRUE
2.74,2.791,2.763,3.006,3.0885,3.0625,3.001,3.039,3.0285,Q6ZQM8,Q6ZQM8,Ugt1a7c,1,359,33,16,Q6ZQM8|D3Z748|D3YZE6|D6RH94,MOUSE,60498.4,71.7,119,119.1,532.87,286,NA,531,UDP-glucuronosyltransferase 1-7C,endoplasmic reticulum membrane|integral component of membrane|intracellular membrane-bounded organelle|,flavonoid biosynthetic process|cellular response to hormone stimulus|flavonoid glucuronidation|xenobiotic glucuronidation|,glucuronosyltransferase activity|,33,359,1.73E+13,0.717,2.19E-06,-0.515833333,78.02931237,2.979333333,1.57E-08,32.11588279,-1.9845,-1.969,-2.063,0.786,1.111,1.0245,undefined,9,TRUE,TRUE
2.328,2.32,2.346,2.208,2.2095,2.2535,2.589,2.561,2.5895,P70691,P70691,Ugt1a2,1,83,25,12,P70691|B2RT14,MOUSE,61026,55.1,119,119.2,410.8,200.07,NA,533,UDP-glucuronosyltransferase 1-2,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|intracellular membrane-bounded organelle|,flavonoid biosynthetic process|cellular response to hormone stimulus|cellular glucuronidation|flavonoid glucuronidation|xenobiotic glucuronidation|,retinoic acid binding|glucuronosyltransferase activity|enzyme binding|protein homodimerization activity|protein heterodimerization activity|,12,83,7.16E+11,0.288,2.19E-06,-0.338333333,77.53095641,2.337,1.77E-08,31.10335896,-1.5455,-1.435,-1.54,0.757,0.776,0.9575,undefined,9,TRUE,TRUE
1.399,1.798,1.34,1.23,1.4485,1.1665,1.627,2.03,1.7195,Q91WH2,Q91WH2,Ugt2b38,1,5,4,3,Q91WH2|Q8VCN3|Q8K169|P17717|Q8BJL9|Q8R084|Q3UEP4,MOUSE,61498.5,8.3,119,119.7,54.31,36.91,NA,530,MCG131371,endoplasmic reticulum|intracellular membrane-bounded organelle|,flavonoid biosynthetic process|cellular response to hormone stimulus|flavonoid glucuronidation|,glucuronosyltransferase activity|,3,5,1.16E+09,0.06,0.000293025,0.019,42.91201857,1.647,5.11E-05,9.20655767,-0.8055,-0.83,-0.778,0.817,0.473,1.2375,undefined,9,TRUE,TRUE
1.343,1.578,1.68,1.202,1.4565,1.5885,1.572,1.78,2.0095,P01132,P01132,Egf,1,111,33,33,P01132|A0A0G2JF92|A0A0G2JDT8|A0A0G2JFB8,MOUSE,136607.2,32,164,164.1,445.4,445.4,NA,1217,Pro-epidermal growth factor,extracellular region|extracellular space|lysosomal membrane|plasma membrane|integral component of membrane|extracellular exosome|,"activation of MAPKK activity|angiogenesis|epidermal growth factor receptor signaling pathway|STAT protein import into nucleus|positive regulation of cell proliferation|positive regulation of peptidyl-threonine phosphorylation|peptidyl-tyrosine phosphorylation|positive regulation of cerebellar granule cell precursor proliferation|positive regulation of catenin import into nucleus|positive regulation of phosphorylation|positive regulation of DNA binding|positive regulation of MAP kinase activity|positive regulation of epidermal growth factor-activated receptor activity|positive regulation of mitotic nuclear division|positive regulation of transcription, DNA-templated|branching morphogenesis of an epithelial tube|regulation of peptidyl-tyrosine phosphorylation|negative regulation of secretion|regulation of protein transport|mammary gland alveolus development|ERK1 and ERK2 cascade|regulation of calcium ion import|negative regulation of cholesterol efflux|positive regulation of hyaluronan biosynthetic process|regulation of protein localization to cell surface|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|",epidermal growth factor receptor binding|calcium ion binding|protein binding|growth factor activity|,33,111,9.86E+10,0.32,9.62E-05,-0.164,48.61844227,1.624333333,1.37E-05,11.34879833,-0.7615,-0.948,-1.219,0.592,0.49,0.8625,undefined,9,TRUE,TRUE
0.802,0.634,1.19,0.608,0.4555,1.0115,0.77,0.597,1.1575,D3Z4J2,D3Z4J2,Katnal2,1,2,3,2,D3Z4J2|Q9D3R6|Q9D3R6-3|D6RGM7|Q9D3R6-2,MOUSE,56216.3,12.1,165,165.2,22.09,10.46,NA,495,Katanin p60 ATPase-containing subunit A-like 2,cytoplasm|microtubule|,metabolic process|cytoplasmic microtubule organization|microtubule severing|,ATP binding|microtubule binding|microtubule-severing ATPase activity|,2,2,1.30E+08,0.096,0.005013828,-0.108333333,28.62229754,0.834333333,0.001373315,5.271976755,-0.4315,-0.26,-0.885,0.373,0.204,0.3495,NC,9,NA,NA
2.012,2.003,2.12,1.835,1.7225,2.0325,2.035,1.951,2.1175,P28825,P28825,Mep1a,1,102,27,27,A0A0R4J043|P28825,MOUSE,85313.7,43.7,190,190.1,412.14,412.14,NA,747,Meprin A subunit alpha,membrane|integral component of membrane|extracellular exosome|,proteolysis|,metalloendopeptidase activity|zinc ion binding|,27,102,1.51E+11,0.437,4.49E-06,-0.299666667,69.01012989,1.974333333,1.26E-07,23.35576411,-1.2685,-1.157,-1.435,0.705,0.617,0.7405,PC,9,TRUE,TRUE
1.687,1.498,1.649,1.705,1.4985,1.6705,1.693,1.578,1.6835,P35822,P35822,Ptprk,1,93,35,35,A0A1W2P7Y1|P35822|B2RRF0|Q68FM4|P28828,MOUSE,166179.6,26.3,202,202.1,405.51,405.51,NA,1457,Receptor-type tyrosine-protein phosphatase kappa,photoreceptor outer segment|cell-cell junction|cell surface|integral component of membrane|axon|dendrite|leading edge membrane|neuronal cell body|,"protein dephosphorylation|cell adhesion|signal transduction|transforming growth factor beta receptor signaling pathway|negative regulation of cell proliferation|negative regulation of keratinocyte proliferation|cell migration|negative regulation of cell migration|protein localization to cell surface|cellular response to reactive oxygen species|cellular response to UV|peptidyl-tyrosine dephosphorylation|negative regulation of cell cycle|negative regulation of transcription, DNA-templated|focal adhesion assembly|",protein tyrosine phosphatase activity|beta-catenin binding|protein kinase binding|gamma-catenin binding|,35,93,9.14E+10,0.263,3.06E-06,-0.1785,72.98633403,1.674,5.03E-08,26.42910704,-1.0635,-0.923,-1.06,0.633,0.703,0.6395,undefined,9,TRUE,TRUE
2.023,2.009,2.236,1.597,1.7135,1.9035,1.992,2.024,2.2815,Q921L8,Q921L8,Galnt11,1,116,27,27,Q921L8,MOUSE,70056,49.6,204,204.1,403.59,403.59,NA,608,Polypeptide N-acetylgalactosaminyltransferase 11,Golgi membrane|integral component of membrane|,Notch receptor processing|determination of left/right symmetry|regulation of Notch signaling pathway|protein O-linked glycosylation via threonine|cilium morphogenesis|Notch signaling involved in heart development|,polypeptide N-acetylgalactosaminyltransferase activity|Notch binding|carbohydrate binding|metal ion binding|,27,116,1.24E+11,0.496,3.91E-05,-0.201,53.22272622,1.995,4.76E-06,13.39783782,-1.0555,-1.045,-1.495,0.911,0.589,0.8895,undefined,9,NA,TRUE
1.187,1.703,0.59,0.829,1.4325,0.1825,1.054,1.564,0.4845,Q8CJ40,Q8CJ40,Crocc,1,50,37,37,Q8CJ40|Q8CJ40-2|Q8CJ40-3,MOUSE,227511.1,21.2,211,211.1,394.74,394.74,NA,2009,Rootletin,photoreceptor inner segment|cytoplasm|centrosome|centriole|plasma membrane|actin cytoskeleton|ciliary rootlet|extracellular exosome|,cell cycle|protein localization|centriole-centriole cohesion|epithelial structure maintenance|cell projection organization|ciliary basal body organization|protein localization to organelle|photoreceptor cell maintenance|centrosome organization|establishment of organelle localization|,actin binding|structural molecule activity|protein binding|kinesin binding|,37,50,1.36E+10,0.212,0.020408812,-0.1885,21.17152837,0.958,0.00763567,3.777871905,-0.7065,-1.175,-0.121,0.415,0.096,0.3605,NC,8,NA,NA
1.759,1.68,1.846,1.623,1.6395,1.6915,1.712,1.735,1.9215,O88307,O88307,Sorl1,1,61,33,33,O88307,MOUSE,252559.2,19.8,215,215.1,390.03,390.03,NA,2215,Sortilin-related receptor,extracellular space|nuclear envelope lumen|endosome|early endosome|endoplasmic reticulum|Golgi apparatus|trans-Golgi network|membrane|integral component of membrane|Golgi cisterna|low-density lipoprotein particle|perinuclear region of cytoplasm|recycling endosome|extracellular exosome|,protein targeting to Golgi|protein targeting|protein targeting to lysosome|lipid transport|post-Golgi vesicle-mediated transport|endocytosis|cholesterol metabolic process|regulation of smooth muscle cell migration|negative regulation of protein binding|negative regulation of protein oligomerization|negative regulation of MAP kinase activity|protein retention in Golgi apparatus|positive regulation of protein catabolic process|negative regulation of neurogenesis|protein maturation|positive regulation of protein exit from endoplasmic reticulum|negative regulation of neuron death|negative regulation of beta-amyloid formation|positive regulation of choline O-acetyltransferase activity|negative regulation of tau-protein kinase activity|positive regulation of ER to Golgi vesicle-mediated transport|positive regulation of early endosome to recycling endosome transport|negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process|negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process|positive regulation of protein localization to early endosome|negative regulation of neurofibrillary tangle assembly|positive regulation of endocytic recycling|,beta-amyloid binding|protein binding|low-density lipoprotein particle binding|ADP-ribosylation factor binding|,33,61,5.05E+09,0.198,1.11E-05,-0.2185,61.33040689,1.756,7.36E-07,17.87632305,-1.0435,-0.953,-1.293,0.622,0.615,0.7415,PC,9,TRUE,TRUE
2.667,2.617,2.607,2.177,2.0755,2.4445,2.675,2.662,2.7485,P56677,P56677,St14,1,76,26,26,P56677|D6RIN3|A0A1L1SU89,MOUSE,96935.4,43.8,222,222.1,382.78,382.78,NA,855,Suppressor of tumorigenicity 14 protein homolog,extracellular region|extracellular space|integral component of plasma membrane|basolateral plasma membrane|extrinsic component of plasma membrane|extracellular exosome|,neural tube closure|proteolysis|cell migration|keratinocyte differentiation|epithelial cell morphogenesis involved in placental branching|,serine-type endopeptidase activity|serine-type peptidase activity|,26,76,5.05E+10,0.438,7.43E-06,-0.291333333,64.1577522,2.468333333,3.84E-07,19.75180436,-1.5435,-1.358,-1.675,1.03,0.713,1.0855,undefined,9,NA,TRUE
2.669,2.682,2.852,2.15,2.2945,2.3965,2.792,2.867,2.9365,Q09324,Q09324,Gcnt1,1,81,28,28,Q09324,MOUSE,50465.4,52.8,244,244.1,365.33,365.33,NA,428,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Golgi membrane|extracellular space|trans-Golgi network|integral component of membrane|Golgi cisterna|,protein glycosylation|glycoprotein biosynthetic process|response to insulin|tissue morphogenesis|leukocyte tethering or rolling|cell adhesion molecule production|kidney morphogenesis|,"beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity|",28,81,6.38E+10,0.528,1.58E-05,-0.302333333,58.59032259,2.619,1.38E-06,16.22325754,-1.4665,-1.536,-1.833,1.113,0.687,1.2215,undefined,9,NA,TRUE
0.851,0.858,0.767,0.765,0.7965,0.7675,0.779,0.877,0.7895,E9PUJ6,E9PUJ6,Mycbp2,1,49,33,33,E9PUJ6|Q7TPH6|Q7TPH6-2,MOUSE,529004.7,8.5,256,256.1,354.75,354.75,NA,4746,E3 ubiquitin-protein ligase MYCBP2,microtubule cytoskeleton|membrane|axon|,motor neuron axon guidance|protein ubiquitination|branchiomotor neuron axon guidance|central nervous system projection neuron axonogenesis|regulation of protein localization|negative regulation of protein catabolic process|cell morphogenesis involved in neuron differentiation|regulation of cytoskeleton organization|,ubiquitin-protein transferase activity|protein binding|zinc ion binding|protein homodimerization activity|,33,49,6.18E+09,0.085,1.62E-05,-0.058,58.38753731,0.825,1.45E-06,15.88280707,-0.4775,-0.496,-0.438,0.34,0.345,0.3785,undefined,9,NA,NA
0.913,0.866,0.953,0.866,0.8335,0.9475,0.882,0.831,0.8705,Q80YQ1,Q80YQ1,Thbs1,1,70,27,27,Q80YQ1|P35441,MOUSE,133681.8,26.8,257,257.1,352.62,352.62,NA,1171,Thrombospondin-1,fibrinogen complex|extracellular space|external side of plasma membrane|cell surface|secretory granule|extracellular matrix|platelet alpha granule|extracellular exosome|extracellular matrix|,activation of MAPK activity|negative regulation of endothelial cell proliferation|negative regulation of cell-matrix adhesion|sprouting angiogenesis|chronic inflammatory response|negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|negative regulation of dendritic cell antigen processing and presentation|outflow tract morphogenesis|endocardial cushion development|growth plate cartilage development|inflammatory response|immune response|cell cycle arrest|cell adhesion|response to glucose|positive regulation of endothelial cell migration|negative regulation of endothelial cell migration|negative regulation of plasma membrane long-chain fatty acid transport|negative regulation of nitric oxide mediated signal transduction|negative regulation of cGMP-mediated signaling|negative regulation of plasminogen activation|positive regulation of fibroblast migration|positive regulation of cell-substrate adhesion|cell migration|negative regulation of angiogenesis|peptide cross-linking|positive regulation of blood coagulation|positive regulation of cell migration|positive regulation of transforming growth factor beta receptor signaling pathway|regulation of cGMP metabolic process|response to magnesium ion|negative regulation of interleukin-12 production|negative regulation of fibroblast growth factor receptor signaling pathway|positive regulation of phosphorylation|response to drug|positive regulation of tumor necrosis factor biosynthetic process|positive regulation of macrophage activation|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of blood vessel endothelial cell migration|negative regulation of blood vessel endothelial cell migration|engulfment of apoptotic cell|positive regulation of translation|positive regulation of angiogenesis|blood vessel morphogenesis|positive regulation of chemotaxis|response to calcium ion|positive regulation of protein kinase B signaling|negative regulation of fibrinolysis|cellular response to nitric oxide|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors|positive regulation of endothelial cell apoptotic process|positive regulation of reactive oxygen species metabolic process|negative regulation of endothelial cell chemotaxis|,phosphatidylserine binding|fibronectin binding|integrin binding|calcium ion binding|heparin binding|fibroblast growth factor binding|low-density lipoprotein particle binding|laminin binding|extracellular matrix binding|fibrinogen binding|collagen V binding|,27,70,1.51E+10,0.268,1.50E-05,-0.0425,59.03477127,0.916,1.25E-06,16.24843532,-0.4605,-0.471,-0.57,0.412,0.409,0.4255,PC,9,TRUE,NA
2.42,2.56,2.752,1.96,2.1395,2.4695,2.504,2.665,2.8445,Q9Z0T9,Q9Z0T9,Itgb6,1,18,12,11,Q9Z0T9|B1AYG6,MOUSE,89349.5,19.3,269,269.2,127.89,116.94,NA,787,Integrin beta-6,integrin complex|external side of plasma membrane|receptor complex|extracellular exosome|,inflammatory response|cell-matrix adhesion|integrin-mediated signaling pathway|,receptor activity|integrin binding|,11,18,2.84E+09,0.193,4.68E-05,-0.386333333,52.30538754,2.407666667,5.88E-06,12.96405734,-1.3335,-1.411,-2.026,0.836,0.684,0.9325,undefined,9,TRUE,TRUE
1.418,1.319,1.604,1.345,1.3465,1.4675,1.379,1.389,1.5885,Q3UP75,Q3UP75,Ugt3a1,1,38,12,9,Q3UP75,MOUSE,59868.5,28.2,271,271.2,198.25,130.82,NA,523,UDP-glucuronosyltransferase 3A1,integral component of membrane|intracellular membrane-bounded organelle|UDP-N-acetylglucosamine transferase complex|,flavonoid biosynthetic process|cellular response to hormone stimulus|flavonoid glucuronidation|cellular response to genistein|,UDP-glycosyltransferase activity|glucuronosyltransferase activity|,9,38,1.45E+11,0.223,1.92E-05,-0.170333333,57.28275611,1.456333333,1.87E-06,15.4870264,-0.8425,-0.756,-1.097,0.582,0.532,0.5595,undefined,9,TRUE,TRUE
0.913,0.96,0.726,1.067,1.1245,0.8835,1.052,1.07,0.8285,O35728,O35728,Cyp4a14,1,103,24,22,O35728|Q91WL5|A2A974|A0A087WS15|F8WGU9|A0A087WPC3,MOUSE,59289.6,45.9,275,275.1,337.11,312.52,NA,507,Cytochrome P450 4A14,endoplasmic reticulum membrane|,oxidation-reduction process|,iron ion binding|alkane 1-monooxygenase activity|heme binding|arachidonic acid omega-hydroxylase activity|,25,103,1.69E+11,0.459,6.42E-05,-0.087333333,50.71317727,0.971666667,8.49E-06,12.15246417,-0.6095,-0.656,-0.454,0.298,0.482,0.4155,undefined,9,NA,TRUE
2.81,2.88,3.209,2.251,2.4575,2.5865,2.65,2.84,3.0885,P09242,P09242,Alpl,1,83,20,20,P09242,MOUSE,57855.5,41.2,293,293.1,323.21,323.21,NA,524,"Alkaline phosphatase, tissue-nonspecific isozyme",proteinaceous extracellular matrix|extracellular space|plasma membrane|membrane|anchored component of membrane|extracellular membrane-bounded organelle|extracellular exosome|,osteoblast differentiation|endochondral ossification|developmental process involved in reproduction|dephosphorylation|response to lipopolysaccharide|response to vitamin D|response to antibiotic|response to glucocorticoid|cellular response to organic cyclic compound|cementum mineralization|,alkaline phosphatase activity|protein binding|pyrophosphatase activity|metal ion binding|,20,83,1.18E+11,0.412,1.92E-05,-0.398666667,57.34072714,2.790333333,1.84E-06,15.51898066,-1.5815,-1.653,-2.147,1.186,0.737,1.0665,undefined,9,TRUE,NA
1.19,1.224,1.349,0.883,0.9125,1.0825,0.987,1.055,1.2515,Q9DBG6,Q9DBG6,Rpn2,1,54,19,19,Q9DBG6|A2ACG7,MOUSE,69175.7,37,325,325.1,301.59,301.59,NA,631,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2,autophagosome membrane|nucleus|endoplasmic reticulum|rough endoplasmic reticulum|oligosaccharyltransferase complex|membrane|integral component of membrane|,protein N-linked glycosylation|aging|response to drug|,"transferase activity, transferring glycosyl groups|ribosome binding|",19,54,9.17E+10,0.37,9.20E-05,-0.051833333,48.88178347,1.067333333,1.29E-05,11.45770992,-0.5135,-0.479,-0.764,0.529,0.385,0.5315,undefined,9,TRUE,TRUE
1.476,1.586,1.565,1.222,1.2695,1.3585,1.362,1.515,1.4935,Q921X9,Q921X9,Pdia5,1,49,21,21,Q921X9|Q2KIL5,MOUSE,60007.8,40.2,371,371.1,279.87,279.87,NA,517,Protein disulfide-isomerase A5,endoplasmic reticulum lumen|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|,protein disulfide isomerase activity|,22,49,5.09E+10,0.402,6.03E-06,-0.1505,65.81356326,1.423333333,2.62E-07,20.59778314,-0.7805,-0.857,-0.949,0.616,0.485,0.5825,undefined,9,TRUE,NA
2.397,2.325,2.599,2.305,2.3065,2.4635,2.359,2.309,2.5005,G5E8G5,G5E8G5,Prom1,1,59,18,18,G5E8G5|G3X9J8|A0A0G2JDH9|Q8CDK8|Q8R056|O54990|O54990-2|O54990-3|O54990-6|A0A0R4J0B0|A0A0G2JE50|O54990-5|O54990-4,MOUSE,98338.7,22.9,386,386.1,275.03,275.03,NA,867,"Prominin 1, isoform CRA_a",extracellular space|endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|plasma membrane|integral component of plasma membrane|microvillus|brush border|cell surface|apical plasma membrane|vesicle|stereocilium|photoreceptor outer segment membrane|cell projection|extracellular exosome|,photoreceptor cell maintenance|retina morphogenesis in camera-type eye|camera-type eye photoreceptor cell differentiation|glomerular visceral epithelial cell differentiation|glomerular parietal epithelial cell differentiation|positive regulation of nephron tubule epithelial cell differentiation|,actinin binding|cadherin binding|,18,59,2.49E+11,0.229,3.74E-06,-0.475166667,70.75820091,2.423333333,8.40E-08,24.90577979,-1.6515,-1.52,-1.889,0.734,0.751,0.7245,undefined,9,TRUE,TRUE
2.282,2.462,2.605,1.872,2.1005,2.1715,2.078,2.234,2.3765,O08912,O08912,Galnt1,1,35,20,20,O08912|Q8CF93-2|Q8CF93,MOUSE,65166.7,39.8,395,395.1,270.49,270.49,NA,559,Polypeptide N-acetylgalactosaminyltransferase 1,extracellular region|membrane|integral component of membrane|Golgi cisterna membrane|perinuclear region of cytoplasm|Golgi apparatus|,protein O-linked glycosylation|protein O-linked glycosylation via serine|protein O-linked glycosylation via threonine|,polypeptide N-acetylgalactosaminyltransferase activity|manganese ion binding|carbohydrate binding|,20,35,1.38E+10,0.398,8.33E-06,-0.333,63.31429868,2.213,4.66E-07,19.17324148,-1.2775,-1.37,-1.671,0.885,0.666,0.7695,PC,9,NA,TRUE
2.507,2.501,2.509,2.584,2.5985,2.7275,2.674,2.678,2.6705,Q9QY96,Q9QY96,Casr,1,71,17,17,Q9QY96|Q9QY96-2,MOUSE,122783.6,20,399,399.1,268.36,268.36,NA,1079,Extracellular calcium-sensing receptor,plasma membrane|integral component of membrane|,G-protein coupled receptor signaling pathway|positive regulation of gene expression|positive regulation of ATPase activity|regulation of calcium ion transport|calcium ion import|,G-protein coupled receptor activity|,17,71,7.29E+10,0.2,4.49E-06,-0.447666667,68.9745487,2.583,1.27E-07,23.39602198,-1.6725,-1.59,-1.955,0.732,0.848,0.9515,undefined,9,TRUE,TRUE
1.5,1.429,1.754,1.114,1.1785,1.3375,1.309,1.379,1.5225,Q91WG0,Q91WG0,Ces2c,1,27,18,9,Q91WG0,MOUSE,62753.8,38.5,402,402.2,266.28,138.17,NA,561,Acylcarnitine hydrolase,endoplasmic reticulum|intracellular membrane-bounded organelle|,metabolic process|,acylcarnitine hydrolase activity|,9,27,3.35E+10,0.215,0.000120163,-0.086,47.43003948,1.461666667,1.81E-05,10.86894811,-0.6895,-0.708,-1.053,0.791,0.43,0.7135,PC,9,TRUE,NA
2.395,2.34,2.214,1.95,1.9175,1.6395,2.687,2.637,2.5655,Q6PDB7,Q6PDB7,Ces2b,1,39,16,6,Q6PDB7,MOUSE,62211.2,41.1,402,402.3,263.72,113.2,NA,556,Carboxylic ester hydrolase,NA,metabolic process|,hydrolase activity|,6,39,7.40E+10,0.215,8.93E-05,-0.086833333,49.05422242,2.429333333,1.24E-05,11.52954381,-1.3075,-1.312,-1.285,1.14,0.665,1.5785,undefined,9,TRUE,NA
0.859,0.96,1.285,0.624,0.7095,1.1155,0.956,1.034,1.3805,Q8K0C4,Q8K0C4,Cyp51a1,1,62,20,20,Q8K0C4,MOUSE,57174,38.7,407,407.1,264.26,264.26,NA,503,Lanosterol 14-alpha demethylase,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|,"steroid biosynthetic process|cholesterol biosynthetic process|cholesterol biosynthetic process via 24,25-dihydrolanosterol|oxidation-reduction process|demethylation|",iron ion binding|sterol 14-demethylase activity|heme binding|,20,62,3.68E+12,0.387,0.001407991,-0.067,34.94902961,0.999666667,0.000319961,6.804452034,-0.3625,-0.453,-0.885,0.445,0.295,0.5585,undefined,9,NA,TRUE
2.16,2.304,2.235,1.82,1.9315,1.9565,2.197,2.262,2.2725,Q91WV7,Q91WV7,Slc3a1,1,60,21,21,Q91WV7,MOUSE,78573,35.4,411,411.1,262.02,262.02,NA,685,Neutral and basic amino acid transport protein rBAT,mitochondrial inner membrane|vacuolar membrane|integral component of plasma membrane|brush border membrane|extracellular exosome|,carbohydrate metabolic process|amino acid transport|,catalytic activity|protein binding|cation binding|protein heterodimerization activity|,21,60,4.88E+10,0.354,6.14E-06,-0.2895,65.59095817,2.125333333,2.76E-07,20.77399717,-1.2245,-1.323,-1.509,0.787,0.628,0.9045,PC,9,NA,TRUE
2.239,2.304,2.376,1.854,1.9495,2.0115,2.227,2.355,2.4165,Q9WTS2,Q9WTS2,Fut8,1,53,20,20,Q9WTS2,MOUSE,67012,34.7,414,414.1,260.54,260.54,NA,575,"Alpha-(1,6)-fucosyltransferase",cytoplasm|membrane|integral component of membrane|Golgi cisterna membrane|extracellular exosome|,protein N-linked glycosylation|transforming growth factor beta receptor signaling pathway|integrin-mediated signaling pathway|respiratory gaseous exchange|cell migration|protein N-linked glycosylation via asparagine|protein glycosylation in Golgi|N-glycan fucosylation|receptor metabolic process|GDP-L-fucose metabolic process|,"glycoprotein 6-alpha-L-fucosyltransferase activity|transferase activity, transferring glycosyl groups|SH3 domain binding|alpha-(1->6)-fucosyltransferase activity|",20,53,4.18E+10,0.347,6.83E-06,-0.2565,64.73609713,2.154666667,3.36E-07,20.15826961,-1.2185,-1.287,-1.496,0.914,0.642,0.9065,undefined,9,NA,TRUE
1.791,1.875,1.863,1.985,2.0095,2.0615,1.834,1.951,1.8905,A0A0R4J0A9,A0A0R4J0A9,Lrp6,1,38,23,22,A0A0R4J0A9|O88572,MOUSE,183329.7,17.4,415,415.1,259.62,244.71,NA,1613,Low-density lipoprotein receptor-related protein,NA,NA,NA,23,38,3.35E+09,0.174,5.08E-06,-0.300833333,67.89408651,1.960666667,1.62E-07,22.52545319,-1.1225,-1.304,-1.417,0.652,0.749,0.6375,PC,9,TRUE,TRUE
2.317,2.428,2.789,2.076,2.2015,2.5435,2.601,2.849,3.1355,P06869,P06869,Plau,1,67,19,19,P06869,MOUSE,49693.4,55.8,427,427.1,256.51,256.51,NA,433,Urokinase-type plasminogen activator,extracellular space|focal adhesion|cell surface|membrane|extracellular exosome|,angiogenesis|response to hypoxia|spermatogenesis|embryo implantation|positive regulation of cell proliferation|regulation of receptor activity|response to activity|smooth muscle cell migration|regulation of smooth muscle cell migration|positive regulation of smooth muscle cell migration|plasminogen activation|regulation of cell adhesion mediated by integrin|cellular response to hepatocyte growth factor stimulus|regulation of cell proliferation|fibrinolysis|skeletal muscle tissue regeneration|response to hyperoxia|positive regulation of ovulation|neuron death|cellular response to lipopolysaccharide|cellular response to glucose stimulus|cellular response to hypoxia|cellular response to fluid shear stress|cellular response to staurosporine|regulation of smooth muscle cell-matrix adhesion|regulation of hepatocyte proliferation|positive regulation of reactive oxygen species metabolic process|,serine-type endopeptidase activity|,19,67,3.45E+10,0.558,2.89E-05,-0.356166667,54.86078314,2.581333333,3.27E-06,14.20647726,-1.4465,-1.494,-2,0.937,0.692,1.1745,PC,9,TRUE,NA
0.771,0.816,0.821,0.694,0.7535,0.8075,0.773,0.785,0.8185,Q9JI78,Q9JI78,Ngly1,1,43,23,23,Q9JI78|A0A286YCI0,MOUSE,75243.7,30.5,436,436.1,253.45,253.45,NA,651,Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase,nucleus|cytoplasm|,glycoprotein catabolic process|,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity|protein binding|metal ion binding|,23,43,6.42E+09,0.305,1.92E-05,-0.039333333,57.28752998,0.780333333,1.87E-06,15.27933802,-0.4135,-0.417,-0.458,0.356,0.333,0.3635,undefined,9,NA,NA
2.194,2.202,2.275,1.986,1.9165,1.9935,2.139,2.086,2.1685,O88338,O88338,Cdh16,1,66,15,15,O88338|Q8C730|Q3TPA4,MOUSE,90257.9,32.6,438,438.1,252.23,252.23,NA,830,Cadherin-16,plasma membrane|integral component of membrane|basolateral plasma membrane|extracellular exosome|,homophilic cell adhesion via plasma membrane adhesion molecules|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|,calcium ion binding|,15,66,2.34E+11,0.326,3.18E-06,-0.283166667,72.35313657,2.244666667,5.82E-08,26.253547,-1.4495,-1.266,-1.501,0.939,0.748,0.8305,undefined,9,TRUE,TRUE
0.807,0.771,0.43,0.327,0.4845,0.0815,0.774,0.772,0.4045,Q6AW69-4,Q6AW69,Cgnl1,1,41,21,20,Q6AW69-4|B2RSU6|Q6AW69-5|Q6AW69|D3Z3H4|Q6AW69-3,MOUSE,148912.6,20.3,445,445.1,250.17,245.04,NA,1298,Isoform 4 of Cingulin-like protein 1,bicellular tight junction|actin cytoskeleton|myosin complex|apical junction complex|,metabolic process|,motor activity|,21,41,5.28E+09,0.203,0.014517371,-0.005333333,22.96624793,0.544333333,0.005050975,4.112875423,-0.3435,-0.42,-0.069,0.395,0.033,0.3725,undefined,6,NA,NA
0.779,0.784,1.253,0.361,0.3805,0.9195,0.699,0.747,1.1895,Q8BLF1,Q8BLF1,Nceh1,1,77,16,16,Q8BLF1|Q8BYQ0,MOUSE,45967,41.6,467,467.1,241.67,241.67,NA,408,Neutral cholesterol ester hydrolase 1,endoplasmic reticulum|membrane|integral component of membrane|,protein dephosphorylation|xenobiotic metabolic process|lipid catabolic process|SMAD protein signal transduction|,serine hydrolase activity|phosphate ion binding|carboxylic ester hydrolase activity|,16,77,1.20E+11,0.416,0.009406677,0.0215,25.31313674,0.788,0.002942296,4.573270233,-0.2075,-0.193,-0.717,0.577,0.17,0.4995,undefined,7,TRUE,TRUE
0.625,0.491,0.963,0.661,0.4745,1.0185,0.747,0.531,1.0225,O54909,O54909,Rdh16,1,37,14,11,O54909|Q8K5C8|E9Q9P8|O88451|Q6PHA1|D6RFQ4|Q9R092,MOUSE,36142.3,47.6,478,478.2,204.42,155.33,NA,317,Cis-retinol androgen dehydrogenase 1,endoplasmic reticulum lumen|integral component of organelle membrane|,9-cis-retinoic acid biosynthetic process|oxidation-reduction process|,retinol dehydrogenase activity|protein homodimerization activity|,11,37,2.04E+10,0.451,0.002258872,-0.060333333,32.59317766,0.744333333,0.000550405,6.200233547,-0.3945,-0.21,-0.693,0.301,0.301,0.3335,undefined,9,NA,NA
0.741,0.608,0.312,0.678,0.5875,0.3095,0.78,0.701,0.4495,P57780,P57780,Actn4,1,32,20,12,A0A1L1SV25|P57780|Q9JI91|O88990,MOUSE,105431.6,24.1,486,486.1,236.68,133.32,NA,912,Alpha-actinin-4,stress fiber|extracellular space|intracellular|nucleus|cytoplasm|cell-cell junction|focal adhesion|Z disc|ribonucleoprotein complex|cortical cytoskeleton|pseudopodium|neuron projection|protein complex|perinuclear region of cytoplasm|extracellular exosome|stress fiber|actin cytoskeleton|,response to hypoxia|protein transport|vesicle transport along actin filament|positive regulation of cell migration|peroxisome proliferator activated receptor signaling pathway|regulation of apoptotic process|retinoic acid receptor signaling pathway|positive regulation of pinocytosis|actin filament bundle assembly|negative regulation of cellular component movement|positive regulation of cellular component movement|bicellular tight junction assembly|negative regulation of substrate adhesion-dependent cell spreading|positive regulation of NIK/NF-kappaB signaling|protein localization to bicellular tight junction|regulation of nucleic acid-templated transcription|,RNA polymerase II regulatory region sequence-specific DNA binding|nucleoside binding|calcium ion binding|protein binding|ligand-dependent nuclear receptor transcription coactivator activity|chromatin DNA binding|nuclear hormone receptor binding|protein homodimerization activity|retinoic acid receptor binding|ion channel binding|poly(A) RNA binding|protein N-terminus binding|actin filament binding|,20,32,3.46E+09,0.241,0.005245974,-0.102166667,28.37578497,0.610666667,0.001453522,5.217735906,-0.5895,-0.465,-0.168,0.144,0.151,0.3145,undefined,7,NA,NA
0.29,0.605,-0.015,0.662,0.4805,0.4055,0.614,0.702,0.4215,Q7TPR4,Q7TPR4,Actn1,1,7,12,4,Q7TPR4|A1BN54,MOUSE,103694.3,15.6,486,486.2,142.64,39.28,NA,892,Alpha-actinin-1,stress fiber|ruffle|extracellular space|intracellular|cytoplasm|plasma membrane|brush border|cell-cell junction|fascia adherens|focal adhesion|Z disc|secretory granule|cortical cytoskeleton|dense core granule membrane|cell projection|extracellular exosome|stress fiber|actin filament|,actin filament organization|platelet formation|cortical cytoskeleton organization|platelet morphogenesis|focal adhesion assembly|actin filament bundle assembly|negative regulation of cellular component movement|actin filament network formation|actin crosslink formation|regulation of nucleic acid-templated transcription|,double-stranded RNA binding|integrin binding|calcium ion binding|protein binding|vinculin binding|ligand-dependent nuclear receptor transcription coactivator activity|protein homodimerization activity|ion channel binding|actin filament binding|,4,7,94700000,0.059,0.029597616,-0.047833333,19.20411994,0.371333333,0.012011244,3.425479467,-0.3325,-0.328,-0.04,-0.015,0.184,0.2445,undefined,7,NA,NA
1.986,1.969,2.125,1.972,1.9335,2.1095,2.015,1.934,2.2275,P23780,P23780,Glb1,1,55,20,19,P23780|A0A1L1SSJ7,MOUSE,73576,31.5,494,494.1,232.76,223.3,NA,647,Beta-galactosidase,cytoplasm|lysosome|Golgi apparatus|extracellular exosome|,galactose catabolic process|cellular carbohydrate metabolic process|,beta-galactosidase activity|galactoside binding|,20,55,6.30E+10,0.315,3.92E-06,-0.341166667,70.44196859,2.082,9.03E-08,24.55632784,-1.3555,-1.244,-1.547,0.718,0.681,0.7005,undefined,9,TRUE,NA
1.828,1.891,1.986,1.713,1.7395,1.9345,1.902,2.045,2.0375,Q8VC60,Q8VC60,Glb1l,1,15,8,7,Q8VC60|Q8VC60-2,MOUSE,73505.7,17,494,494.2,92.25,82.79,NA,646,Beta-galactosidase-1-like protein,extracellular region|,carbohydrate metabolic process|,beta-galactosidase activity|,7,15,4.21E+09,0.151,9.51E-06,-0.2965,62.36267192,1.903333333,5.80E-07,18.54018043,-1.1475,-1.128,-1.469,0.618,0.621,0.7265,PC,9,TRUE,NA
0.543,0.466,0.522,0.505,0.5815,0.5445,0.508,0.574,0.5745,Q8VCM8,Q8VCM8,Ncln,1,48,16,16,Q8VCM8|D3YU17,MOUSE,63135.2,31.6,496,496.1,231.86,231.86,NA,563,Nicalin,endoplasmic reticulum membrane|membrane|integral component of membrane|,regulation of signal transduction|protein destabilization|regulation of protein complex assembly|,NA,16,48,2.86E+10,0.316,0.000145818,-0.0425,46.45178885,0.54,2.26E-05,10.37937695,-0.2865,-0.316,-0.335,0.196,0.239,0.2475,undefined,9,NA,TRUE
1.742,1.516,1.882,1.449,1.5165,1.7165,1.716,1.476,1.9315,E9PZ36,E9PZ36,Pkhd1,1,34,20,20,E9PZ36,MOUSE,450351.1,7.1,505,505.1,229.42,229.42,NA,4059,Polycystic kidney and hepatic disease 1,cytoplasm|centrosome|apical plasma membrane|ciliary basal body|perinuclear region of cytoplasm|extracellular exosome|primary cilium|mitotic spindle|,kidney development|cellular calcium ion homeostasis|positive regulation of cell proliferation|regulation of centrosome duplication|regulation of TOR signaling|negative regulation of NF-kappaB transcription factor activity|cilium assembly|negative regulation of apoptotic process|negative regulation of protein kinase B signaling|regulation of ERK1 and ERK2 cascade|,protein binding|,20,34,2.39E+09,0.071,1.83E-05,-0.194833333,57.74286577,1.656666667,1.68E-06,15.74237991,-0.9695,-0.849,-1.251,0.608,0.636,0.6565,undefined,9,TRUE,TRUE
1.789,1.421,1.967,1.72,1.3775,1.7405,1.717,1.36,1.8835,Q61391,Q61391,Mme,1,37,16,16,Q61391,MOUSE,86385,27.4,520,520.1,226.63,226.63,NA,750,Neprilysin,cytoplasm|plasma membrane|brush border|focal adhesion|synaptic vesicle|membrane|integral component of membrane|axon|dendrite|neuron projection terminus|synapse|extracellular exosome|,kidney development|proteolysis|peptide metabolic process|sensory perception of pain|creatinine metabolic process|beta-amyloid metabolic process|cellular response to cytokine stimulus|cellular response to UV-A|cellular response to UV-B|replicative senescence|,endopeptidase activity|metalloendopeptidase activity|peptidase activity|exopeptidase activity|zinc ion binding|peptide binding|,16,37,6.18E+09,0.274,4.48E-05,-0.248,52.55078941,1.639,5.56E-06,13.07879548,-1.0565,-0.822,-1.324,0.632,0.56,0.5225,PC,9,NA,TRUE
1.019,1.057,1.23,0.797,0.8935,1.0665,1.304,1.22,1.5105,P14094,P14094,Atp1b1,1,79,17,17,P14094,MOUSE,35593.3,44.7,522,522.1,226.01,226.01,NA,304,Sodium/potassium-transporting ATPase subunit beta-1,intracellular|plasma membrane|sodium:potassium-exchanging ATPase complex|caveola|intercalated disc|basolateral plasma membrane|apical plasma membrane|sarcolemma|myelin sheath|extracellular exosome|extracellular vesicle|,response to hypoxia|positive regulation of defense response to virus by host|cellular calcium ion homeostasis|cellular sodium ion homeostasis|cell adhesion|potassium ion import|regulation of gene expression|regulation of cardiac muscle contraction by calcium ion signaling|cellular potassium ion homeostasis|positive regulation of ATPase activity|sodium ion export from cell|protein stabilization|relaxation of cardiac muscle|cardiac muscle contraction|protein localization to plasma membrane|membrane repolarization|activation of mitophagy in response to mitochondrial depolarization|positive regulation of potassium ion transmembrane transporter activity|regulation of calcium ion transmembrane transport|positive regulation of sodium ion export from cell|positive regulation of calcium:sodium antiporter activity|positive regulation of potassium ion import|,ATPase activator activity|protein binding|protein C-terminus binding|MHC class II protein complex binding|ATPase binding|sodium:potassium-exchanging ATPase activity|,17,79,1.92E+11,0.447,0.000266002,-0.0375,43.43282149,1.134,4.54E-05,9.385928442,-0.5005,-0.516,-0.797,0.492,0.37,0.7265,undefined,9,NA,TRUE
2.345,2.44,2.65,2.06,2.1375,2.3295,2.517,2.532,2.6855,Q60928,Q60928,Ggt1,1,42,16,16,Q60928,MOUSE,61903.8,30.8,549,549.1,219.6,219.6,NA,568,Glutathione hydrolase 1 proenzyme,extracellular space|plasma membrane|integral component of plasma membrane|membrane-bounded vesicle|extracellular exosome|,regulation of immune system process|glutamate metabolic process|glutathione metabolic process|glutathione biosynthetic process|glutathione catabolic process|spermatogenesis|cysteine biosynthetic process|leukotriene biosynthetic process|zymogen activation|regulation of inflammatory response|lung connective tissue development|cellular response to mechanical stimulus|,gamma-glutamyltransferase activity|glutathione hydrolase activity|,16,42,2.12E+10,0.308,5.66E-06,-0.3235,66.69482825,2.360666667,2.14E-07,21.59621354,-1.4235,-1.431,-1.657,0.865,0.68,1.0255,undefined,9,NA,TRUE
1.683,1.876,1.703,1.495,1.6015,1.4335,1.426,1.637,1.4555,M0QWP1,M0QWP1,Agrn,1,26,16,16,M0QWP1|A2ASQ1|A2ASQ1-2|Z4YK85|A2ASQ1-3|Z4YJS5,MOUSE,224746.9,13.6,552,552.1,219.12,219.12,NA,2034,Agrin,basement membrane|basal lamina|extracellular space|cytoplasm|plasma membrane|cell surface|extracellular matrix|synapse|extracellular exosome|extracellular matrix|,plasma membrane organization|G-protein coupled acetylcholine receptor signaling pathway|synaptic transmission|neuromuscular junction development|regulation of synaptic growth at neuromuscular junction|regulation of receptor activity|receptor clustering|positive regulation of neuron apoptotic process|neurotransmitter receptor metabolic process|positive regulation of transcription from RNA polymerase II promoter|,acetylcholine receptor regulator activity|laminin binding|,16,26,1.87E+09,0.136,7.94E-06,-0.136,63.72425635,1.775,4.24E-07,19.45236726,-0.9605,-1.062,-1.048,0.91,0.585,0.7595,PC,9,TRUE,NA
1.414,1.994,0.893,1.497,1.9785,0.9605,1.667,2.25,1.0995,Q60605-2,Q60605,Myl6,1,96,14,1,Q60605-2|A0A1W2P7Q9|A0A1W2P6F6|A0A1W2P6G5|P09542|P05977|E9PWG4|P05977-2|A0A0G2JDM3|A0A087WRZ7|Q8CI43,MOUSE,17132,88,556,556.1,217.71,20.07,NA,151,Isoform Smooth muscle of Myosin light polypeptide 6,brush border|membrane|myosin complex|unconventional myosin complex|vesicle|extracellular exosome|,muscle contraction|skeletal muscle tissue development|muscle filament sliding|,motor activity|calcium ion binding|protein binding|structural constituent of muscle|actin-dependent ATPase activity|,14,96,8.30E+11,0.88,0.001950182,-0.272,33.32999106,1.531,0.000464516,6.384634239,-1.0375,-1.545,-0.53,0.372,0.48,0.6285,undefined,9,NA,NA
0.859,0.915,0.93,0.646,0.6865,0.7095,0.644,0.703,0.6845,Q91VW5,Q91VW5,Golga4,1,24,21,21,Q91VW5,MOUSE,258985.5,11.7,557,557.1,217.46,217.46,NA,2238,Golgin subfamily A member 4,Golgi membrane|nucleoplasm|cytoplasm|Golgi apparatus|intracellular membrane-bounded organelle|extracellular exosome|,protein targeting to Golgi|Golgi to plasma membrane protein transport|positive regulation of axon extension|,GTPase binding|,21,24,1.63E+09,0.117,0.000200403,-0.017666667,44.84327965,0.754333333,3.28E-05,9.825598219,-0.3545,-0.389,-0.441,0.502,0.304,0.2725,undefined,9,NA,NA
2.458,2.518,2.67,2.287,2.3455,2.5565,2.418,2.523,2.6645,P70419,P70419,Galnt3,1,60,17,17,P70419|Q8C7U7,MOUSE,73786.3,37.1,582,582.1,212.59,212.59,NA,633,Polypeptide N-acetylgalactosaminyltransferase 3,integral component of membrane|Golgi cisterna membrane|perinuclear region of cytoplasm|extracellular exosome|Golgi apparatus|,protein O-linked glycosylation via serine|protein O-linked glycosylation via threonine|,polypeptide N-acetylgalactosaminyltransferase activity|calcium ion binding|manganese ion binding|carbohydrate binding|,17,60,8.30E+10,0.371,6.03E-06,-0.458333333,66.01654303,2.499,2.50E-07,21.08731613,-1.5485,-1.596,-1.979,0.822,0.737,0.8145,undefined,9,NA,TRUE
1.201,1.232,1.199,1.29,1.2265,1.1365,1.352,1.312,1.2755,A2A8L5,A2A8L5,Ptprf,1,28,19,16,A2A8L5|B0V2N1|B0V2N1-2|B0V2N1-6|B0V2N1-3|B0V2N1-4|B0V2N1-5,MOUSE,212569.5,13.3,589,589.1,210.51,169.09,NA,1898,Receptor-type tyrosine-protein phosphatase F,integral component of membrane|neuron projection|neuronal cell body|extracellular exosome|,cell adhesion|regulation of neuron projection development|cell migration|neuron projection regeneration|peptidyl-tyrosine dephosphorylation|regulation of axon regeneration|negative regulation of receptor binding|,phosphoprotein phosphatase activity|protein tyrosine phosphatase activity|heparin binding|protein complex binding|chondroitin sulfate proteoglycan binding|,19,28,2.73E+09,0.133,7.94E-06,-0.102833333,63.7134111,1.257333333,4.25E-07,19.1423532,-0.6725,-0.698,-0.824,0.47,0.531,0.5765,undefined,9,TRUE,TRUE
0.715,0.554,0.44,0.715,0.5695,0.4555,0.481,0.316,0.2075,Q64487,Q64487,Ptprd,1,6,7,4,Q64487|Q64487-6|Q64487-5|Q64487-8|Q64487-7|Q64487-10|Q64487-9|Q64487-11|Q64487-1|G3UY75|Q64487-3|B9EJA3|E9PVW8|G3UWK6|E9Q7I7|G3UX60|Q64487-12|G3UYU6|Q64487-2|Q5SPA9,MOUSE,215603.8,5.3,589,589.2,68.24,26.82,NA,1912,Receptor-type tyrosine-protein phosphatase delta,integral component of membrane|,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|neuron differentiation|peptidyl-tyrosine dephosphorylation|negative regulation of JAK-STAT cascade|positive regulation of dendrite morphogenesis|regulation of immune response|presynaptic membrane assembly|,protein tyrosine phosphatase activity|receptor binding|protein binding|cell adhesion molecule binding|,4,6,4.01E+09,0.037,0.002543204,-0.028833333,32.00700078,0.542666667,0.000629941,6.056384976,-0.4285,-0.266,-0.206,0.296,0.328,0.1035,undefined,6,TRUE,TRUE
1.669,1.829,1.773,1.463,1.4635,1.5145,1.67,1.74,1.7615,Q80VA0,Q80VA0,Galnt7,1,30,18,1,Q80VA0,MOUSE,76102.4,33.6,605,605.1,207.72,18.91,NA,657,N-acetylgalactosaminyltransferase 7,Golgi membrane|membrane|integral component of membrane|extracellular exosome|,protein O-linked glycosylation|,polypeptide N-acetylgalactosaminyltransferase activity|carbohydrate binding|metal ion binding|,18,30,7.12E+09,0.336,6.03E-06,-0.175333333,65.69954305,1.689666667,2.69E-07,20.66412535,-0.9855,-0.968,-1.107,0.716,0.528,0.7645,PC,9,NA,TRUE
1.868,1.584,1.58,1.968,1.7515,1.7245,1.597,1.429,1.3945,O35409,O35409,Folh1,1,41,16,16,O35409|Q0VDM6|G3UWC2|Q9CZR2,MOUSE,84743.7,24.3,606,606.1,207.48,207.48,NA,752,Glutamate carboxypeptidase 2,integral component of plasma membrane|integral component of membrane|extracellular exosome|,proteolysis|folic acid-containing compound metabolic process|,carboxypeptidase activity|peptidase activity|metallopeptidase activity|dipeptidase activity|metal ion binding|,16,41,2.43E+10,0.243,2.43E-05,-0.160666667,55.84989417,1.651666667,2.60E-06,14.71681571,-1.0985,-0.875,-0.986,0.645,0.87,0.4805,undefined,9,NA,TRUE
1.611,1.848,1.961,1.418,1.8935,1.8925,2.265,2.599,2.6515,Q917,Q917,Umod,1,50,16,16,Q917,MOUSE,73582.4,28.1,610,610.1,206.91,206.91,NA,642,Uromodulin,spindle pole|basolateral plasma membrane|apical plasma membrane|anchored component of membrane|ciliary membrane|extracellular exosome|primary cilium|,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|leukocyte cell-cell adhesion|excretion|chemical homeostasis|metanephric ascending thin limb development|metanephric distal convoluted tubule development|metanephric thick ascending limb development|neutrophil migration|regulation of ion homeostasis|,calcium ion binding|IgG binding|,16,50,4.88E+10,0.281,0.000290296,-0.166333333,42.95982907,2.011666667,5.06E-05,9.222898329,-0.9125,-1.156,-1.448,0.646,0.583,1.2895,PC,9,NA,NA
1.918,1.855,1.816,1.849,1.7745,1.7005,1.683,1.624,1.6355,P16406,P16406,Enpep,1,31,18,18,P16406,MOUSE,108467.9,21.4,612,612.1,206.04,206.04,NA,945,Glutamyl aminopeptidase,lysosomal membrane|plasma membrane|brush border|external side of plasma membrane|integral component of membrane|apical plasma membrane|cytoplasmic vesicle|apical part of cell|extracellular exosome|,angiogenesis|regulation of systemic arterial blood pressure by renin-angiotensin|proteolysis|cell proliferation|cell migration|glomerulus development|,aminopeptidase activity|peptidase activity|metallopeptidase activity|zinc ion binding|metalloaminopeptidase activity|,18,31,3.55E+09,0.214,3.97E-06,-0.299833333,70.3372199,1.780666667,9.25E-08,24.22543151,-1.2065,-1.098,-1.266,0.628,0.653,0.4905,undefined,9,NA,TRUE
1.994,2.067,1.885,1.357,1.3525,1.2255,1.933,2.028,1.7385,O89017,O89017,Lgmn,1,57,14,14,O89017,MOUSE,49771.5,33.5,638,638.1,200.92,200.92,NA,435,Legumain,lysosome|late endosome|apical part of cell|extracellular exosome|,renal system process|proteolysis|response to acidic pH|receptor catabolic process|negative regulation of multicellular organism growth|negative regulation of neuron apoptotic process|proteolysis involved in cellular protein catabolic process|negative regulation of ERBB signaling pathway|,cysteine-type endopeptidase activity|peptidase activity|,14,57,6.11E+10,0.335,5.78E-05,-0.054,51.23464086,1.663666667,7.53E-06,12.47431485,-0.9245,-0.896,-0.837,0.961,0.464,0.9085,undefined,9,TRUE,NA
1.572,1.511,1.554,1.418,1.3965,1.5165,1.514,1.42,1.5475,A0A1L1SSC7,A0A1L1SSC7,Ttc13,1,36,16,16,A0A1L1SSC7|E9Q723|D3YVV0|Q3UMK4,MOUSE,95830,23.5,651,651.1,197.28,197.28,NA,844,Tetratricopeptide repeat domain 13,NA,NA,NA,16,36,1.82E+10,0.235,5.29E-06,-0.188,67.40864927,1.505666667,1.82E-07,21.77452515,-0.9195,-0.852,-1.051,0.61,0.539,0.5455,undefined,9,TRUE,NA
2.14,2.224,2.263,2.061,2.1995,2.3315,2.444,2.483,2.4685,O35082,O35082,Kl,1,42,16,16,O35082|O35082-2,MOUSE,117080.4,15,657,657.1,196.63,196.63,NA,1014,Klotho,extracellular region|extracellular space|plasma membrane|integral component of membrane|extracellular exosome|,acute inflammatory response|carbohydrate metabolic process|energy reserve metabolic process|aging|insulin receptor signaling pathway|positive regulation of bone mineralization|calcium ion homeostasis|positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway|,beta-glucuronidase activity|signal transducer activity|fibroblast growth factor receptor binding|protein binding|fibroblast growth factor binding|,16,42,7.41E+10,0.15,7.24E-06,-0.392,64.38466022,2.345,3.64E-07,19.91031936,-1.4285,-1.491,-1.774,0.667,0.721,0.9535,PC,9,TRUE,TRUE
1.955,2.249,2.23,1.643,1.8775,2.0205,1.92,2.01,2.1065,O35598,O35598,Adam10,1,44,16,16,O35598|E9PYF2,MOUSE,86020.6,29.5,665,665.1,194.39,194.39,NA,749,Disintegrin and metalloproteinase domain-containing protein 10,nucleus|cytoplasm|Golgi apparatus|Golgi-associated vesicle|plasma membrane|focal adhesion|cell surface|postsynaptic density|membrane|integral component of membrane|intracellular membrane-bounded organelle|extracellular exosome|perinuclear endoplasmic reticulum|tetraspanin-enriched microdomain|,in utero embryonic development|protein phosphorylation|membrane protein ectodomain proteolysis|nucleocytoplasmic transport|negative regulation of cell adhesion|Notch signaling pathway|Notch receptor processing|positive regulation of cell proliferation|positive regulation of T cell chemotaxis|positive regulation of cell growth|positive regulation of cell migration|response to tumor necrosis factor|monocyte activation|PMA-inducible membrane protein ectodomain proteolysis|constitutive protein ectodomain proteolysis|,endopeptidase activity|metalloendopeptidase activity|protein binding|metallopeptidase activity|zinc ion binding|SH3 domain binding|protein kinase binding|SH2 domain binding|protein homodimerization activity|,16,44,5.33E+09,0.295,1.02E-05,-0.238833333,61.80248789,2.020666667,6.60E-07,18.1770238,-1.0905,-1.231,-1.426,0.883,0.607,0.8245,PC,9,TRUE,TRUE
1.014,1.135,-0.273,0.311,0.5265,-0.9955,0.426,0.666,-0.8515,G3X8T9,G3X8T9,Serpina3n,1,3,3,2,G3X8T9|Q91WP6,MOUSE,46936.4,10.2,685,685.2,29.39,16.49,NA,418,"Serine (Or cysteine) peptidase inhibitor, clade A, member 3N, isoform CRA_a",extracellular region|extracellular space|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,2,3,34400000,0.066,0.735529637,0.002166667,1.748425454,0.178666667,0.668586271,0.447752515,-0.4655,-0.663,0.867,0.426,-0.137,-0.0145,PC,5,TRUE,NA
0.628,0.407,0.677,0.503,0.2825,0.4915,0.584,0.346,0.5595,Q62433,Q62433,Ndrg1,1,94,12,12,Q62433|E9Q7V2|E9Q7G8|E9PZC7|E9Q0J8,MOUSE,43464.4,52,687,687.1,188.95,188.95,NA,394,Protein NDRG1,nucleus|cytoplasm|centrosome|cytosol|microtubule|plasma membrane|cell-cell adherens junction|microtubule cytoskeleton|myelin sheath|perinuclear region of cytoplasm|recycling endosome membrane|extracellular exosome|,"signal transduction|negative regulation of cell proliferation|DNA damage response, signal transduction by p53 class mediator|peripheral nervous system myelin maintenance|mast cell activation|cellular response to hypoxia|positive regulation of spindle checkpoint|",microtubule binding|Rab GTPase binding|gamma-tubulin binding|cadherin binding|,12,94,2.95E+11,0.52,0.002544696,0.030666667,31.99940631,0.512333333,0.000631044,6.047939051,-0.3175,-0.086,-0.273,0.373,0.188,0.2995,undefined,6,NA,NA
1.663,1.619,1.865,1.557,1.5585,1.8235,1.822,1.756,2.0225,F8VQL0,F8VQL0,Met,1,22,14,14,F8VQL0|P16056,MOUSE,155882,14.3,689,689.1,188.55,188.55,NA,1379,Hepatocyte growth factor receptor,basal plasma membrane|cell surface|membrane|integral component of membrane|,activation of MAPK activity|endothelial cell morphogenesis|liver development|placenta development|brain development|muscle organ development|skeletal muscle tissue development|positive regulation of glucose transport|muscle cell migration|myotube differentiation|peptidyl-tyrosine phosphorylation|adult behavior|glucose homeostasis|positive regulation of transcription from RNA polymerase II promoter|protein autophosphorylation|hepatocyte growth factor receptor signaling pathway|branching morphogenesis of an epithelial tube|positive chemotaxis|myoblast proliferation|regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling|semaphorin-plexin signaling pathway|negative regulation of hydrogen peroxide-mediated programmed cell death|positive regulation of endothelial cell chemotaxis|,protein kinase activity|hepatocyte growth factor-activated receptor activity|ATP binding|protein phosphatase binding|,14,22,1.68E+09,0.143,1.50E-05,-0.235666667,58.97365013,1.830333333,1.27E-06,16.44535535,-1.0895,-0.985,-1.378,0.591,0.675,0.7725,undefined,9,TRUE,TRUE
1.972,2.142,2.187,1.617,1.7965,1.7765,1.948,2.139,2.1925,Q9WUR0,Q9WUR0,Tinag,1,29,15,15,Q9WUR0|V9GXH5,MOUSE,55696.4,38.1,692,692.1,187.74,187.74,NA,475,Tubulo-interstitial nephritis antigen,basement membrane|extracellular space|lysosome|,receptor-mediated endocytosis|immune response|cell adhesion|proteolysis involved in cellular protein catabolic process|,scavenger receptor activity|polysaccharide binding|cysteine-type endopeptidase activity|,15,29,8.79E+09,0.381,1.22E-05,-0.2495,60.70594116,2.044666667,8.50E-07,17.48591699,-1.1165,-1.248,-1.451,0.849,0.582,0.8875,undefined,9,TRUE,NA
0.949,1.173,1.097,0.985,1.1535,1.1385,1.011,1.133,1.0665,Q8VHE0,Q8VHE0,Sec63,1,31,13,13,Q8VHE0,MOUSE,88267.8,20.6,731,731.1,178.54,178.54,NA,760,Translocation protein SEC63 homolog,endoplasmic reticulum membrane|membrane|integral component of membrane|,"liver development|SRP-dependent cotranslational protein targeting to membrane|posttranslational protein targeting to membrane|nitrogen compound metabolic process|multicellular organismal aging|posttranslational protein targeting to membrane, translocation|renal system development|",protein transporter activity|poly(A) RNA binding|,13,31,1.40E+10,0.206,1.19E-05,-0.118333333,60.85081475,1.093666667,8.22E-07,17.31786482,-0.5675,-0.701,-0.727,0.41,0.423,0.4525,undefined,9,NA,TRUE
2.76,2.543,2.973,2.366,2.3115,2.6555,2.747,2.605,3.0285,Q9R097,Q9R097,Spint1,1,23,15,15,Q9R097,MOUSE,58358.6,33.3,735,735.1,177.67,177.67,NA,507,Kunitz-type protease inhibitor 1,extracellular space|plasma membrane|extracellular exosome|,neural tube closure|embryonic placenta development|negative regulation of endopeptidase activity|extracellular matrix organization|branching involved in labyrinthine layer morphogenesis|placenta blood vessel development|,serine-type endopeptidase inhibitor activity|,15,23,4.43E+09,0.333,1.92E-05,-0.456166667,57.28653122,2.682,1.87E-06,15.48910537,-1.6775,-1.532,-2.182,0.901,0.733,1.0205,PC,9,TRUE,TRUE
2.293,2.132,2.505,2.056,1.9755,2.2455,2.314,2.169,2.5595,P97449,P97449,Anpep,1,26,14,14,P97449,MOUSE,110105.6,15.8,754,754.1,173.15,173.15,NA,966,Aminopeptidase N,extracellular space|lysosomal membrane|endoplasmic reticulum-Golgi intermediate compartment|external side of plasma membrane|integral component of membrane|extracellular exosome|,angiogenesis|proteolysis|cell differentiation|,aminopeptidase activity|metallopeptidase activity|zinc ion binding|,14,26,1.98E+10,0.158,1.35E-05,-0.356666667,59.82852568,2.269,1.04E-06,16.95120696,-1.4205,-1.271,-1.782,0.86,0.681,0.7925,undefined,9,NA,TRUE
1.802,1.926,2.159,1.558,1.7555,1.8835,1.895,2.101,2.2805,B8JJN0,B8JJN0,Gm20547,1,28,15,15,B8JJN0|B8JJM5|P04186|B8JJM6|F6XQ00|P21180|P21180-2|B8JJN2|B8JJM9,MOUSE,144605,13.7,791,791.1,166.63,166.63,NA,1276,Predicted gene 20547,NA,proteolysis|,serine-type endopeptidase activity|,15,28,3.28E+09,0.137,2.31E-05,-0.193333333,56.12736922,1.971,2.44E-06,14.8630686,-1.0085,-1.139,-1.389,0.821,0.584,0.9715,undefined,9,TRUE,NA
2.21,2.286,2.537,2.005,2.1245,2.3655,2.199,2.271,2.4405,Q9ESG4,Q9ESG4,Tmem27,1,48,10,10,Q9ESG4,MOUSE,25354.8,34.2,798,798.1,165.85,165.85,NA,222,Collectrin,cytoplasm|integral component of membrane|brush border membrane|extracellular exosome|,proteolysis|positive regulation of SNARE complex assembly|positive regulation of insulin secretion involved in cellular response to glucose stimulus|positive regulation of calcium ion-dependent exocytosis|positive regulation of amino acid transport|,protein binding|metallopeptidase activity|peptidyl-dipeptidase activity|,10,48,2.87E+11,0.342,3.02E-06,-0.303833333,73.1253471,2.156,4.87E-08,26.74114074,-1.2415,-1.397,-1.507,0.767,0.727,0.8285,undefined,9,TRUE,TRUE
1.879,1.923,1.818,1.762,1.6945,1.8795,1.699,1.75,1.6685,Q5RKT9,Q5RKT9,Mgat3,1,20,13,13,Q5RKT9|Q10470,MOUSE,62620.1,31.7,822,822.1,162.16,162.16,NA,538,"Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase",membrane|,protein N-linked glycosylation|,"beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity|",13,20,4.69E+09,0.317,3.57E-06,-0.273666667,71.37484094,1.771666667,7.29E-08,24.99240082,-1.1505,-1.057,-1.271,0.635,0.634,0.5675,undefined,9,NA,TRUE
2.02,2.05,2.131,1.729,1.6845,1.8655,2.135,2.157,2.3395,Q61592,Q61592,Gas6,1,30,16,16,Q61592,MOUSE,76548.1,28.1,826,826.1,161.82,161.82,NA,674,Growth arrest-specific protein 6,extracellular space|cytoplasm|extracellular exosome|,"neuron migration|positive regulation of protein phosphorylation|positive regulation of cytokine-mediated signaling pathway|positive regulation of glomerular filtration|protein phosphorylation|phagocytosis|signal transduction|enzyme linked receptor protein signaling pathway|blood coagulation|cellular response to starvation|positive regulation of gene expression|negative regulation of tumor necrosis factor-mediated signaling pathway|macrophage cytokine production|peptidyl-serine phosphorylation|fusion of virus membrane with host plasma membrane|viral genome replication|organ regeneration|cell-substrate adhesion|positive regulation of TOR signaling|activation of protein kinase B activity|negative regulation of interferon-gamma production|negative regulation of interleukin-6 production|negative regulation of tumor necrosis factor production|positive regulation of natural killer cell differentiation|positive regulation of peptidyl-serine phosphorylation|negative regulation of protein import into nucleus, translocation|cellular response to interferon-alpha|cellular response to drug|B cell chemotaxis|regulation of growth|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|apoptotic cell clearance|negative regulation of sequence-specific DNA binding transcription factor activity|protein kinase B signaling|positive regulation of protein kinase activity|negative regulation of transcription, DNA-templated|viral entry into host cell|receptor-mediated virion attachment to host cell|positive regulation of protein export from nucleus|positive regulation of fibroblast proliferation|negative regulation of interleukin-1 secretion|positive regulation of phagocytosis|positive regulation of protein kinase B signaling|positive regulation of protein tyrosine kinase activity|negative regulation of biomineral tissue development|positive regulation of ERK1 and ERK2 cascade|calcium ion transmembrane transport|cellular response to vitamin K|cellular response to glucose stimulus|cellular response to growth factor stimulus|protein targeting to plasma membrane|extracellular matrix assembly|dendritic cell differentiation|hematopoietic stem cell migration to bone marrow|negative regulation of oligodendrocyte apoptotic process|negative regulation of interleukin-6 secretion|negative regulation of fibroblast apoptotic process|negative regulation of endothelial cell apoptotic process|positive regulation of dendritic cell chemotaxis|negative regulation of renal albumin absorption|negative regulation of dendritic cell apoptotic process|","phosphatidylserine binding|receptor binding|voltage-gated calcium channel activity|calcium ion binding|protein tyrosine kinase activator activity|receptor tyrosine kinase binding|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|receptor agonist activity|binding, bridging|",16,30,4.01E+09,0.281,2.12E-05,-0.217333333,56.63429009,2.047666667,2.17E-06,15.13382688,-1.1595,-1.098,-1.466,0.784,0.618,1.0175,PC,9,TRUE,NA
1.793,1.565,1.603,1.531,1.4035,1.3675,1.71,1.581,1.5485,Q920A5,Q920A5,Scpep1,1,37,13,13,Q920A5,MOUSE,51249,28.7,831,831.1,161.21,161.21,NA,452,Retinoid-inducible serine carboxypeptidase,cytosol|extracellular exosome|,proteolysis|retinoic acid metabolic process|negative regulation of blood pressure|positive regulation of vasodilation|,NA,13,37,3.29E+10,0.287,4.51E-06,-0.179333333,68.91086555,1.566333333,1.29E-07,22.94255893,-1.0425,-0.876,-0.969,0.652,0.53,0.6295,PC,9,TRUE,TRUE
0.84,0.744,0.609,0.818,0.7375,0.6025,0.748,0.648,0.5175,Q8R4U6,Q8R4U6,Top1mt,1,3,5,3,Q8R4U6,MOUSE,69743.8,9.7,844,844.2,37.21,18.58,NA,593,"DNA topoisomerase I, mitochondrial",nucleus|mitochondrion|mitochondrial nucleoid|nucleolus|replication fork protection complex|,DNA replication|DNA topological change|chromatin remodeling|chromosome segregation|,DNA binding|DNA topoisomerase type I activity|DNA topoisomerase type II (ATP-hydrolyzing) activity|,3,3,3.04E+09,0.06,0.000234722,-0.097166667,44.06525998,0.711333333,3.92E-05,9.540308689,-0.5625,-0.459,-0.337,0.281,0.298,0.1965,NC,9,NA,NA
1.037,1.005,1.24,0.959,0.8925,1.1505,1.169,1.097,1.2605,Q80TN4,Q80TN4,Dnajc16,1,24,14,14,Q80TN4,MOUSE,89533.5,25.2,861,861.1,156.14,156.14,NA,772,DnaJ homolog subfamily C member 16,cell|integral component of membrane|,cell redox homeostasis|,NA,14,24,2.01E+09,0.252,2.87E-05,-0.0725,54.91945605,1.12,3.22E-06,14.1206897,-0.6135,-0.544,-0.74,0.457,0.409,0.5965,undefined,9,TRUE,TRUE
0.465,0.323,0.607,0.328,0.2925,0.5285,0.481,0.405,0.6315,E9Q9B7,E9Q9B7,Kidins220,1,20,14,14,E9Q9B7|A0A1Y7VME9|A0A1Y7VMH7,MOUSE,200835.2,10.3,864,864.1,155.88,155.88,NA,1793,Kinase D-interacting substrate 220,nucleoplasm|membrane|,in utero embryonic development|nerve growth factor signaling pathway|regulation of protein kinase activity|dendrite morphogenesis|,protein kinase regulator activity|PDZ domain binding|,14,20,2.97E+09,0.103,0.00336364,-0.005833333,30.64380215,0.454666667,0.000862223,5.709543269,-0.1735,-0.143,-0.383,0.188,0.197,0.2795,undefined,5,NA,TRUE
0.566,0.607,0.564,0.538,0.5095,0.5245,0.489,0.482,0.4855,Q923I7,Q923I7,Slc5a2,1,64,12,11,Q923I7|A0A0U1RNI8|A0A0U1RNT9,MOUSE,73976.7,15.9,870,870.1,155.26,146.4,NA,670,Sodium/glucose cotransporter 2,integral component of membrane|brush border membrane|extracellular exosome|,sodium ion transport|glucose transport|transmembrane transport|,glucose:sodium symporter activity|protein binding|,12,64,1.40E+11,0.159,0.000190821,-0.027333333,45.07136095,0.517666667,3.11E-05,9.871351234,-0.2965,-0.263,-0.299,0.26,0.241,0.1935,undefined,9,NA,TRUE
2.061,2.234,2.181,1.761,1.6215,1.8895,2.293,2.458,2.6455,E9Q5D9,E9Q5D9,Igfbp7,1,27,11,11,E9Q5D9|F8WH23|Q61581,MOUSE,33887.1,40.2,879,879.1,153.25,153.25,NA,313,Insulin-like growth factor-binding protein 7,extracellular space|extracellular matrix|extracellular exosome|,regulation of cell growth|cell adhesion|,insulin-like growth factor binding|,11,27,7.79E+09,0.402,6.19E-05,-0.0965,50.91193671,2.128666667,8.11E-06,12.3301212,-1.1715,-1.015,-1.296,0.977,0.622,1.3045,PC,9,TRUE,NA
1.953,2.119,2.243,1.205,1.3645,1.4715,2.208,2.34,2.5465,Q91V88,Q91V88,Npnt,1,23,10,10,Q91V88|D3Z4D3|Q91V88-3|Q91V88-2|Q91V88-4|D3YT,MOUSE,63657.2,23.7,882,882.1,152.39,152.39,NA,561,Nephronectin,extracellular region|proteinaceous extracellular matrix|basement membrane|smooth muscle contractile fiber|extracellular matrix|extracellular exosome|integrin alpha8-beta1 complex|,ureteric bud development|branching involved in ureteric bud morphogenesis|cell-matrix adhesion|positive regulation of alkaline phosphatase activity|positive regulation of cell-substrate adhesion|extracellular matrix organization|positive regulation of transforming growth factor beta receptor signaling pathway|cell-cell adhesion mediated by integrin|establishment of protein localization|positive regulation of osteoblast differentiation|positive regulation of smooth muscle contraction|positive regulation of ERK1 and ERK2 cascade|cellular response to tumor necrosis factor|pilomotor reflex|positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation|,integrin binding|calcium ion binding|,10,23,3.99E+09,0.237,0.000939818,0.043166667,36.87866755,1.935333333,0.000205179,7.33266446,-0.7155,-0.848,-1.21,1.139,0.44,1.4535,PC,9,TRUE,NA
1.65,1.839,1.851,1.662,1.7015,1.7605,1.834,2.04,1.9425,Q9Z222,Q9Z222,B3GNT2,1,23,12,12,Q9Z222|G3UWI7,MOUSE,46281.5,31.2,897,897.1,149.44,149.44,NA,397,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2",Golgi membrane|integral component of membrane|extracellular exosome|,protein glycosylation|axon guidance|sensory perception of smell|poly-N-acetyllactosamine biosynthetic process|,"galactosyltransferase activity|N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity|",12,23,3.75E+09,0.312,5.54E-06,-0.244666667,66.96425012,1.831,2.01E-07,21.73942493,-1.0805,-1.103,-1.297,0.617,0.614,0.7815,undefined,9,NA,NA
2.037,2.099,2.186,1.358,1.3985,1.6795,1.905,2.061,2.2445,P51655,P51655,Gpc4,1,20,10,10,P51655,MOUSE,63669.2,29.6,914,914.1,146.92,146.92,NA,557,Glypican-4,proteinaceous extracellular matrix|extracellular space|nucleus|Golgi lumen|external side of plasma membrane|anchored component of membrane|extracellular exosome|,NA,heparan sulfate proteoglycan binding|,10,20,9.16E+09,0.296,0.000120163,-0.030666667,47.41476571,1.853,1.81E-05,10.86290279,-0.8955,-0.834,-1.142,1.127,0.523,1.0375,PC,9,TRUE,NA
1.927,1.969,2.046,1.835,1.7835,1.8605,2.234,2.278,2.3595,Q6S9I3,Q6S9I3,Kng2,1,9,8,7,Q6S9I3|Q6S9I2|Q6S9I0|E0CYI5,MOUSE,72355.1,15,921,921.2,89.12,77.91,NA,644,HMW kininogen-II,extracellular space|cytosol|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|,cysteine-type endopeptidase inhibitor activity|receptor binding|,7,9,2.30E+09,0.15,1.93E-05,-0.261666667,57.24580308,2.087666667,1.89E-06,15.46669021,-1.2425,-1.19,-1.484,0.701,0.601,1.0445,PC,9,TRUE,NA
0.363,0.61,0.485,0.272,0.5925,0.4715,0.207,0.484,0.2845,Q99KC8,Q99KC8,Vwa5a,1,19,12,12,Q99KC8,MOUSE,87882.9,17.2,924,924.1,146.01,146.01,NA,793,von Willebrand factor A domain-containing protein 5A,nucleus|nucleoplasm|,NA,NA,12,19,3.31E+09,0.172,0.006630882,-0.036833333,27.16842342,0.412,0.001919365,4.951063639,-0.1035,-0.342,-0.283,0.243,0.187,0.0775,NC,5,NA,NA
2.395,2.529,2.627,2.202,2.3035,2.5815,2.392,2.609,3.0755,Q8K154,Q8K154,Ugt2b34,1,33,9,9,Q8K154|E9PZ30|A0A0J9YU36|Q8BWQ1|Q80X89|Q6PDD0|D3YUX6,MOUSE,61389.4,25.7,935,935.1,144.71,144.71,NA,532,UDP-glucuronosyltransferase,intracellular membrane-bounded organelle|,flavonoid biosynthetic process|cellular response to hormone stimulus|flavonoid glucuronidation|,glucuronosyltransferase activity|,9,33,4.57E+10,0.257,4.04E-05,-0.469833333,53.06848916,2.604666667,4.93E-06,13.32396694,-1.5335,-1.552,-2.231,0.792,0.715,0.9905,undefined,9,TRUE,TRUE
1.349,1.121,1.286,1.055,1.0475,1.1515,1.303,1.146,1.2485,O35657,O35657,Neu1,1,30,11,11,O35657,MOUSE,45046.9,27.8,936,936.1,144.67,144.67,NA,409,Sialidase-1,lysosome|lysosomal membrane|plasma membrane|cell surface|cytoplasmic membrane-bounded vesicle|cell junction|lysosomal lumen|intracellular membrane-bounded organelle|extracellular exosome|,oligosaccharide catabolic process|positive regulation of neuron projection development|lipid catabolic process|regulation of myoblast proliferation|,exo-alpha-sialidase activity|protein binding|exo-alpha-(2->3)-sialidase activity|exo-alpha-(2->6)-sialidase activity|exo-alpha-(2->8)-sialidase activity|,11,30,2.30E+10,0.278,1.98E-05,-0.094833333,57.00004963,1.204666667,2.00E-06,15.2014677,-0.7055,-0.589,-0.797,0.544,0.403,0.5755,undefined,9,TRUE,NA
0.637,0.637,0.554,0.363,0.4815,0.3505,0.457,0.545,0.3805,Q925E7,Q925E7,Ppp2r2d,1,4,6,3,Q925E7|F6RV17,MOUSE,52527.1,17.8,940,940.2,64.86,25.81,NA,453,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform,protein phosphatase type 2A complex|cytoplasm|,mitotic nuclear division|signal transduction|exit from mitosis|regulation of protein phosphatase type 2A activity|cell division|,protein phosphatase type 2A regulator activity|,3,4,1.91E+09,0.088,0.001493816,0.030666667,34.66462212,0.498333333,0.000341616,6.694645913,-0.2015,-0.262,-0.192,0.392,0.155,0.2925,undefined,6,NA,NA
1.641,1.286,1.585,1.28,0.9455,1.1705,1.825,1.357,1.5825,P46412,P46412,Gpx3,1,44,11,11,P46412|P21765,MOUSE,25581.2,42.4,957,957.1,141.73,141.73,NA,226,Glutathione peroxidase 3,extracellular space|extracellular exosome|,response to oxidative stress|hydrogen peroxide catabolic process|protein homotetramerization|oxidation-reduction process|,glutathione peroxidase activity|selenium binding|,11,44,1.11E+11,0.424,0.000132405,-0.042,46.91948365,1.420333333,2.03E-05,10.66851333,-0.8785,-0.549,-0.829,0.716,0.437,0.8515,PC,9,TRUE,NA
0.746,0.74,0.527,0.418,0.5215,0.2755,0.45,0.48,0.4615,P57016,P57016,Lad1,1,30,13,13,P57016,MOUSE,58920,26.7,959,959.1,141.42,141.42,NA,528,Ladinin-1,extracellular exosome|,NA,NA,13,30,6.02E+09,0.267,0.001497922,0.03,34.64177503,0.617666667,0.000343418,6.723190918,-0.2255,-0.394,-0.217,0.49,0.209,0.3175,PC,8,NA,NA
1.347,1.407,1.491,1.345,1.3575,1.5415,1.508,1.508,1.6255,P01901,P01901,H2-K1,1,25,10,8,P01901|Q3TH01|P04223|P04223-2|P14426|P03991|A0A0B4J1G3|P01900|P14427|P01895-2,MOUSE,41700.5,35.7,1005,1005.1,134.66,105.6,NA,369,"H-2 class I histocompatibility antigen, K-B alpha chain",endoplasmic reticulum|Golgi apparatus|Golgi medial cisterna|external side of plasma membrane|cell surface|membrane|phagocytic vesicle membrane|MHC class I protein complex|extracellular exosome|endoplasmic reticulum exit site|integral component of lumenal side of endoplasmic reticulum membrane|,"positive regulation of T cell mediated cytotoxicity|antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent|immune response|antigen processing and presentation of exogenous peptide antigen via MHC class I|defense response to bacterium|inner ear development|",receptor binding|protein binding|beta-2-microglobulin binding|peptide antigen binding|T cell receptor binding|poly(A) RNA binding|TAP binding|,10,25,6.53E+09,0.357,1.19E-05,-0.181,60.96721586,1.495666667,8.00E-07,17.60358491,-0.8285,-0.867,-1.091,0.51,0.557,0.6335,undefined,9,TRUE,TRUE
1.678,1.696,1.477,1.31,1.4855,1.2865,1.729,1.853,1.6145,P01899,P01899,H2-D1,1,8,9,6,P01899|P01897|Q8HWB2|P01898|Q4KN81|G3UXE9|E9Q0G4|A7VMS6|O19441|E9PX63|Q05A75|G3UZL7,MOUSE,41120.7,26.7,1005,1005.2,88.87,52.53,NA,362,"H-2 class I histocompatibility antigen, D-B alpha chain",endoplasmic reticulum|Golgi apparatus|Golgi medial cisterna|plasma membrane|external side of plasma membrane|cell surface|membrane|phagocytic vesicle membrane|MHC class I protein complex|extracellular exosome|endoplasmic reticulum exit site|integral component of lumenal side of endoplasmic reticulum membrane|,"positive regulation of T cell mediated cytotoxicity|antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent|immune response|",receptor binding|protein binding|beta-2-microglobulin binding|peptide antigen binding|T cell receptor binding|poly(A) RNA binding|TAP binding|,6,8,2.53E+09,0.176,9.85E-06,-0.126666667,62.04816372,1.545,6.24E-07,18.28796847,-0.8595,-0.966,-0.872,0.735,0.482,0.7205,PC,9,TRUE,TRUE
0.368,0.412,0.473,0.409,0.4505,0.4505,0.38,0.43,0.4425,A0A0R4J0B5,A0A0R4J0B5,BC017158,1,20,10,2,A0A0R4J0B5|D6RDS0|Q91W34-2,MOUSE,50928.7,24.8,1013,1013.1,132.73,30.09,NA,466,cDNA sequence BC017158,NA,NA,NA,10,20,3.10E+09,0.248,0.001494344,-0.005,34.65761878,0.404333333,0.000342167,6.679920811,-0.1415,-0.196,-0.284,0.167,0.23,0.1945,undefined,5,NA,NA
1.285,1.183,1.054,1.167,1.0165,0.9575,1.32,1.117,1.0915,Q91YL7,Q91YL7,Cwh43,1,20,11,11,Q91YL7|Q91YL7-2,MOUSE,78577.6,19,1027,1027.1,131.07,131.07,NA,699,PGAP2-interacting protein,integral component of membrane|,GPI anchor biosynthetic process|,NA,11,20,3.09E+11,0.19,1.92E-05,-0.1105,57.33765231,1.130666667,1.85E-06,15.36356596,-0.8115,-0.612,-0.604,0.469,0.416,0.4795,undefined,9,NA,TRUE
1.004,1.009,1.222,1.038,1.1125,1.2645,1.186,1.209,1.4155,P09803,P09803,Cdh1,1,26,14,14,A0A0R4IZW5|P09803,MOUSE,98767.5,22,1033,1033.1,130.6,130.6,NA,884,Cadherin-1,cytoplasm|endosome|trans-Golgi network|plasma membrane|cell-cell junction|adherens junction|cell-cell adherens junction|focal adhesion|cytoplasmic side of plasma membrane|cell surface|actin cytoskeleton|integral component of membrane|aggresome|basolateral plasma membrane|lateral plasma membrane|catenin complex|flotillin complex|lamellipodium|cell junction|axon|node of Ranvier|lateral loop|Schmidt-Lanterman incisure|apical junction complex|axon terminus|apical part of cell|perinuclear region of cytoplasm|extracellular exosome|cell periphery|catenin complex|cortical actin cytoskeleton|,"in utero embryonic development|trophectodermal cell differentiation|epithelial cell morphogenesis|homophilic cell adhesion via plasma membrane adhesion molecules|embryo implantation|sensory perception of sound|single organismal cell-cell adhesion|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|protein metabolic process|negative regulation of cell-cell adhesion|regulation of protein localization|regulation of water loss via skin|adherens junction organization|uterine epithelium development|positive regulation of transcription factor import into nucleus|regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of transcription, DNA-templated|decidualization|negative regulation of epithelial cell proliferation|protein homooligomerization|intestinal epithelial cell development|salivary gland cavitation|regulation of branching involved in salivary gland morphogenesis|bicellular tight junction assembly|cellular response to amino acid stimulus|cellular response to lithium ion|cellular response to indole-3-methanol|protein localization to plasma membrane|establishment of protein localization to plasma membrane|negative regulation of canonical Wnt signaling pathway|cochlea development|regulation of protein localization to cell surface|regulation of neuron migration|",glycoprotein binding|calcium ion binding|protein binding|beta-catenin binding|protein phosphatase binding|protein domain specific binding|ankyrin binding|GTPase activating protein binding|gamma-catenin binding|cell adhesion molecule binding|,14,26,4.94E+10,0.22,6.22E-05,-0.1005,50.87858669,1.217333333,8.17E-06,12.31530785,-0.6155,-0.616,-0.896,0.418,0.487,0.6195,PC,9,TRUE,TRUE
2.569,2.783,2.725,2.177,2.3955,2.3675,2.529,2.811,2.6945,A6PW84,A6PW84,P3h1,1,24,10,10,A6PW84|A2A7Q5|Q3V1T4|Q3V1T4-3|Q3V1T4-2|F2Z499,MOUSE,85441.4,17.9,1043,1043.1,129.23,129.23,NA,746,Prolyl 3-hydroxylase 1,basement membrane|nucleus|cytoplasm|endoplasmic reticulum|plasma membrane|membrane|extracellular exosome|,protein folding|cell growth|protein hydroxylation|peptidyl-proline hydroxylation|collagen fibril organization|regulation of ossification|collagen metabolic process|regulation of protein secretion|protein stabilization|oxidation-reduction process|bone development|negative regulation of post-translational protein modification|,iron ion binding|procollagen-proline 3-dioxygenase activity|L-ascorbic acid binding|,10,24,5.24E+09,0.179,5.29E-06,-0.411833333,67.45444998,2.546,1.80E-07,22.18035776,-1.5205,-1.648,-1.886,0.961,0.703,0.9195,PC,9,TRUE,NA
1.716,1.847,2.033,1.444,1.6345,1.6635,1.835,1.896,2.0965,A0A087WR24,A0A087WR24,Edem3,1,20,10,10,A0A087WR24|Q2HXL6|A0A087WQK5|B7ZNP0,MOUSE,106696.6,14.5,1046,1046.1,128.75,128.75,NA,947,"alpha-1,2-Mannosidase",endoplasmic reticulum lumen|membrane|,N-glycan processing|glycoprotein catabolic process|ER-associated ubiquitin-dependent protein catabolic process|endoplasmic reticulum unfolded protein response|proteasome-mediated ubiquitin-dependent protein catabolic process|glycoprotein ERAD pathway|,"glycoprotein endo-alpha-1,2-mannosidase activity|mannosyl-oligosaccharide 1,2-alpha-mannosidase activity|calcium ion binding|",10,20,1.68E+09,0.145,2.18E-05,-0.166166667,56.50275159,1.791333333,2.24E-06,15.06312257,-0.9305,-1.016,-1.239,0.725,0.55,0.9135,undefined,9,TRUE,TRUE
2.31,2.124,2.305,1.742,1.5195,1.7885,2.616,2.494,2.6245,P11152,P11152,Lpl,1,28,8,8,P11152,MOUSE,53679,24.2,1068,1068.1,125.59,125.59,NA,474,Lipoprotein lipase,extracellular space|plasma membrane|cell surface|extracellular matrix|anchored component of membrane|very-low-density lipoprotein particle|chylomicron|extracellular exosome|,fatty acid biosynthetic process|response to cold|positive regulation of macrophage derived foam cell differentiation|positive regulation of cholesterol storage|positive regulation of sequestering of triglyceride|triglyceride biosynthetic process|triglyceride catabolic process|very-low-density lipoprotein particle remodeling|response to drug|triglyceride homeostasis|,lipoprotein lipase activity|triglyceride lipase activity|receptor binding|protein binding|heparin binding|triglyceride binding|apolipoprotein binding|,8,28,2.88E+10,0.242,0.000286628,-0.089666667,43.04387388,2.241,4.96E-05,9.251684508,-1.2715,-0.972,-1.387,1.076,0.526,1.4905,PC,9,TRUE,NA
2.997,2.848,3.04,2.813,2.8015,2.8795,3.039,2.904,3.2195,Q9R0Q3,Q9R0Q3,Tmed2,1,43,9,9,Q9R0Q3,MOUSE,22818.8,43.2,1079,1079.1,124.2,124.2,NA,201,Transmembrane emp24 domain-containing protein 2,endoplasmic reticulum|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|integral component of membrane|COPI-coated vesicle|COPI-coated vesicle membrane|Golgi cisterna membrane|endoplasmic reticulum-Golgi intermediate compartment membrane|zymogen granule membrane|,maternal placenta development|Golgi organization|vesicle-mediated transport|negative regulation of GTPase activity|embryonic morphogenesis|labyrinthine layer blood vessel development|protein targeting to plasma membrane|,NA,9,43,1.61E+10,0.432,1.32E-06,-0.566666667,87.15005939,2.921666667,1.93E-09,43.12033805,-2.0865,-2.06,-1.936,0.856,0.856,0.9705,PC,9,TRUE,TRUE
0.862,0.577,0.735,0.817,0.6475,0.6915,0.799,0.683,0.5435,Q9WVA4,Q9WVA4,Tagln2,1,18,11,11,Q9WVA4|Q9R1Q8,MOUSE,22566.2,56.2,1080,1080.1,123.27,123.27,NA,199,Transgelin-2,vesicle|extracellular exosome|,epithelial cell differentiation|,actin filament binding|,11,18,3.77E+09,0.562,9.34E-05,-0.0585,48.7834942,0.717333333,1.32E-05,11.29108708,-0.5105,-0.372,-0.369,0.325,0.32,0.2555,undefined,9,NA,NA
1.98,1.87,2.265,1.912,1.8505,2.3115,2.071,1.982,2.4665,Q61847-2,Q61847,Mep1b,1,20,11,11,Q61847-2|Q61847,MOUSE,81373.1,21.3,1081,1081.1,123.23,123.23,NA,704,Isoform 2 of Meprin A subunit beta,plasma membrane|membrane|integral component of membrane|,proteolysis|inflammatory response|toxin transport|,metalloendopeptidase activity|zinc ion binding|,11,20,8.69E+09,0.213,5.48E-05,-0.362833333,51.50207391,2.136,7.08E-06,12.59499563,-1.3005,-1.158,-1.834,0.657,0.68,0.7785,PC,9,TRUE,TRUE
2.233,2.454,2.228,1.993,2.2655,2.1015,2.252,2.486,2.3705,Q8VCS3,Q8VCS3,Fam20b,1,24,9,9,Q8VCS3,MOUSE,47036.2,27.6,1085,1085.1,122.53,122.53,NA,409,Glycosaminoglycan xylosylkinase,Golgi membrane|nucleoplasm|Golgi apparatus|integral component of membrane|,phosphorylation|positive regulation of protein targeting to mitochondrion|,"ATP binding|kinase activity|phosphotransferase activity, alcohol group as acceptor|",9,24,1.46E+10,0.276,2.36E-06,-0.364333333,75.9168631,2.227666667,2.56E-08,29.41567996,-1.3895,-1.502,-1.543,0.746,0.65,0.8525,undefined,9,NA,TRUE
1.177,1.306,1.217,0.823,0.9765,0.9055,1.044,1.251,1.1715,O35350,O35350,Capn1,1,21,15,15,O35350,MOUSE,82789.5,22,1087,1087.1,122.47,122.47,NA,713,Calpain-1 catalytic subunit,cytoplasm|mitochondrion|lysosome|cytosol|plasma membrane|focal adhesion|membrane|extracellular exosome|,proteolysis|protein autoprocessing|receptor catabolic process|mammary gland involution|,calcium-dependent cysteine-type endopeptidase activity|calcium ion binding|protein binding|cytoskeletal protein binding|,15,21,1.37E+10,0.22,4.57E-05,-0.049666667,52.43986241,1.091666667,5.70E-06,12.99969653,-0.5095,-0.609,-0.668,0.609,0.355,0.5245,undefined,9,NA,NA
2.46,2.245,2.544,1.55,1.5155,1.8185,2.383,2.257,2.4585,Q91XL3,Q91XL3,Uxs1,1,16,8,8,Q91XL3|G5E8H4,MOUSE,47665.9,31.1,1101,1101.1,120.8,120.8,NA,420,UDP-glucuronic acid decarboxylase 1,mitochondrion|integral component of membrane|Golgi cisterna membrane|extracellular exosome|,UDP-D-xylose biosynthetic process|protein tetramerization|,protein homodimerization activity|UDP-glucuronate decarboxylase activity|NAD+ binding|,8,16,3.79E+09,0.311,0.000265273,-0.017333333,43.45299659,2.123,4.52E-05,9.392938107,-1.0025,-0.888,-1.346,1.298,0.547,1.2875,undefined,9,NA,TRUE
2.465,2.407,2.63,2.474,2.2975,2.3685,2.722,2.717,3.0095,O09043,O09043,Napsa,1,37,7,7,O09043,MOUSE,45942.9,24.1,1108,1108.1,120.03,120.03,NA,419,Napsin-A,extracellular space|lysosome|extracellular exosome|alveolar lamellar body|,protein catabolic process|membrane protein proteolysis|surfactant homeostasis|,endopeptidase activity|aspartic-type endopeptidase activity|protein binding|peptidase activity|,7,37,1.26E+11,0.241,6.44E-06,-0.353833333,65.14928171,2.490666667,3.06E-07,20.45362352,-1.7835,-1.543,-1.471,0.811,0.758,1.1055,PC,9,TRUE,NA
0.532,0.517,0.479,0.45,0.3555,0.2715,0.791,0.626,0.5285,Q68FL4,Q68FL4,Ahcyl2,1,7,9,4,Q68FL4|F8WGT1|F8WI65|Q68FL4-2|H3BKT5,MOUSE,67925.2,17.4,1120,1120.2,99.06,44.81,NA,613,Putative adenosylhomocysteinase 3,endoplasmic reticulum|cytosol|neuron projection|intracellular membrane-bounded organelle|,one-carbon metabolic process|S-adenosylmethionine cycle|,adenosylhomocysteinase activity|,4,7,2.66E+08,0.088,0.004040163,0.014333333,29.73234676,0.543666667,0.001063568,5.520914684,-0.3845,-0.225,-0.163,0.316,0.121,0.4215,undefined,7,NA,NA
2.397,2.566,2.664,1.925,2.0395,2.2595,1.971,2.205,2.5065,O09164,O09164,Sod3,1,39,7,7,O09164,MOUSE,27733.7,37.4,1131,1131.1,116.93,116.93,NA,251,Extracellular superoxide dismutase [Cu-Zn],extracellular space|nucleus|cytoplasm|Golgi lumen|trans-Golgi network|extracellular exosome|extracellular matrix|,response to hypoxia|removal of superoxide radicals|response to copper ion|oxidation-reduction process|,superoxide dismutase activity|copper ion binding|protein binding|zinc ion binding|,7,39,2.87E+10,0.374,9.85E-06,-0.237,62.06366581,2.270333333,6.22E-07,18.34547724,-1.2315,-1.306,-1.579,1.066,0.716,0.9125,PC,9,TRUE,NA
0.958,1.06,1.277,0.694,0.6555,0.8625,1.03,1.088,1.2385,P70277,P70277,St6galnac2,1,19,10,10,P70277,MOUSE,42709.2,28.6,1138,1138.1,115.81,115.81,NA,373,"Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2",integral component of Golgi membrane|,protein glycosylation|sialylation|,sialyltransferase activity|,10,19,2.74E+09,0.286,0.000283646,0.0245,43.11829317,1.016,4.88E-05,9.277239333,-0.4965,-0.364,-0.59,0.64,0.317,0.6405,undefined,9,NA,TRUE
1.493,1.435,1.737,1.519,1.5305,1.7275,1.619,1.676,1.8515,Q99KR8,Q99KR8,Fuca2,1,19,10,10,Q99KR8,MOUSE,53929.5,23.8,1142,1142.1,115.66,115.66,NA,461,Plasma alpha-L-fucosidase,extracellular space|extracellular exosome|,fucose metabolic process|response to bacterium|glycoside catabolic process|regulation of entry of bacterium into host cell|,alpha-L-fucosidase activity|,10,19,4.58E+10,0.238,3.83E-05,-0.187333333,53.34059721,1.642333333,4.63E-06,13.45454993,-0.9145,-0.834,-1.277,0.541,0.686,0.6745,PC,9,TRUE,NA
2.025,1.923,2.008,1.771,1.5945,1.7065,2.03,1.811,2.0085,Q9JLL0,Q9JLL0,Crim1,1,19,12,12,Q9JLL0,MOUSE,121480.9,13.1,1151,1151.1,114.53,114.53,NA,1037,Cysteine-rich motor neuron 1 protein,integral component of membrane|extracellular exosome|,regulation of cell growth|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|insulin-like growth factor binding|PDZ domain binding|,12,19,4.45E+09,0.131,8.99E-06,-0.177833333,62.8358301,2.022666667,5.20E-07,18.85237389,-1.2545,-1.02,-1.293,0.89,0.66,0.9505,undefined,9,TRUE,TRUE
1.183,1.109,1.233,1.086,0.9395,1.0765,1.299,1.095,1.2755,Q9R013,Q9R013,Ctsf,1,24,9,9,Q9R013,MOUSE,52287.6,25.7,1154,1154.1,114.02,114.02,NA,462,Cathepsin F,extracellular space|lysosome|extracellular exosome|extracellular vesicle|,proteolysis involved in cellular protein catabolic process|,cysteine-type endopeptidase activity|cysteine-type peptidase activity|,9,24,4.68E+09,0.257,2.29E-05,-0.058833333,56.19698804,1.177333333,2.40E-06,14.77534553,-0.6795,-0.524,-0.739,0.591,0.432,0.5665,undefined,9,TRUE,NA
1.269,0.918,1.178,1.11,0.9485,1.1585,1.285,0.834,1.4255,Q3U492,Q3U492,Kcp,1,19,11,11,Q3U492|Q3U492-2|E9QNB3|E0CYL0,MOUSE,178777.4,10.3,1157,1157.1,113.66,113.66,NA,1550,Kielin/chordin-like protein,extracellular space|,hematopoietic progenitor cell differentiation|positive regulation of BMP signaling pathway|,protein binding|,11,19,5.94E+08,0.103,3.14E-05,-0.044833333,54.33546521,1.272,3.69E-06,13.94227801,-0.7635,-0.486,-0.793,0.582,0.569,0.6225,PC,9,TRUE,NA
2.162,2.192,2.305,1.78,1.6985,1.8775,2.128,1.935,2.2155,Q6PB93,Q6PB93,Galnt2,1,18,11,10,Q6PB93|Q6PB93-2,MOUSE,65255.1,22.6,1161,1161.1,113.37,98.71,NA,570,Polypeptide N-acetylgalactosaminyltransferase 2,Golgi apparatus|Golgi stack|Golgi lumen|membrane|integral component of membrane|Golgi cisterna membrane|perinuclear region of cytoplasm|extracellular exosome|Golgi apparatus|,immunoglobulin biosynthetic process|protein O-linked glycosylation|O-glycan processing|protein O-linked glycosylation via serine|protein O-linked glycosylation via threonine|,polypeptide N-acetylgalactosaminyltransferase activity|manganese ion binding|carbohydrate binding|,11,18,3.20E+09,0.226,1.26E-05,-0.1935,60.41539096,2.015333333,9.09E-07,17.30708035,-1.1925,-1.041,-1.37,0.945,0.624,0.8735,PC,9,NA,TRUE
1.534,1.87,1.826,1.621,1.9725,1.9285,1.56,1.892,1.8525,O08832,O08832,Galnt4,1,2,3,2,O08832,MOUSE,67409.5,5,1161,1161.2,24.26,9.6,NA,578,Polypeptide N-acetylgalactosaminyltransferase 4,Golgi membrane|integral component of membrane|perinuclear region of cytoplasm|extracellular exosome|Golgi apparatus|,protein glycosylation|,polypeptide N-acetylgalactosaminyltransferase activity|carbohydrate binding|metal ion binding|,2,2,3.12E+08,0.032,1.50E-05,-0.249,59.01354416,1.819,1.26E-06,16.46863625,-0.9325,-1.207,-1.336,0.596,0.749,0.6365,undefined,9,NA,TRUE
0.879,1.131,1.058,0.519,0.7795,0.9095,0.82,1.112,1.0005,Q3U9N4,Q3U9N4,Grn,1,22,7,7,Q3U9N4|P28798,MOUSE,70037.8,18.1,1175,1175.1,111.95,111.95,NA,602,Granulins,extracellular space|mitochondrion|cell surface|intracellular membrane-bounded organelle|extracellular exosome|,blastocyst hatching|embryo implantation|response to estradiol|chondrocyte proliferation|synaptic vesicle endocytosis|positive regulation of epithelial cell proliferation|male mating behavior|positive regulation of dendritic spine development|neural precursor cell proliferation|,poly(A) RNA binding|,7,22,4.44E+09,0.181,0.000479693,0.087833333,40.32247488,1.164666667,9.28E-05,8.358062306,-0.2905,-0.559,-0.634,0.779,0.408,0.8235,PC,9,TRUE,NA
0.956,0.984,0.97,0.739,0.7525,0.8705,1.027,1.013,1.0965,Q9R0E2,Q9R0E2,Plod1,1,13,10,10,Q9R0E2|A8Y5E6,MOUSE,84164,16.7,1181,1181.1,110.82,110.82,NA,728,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",rough endoplasmic reticulum membrane|extracellular exosome|,response to hypoxia|epidermis development|peptidyl-lysine hydroxylation|cellular response to hormone stimulus|oxidation-reduction process|,ferrous iron binding|procollagen-lysine 5-dioxygenase activity|L-ascorbic acid binding|peptide binding|,10,13,1.38E+09,0.167,6.08E-05,-0.007333333,51.00299467,0.929666667,7.94E-06,12.26701402,-0.4385,-0.416,-0.562,0.507,0.34,0.5255,PC,9,TRUE,NA
0.521,0.392,0.618,0.405,0.2745,0.4945,0.489,0.318,0.4275,E9Q9C3,E9Q9C3,Afdn,1,16,10,10,E9Q9C3|Q9QZQ1|Q9QZQ1-2|E9Q852|E9PYX7,MOUSE,208278.9,6.6,1186,1186.1,109.78,109.78,NA,1827,Afadin,nucleoplasm|cytoplasm|plasma membrane|cell-cell junction|adherens junction|cell-cell adherens junction|cell junction|apical part of cell|,signal transduction|positive regulation of GTPase activity|establishment of endothelial intestinal barrier|,protein binding|Ras GTPase binding|,10,16,1.68E+09,0.066,0.001632888,0.031166667,34.21288187,0.429333333,0.000379063,6.565177342,-0.2285,-0.085,-0.237,0.283,0.197,0.2575,NC,6,NA,NA
0.447,0.448,0.443,0.465,0.4815,0.4755,0.471,0.468,0.4665,D3YV00,D3YV00,Atp9b,1,2,5,2,D3YV00|P98195|A0A286YCV0|P98195-2,MOUSE,130526.2,5.2,1189,1189.2,40.37,16.2,NA,1146,Phospholipid-transporting ATPase,endosome|trans-Golgi network|plasma membrane|integral component of membrane|perinuclear region of cytoplasm|,"retrograde vesicle-mediated transport, Golgi to ER|endocytosis|metabolic process|phospholipid translocation|establishment of protein localization to Golgi|",magnesium ion binding|phospholipid-translocating ATPase activity|ATP binding|,2,2,12800000,0.027,0.00022567,-0.0175,44.26683701,0.482666667,3.74E-05,9.58556738,-0.2575,-0.251,-0.268,0.202,0.243,0.2265,undefined,7,NA,TRUE
0.504,0.862,0.469,0.375,0.7475,0.3725,0.834,1.154,0.7505,Q60604,Q60604,Scin,1,16,10,10,Q60604|Q60604-2,MOUSE,80708.6,15.1,1190,1190.1,109.42,109.42,NA,715,Adseverin,cytoplasm|cytoskeleton|brush border|extracellular exosome|,negative regulation of cell proliferation|regulation of chondrocyte differentiation|sequestering of actin monomers|positive regulation of apoptotic process|positive regulation of megakaryocyte differentiation|actin filament severing|positive regulation of actin nucleation|actin filament capping|,calcium ion binding|actin filament binding|,10,16,7.41E+09,0.151,0.005910807,-0.026666667,27.74175985,0.683,0.001681992,5.079914817,-0.2775,-0.583,-0.244,0.256,0.143,0.5455,NC,7,NA,NA
2.507,2.635,2.356,2.571,2.8045,2.4845,2.245,2.467,2.0845,Q9DBX3,Q9DBX3,Susd2,1,14,10,10,Q9DBX3|Q9DBX3-2|Q9DBX3-3,MOUSE,92237.4,12.1,1192,1192.1,108.98,108.98,NA,820,Sushi domain-containing protein 2,plasma membrane|integral component of membrane|extracellular exosome|,receptor-mediated endocytosis|immune response|negative regulation of cell division|negative regulation of cell cycle G1/S phase transition|,scavenger receptor activity|polysaccharide binding|,10,14,2.75E+09,0.121,2.39E-06,-0.441,75.02470673,2.396333333,3.14E-08,28.77958889,-1.6215,-1.695,-1.601,0.737,0.908,0.6265,undefined,9,TRUE,TRUE
1.601,2.171,2.123,1.355,1.8945,2.0885,1.726,2.122,2.4525,O88819,O88819,Fut9,1,14,7,7,O88819,MOUSE,42553.7,35.6,1196,1196.1,108.64,108.64,NA,359,"Alpha-(1,3)-fucosyltransferase 9",integral component of membrane|Golgi cisterna membrane|,protein glycosylation|nervous system development|fucosylation|,alpha-(1->3)-fucosyltransferase activity|,7,14,1.77E+09,0.356,4.23E-05,-0.1415,52.8385839,1.872,5.20E-06,13.21456287,-0.8385,-1.217,-1.177,0.744,0.613,1.0265,undefined,9,NA,TRUE
0.695,0.536,0.647,-0.012,-0.1555,-0.0445,0.608,0.445,0.5605,Q8CCK0,Q8CCK0,H2afy2,1,3,5,3,Q8CCK0,MOUSE,40319.7,17.2,1199,1199.2,57.35,27.17,NA,372,Core histone macro-H2A.2,nucleosome|nuclear chromatin|Barr body|nucleus|nucleoplasm|extracellular exosome|ESC/E(Z) complex|,"negative regulation of transcription from RNA polymerase II promoter|nucleosome assembly|brain development|dosage compensation|chromatin modification|positive regulation of keratinocyte differentiation|negative regulation of gene expression, epigenetic|establishment of protein localization to chromatin|negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter|",RNA polymerase II regulatory region sequence-specific DNA binding|chromatin DNA binding|transcription regulatory region DNA binding|protein heterodimerization activity|,3,3,6.80E+07,0.102,0.291258763,0.13,6.73916787,0.175,0.211876706,1.381437336,-0.0335,0.138,0.023,0.438,-0.047,0.2615,NC,5,NA,NA
1.162,1.076,1.109,1.467,1.3975,1.5065,1.313,1.14,1.2905,Q5SSE9,Q5SSE9,Abca13,1,13,9,9,Q5SSE9|Q5SSE9-2|Q5SSE9-3,MOUSE,573565.2,2.9,1200,1200.1,108.43,108.43,NA,5034,ATP-binding cassette sub-family A member 13,integral component of plasma membrane|intracellular membrane-bounded organelle|,metabolic process|cholesterol efflux|phospholipid efflux|transmembrane transport|,"ATP binding|phospholipid transporter activity|cholesterol transporter activity|ATPase activity, coupled to transmembrane movement of substances|",9,13,1.12E+09,0.029,7.38E-05,-0.0485,50.04963753,1.298666667,9.89E-06,11.95235281,-0.7295,-0.643,-0.721,0.411,0.828,0.5635,undefined,9,NA,TRUE
0.265,0.569,0.583,0.092,0.4705,0.4085,0.316,0.569,0.6195,P10639,P10639,Txn,1,28,8,8,P10639,MOUSE,12017.6,52.3,1209,1209.1,107.55,107.55,NA,105,Thioredoxin,nucleus|cytoplasm|mitochondrion|cytosol|extracellular exosome|,"sulfate assimilation|negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|protein folding|glycerol ether metabolic process|response to radiation|positive regulation of peptidyl-serine phosphorylation|regulation of protein import into nucleus, translocation|cellular response to oxidative stress|positive regulation of DNA binding|cell redox homeostasis|negative regulation of protein export from nucleus|oxidation-reduction process|negative regulation of hydrogen peroxide-induced cell death|","protein binding|protein disulfide oxidoreductase activity|peptide disulfide oxidoreductase activity|oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor|poly(A) RNA binding|",8,28,6.31E+10,0.523,0.016456195,0.001166667,22.28035712,0.428,0.00591513,3.983208723,-0.0165,-0.327,-0.295,0.234,0.079,0.3325,PC,6,NA,NA
2.178,1.715,2.459,2.123,1.8465,2.5045,2.283,1.898,2.6295,Q6PDJ1,Q6PDJ1,Cachd1,1,16,9,9,Q6PDJ1|Q6PDJ1-2|Z4YK18,MOUSE,145978,7.7,1220,1220.1,106.78,106.78,NA,1288,VWFA and cache domain-containing protein 1,integral component of membrane|,calcium ion transport|,NA,9,16,8.70E+08,0.077,0.000248484,-0.405833333,43.7664315,2.267333333,4.20E-05,9.502430166,-1.4475,-1.077,-2.094,0.702,0.664,0.8175,undefined,9,NA,TRUE
2.5,2.534,2.774,2.052,2.0485,2.2525,2.732,2.832,2.9155,P39876,P39876,Timp3,1,25,9,9,P39876,MOUSE,24923.3,33.1,1232,1232.1,105.96,105.96,NA,211,Metalloproteinase inhibitor 3,proteinaceous extracellular matrix|basement membrane|extracellular space|nucleus|cytoplasm|extracellular exosome|extracellular matrix|,central nervous system development|aging|response to mechanical stimulus|response to hormone|negative regulation of endopeptidase activity|response to cytokine|tissue regeneration|response to estrogen|negative regulation of metalloenzyme activity|negative regulation of membrane protein ectodomain proteolysis|response to folic acid|cellular response to organic substance|,protease binding|metalloendopeptidase inhibitor activity|metal ion binding|,9,25,1.75E+10,0.331,8.04E-05,-0.273166667,49.58806474,2.554666667,1.10E-05,11.75455591,-1.3955,-1.366,-1.89,0.996,0.639,1.3775,PC,9,TRUE,NA
1.383,1.172,1.231,1.39,1.3765,1.3295,1.507,1.392,1.3355,F8VQD7,F8VQD7,Ptprg,1,12,8,8,F8VQD7|Q05909|E9Q6E7|D6RD11,MOUSE,162430.7,8.5,1234,1234.1,105.63,105.63,NA,1442,Receptor-type tyrosine-protein phosphatase gamma,extracellular exosome|,negative regulation of epithelial cell migration|peptidyl-tyrosine dephosphorylation|toxin transport|,protein tyrosine phosphatase activity|identical protein binding|,8,12,1.04E+09,0.085,6.44E-06,-0.124,65.0637713,1.393666667,3.12E-07,20.06624835,-0.8985,-0.795,-0.769,0.524,0.523,0.6715,undefined,9,TRUE,TRUE
1.419,1.322,1.461,1.213,1.2445,1.3835,0.404,0.558,0.4635,Q8C165,Q8C165,Pm20d1,1,12,7,7,Q8C165,MOUSE,55776.1,20.6,1243,1243.1,105.01,105.01,NA,503,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,extracellular exosome|,proteolysis|regulation of defense response to virus by host|regulation of viral process|negative regulation of neuron death|,peptidase activity|metal ion binding|,7,12,7.84E+08,0.206,0.009323594,0.138166667,25.36367902,1.050666667,0.002908252,4.583487383,-0.3745,-0.357,-0.43,0.943,0.959,0.0885,PC,8,TRUE,NA
0.987,1.027,1.019,0.786,0.8315,0.8505,0.726,0.786,0.7235,D3Z3Y1,D3Z3Y1,Pigg,1,21,8,8,D3Z3Y1|D3Z4I0|D3YTQ6,MOUSE,109708.9,12.1,1248,1248.1,103.98,103.98,NA,983,"Phosphatidylinositol glycan anchor biosynthesis, class G",endoplasmic reticulum|membrane|integral component of endoplasmic reticulum membrane|,GPI anchor biosynthetic process|,CP2 mannose-ethanolamine phosphotransferase activity|,8,21,3.28E+09,0.121,0.00021024,-0.033833333,44.61988643,0.842,3.45E-05,9.80106159,-0.4445,-0.453,-0.467,0.549,0.377,0.2355,undefined,9,NA,TRUE
1.987,2.021,2.279,1.681,1.8555,2.1195,1.918,2.035,2.3315,Q8BH01,Q8BH01,Tmco3,1,14,9,9,Q8BH01|Q8BH01-2|Q8BH01-3,MOUSE,76415.4,15.6,1249,1249.1,103.66,103.66,NA,678,Transmembrane and coiled-coil domain-containing protein 3,integral component of membrane|,hydrogen ion transmembrane transport|,solute:proton antiporter activity|,9,14,5.00E+09,0.156,2.92E-05,-0.304833333,54.78321157,2.045333333,3.32E-06,14.16716911,-1.1195,-1.2,-1.663,0.747,0.632,0.7745,undefined,9,TRUE,TRUE
0.314,0.523,0.491,0.163,0.3305,0.4015,0.441,0.506,0.5825,Q6NZJ6,Q6NZJ6,Eif4g1,1,5,4,3,Q6NZJ6|E9PVC5|E9Q9E1|Q6NZJ6-2|E9PVC6|A0A0J9YUS5,MOUSE,176929.5,2.1,1250,1250.2,47.55,34.72,NA,1600,Eukaryotic translation initiation factor 4 gamma 1,cytoplasm|membrane|,behavioral fear response|translational initiation|regulation of translational initiation|positive regulation of neuron differentiation|,translation initiation factor activity|protein binding|eukaryotic initiation factor 4E binding|poly(A) RNA binding|,3,5,2.61E+08,0.015,0.008296197,-0.017333333,25.96804709,0.502333333,0.002530436,4.706703393,-0.0835,-0.325,-0.397,0.231,0.102,0.3685,undefined,6,NA,NA
0.773,0.708,0.48,0.547,0.5475,0.3265,0.562,0.598,0.3365,P11862,P11862,Gas2,1,12,8,8,P11862,MOUSE,35527.5,35.6,1253,1253.1,103.17,103.17,NA,314,Growth arrest-specific protein 2,cytoplasm|cytoskeleton|membrane|,apoptotic process|cell cycle arrest|regulation of cell shape|,NA,8,12,8.85E+09,0.356,0.003865523,-0.023666667,29.96722922,0.520333333,0.001007574,5.574597646,-0.3465,-0.376,-0.129,0.367,0.192,0.1505,NC,7,NA,NA
1.4,1.623,1.668,1.523,1.7255,1.7215,1.535,1.756,1.7895,Q8BMD6,Q8BMD6,Tmem260,1,18,9,9,Q8BMD6|Q8BMD6-2,MOUSE,79629.7,16.5,1258,1258.1,102.9,102.9,NA,703,Transmembrane protein 260,integral component of membrane|,NA,NA,9,18,3.93E+09,0.165,9.85E-06,-0.216166667,62.08770516,1.656666667,6.18E-07,18.36105759,-0.8885,-1.026,-1.219,0.58,0.643,0.6135,undefined,9,NA,TRUE
2.826,2.984,3.656,2.576,2.6715,3.4205,3.018,3.174,3.8795,Q64444,Q64444,Ca4,1,28,9,9,Q64444,MOUSE,34693.2,23.2,1260,1260.1,102.67,102.67,NA,305,Carbonic anhydrase 4,rough endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|trans-Golgi network|plasma membrane|cell surface|membrane|apical plasma membrane|sarcoplasmic reticulum|transport vesicle membrane|secretory granule membrane|anchored component of external side of plasma membrane|brush border membrane|sarcolemma|anchored component of plasma membrane|perinuclear region of cytoplasm|extracellular exosome|,one-carbon metabolic process|regulation of pH|carbon dioxide transport|bicarbonate transport|response to drug|organ development|response to steroid hormone|,carbonate dehydratase activity|protein binding|zinc ion binding|,9,28,9.35E+09,0.232,1.38E-05,-0.5375,59.59122412,2.964666667,1.10E-06,16.80931275,-1.8645,-1.814,-2.381,0.905,0.757,1.1725,undefined,9,TRUE,NA
1.985,2.063,2.083,1.32,1.3665,1.4175,1.616,1.556,1.5945,O88968,O88968,Tcn2,1,24,9,9,O88968,MOUSE,48041.3,24.6,1265,1265.1,102.45,102.45,NA,430,Transcobalamin-2,extracellular space|extracellular exosome|,cobalt ion transport|cobalamin transport|,cobalamin binding|metal ion binding|,9,24,3.89E+09,0.246,0.000112192,-0.1055,47.7628973,1.712,1.67E-05,11.00145259,-0.9235,-0.887,-1.074,1.107,0.514,0.6305,PC,9,TRUE,NA
1.648,1.786,2.132,1.226,1.5205,1.8395,1.795,1.892,2.1905,Q8C4C9,Q8C4C9,Dnajb12,1,18,8,8,Q8C4C9|Q9QYI4|D6RHR9,MOUSE,42659.8,19.3,1268,1268.1,102.22,102.22,NA,378,"DnaJ (Hsp40) homolog, subfamily B, member 12, isoform CRA_d",membrane|,NA,NA,8,18,1.53E+09,0.193,0.000455107,-0.146666667,40.59644644,1.833,8.72E-05,8.444536676,-0.7665,-0.914,-1.509,0.831,0.484,0.9945,undefined,9,NA,TRUE
1.681,1.607,1.595,1.684,1.5775,1.6935,1.729,1.626,1.6445,Q01279,Q01279,Egfr,1,11,8,7,Q01279|Q9WVF5|Q61527|Q61527-2|Q61527-3,MOUSE,138274.2,8.5,1282,1282.1,101.28,83.18,NA,1210,Epidermal growth factor receptor,"Golgi membrane|intracellular|nucleus|cytoplasm|endosome|endoplasmic reticulum membrane|plasma membrane|focal adhesion|cell surface|endosome membrane|membrane|integral component of membrane|basolateral plasma membrane|endocytic vesicle|early endosome membrane|nuclear membrane|receptor complex|membrane raft|perinuclear region of cytoplasm|multivesicular body, internal vesicle lumen|",cell morphogenesis|embryonic placenta development|positive regulation of protein phosphorylation|hair follicle development|signal transduction|cell surface receptor signaling pathway|epidermal growth factor receptor signaling pathway|salivary gland morphogenesis|learning or memory|cell proliferation|positive regulation of cell proliferation|epidermis development|single organismal cell-cell adhesion|peptidyl-tyrosine phosphorylation|cerebral cortex cell migration|signal transduction by protein phosphorylation|positive regulation of cell migration|positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle|positive regulation of catenin import into nucleus|regulation of cell proliferation|negative regulation of protein catabolic process|positive regulation of phosphorylation|negative regulation of apoptotic process|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of DNA repair|positive regulation of DNA replication|positive regulation of transcription from RNA polymerase II promoter|protein autophosphorylation|positive regulation of fibroblast proliferation|digestive tract morphogenesis|positive regulation of epithelial cell proliferation|regulation of peptidyl-tyrosine phosphorylation|regulation of nitric-oxide synthase activity|positive regulation of protein kinase B signaling|morphogenesis of an epithelial fold|response to UV-A|positive regulation of ERK1 and ERK2 cascade|cellular response to amino acid stimulus|cellular response to epidermal growth factor stimulus|cellular response to estradiol stimulus|,chromatin binding|protein tyrosine kinase activity|receptor signaling protein tyrosine kinase activity|signal transducer activity|transmembrane signaling receptor activity|epidermal growth factor-activated receptor activity|protein binding|ATP binding|kinase activity|enzyme binding|protein phosphatase binding|ubiquitin protein ligase binding|identical protein binding|protein heterodimerization activity|actin filament binding|nitric-oxide synthase regulator activity|,9,11,2.64E+09,0.085,4.02E-06,-0.225833333,69.9166617,1.633333333,1.02E-07,23.75860729,-1.0805,-0.926,-1.121,0.556,0.606,0.6105,PC,9,TRUE,TRUE
1.82,1.922,1.865,1.6,1.7295,1.6065,1.664,1.789,1.6865,Q8BYW9,Q8BYW9,Eogt,1,13,8,8,Q8BYW9,MOUSE,62300.5,17.2,1294,1294.1,100.24,100.24,NA,527,EGF domain-specific O-linked N-acetylglucosamine transferase,endoplasmic reticulum lumen|,protein O-linked glycosylation|metabolic process|,protein N-acetylglucosaminyltransferase activity|,8,13,7.43E+08,0.172,3.61E-06,-0.188,71.25155375,1.739,7.50E-08,24.88569894,-0.9625,-1.118,-1.092,0.744,0.601,0.6995,undefined,9,TRUE,NA
1.985,2.069,1.929,1.784,1.8075,1.8125,2.047,2.135,2.1205,Q8K135-2,Q8K135,Kiaa0319l,1,15,10,10,Q8K135-2|Z4YK56|Q8K135,MOUSE,120748.4,8.3,1299,1299.1,99.92,99.92,NA,1048,Isoform 2 of Dyslexia-associated protein KIAA0319-like protein,integral component of membrane|cytoplasmic vesicle|extracellular exosome|,NA,NA,10,15,4.70E+09,0.083,3.67E-06,-0.256833333,71.05062469,2.008666667,7.85E-08,24.8781556,-1.2145,-1.213,-1.356,0.801,0.613,0.8285,undefined,9,NA,TRUE
1.728,1.665,1.609,1.421,1.4205,1.6335,1.519,1.44,1.6565,Q9Z0K8,Q9Z0K8,Vnn1,1,12,8,8,Q9Z0K8,MOUSE,57889.1,18.9,1301,1301.1,99.8,99.8,NA,512,Pantetheinase,plasma membrane|integral component of membrane|anchored component of membrane|extracellular exosome|extracellular space|,acute inflammatory response|chronic inflammatory response|inflammatory response|pantothenate metabolic process|single organismal cell-cell adhesion|positive regulation of T cell differentiation in thymus|innate immune response|negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|,pantetheine hydrolase activity|GPI anchor binding|,8,12,1.32E+09,0.189,1.43E-05,-0.172166667,59.37214669,1.622666667,1.16E-06,16.67932794,-0.9395,-0.848,-1.163,0.748,0.586,0.5835,undefined,9,TRUE,NA
2.211,2.379,2.496,1.927,1.9965,2.1985,2.324,2.529,2.6625,Q61789,Q61789,Lama3,1,12,9,9,Q61789|Q61789-2,MOUSE,375292.2,3.6,1302,1302.1,99.66,99.66,NA,3330,Laminin subunit alpha-3,extracellular region|basement membrane|laminin-5 complex|extracellular exosome|basement membrane|,cell adhesion|regulation of cell adhesion|regulation of cell migration|endodermal cell differentiation|regulation of embryonic development|,receptor binding|,9,12,3.40E+08,0.036,6.03E-06,-0.357166667,65.7272793,2.199333333,2.67E-07,20.8738612,-1.3805,-1.324,-1.666,0.737,0.647,0.8435,PC,9,TRUE,NA
0.642,0.95,0.695,0.314,0.6245,0.3665,0.915,1.239,0.9525,P13020,P13020,Gsn,1,16,9,9,P13020|P13020-2,MOUSE,86339.4,12.5,1308,1308.1,99.08,99.08,NA,780,Gelsolin,ruffle|podosome|extracellular region|extracellular space|cytoplasm|cytosol|plasma membrane|focal adhesion|sarcoplasm|lamellipodium|actin cap|cortical actin cytoskeleton|myelin sheath|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|nucleus|focal adhesion|cortical actin cytoskeleton|,"phagocytosis, engulfment|aging|positive regulation of gene expression|oligodendrocyte development|striated muscle atrophy|vesicle-mediated transport|actin filament polymerization|protein destabilization|tissue regeneration|sequestering of actin monomers|actin nucleation|response to ethanol|negative regulation of viral entry into host cell|phosphatidylinositol-mediated signaling|actin filament severing|barbed-end actin filament capping|positive regulation of actin nucleation|response to folic acid|actin filament capping|cilium morphogenesis|cellular response to cadmium ion|regulation of podosome assembly|actin filament reorganization|renal protein absorption|hepatocyte apoptotic process|positive regulation of keratinocyte apoptotic process|regulation of wound healing, spreading of epidermal cells|regulation of establishment of T cell polarity|regulation of plasma membrane raft polarization|regulation of receptor clustering|positive regulation of protein processing in phagocytic vesicle|amyloid fibril formation|positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|",actin binding|calcium ion binding|protein binding|protein domain specific binding|myosin II binding|,9,16,2.43E+09,0.125,0.007065134,0.071166667,26.84759617,0.77,0.002066524,4.889554613,-0.2485,-0.468,-0.225,0.513,0.126,0.7295,PC,7,TRUE,NA
0.62,0.737,0.603,0.489,0.5095,0.5505,0.524,0.677,0.4965,O08553,O08553,Dpysl2,1,15,10,9,O08553|Q6P1J1|P97427,MOUSE,62675.8,24.6,1316,1316.1,98.39,93.2,NA,572,Dihydropyrimidinase-related protein 2,mitochondrion|cytosol|axon|dendrite|growth cone|neuronal cell body|terminal bouton|myelin sheath|extracellular exosome|microtubule|membrane|,response to amphetamine|endocytosis|cytoskeleton organization|axon guidance|metabolic process|regulation of neuron projection development|positive regulation of glutamate secretion|spinal cord development|olfactory bulb development|regulation of axon extension|response to cocaine|response to drug|synaptic vesicle transport|,"protein binding|microtubule binding|hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds|protein kinase binding|",11,15,6.59E+08,0.246,0.000353369,-0.027,41.93700955,0.590333333,6.40E-05,8.798430542,-0.3145,-0.303,-0.349,0.358,0.162,0.2845,undefined,9,NA,NA
2.075,2.098,1.983,1.897,1.8005,1.8395,2.271,2.013,2.0355,P27808,P27808,Mgat1,1,18,8,8,P27808,MOUSE,51974.5,24.1,1323,1323.1,97.59,97.59,NA,447,"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase",Golgi membrane|membrane|integral component of membrane|extracellular exosome|extracellular vesicle|,in utero embryonic development|UDP-N-acetylglucosamine catabolic process|protein glycosylation|,"alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity|acetylglucosaminyltransferase activity|metal ion binding|",8,18,1.80E+09,0.241,3.97E-06,-0.235,70.27925495,2.034333333,9.38E-08,24.38651181,-1.2825,-1.146,-1.328,0.846,0.647,0.8535,undefined,9,NA,TRUE
0.754,0.738,0.759,0.612,0.6525,0.6585,0.712,0.706,0.7045,Q9WTL7,Q9WTL7,Lypla2,1,23,9,9,Q9WTL7,MOUSE,25135.9,45.4,1324,1324.1,97.52,97.52,NA,231,Acyl-protein thioesterase 2,cytoplasm|extracellular exosome|,fatty acid metabolic process|,hydrolase activity|,9,23,4.88E+10,0.454,3.68E-05,-0.015833333,53.58003,0.723333333,4.39E-06,13.40144965,-0.3745,-0.368,-0.39,0.377,0.291,0.3695,undefined,9,NA,NA
1.048,0.892,1.006,0.849,0.8825,0.7765,0.924,0.938,0.9675,P10493,P10493,Nid1,1,13,10,9,P10493,MOUSE,139387.9,9,1336,1336.1,95.62,90.88,NA,1245,Nidogen-1,extracellular region|proteinaceous extracellular matrix|basement membrane|basal lamina|extracellular matrix|extracellular exosome|cell periphery|extracellular matrix|,cell-matrix adhesion|positive regulation of cell-substrate adhesion|extracellular matrix organization|glomerular basement membrane development|,calcium ion binding|protein binding|collagen binding|laminin binding|laminin-1 binding|proteoglycan binding|extracellular matrix binding|,10,13,2.82E+09,0.09,1.76E-05,-0.0485,57.94846291,0.954666667,1.60E-06,15.63925535,-0.6025,-0.486,-0.489,0.474,0.383,0.4295,PC,9,TRUE,NA
0.673,0.595,0.474,0.595,0.4185,0.5215,0.436,0.47,0.2475,Q99N57-2,Q99N57,Raf1,1,6,5,3,Q99N57-2|Q99N57,MOUSE,76062.4,11,1357,1357.2,63.32,36.9,NA,648,Isoform 2 of RAF proto-oncogene serine/threonine-protein kinase,nucleus|cytoplasm|mitochondrion|Golgi apparatus|cytosol|plasma membrane|pseudopodium|plasma membrane|,MAPK cascade|activation of MAPKK activity|response to hypoxia|cellular glucose homeostasis|positive regulation of protein phosphorylation|heart development|negative regulation of cell proliferation|cell differentiation|negative regulation of protein complex assembly|positive regulation of peptidyl-serine phosphorylation|somatic stem cell maintenance|intracellular signal transduction|insulin secretion involved in cellular response to glucose stimulus|response to muscle stretch|negative regulation of apoptotic process|intermediate filament cytoskeleton organization|positive regulation of transcription from RNA polymerase II promoter|neurotrophin TRK receptor signaling pathway|death-inducing signaling complex assembly|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|,protein kinase activity|protein serine/threonine kinase activity|MAP kinase kinase kinase activity|protein binding|ATP binding|Ras GTPase binding|mitogen-activated protein kinase kinase binding|identical protein binding|metal ion binding|protein heterodimerization activity|,3,6,3.76E+09,0.077,0.002848607,-0.010333333,31.44435775,0.477,0.000717074,5.897426699,-0.3375,-0.227,-0.182,0.298,0.296,0.0905,undefined,7,NA,NA
1.71,1.72,1.646,1.5,1.4715,1.4745,1.779,1.902,1.8405,Q8C8K1,Q8C8K1,Ephb4,1,12,8,7,Q8C8K1|P54761|E9PWK7|P54754|G1K381|Q62413|Q61772|A2BDQ4|Q61772-3|Q61772-2|Q8CBF3|Q03137|Q03145|Q8CBF3-2|Q03137-2|E9PUK8,MOUSE,111285.4,11.1,1362,1362.1,93.63,81.28,NA,996,Ephrin type-B receptor 4,integral component of plasma membrane|extracellular exosome|,cell migration involved in sprouting angiogenesis|cell adhesion|peptidyl-tyrosine phosphorylation|protein autophosphorylation|ephrin receptor signaling pathway|,transmembrane receptor protein tyrosine kinase activity|ephrin receptor activity|protein binding|ATP binding|,8,12,1.15E+09,0.111,1.58E-05,-0.138333333,58.5876635,1.651666667,1.38E-06,16.22172695,-0.9735,-0.998,-0.921,0.673,0.5,0.8895,undefined,9,TRUE,TRUE
2.703,2.921,3.526,1.923,2.1805,2.4975,2.506,2.994,3.3975,Q8K0D2,Q8K0D2,Habp2,1,12,8,8,Q8K0D2|E9QM92|E9Q092|Q8K0D2-2|Q3V1J8|E9Q0C5,MOUSE,64409.4,21.3,1363,1363.1,93.37,93.37,NA,558,Hyaluronan-binding protein 2,extracellular region|,proteolysis|,serine-type endopeptidase activity|peptidase activity|,8,12,6.83E+08,0.213,0.000158471,-0.177,45.99477552,2.725666667,2.51E-05,10.31395938,-1.2905,-1.429,-1.9,1.472,0.628,1.4575,PC,9,TRUE,TRUE
2.654,2.899,2.991,2.413,2.6055,2.5765,2.344,2.664,2.6895,Q60648,Q60648,Gm2a,1,13,7,7,Q60648,MOUSE,21280.3,29.5,1367,1367.1,93.07,93.07,NA,193,Ganglioside GM2 activator,mitochondrion|lysosome|hydrogen:potassium-exchanging ATPase complex|cytoplasmic side of plasma membrane|apical cortex|extracellular exosome|,ganglioside catabolic process|lipid transport|learning or memory|oligosaccharide catabolic process|lipid storage|neurological system process|neuromuscular process controlling balance|positive regulation of hydrolase activity|,lipid transporter activity|enzyme activator activity|phospholipase activator activity|beta-N-acetylgalactosaminidase activity|,7,13,6.10E+09,0.295,4.02E-06,-0.509,69.89369235,2.675666667,1.02E-07,24.16246509,-1.6925,-1.779,-2.069,0.939,0.741,0.8065,NC,9,TRUE,NA
2.151,2.268,2.218,1.533,1.6695,1.7125,2.062,2.238,2.2165,Q8C4U3,Q8C4U3,Sfrp1,1,18,6,6,Q8C4U3,MOUSE,36324.9,26.1,1368,1368.1,93.01,93.01,NA,314,Secreted frizzled-related protein 1,proteinaceous extracellular matrix|extracellular space|intracellular|cytosol|plasma membrane|cell surface|extracellular matrix|extracellular exosome|integral component of membrane|extracellular matrix|,"osteoblast differentiation|ureteric bud development|somitogenesis|neural tube closure|hematopoietic progenitor cell differentiation|proteolysis|positive regulation of cell proliferation|negative regulation of cell proliferation|male gonad development|female gonad development|cellular response to starvation|dorsal/ventral axis specification|anterior/posterior pattern specification|regulation of cell cycle process|negative regulation of gene expression|negative regulation of epithelial to mesenchymal transition|neural crest cell fate commitment|response to organic cyclic compound|neural tube development|actin cytoskeleton organization|hemopoiesis|positive regulation of Wnt signaling pathway|negative regulation of Wnt signaling pathway|negative regulation of ossification|positive regulation of cell growth|negative regulation of cell growth|negative regulation of cell migration|negative regulation of BMP signaling pathway|negative regulation of osteoblast proliferation|substrate adhesion-dependent cell spreading|somatic stem cell maintenance|response to drug|positive regulation of apoptotic process|negative regulation of apoptotic process|negative regulation of JUN kinase activity|cellular response to fibroblast growth factor stimulus|stromal-epithelial cell signaling involved in prostate gland development|negative regulation of B cell differentiation|positive regulation of fat cell differentiation|negative regulation of osteoblast differentiation|negative regulation of osteoclast differentiation|positive regulation of smoothened signaling pathway|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|development of primary male sexual characteristics|negative regulation of insulin secretion|negative regulation of bone remodeling|negative regulation of fibroblast proliferation|digestive tract morphogenesis|positive regulation of epithelial cell proliferation|negative regulation of epithelial cell proliferation|negative regulation of peptidyl-tyrosine phosphorylation|canonical Wnt signaling pathway|Wnt signaling pathway, planar cell polarity pathway|hematopoietic stem cell differentiation|bone trabecula formation|prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis|regulation of branching involved in prostate gland morphogenesis|negative regulation of androgen receptor signaling pathway|cellular response to vitamin D|cellular response to interleukin-1|cellular response to tumor necrosis factor|cellular response to growth factor stimulus|cellular response to prostaglandin E stimulus|cellular response to estrogen stimulus|cellular response to estradiol stimulus|cellular response to hypoxia|cellular response to X-ray|cellular response to heparin|cellular response to transforming growth factor beta stimulus|cellular response to BMP stimulus|negative regulation of canonical Wnt signaling pathway|regulation of establishment of planar polarity|planar cell polarity pathway involved in neural tube closure|Wnt signaling pathway involved in somitogenesis|convergent extension involved in somitogenesis|positive regulation of canonical Wnt signaling pathway|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors|negative regulation of planar cell polarity pathway involved in axis elongation|positive regulation of non-canonical Wnt signaling pathway|negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification|negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation|negative regulation of fibroblast apoptotic process|positive regulation of fibroblast apoptotic process|positive regulation of extrinsic apoptotic signaling pathway|",cysteine-type endopeptidase activity|frizzled binding|protein binding|drug binding|heparin binding|Wnt-protein binding|identical protein binding|G-protein coupled receptor activity|Wnt-activated receptor activity|,6,18,3.51E+10,0.261,5.67E-05,-0.100166667,51.33471103,2.05,7.35E-06,12.51934584,-1.0095,-1.068,-1.298,1.108,0.563,1.1035,PC,9,TRUE,NA
1.247,1.545,1.562,0.815,1.1445,1.2165,0.996,1.323,1.3435,Q61249,Q61249,Igbp1,1,15,7,7,Q61249|A0A0B4J1F7|Q9QZ29,MOUSE,39141.4,24.1,1378,1378.1,92.2,92.2,NA,340,Immunoglobulin-binding protein 1,cytoplasm|cytosol|microtubule|,negative regulation of transcription from RNA polymerase II promoter|negative regulation of stress-activated MAPK cascade|regulation of protein phosphatase type 2A activity|response to tumor necrosis factor|positive regulation of dephosphorylation|negative regulation of protein dephosphorylation|B cell activation|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of transcription from RNA polymerase II promoter|regulation of microtubule-based movement|response to interleukin-1|negative regulation of apoptotic signaling pathway|,protein binding|protein phosphatase type 2A regulator activity|protein domain specific binding|mitogen-activated protein kinase kinase binding|protein complex binding|protein phosphatase 2A binding|,7,15,9.57E+09,0.241,0.000364331,-0.111666667,41.76309735,1.266333333,6.66E-05,8.82137326,-0.4775,-0.83,-0.927,0.724,0.358,0.4825,undefined,9,NA,NA
3.655,4.076,4.118,3.319,3.7795,3.7995,3.535,4.215,4.0495,Q8BH24,Q8BH24,Tm9sf4,1,13,7,7,Q8BH24,MOUSE,75490.6,9.6,1381,1381.1,91.96,91.96,NA,643,Transmembrane 9 superfamily member 4,integral component of membrane|,NA,NA,7,13,1.17E+09,0.096,1.30E-05,-0.948,60.14218376,3.921666667,9.68E-07,17.14052417,-2.5405,-2.74,-3.446,1.114,0.842,1.0825,undefined,9,TRUE,TRUE
2.313,2.179,2.372,1.874,1.7855,1.9885,2.22,2.352,2.4005,P16882,P16882,Ghr,1,14,7,7,P16882|Q3UP14|P16882-2,MOUSE,73751.8,11.8,1386,1386.1,91.68,91.68,NA,650,Growth hormone receptor,extracellular region|extracellular space|nucleus|plasma membrane|integral component of plasma membrane|cell surface|integral component of membrane|extrinsic component of membrane|receptor complex|growth hormone receptor complex|,allantoin metabolic process|citrate metabolic process|2-oxoglutarate metabolic process|succinate metabolic process|oxaloacetate metabolic process|isoleucine metabolic process|valine metabolic process|creatine metabolic process|fatty acid metabolic process|endocytosis|cytokine-mediated signaling pathway|taurine metabolic process|response to estradiol|cellular response to hormone stimulus|regulation of multicellular organism growth|positive regulation of multicellular organism growth|multicellular organismal metabolic process|creatinine metabolic process|insulin-like growth factor receptor signaling pathway|positive regulation of peptidyl-tyrosine phosphorylation|growth hormone receptor signaling pathway|,growth hormone receptor activity|protein binding|peptide hormone binding|growth factor binding|protein homodimerization activity|,7,14,1.76E+09,0.118,1.94E-05,-0.233166667,57.21303209,2.232,1.90E-06,15.44867678,-1.3105,-1.175,-1.562,0.981,0.619,1.0485,PC,9,TRUE,TRUE
1.618,1.355,1.41,1.308,1.2975,1.0765,1.366,1.372,1.2615,P50429,P50429,Arsb,1,19,8,8,A0A0R4J138|P50429|P50429-2,MOUSE,60216.5,17.2,1392,1392.1,91.41,91.41,NA,534,Arylsulfatase B,lysosome|cell surface|extracellular exosome|,metabolic process|regulation of epithelial cell migration|positive regulation of neuron projection development|colon epithelial cell migration|,N-acetylgalactosamine-4-sulfatase activity|arylsulfatase activity|metal ion binding|,8,19,6.48E+09,0.172,1.33E-05,-0.133,60.00869726,1.419,9.98E-07,17.00010039,-0.9065,-0.883,-0.738,0.696,0.456,0.5775,undefined,9,TRUE,NA
2.22,2.007,2.333,2.119,1.9225,2.3275,2.207,1.991,2.4075,Q3TCN2,Q3TCN2,Plbd2,1,10,6,6,Q3TCN2|Q3TCN2-2,MOUSE,66687.6,16.3,1396,1396.1,90.93,90.93,NA,594,Putative phospholipase B-like 2,lysosome|lysosomal lumen|extracellular exosome|,lipid catabolic process|,hydrolase activity|,6,10,2.46E+09,0.163,1.91E-05,-0.39,57.39226455,2.267666667,1.82E-06,15.54744138,-1.4965,-1.243,-1.832,0.723,0.675,0.8335,undefined,9,NA,TRUE
0.596,0.692,0.569,0.401,0.5255,0.4025,0.553,0.608,0.4895,E9PVG7,E9PVG7,Map4k4,1,4,6,2,E9PVG7|A0A0A6YW53|A0A0A6YWM8|F8VPL5|A0A0A6YWR8|P97820|B2RUE8|B7ZNR9,MOUSE,147456.6,3.5,1400,1400.2,73.77,24.42,NA,1288,Mitogen-activated protein kinase kinase kinase kinase 4,cytoplasm|,MAPK cascade|protein phosphorylation|regulation of mitotic cell cycle|stress-activated protein kinase signaling cascade|activation of protein kinase activity|intracellular signal transduction|regulation of apoptotic process|negative regulation of apoptotic process|regulation of JNK cascade|neuron projection morphogenesis|,creatine kinase activity|protein serine/threonine kinase activity|ATP binding|MAP kinase kinase kinase kinase activity|,2,4,3.42E+09,0.013,0.000397082,-0.057,41.32139313,0.554333333,7.38E-05,8.600033359,-0.3225,-0.39,-0.29,0.282,0.133,0.2455,undefined,9,NA,NA
0.677,0.51,0.733,0.81,0.7215,0.8415,0.661,0.526,0.7915,Q91V35,Q91V35,Ptpra,1,14,8,8,Q91V35|P18052|P18052-2,MOUSE,90696.2,11.7,1404,1404.1,90.11,90.11,NA,793,Receptor-type tyrosine-protein phosphatase,receptor complex|extracellular exosome|,protein phosphorylation|insulin receptor signaling pathway|peptidyl-tyrosine dephosphorylation|,protein tyrosine phosphatase activity|,8,14,6.15E+08,0.117,0.000345014,-0.0185,42.06168673,0.7,6.22E-05,8.868980639,-0.3805,-0.238,-0.487,0.303,0.399,0.2925,undefined,9,TRUE,TRUE
1.21,1.555,0.834,1.564,1.6895,1.0525,1.047,1.378,0.7935,O35452,O35452,Tnxb,1,18,12,12,O35452|E9Q2T3,MOUSE,442488.3,3.3,1408,1408.1,89.86,89.86,NA,4006,Tenascin X,extracellular region|proteinaceous extracellular matrix|extracellular space|intracellular|extracellular exosome|fibrillar collagen trimer|extracellular matrix|,lipid metabolic process|fatty acid metabolic process|triglyceride metabolic process|cell-matrix adhesion|single organismal cell-cell adhesion|extracellular matrix organization|collagen fibril organization|collagen metabolic process|extracellular fibril organization|regulation of JUN kinase activity|elastic fiber assembly|phospholipid metabolic process|positive regulation of cell adhesion|,collagen binding|heparin binding|,12,18,1.09E+10,0.033,0.000690749,-0.163833333,38.45134805,1.204,0.000142845,7.787168659,-0.7685,-1.048,-0.481,0.4,0.617,0.2975,undefined,9,TRUE,NA
1.978,2.009,2.14,1.665,1.8265,2.0035,2.015,2.062,2.2765,E9PXU2,E9PXU2,Adam17,1,17,8,8,E9PXU2|Q9Z0F8|Q9Z0F8-2|J3QNB3,MOUSE,97283.8,9.5,1443,1443.1,86.78,86.78,NA,846,Disintegrin and metalloproteinase domain-containing protein 17,cytoplasm|integral component of plasma membrane|cell surface|actin cytoskeleton|membrane|apical plasma membrane|membrane raft|cell-cell junction|focal adhesion|ruffle membrane|,"response to hypoxia|positive regulation of protein phosphorylation|proteolysis|membrane protein ectodomain proteolysis|cell adhesion|epidermal growth factor receptor signaling pathway|Notch receptor processing|positive regulation of cell proliferation|positive regulation of T cell chemotaxis|positive regulation of cell growth|positive regulation of cell migration|negative regulation of transforming growth factor beta receptor signaling pathway|positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle|response to lipopolysaccharide|positive regulation of chemokine production|cell adhesion mediated by integrin|wound healing, spreading of epidermal cells|epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway|positive regulation of epidermal growth factor-activated receptor activity|defense response to Gram-positive bacterium|PMA-inducible membrane protein ectodomain proteolysis|response to high density lipoprotein particle|",metalloendopeptidase activity|Notch binding|interleukin-6 receptor binding|integrin binding|protein binding|metallopeptidase activity|zinc ion binding|PDZ domain binding|,8,17,3.11E+09,0.095,6.69E-05,-0.305333333,50.51684442,2.055,8.88E-06,12.15568463,-1.0085,-1.326,-1.664,0.635,0.635,0.8965,PC,9,TRUE,TRUE
0.916,0.889,0.791,0.489,0.4925,0.4305,0.742,0.766,0.6215,Q60598,Q60598,Cttn,1,14,8,8,Q60598|Q921L6,MOUSE,61419.8,16.6,1457,1457.1,85.06,85.06,NA,546,Src substrate cortactin,ruffle|podosome|cytoplasm|cytosol|coated pit|focal adhesion|cell cortex|lamellipodium|cell junction|cortical cytoskeleton|dendritic spine|extracellular exosome|mitotic spindle midzone|actin filament|focal adhesion|voltage-gated potassium channel complex|growth cone|,"intracellular protein transport|receptor-mediated endocytosis|substrate-dependent cell migration, cell extension|actin filament polymerization|regulation of axon extension|positive regulation of actin filament polymerization|actin cytoskeleton reorganization|positive regulation of smooth muscle contraction|focal adhesion assembly|neuron projection morphogenesis|cell motility|dendritic spine maintenance|lamellipodium organization|regulation of mitochondrion degradation|negative regulation of extrinsic apoptotic signaling pathway|",protein binding|profilin binding|,8,14,1.45E+09,0.166,0.001834173,0.016333333,33.63855595,0.691666667,0.000432658,6.463072299,-0.3035,-0.372,-0.313,0.523,0.126,0.4375,undefined,9,NA,NA
0.507,0.645,0.524,0.162,0.3315,0.3025,0.426,0.453,0.5475,D3Z7W0,D3Z7W0,Iscu,1,16,8,8,D3Z7W0|Q9D7P6,MOUSE,22451.5,33.9,1463,1463.1,84.42,84.42,NA,209,"Iron-sulfur cluster assembly enzyme ISCU, mitochondrial",cytoplasm|mitochondrion|mitochondrial matrix|cytosol|,cellular iron ion homeostasis|[2Fe-2S] cluster assembly|protein maturation by iron-sulfur cluster transfer|,"ferrous iron binding|protein complex scaffold|iron-sulfur transferase activity|2 iron, 2 sulfur cluster binding|4 iron, 4 sulfur cluster binding|",8,16,1.02E+10,0.339,0.008532232,0.0435,25.8257542,0.394666667,0.002614716,4.67365628,-0.1125,-0.142,-0.207,0.352,0.076,0.2945,NC,6,NA,NA
1.891,1.902,1.776,1.499,1.7965,1.6705,1.679,2.103,1.9815,P39098,P39098,Man1a2,1,11,7,7,P39098|P39098-2|A0A0G2JGT9,MOUSE,73098.3,12.3,1470,1470.1,83.98,83.98,NA,641,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",Golgi membrane|endoplasmic reticulum|Golgi apparatus|membrane|integral component of membrane|extracellular exosome|,N-glycan processing|respiratory gaseous exchange|glycoprotein metabolic process|lung alveolus development|,"mannosyl-oligosaccharide 1,2-alpha-mannosidase activity|calcium ion binding|",7,11,2.30E+09,0.123,7.13E-06,-0.244333333,64.49683921,1.890333333,3.55E-07,19.9891417,-1.0915,-1.245,-1.232,0.777,0.518,0.8075,undefined,9,NA,TRUE
0.486,0.613,0.576,0.369,0.5555,0.5485,0.368,0.595,0.5235,Q8BHC4,Q8BHC4,Dcakd,1,16,7,7,Q8BHC4,MOUSE,26589.7,32.9,1472,1472.1,83.68,83.68,NA,231,Dephospho-CoA kinase domain-containing protein,mitochondrion|membrane|,coenzyme A biosynthetic process|phosphorylation|,dephospho-CoA kinase activity|ATP binding|,7,16,6.14E+09,0.329,0.000473555,-0.065833333,40.39134875,0.520666667,9.14E-05,8.307544714,-0.2345,-0.372,-0.372,0.219,0.155,0.2095,NC,7,NA,TRUE
1.515,1.571,1.337,1.272,1.2295,1.1345,1.453,1.425,1.2065,G5E897,G5E897,Kdelc2,1,14,8,8,G5E897,MOUSE,58084.4,19.8,1481,1481.1,82.61,82.61,NA,503,"KDEL (Lys-Asp-Glu-Leu) containing 2, isoform CRA_b",NA,NA,NA,8,14,2.85E+09,0.198,5.84E-06,-0.127666667,66.43964374,1.343666667,2.27E-07,21.05208524,-0.8535,-0.798,-0.747,0.595,0.46,0.5775,undefined,9,TRUE,NA
0.66,0.765,0.791,0.401,0.4925,0.5765,0.479,0.559,0.6355,Q6P8Q0,Q6P8Q0,Gsta1,1,21,8,0,Q6P8Q0|P13745|P10648,MOUSE,25695.6,37.2,1487,1487.1,82.3,0,NA,223,Glutathione S-transferase,NA,NA,NA,8,21,6.50E+09,0.372,0.000553871,-0.004166667,39.59583003,0.604666667,0.000109753,8.082623309,-0.2855,-0.271,-0.363,0.432,0.233,0.2295,undefined,9,NA,NA
1.334,1.446,1.52,1.431,1.4675,1.5275,1.892,1.911,2.0115,Q99N23,Q99N23,Ca15,1,25,5,5,Q99N23,MOUSE,35881.1,25.6,1495,1495.1,81.54,81.54,NA,324,Carbonic anhydrase 15,extracellular region|membrane|anchored component of plasma membrane|,metabolic process|,carbonate dehydratase activity|metal ion binding|,5,25,1.10E+10,0.256,3.81E-05,-0.1495,53.39461252,1.609333333,4.58E-06,13.48061383,-0.8435,-0.889,-1.13,0.499,0.603,0.8635,PC,9,TRUE,NA
0.843,0.913,1.074,0.896,0.8105,1.0065,0.931,0.828,1.1055,Q3TWN3,Q3TWN3,Cnnm2,1,15,8,7,Q3TWN3|Q3TWN3-2|A0A286YDL2|Q0GA42,MOUSE,97672.5,10.7,1508,1508.1,80.07,75.5,NA,875,Metal transporter CNNM2,integral component of membrane|basolateral plasma membrane|,magnesium ion homeostasis|magnesium ion transport|,NA,8,15,1.83E+09,0.107,9.31E-05,-0.063333333,48.80716275,1.033666667,1.32E-05,11.42675193,-0.4775,-0.549,-0.714,0.494,0.32,0.5465,undefined,9,NA,TRUE
1.423,1.273,1.311,1.655,1.3935,1.3035,1.522,1.181,1.1905,Q9D6I7,Q9D6I7,Fam69a,1,7,6,6,Q9D6I7,MOUSE,49905.1,14.2,1509,1509.1,79.65,79.65,NA,428,Protein FAM69A,endoplasmic reticulum membrane|integral component of membrane|,NA,NA,6,7,3.15E+08,0.142,3.51E-05,-0.141833333,53.82829231,1.400666667,4.14E-06,13.6916005,-0.9345,-0.768,-0.824,0.496,0.763,0.4165,undefined,9,NA,TRUE
0.572,0.644,1.032,0.321,0.2835,0.7445,0.532,0.527,0.9925,Q9WUB7,Q9WUB7,Clcnka,1,4,6,3,Q9WUB7,MOUSE,76082.4,10.3,1520,1520.2,71.52,32.91,NA,687,Chloride channel protein ClC-Ka,basolateral plasma membrane|chloride channel complex|,regulation of body fluid levels|renal inner medulla development|chloride transmembrane transport|regulation of anion transmembrane transport|,voltage-gated chloride channel activity|protein binding|metal ion binding|,3,4,2.62E+08,0.062,0.012922498,-0.004166667,23.59195383,0.579333333,0.004373253,4.233025621,-0.2005,-0.096,-0.585,0.367,0.145,0.3445,undefined,7,NA,TRUE
0.405,0.665,0.75,0.378,0.6875,0.6255,0.313,0.591,0.6395,Q9WV55,Q9WV55,Vapa,1,13,7,6,Q9WV55,MOUSE,28083,26.9,1523,1523.1,78.17,72.98,NA,249,Vesicle-associated membrane protein-associated protein A,Golgi membrane|endoplasmic reticulum|endoplasmic reticulum membrane|plasma membrane|microtubule cytoskeleton|integral component of membrane|vesicle|bicellular tight junction|perinuclear region of cytoplasm|,ER to Golgi vesicle-mediated transport|signal transduction|cell death|neuron projection development|positive regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation by host of viral release from host cell|negative regulation by host of viral genome replication|positive regulation by host of viral genome replication|protein localization to endoplasmic reticulum|COPII-coated vesicle budding|,signal transducer activity|microtubule binding|protein domain specific binding|FFAT motif binding|protein heterodimerization activity|,7,13,2.93E+09,0.269,0.002195948,-0.071,32.73645548,0.548333333,0.000532543,6.235775318,-0.1625,-0.399,-0.474,0.214,0.2,0.1955,undefined,6,NA,TRUE
1.005,1.219,1.291,1.154,1.1765,1.2075,1.213,1.268,1.4315,Q08EC9,Q08EC9,Galnt14,1,12,7,7,Q08EC9|Q8BVG5|Q8BVG5-2,MOUSE,64893.1,13.8,1545,1545.1,76.74,76.74,NA,550,Polypeptide N-acetylgalactosaminyltransferase,Golgi membrane|integral component of membrane|,protein glycosylation|,"transferase activity, transferring glycosyl groups|carbohydrate binding|",7,12,1.39E+09,0.138,1.89E-05,-0.104166667,57.51119077,1.196666667,1.77E-06,15.47874379,-0.6065,-0.691,-0.81,0.401,0.512,0.5695,undefined,9,NA,TRUE
2.532,2.448,2.701,2.329,2.4345,2.7065,2.738,2.622,2.9135,Q9JMG2,Q9JMG2,C1galt1c1,1,12,7,7,Q9JMG2,MOUSE,36466.2,25.6,1551,1551.1,76.06,76.06,NA,316,C1GALT1-specific chaperone 1,integral component of membrane|extracellular exosome|,protein O-linked glycosylation|platelet activation|platelet morphogenesis|,NA,7,12,1.83E+09,0.256,1.92E-05,-0.513166667,57.33112224,2.651333333,1.85E-06,15.513682,-1.6475,-1.641,-2.228,0.741,0.722,0.9745,undefined,9,NA,TRUE
2.28,2.342,2.56,2.047,2.2225,2.3775,2.359,2.456,2.5105,Q9WVT6,Q9WVT6,Ca14,1,16,6,6,Q9WVT6,MOUSE,37732.9,20.1,1555,1555.1,75.89,75.89,NA,337,Carbonic anhydrase 14,integral component of membrane|,regulation of pH|metabolic process|carbon dioxide transport|,carbonate dehydratase activity|metal ion binding|,6,16,8.94E+09,0.201,1.49E-05,-0.4165,59.0819734,2.406,1.24E-06,16.50864294,-1.4105,-1.489,-1.959,0.828,0.699,0.8325,undefined,9,TRUE,TRUE
1.271,1.269,1.314,0.962,1.0215,1.0905,0.994,1.02,1.1455,E9PUK3,E9PUK3,Fnbp1l,1,8,7,7,E9PUK3|E9PUI5|Q8K012|Q8K012-2,MOUSE,64372.8,17.6,1560,1560.1,75.24,75.24,NA,551,Formin-binding protein 1-like,cytoplasm|,endocytosis|cilium assembly|,NA,7,8,3.30E+08,0.176,3.75E-05,-0.078666667,53.48578514,1.143666667,4.48E-06,13.49582618,-0.5955,-0.608,-0.748,0.641,0.404,0.4345,undefined,9,NA,NA
1.846,1.797,1.8,1.608,1.5205,1.8015,1.909,1.797,1.8505,Q9DCT5,Q9DCT5,Sdf2,1,19,6,6,A0A0R4IZW9|Q9DCT5,MOUSE,23386.8,44.5,1570,1570.1,74.8,74.8,NA,211,Stromal cell-derived factor 2,extracellular region|membrane|,NA,NA,6,19,3.04E+09,0.445,1.01E-05,-0.2535,61.85962501,1.805333333,6.52E-07,18.21374775,-1.2235,-0.972,-1.273,0.732,0.532,0.6835,PC,9,TRUE,NA
0.541,0.828,0.589,0.297,0.4785,0.1845,0.395,0.563,0.3385,Q6PGF7,Q6PGF7,Exoc8,1,8,5,5,Q6PGF7,MOUSE,81718.4,9.9,1582,1582.1,73.98,73.98,NA,716,Exocyst complex component 8,exocyst|cytoplasm|late endosome|plasma membrane|membrane|growth cone|,exocyst assembly|exocytosis|endosome organization|protein transport|extracellular matrix disassembly|exocyst localization|,Ral GTPase binding|phosphatidylinositol binding|,5,8,2.13E+09,0.099,0.008094991,-0.0025,26.11587837,0.486666667,0.002445751,4.737139736,-0.2355,-0.342,-0.16,0.432,0.076,0.2145,undefined,5,NA,NA
1.124,1.346,1.189,0.793,0.7875,0.8255,1.007,1.253,1.1825,Q91WU5,Q91WU5,As3mt,1,13,8,8,Q91WU5,MOUSE,42477.5,24.7,1600,1600.1,72.65,72.65,NA,376,Arsenite methyltransferase,mitochondrion|cytosol|,toxin metabolic process|arsonoacetate metabolic process|methylation|response to arsenic-containing substance|,S-adenosylmethionine-dependent methyltransferase activity|arsenite methyltransferase activity|methylarsonite methyltransferase activity|,8,13,1.53E+09,0.247,9.24E-05,-0.013666667,48.8449568,1.061666667,1.30E-05,11.44242201,-0.4735,-0.586,-0.574,0.68,0.351,0.5205,NC,9,NA,NA
1.342,1.498,1.559,1.039,1.1015,1.1125,1.468,1.576,1.7265,O09118,O09118,Ntn1,1,14,5,5,O09118,MOUSE,70148.4,10.2,1602,1602.1,72.58,72.58,NA,604,Netrin-1,extracellular region|basement membrane|cytoplasm|cell periphery|,neuron migration|apoptotic process|axonogenesis|axon guidance|positive regulation of cell proliferation|single organismal cell-cell adhesion|regulation of cell migration|negative regulation of axon extension|mammary gland development|anterior/posterior axon guidance|establishment of nucleus localization|inner ear morphogenesis|positive regulation of axon extension|mammary gland duct morphogenesis|,protein binding|,5,14,1.55E+09,0.102,7.16E-05,-0.024166667,50.20179109,1.420666667,9.55E-06,12.01822385,-0.6505,-0.749,-0.804,0.776,0.428,0.8545,PC,9,TRUE,NA
1.161,1.435,1.191,1.076,1.2655,1.0855,1.311,1.438,1.3325,Q9JHP7,Q9JHP7,Kdelc1,1,11,6,6,Q9JHP7|Q9JHP7-2|Q9JHP7-3|D6RE32,MOUSE,58497.7,15.5,1619,1619.1,71.36,71.36,NA,502,KDEL motif-containing protein 1,endoplasmic reticulum lumen|,NA,NA,6,11,1.88E+08,0.155,1.70E-05,-0.065,58.10721746,1.314333333,1.55E-06,15.88202343,-0.6315,-0.821,-0.714,0.621,0.466,0.6895,undefined,9,TRUE,NA
1.079,1.075,0.849,0.868,0.8995,0.7415,1.016,1.106,0.7415,Q5SUR0,Q5SUR0,Pfas,1,8,7,7,Q5SUR0,MOUSE,146338.3,8.6,1621,1621.1,71.31,71.31,NA,1337,Phosphoribosylformylglycinamidine synthase,cytoplasm|extracellular exosome|,purine nucleotide biosynthetic process|'de novo' IMP biosynthetic process|glutamine metabolic process|ribonucleoside monophosphate biosynthetic process|,phosphoribosylformylglycinamidine synthase activity|ATP binding|metal ion binding|,7,8,5.99E+08,0.086,7.48E-05,-0.053333333,49.97222419,0.944333333,1.01E-05,11.83337439,-0.5885,-0.602,-0.386,0.469,0.337,0.4505,undefined,9,NA,NA
1.946,2.026,2.386,1.86,1.8255,2.1185,1.857,2.011,2.1275,Q9JLB9,Q9JLB9,Nectin3,1,10,5,5,Q9JLB9|Q9JLB9-2|Q9JLB9-3,MOUSE,61095.3,13.8,1622,1622.1,71.24,71.24,NA,549,Nectin-3,plasma membrane|cell-cell junction|cell-cell adherens junction|integral component of membrane|apical junction complex|postsynaptic membrane|,lens morphogenesis in camera-type eye|cell adhesion|homophilic cell adhesion via plasma membrane adhesion molecules|fertilization|single organismal cell-cell adhesion|retina morphogenesis in camera-type eye|,protein binding|protein homodimerization activity|cell adhesion molecule binding|,5,10,9.53E+08,0.138,1.19E-05,-0.346333333,60.85052691,2.043,8.22E-07,17.57557239,-1.2565,-1.217,-1.63,0.74,0.629,0.6565,undefined,9,TRUE,TRUE
0.405,0.533,0.596,0.394,0.4745,0.6075,0.346,0.491,0.5345,D3Z286,D3Z286,Tmppe,1,12,5,5,D3Z286,MOUSE,49685.9,14,1635,1635.1,70.15,70.15,NA,447,Transmembrane protein with metallophosphoesterase domain,NA,metabolic process|,hydrolase activity|,5,12,8.95E+08,0.14,0.001706167,-0.053333333,34.01684635,0.495666667,0.000396566,6.528240673,-0.1945,-0.266,-0.443,0.173,0.209,0.2015,undefined,6,NA,TRUE
1.049,1.095,1.018,0.994,1.0055,0.9345,1.229,1.216,1.1455,Q921T2-2,Q921T2,Tor1aip1,1,20,6,1,Q921T2-2|E9PWW2|Q921T2-3,MOUSE,65129.2,15.4,1641,1641.1,69.84,12.1,NA,595,Isoform 2 of Torsin-1A-interacting protein 1,nucleus|nuclear envelope|nuclear inner membrane|integral component of membrane|,positive regulation of ATPase activity|protein localization to nucleus|nuclear membrane organization|,ATPase activator activity|protein binding|lamin binding|cytoskeletal protein binding|ATPase binding|,6,20,1.59E+10,0.154,1.50E-05,-0.083166667,59.03128342,1.08,1.25E-06,16.24644362,-0.6205,-0.649,-0.6,0.403,0.399,0.5685,undefined,9,NA,NA
1.202,0.504,0.455,0.869,0.4205,0.5185,1.186,0.268,0.4905,P06802,P06802,Enpp1,1,9,6,6,P06802|A0A0R4J1Q7|P06802-2|G3X9S2|E9QQ26,MOUSE,105227.6,11.2,1653,1653.1,68.76,68.76,NA,906,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1,extracellular space|lysosomal membrane|plasma membrane|integral component of plasma membrane|cell surface|integral component of membrane|basolateral plasma membrane|,generation of precursor metabolites and energy|phosphate-containing compound metabolic process|receptor-mediated endocytosis|immune response|nucleoside triphosphate catabolic process|negative regulation of ossification|negative regulation of cell growth|inorganic diphosphate transport|cellular phosphate ion homeostasis|sequestering of triglyceride|biomineral tissue development|negative regulation of protein autophosphorylation|cellular response to insulin stimulus|negative regulation of fat cell differentiation|negative regulation of glycogen biosynthetic process|negative regulation of glucose import|negative regulation of insulin receptor signaling pathway|bone remodeling|3'-phosphoadenosine 5'-phosphosulfate metabolic process|nucleic acid phosphodiester bond hydrolysis|,nucleic acid binding|phosphodiesterase I activity|nucleotide diphosphatase activity|scavenger receptor activity|insulin receptor binding|calcium ion binding|ATP binding|zinc ion binding|polysaccharide binding|NADH pyrophosphatase activity|protein homodimerization activity|nucleoside-triphosphate diphosphatase activity|,6,9,1.03E+09,0.112,0.000484447,-0.070666667,40.26132679,0.621666667,9.42E-05,8.286771133,-0.5215,-0.323,-0.3,0.275,0.24,0.2055,PC,8,NA,TRUE
0.848,1.211,0.622,1.069,1.2895,0.8015,1.004,1.18,0.7855,Q6ZWQ9,Q6ZWQ9,Myl12a,1,16,6,2,Q6ZWQ9|Q3THE2,MOUSE,19952,40.1,1661,1661.1,68.55,20.64,NA,172,MCG5400,stress fiber|myosin II complex|Z disc|extracellular exosome|,regulation of cell shape|platelet aggregation|protein targeting to plasma membrane|,calcium ion binding|protein binding|glutamate receptor binding|,6,16,1.10E+10,0.401,0.000550123,-0.0685,39.63163568,0.997333333,0.000108852,8.14333108,-0.5795,-0.755,-0.367,0.251,0.549,0.4905,undefined,9,NA,NA
2.154,2.129,2.371,1.981,1.9055,2.1475,2.229,2.17,2.4275,Q8R242,Q8R242,Ctbs,1,10,5,5,Q8R242|Q8R242-2,MOUSE,42036,16.6,1665,1665.1,68.39,68.39,NA,366,Di-N-acetylchitobiase,extracellular region|extracellular space|lysosome|extracellular exosome|,chitin catabolic process|oligosaccharide catabolic process|,chitinase activity|chitin binding|,5,10,1.15E+09,0.166,3.08E-06,-0.326,72.73616535,2.135666667,5.33E-08,26.38153121,-1.4025,-1.28,-1.499,0.736,0.652,0.8375,undefined,9,TRUE,NA
0.763,0.543,0.6,0.907,0.6935,0.6925,0.875,0.809,0.5735,Q63ZW6,Q63ZW6,Col4a5,1,12,5,3,Q63ZW6,MOUSE,163116.1,3.6,1667,1667.1,46.41,13.69,NA,1691,Col4a5 protein,collagen type IV trimer|basement membrane|basal lamina|neuromuscular junction|,neuromuscular junction development|,extracellular matrix structural constituent|,5,12,2.69E+09,0.036,4.21E-05,-0.010333333,52.88361787,0.778333333,5.15E-06,13.07387028,-0.4565,-0.363,-0.379,0.316,0.4,0.4205,undefined,9,TRUE,NA
1.741,1.812,1.623,1.496,1.6365,1.5405,1.815,1.938,1.8175,P02463,P02463,Col4a1,1,6,4,2,P02463|A0A1B0GSI7,MOUSE,161817.3,2.3,1667,1667.2,68.31,35.59,NA,1669,Collagen alpha-1(IV) chain,extracellular region|collagen type IV trimer|basement membrane|extracellular matrix|,patterning of blood vessels|brain development|neuromuscular junction development|epithelial cell differentiation|blood vessel morphogenesis|retinal blood vessel morphogenesis|renal tubule morphogenesis|cellular response to amino acid stimulus|basement membrane organization|,extracellular matrix structural constituent|platelet-derived growth factor binding|,2,6,5.76E+08,0.017,6.31E-06,-0.17,65.2969965,1.699,2.95E-07,20.47879609,-0.9805,-1.048,-1.03,0.617,0.576,0.8455,PC,9,TRUE,NA
1.734,1.917,2.011,1.46,1.6585,1.7525,1.678,1.857,1.9555,Q9Z0Z4,Q9Z0Z4,Heph,1,10,6,6,Q9Z0Z4|Q9Z0Z4-2|A2AI62,MOUSE,130576.7,6.3,1676,1676.1,67.74,67.74,NA,1157,Hephaestin,intracellular|integral component of membrane|basolateral plasma membrane|perinuclear region of cytoplasm|,copper ion transport|iron ion transport|cellular iron ion homeostasis|oxidation-reduction process|,ferroxidase activity|copper ion binding|ferrous iron binding|,6,10,4.66E+08,0.063,3.26E-06,-0.1615,71.95480569,1.735333333,6.38E-08,25.50039982,-0.9495,-1.079,-1.059,0.765,0.617,0.7365,undefined,9,TRUE,TRUE
1.607,1.583,1.509,1.507,1.3215,1.5055,1.693,1.678,1.6885,Q04519,Q04519,Smpd1,1,8,5,5,Q04519,MOUSE,70895.6,9.7,1677,1677.1,67.67,67.67,NA,627,Sphingomyelin phosphodiesterase,extracellular space|lysosome|endosome|plasma membrane|lamellar body|extracellular exosome|,sphingomyelin catabolic process|termination of signal transduction|positive regulation of protein dephosphorylation|response to cocaine|response to drug|positive regulation of apoptotic process|negative regulation of MAP kinase activity|ceramide biosynthetic process|,"sphingomyelin phosphodiesterase activity|hydrolase activity, acting on glycosyl bonds|",5,8,8.14E+08,0.097,3.22E-06,-0.2125,72.13042381,1.643333333,6.12E-08,25.65621603,-1.0375,-1.039,-1.026,0.557,0.556,0.7145,PC,9,NA,TRUE
0.692,0.797,0.2,0.561,0.7015,0.0695,0.68,0.651,0.1155,P10605,P10605,Ctsb,1,17,6,6,P10605,MOUSE,38192,19.4,1684,1684.1,67.02,67.02,NA,339,Cathepsin B,extracellular space|nucleolus|mitochondrion|lysosome|caveola|external side of plasma membrane|apical plasma membrane|sarcolemma|melanosome|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|extracellular exosome|,proteolysis|autophagy|spermatogenesis|skeletal muscle tissue development|response to wounding|response to glucose|response to organic cyclic compound|response to amine|collagen catabolic process|epithelial cell differentiation|response to peptide hormone|response to ethanol|decidualization|viral entry into host cell|regulation of catalytic activity|proteolysis involved in cellular protein catabolic process|negative regulation of cell death|response to interleukin-4|cellular response to mechanical stimulus|cellular response to thyroid hormone stimulus|,cysteine-type endopeptidase activity|collagen binding|peptidase activity|cysteine-type peptidase activity|kininogen binding|peptide binding|proteoglycan binding|protein self-association|,6,17,3.64E+09,0.194,0.046034151,-0.140333333,16.70702607,0.487666667,0.021345061,2.997097874,-0.5705,-0.592,0.01,0.159,0.047,0.1045,PC,6,TRUE,NA
1.446,1.274,1.294,0.874,0.8475,1.0545,1.201,1.041,1.1685,Q8K0C9,Q8K0C9,Gmds,1,13,8,8,Q8K0C9|J3QMC6,MOUSE,42326.4,25.8,1690,1690.1,66.33,66.33,NA,372,"GDP-mannose 4,6 dehydratase",extracellular exosome|,Notch signaling pathway|GDP-mannose metabolic process|'de novo' GDP-L-fucose biosynthetic process|,"GDP-mannose 4,6-dehydratase activity|NADP+ binding|",8,13,7.17E+08,0.258,8.41E-05,-0.055166667,49.35343594,1.128666667,1.16E-05,11.65516913,-0.6335,-0.507,-0.718,0.648,0.345,0.5345,undefined,9,NA,NA
2.145,2.383,2.141,1.925,2.0835,1.8355,2.249,2.34,2.2335,P02468,P02468,Lamc1,1,10,7,7,P02468|F8VQJ3,MOUSE,182943.8,6.2,1694,1694.1,66.09,66.09,NA,1607,Laminin subunit gamma-1,extracellular region|basement membrane|basal lamina|extracellular matrix|laminin-10 complex|extracellular exosome|basement membrane|extracellular matrix|,protein complex assembly|cell adhesion|cell migration|extracellular matrix disassembly|neuron projection development|hemidesmosome assembly|substrate adhesion-dependent cell spreading|,extracellular matrix structural constituent|protein binding|glycosphingolipid binding|,7,10,5.79E+08,0.062,2.19E-06,-0.312333333,79.22286689,2.113,1.20E-08,32.79681036,-1.3265,-1.401,-1.379,0.801,0.647,0.7845,PC,9,TRUE,NA
1.194,1.358,1.826,1.006,1.0405,1.6525,1.123,1.401,1.9785,Q99JB7,Q99JB7,Amn,1,15,6,6,Q99JB7,MOUSE,49494.4,14.8,1708,1708.1,65.1,65.1,NA,458,Protein amnionless,extracellular space|integral component of membrane|apical plasma membrane|endocytic vesicle|apical part of cell|extracellular exosome|,receptor-mediated endocytosis|multicellular organismal development|excretion|protein localization|cobalamin transport|Golgi to plasma membrane protein transport|,NA,6,15,1.34E+10,0.148,0.000382582,-0.102166667,41.52354052,1.54,7.04E-05,8.742840336,-0.7145,-0.711,-1.191,0.826,0.371,0.8065,undefined,9,TRUE,TRUE
1.999,2.021,2.405,1.95,2.1895,2.2225,2.021,1.912,2.4325,Q9R069,Q9R069,Bcam,1,10,6,6,Q9R069,MOUSE,68467.7,10.6,1709,1709.1,65.09,65.09,NA,622,Basal cell adhesion molecule,plasma membrane|integral component of plasma membrane|cell surface|extracellular exosome|,cell adhesion|cell-matrix adhesion|,laminin receptor activity|protein C-terminus binding|laminin binding|,6,10,4.69E+08,0.106,2.99E-05,-0.385833333,54.60553897,2.151333333,3.46E-06,14.07752269,-1.2705,-1.293,-1.821,0.666,0.784,0.6195,undefined,9,TRUE,TRUE
1.678,1.255,1.519,1.556,1.2565,1.5745,1.45,1.14,1.4035,P70428,P70428,Ext2,1,9,5,5,P70428|V9GX32|E9Q1M5,MOUSE,82804.6,10.7,1710,1710.1,65.08,65.08,NA,718,Exostosin-2,Golgi membrane|endoplasmic reticulum|endoplasmic reticulum membrane|Golgi apparatus|membrane|integral component of membrane|UDP-N-acetylglucosamine transferase complex|extracellular exosome|,"ossification|mesoderm formation|glycosaminoglycan biosynthetic process|protein glycosylation|heparan sulfate proteoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|cell differentiation|cellular polysaccharide biosynthetic process|","acetylglucosaminyltransferase activity|glucuronosyltransferase activity|transferase activity, transferring glycosyl groups|heparan sulfate N-acetylglucosaminyltransferase activity|protein homodimerization activity|metal ion binding|protein heterodimerization activity|glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity|acetylglucosaminyltransferase activity|",5,9,1.37E+10,0.107,3.66E-05,-0.1875,53.62142149,1.438,4.34E-06,13.59057341,-1.0765,-0.73,-0.913,0.619,0.577,0.3985,undefined,9,NA,TRUE
0.988,1.225,1.135,1.042,0.8895,0.7555,1.168,1.146,1.0615,Q64729,Q64729,Tgfbr1,1,9,6,4,Q64729|Q64729-2|E9Q418|Q9D5H8|Q8K348|A2AJR5|Q3V348|A2AJR6,MOUSE,57261.9,13.7,1712,1712.1,65,41.04,NA,503,TGF-beta receptor type-1,intracellular|cell|endosome|plasma membrane|caveola|bicellular tight junction|membrane|integral component of membrane|receptor complex|membrane raft|,"activation of MAPKK activity|skeletal system development|angiogenesis|in utero embryonic development|kidney development|blastocyst development|epithelial to mesenchymal transition|negative regulation of endothelial cell proliferation|positive regulation of endothelial cell proliferation|lens development in camera-type eye|regulation of transcription, DNA-templated|protein phosphorylation|apoptotic process|signal transduction|transforming growth factor beta receptor signaling pathway|heart development|positive regulation of cell proliferation|germ cell migration|male gonad development|post-embryonic development|anterior/posterior pattern specification|regulation of gene expression|positive regulation of gene expression|regulation of epithelial to mesenchymal transition|positive regulation of pathway-restricted SMAD protein phosphorylation|peptidyl-serine phosphorylation|peptidyl-threonine phosphorylation|signal transduction by protein phosphorylation|collagen fibril organization|positive regulation of cell growth|regulation of protein ubiquitination|negative regulation of chondrocyte differentiation|activin receptor signaling pathway|intracellular signal transduction|endothelial cell activation|negative regulation of apoptotic process|regulation of protein binding|endothelial cell migration|positive regulation of transcription, DNA-templated|thymus development|neuron fate commitment|embryonic cranial skeleton morphogenesis|skeletal system morphogenesis|mesenchymal cell differentiation|artery morphogenesis|cell motility|positive regulation of cellular component movement|positive regulation of filopodium assembly|positive regulation of protein kinase B signaling|parathyroid gland development|palate development|pharyngeal system development|cardiac epithelial to mesenchymal transition|pathway-restricted SMAD protein phosphorylation|positive regulation of SMAD protein import into nucleus|response to cholesterol|cellular response to transforming growth factor beta stimulus|positive regulation of apoptotic signaling pathway|negative regulation of extrinsic apoptotic signaling pathway|","protein kinase activity|protein serine/threonine kinase activity|receptor signaling protein serine/threonine kinase activity|transforming growth factor beta-activated receptor activity|transforming growth factor beta receptor activity, type I|receptor signaling protein activity|type II transforming growth factor beta receptor binding|protein binding|ATP binding|SMAD binding|metal ion binding|transforming growth factor beta binding|I-SMAD binding|transforming growth factor beta-activated receptor activity|growth factor binding|transforming growth factor beta binding|",6,9,3.15E+08,0.137,5.46E-05,-0.098166667,51.53071773,1.091333333,7.03E-06,12.60798541,-0.7615,-0.622,-0.548,0.463,0.324,0.5555,undefined,9,TRUE,TRUE
2.174,2.74,2.36,2.45,2.6415,2.4125,2.753,3.038,2.7885,Q91WR8,Q91WR8,Gpx6,1,10,4,4,Q91WR8,MOUSE,25188.2,25.3,1713,1713.1,64.92,64.92,NA,221,Glutathione peroxidase 6,extracellular region|,response to oxidative stress|oxidation-reduction process|,glutathione peroxidase activity|,4,10,9.31E+09,0.253,1.26E-05,-0.409333333,60.32991211,2.635666667,9.27E-07,17.25480306,-1.4995,-1.852,-1.83,0.718,0.809,1.1985,PC,9,TRUE,NA
1.289,1.382,1.484,1.38,1.4595,1.5905,1.521,1.584,1.7165,Q69ZQ1,Q69ZQ1,Myorg,1,11,7,7,Q69ZQ1,MOUSE,81759.4,10.3,1722,1722.1,64.52,64.52,NA,716,Myogenesis-regulating glycosidase,integral component of membrane|nuclear membrane|,carbohydrate metabolic process|positive regulation of insulin-like growth factor receptor signaling pathway|skeletal muscle fiber development|positive regulation of protein kinase B signaling|,"hydrolase activity, hydrolyzing O-glycosyl compounds|protein binding|",7,11,1.70E+11,0.103,1.38E-05,-0.182,59.56661202,1.477666667,1.10E-06,16.79466139,-0.8105,-0.863,-1.089,0.479,0.607,0.5845,undefined,9,NA,TRUE
0.389,0.546,0.716,0.145,0.3115,0.2835,0.481,0.633,0.7065,Q61792,Q61792,Lasp1,1,13,7,7,Q61792|Q9DC07,MOUSE,30393.3,25,1725,1725.1,64.27,64.27,NA,263,LIM and SH3 domain protein 1,cytoplasm|focal adhesion|cortical actin cytoskeleton|extracellular exosome|,ion transport|ion transmembrane transport|,protein binding|zinc ion binding|ion transmembrane transporter activity|actin filament binding|,7,13,1.53E+09,0.25,0.01034557,0.077333333,24.8128553,0.498333333,0.003301524,4.472849058,-0.0705,-0.209,-0.236,0.426,0.091,0.4625,NC,5,NA,NA
0.571,0.84,0.488,0.469,0.6365,0.3435,0.746,0.919,0.4735,F8VQ28,F8VQ28,Pxn,1,9,6,6,F8VQ28|Q8VI36|Q8VI36-2|A0A0J9YV30,MOUSE,65931.5,9.4,1736,1736.1,63.74,63.74,NA,591,Paxillin,stress fiber|nucleoplasm|cytoplasm|plasma membrane|focal adhesion|lamellipodium|cell leading edge|,activation of MAPK activity|cytoskeleton organization|transforming growth factor beta receptor signaling pathway|integrin-mediated signaling pathway|regulation of cell shape|peptidyl-tyrosine phosphorylation|lamellipodium assembly|substrate adhesion-dependent cell spreading|cellular response to reactive oxygen species|positive regulation of protein kinase activity|focal adhesion assembly|branching morphogenesis of an epithelial tube|growth hormone receptor signaling pathway|,integrin binding|protein binding|beta-catenin binding|zinc ion binding|vinculin binding|protein kinase binding|receptor signaling complex scaffold activity|BH4 domain binding|,6,9,1.32E+09,0.094,0.002303124,-0.062166667,32.49866613,0.620666667,0.000562514,6.176871383,-0.3795,-0.529,-0.209,0.215,0.156,0.3735,undefined,8,NA,NA
1.044,1.705,1.084,0.768,1.4115,0.8775,0.89,1.461,1.0215,Q9JJK5,Q9JJK5,Herpud1,1,14,5,5,Q9JJK5|Q8C4N0,MOUSE,44020.4,19.4,1742,1742.1,63.41,63.41,NA,391,Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|Lewy body core|calcium channel complex|,"ubiquitin-dependent protein catabolic process|endoplasmic reticulum unfolded protein response|retrograde protein transport, ER to cytosol|regulation of protein ubiquitination|positive regulation of protein binding|endoplasmic reticulum calcium ion homeostasis|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|regulation of ER-associated ubiquitin-dependent protein catabolic process|positive regulation of ER-associated ubiquitin-dependent protein catabolic process|negative regulation of intrinsic apoptotic signaling pathway|",protein binding|ion channel binding|,5,14,1.88E+09,0.194,0.000442489,-0.110833333,40.73819528,1.138666667,8.44E-05,8.489574952,-0.4655,-0.971,-0.604,0.553,0.36,0.4625,undefined,9,NA,NA
0.941,0.944,0.762,0.745,0.8915,0.6605,0.738,0.792,0.7455,Q9WTX5,Q9WTX5,Skp1,1,6,6,6,Q9WTX5,MOUSE,18842.9,36.1,1744,1744.1,63.05,63.05,NA,163,S-phase kinase-associated protein 1,centrosome|cytosol|SCF ubiquitin ligase complex|Cul7-RING ubiquitin ligase complex|extracellular exosome|PcG protein complex|,ubiquitin-dependent protein catabolic process|protein ubiquitination|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|histone H2A monoubiquitination|,ubiquitin-protein transferase activity|protein binding|ubiquitin-protein transferase activity|,6,6,1.85E+08,0.361,2.76E-05,-0.050833333,55.11814715,0.808666667,3.08E-06,14.1524204,-0.4315,-0.525,-0.409,0.357,0.371,0.3325,undefined,9,NA,NA
0.803,0.749,0.943,0.612,0.6465,0.7505,0.86,0.794,0.9365,Q9CR89,Q9CR89,Ergic2,1,7,4,4,Q9CR89|Q9CR89-2,MOUSE,42766.2,19.8,1758,1758.1,62.15,62.15,NA,377,Endoplasmic reticulum-Golgi intermediate compartment protein 2,nucleus|nucleolus|cytoplasm|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|membrane|integral component of membrane|endoplasmic reticulum-Golgi intermediate compartment membrane|intracellular membrane-bounded organelle|,ER to Golgi vesicle-mediated transport|,NA,4,7,7.22E+08,0.198,0.000145139,-0.0165,46.48821581,0.847333333,2.24E-05,10.43421569,-0.4055,-0.37,-0.545,0.438,0.284,0.4995,undefined,9,NA,NA
1.299,1.311,1.202,1.171,1.3275,1.1075,1.309,1.55,1.5005,E9Q5P0,E9Q5P0,Hpn,1,9,5,5,E9Q5P0|O35453|O35453-2|G3UWE8|A0A0U1RNM3,MOUSE,48900.6,13,1765,1765.1,61.84,61.84,NA,445,Serine protease hepsin,endoplasmic reticulum membrane|plasma membrane|integral component of plasma membrane|cell surface|integral component of membrane|extracellular exosome|nuclear membrane|,proteolysis|sensory perception of sound|regulation of cell shape|negative regulation of alkaline phosphatase activity|negative regulation of epithelial to mesenchymal transition|positive regulation of plasminogen activation|positive regulation of cell growth|basement membrane disassembly|cholesterol homeostasis|negative regulation of apoptotic process|positive regulation by host of viral transcription|negative regulation of epithelial cell proliferation|positive regulation of hepatocyte proliferation|,serine-type endopeptidase activity|peptidase activity|serine-type peptidase activity|serine-type exopeptidase activity|,5,9,4.62E+09,0.13,1.60E-05,-0.108833333,58.50346724,1.340666667,1.41E-06,16.11771544,-0.7405,-0.867,-0.73,0.523,0.456,0.7055,PC,9,NA,TRUE
0.583,0.485,0.577,0.598,0.5175,0.5895,0.634,0.603,0.5335,O89001,O89001,Cpd,1,9,7,7,O89001,MOUSE,153429.8,5.6,1767,1767.1,61.77,61.77,NA,1377,Carboxypeptidase D,membrane|integral component of membrane|extracellular exosome|,proteolysis|,metallocarboxypeptidase activity|serine-type carboxypeptidase activity|zinc ion binding|,7,9,3.21E+08,0.056,0.000160015,-0.001333333,45.94430491,0.626333333,2.54E-05,10.18996364,-0.3375,-0.247,-0.359,0.271,0.288,0.3765,undefined,9,TRUE,TRUE
1.172,1.266,1.056,0.846,0.9575,0.7535,1.047,1.331,1.1745,Q3TCU5,Q3TCU5,Tapbp,1,8,5,5,Q3TCU5|Q9R233|Q9R233-2,MOUSE,50119.8,10.5,1769,1769.1,61.54,61.54,NA,466,Tapasin,Golgi membrane|endoplasmic reticulum membrane|integral component of plasma membrane|TAP complex|,"MHC class I protein complex assembly|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent|defense response|antigen processing and presentation of endogenous peptide antigen via MHC class I|",protein binding|TAP1 binding|TAP2 binding|,5,8,1.13E+09,0.105,8.41E-05,-0.031166667,49.3529676,1.093333333,1.16E-05,11.65497151,-0.6085,-0.62,-0.505,0.606,0.323,0.6175,undefined,9,TRUE,TRUE
1.509,1.491,1.595,1.343,1.5385,1.5035,1.423,1.571,1.6005,P97326,P97326,Cdh6,1,6,6,6,P97326|F8WHU6|P70408|P70407|H3BKV8,MOUSE,88638.3,6.2,1773,1773.1,61.22,61.22,NA,790,Cadherin-6,plasma membrane|integral component of membrane|extracellular exosome|,homophilic cell adhesion via plasma membrane adhesion molecules|Notch signaling pathway|,calcium ion binding|,6,6,1.07E+09,0.062,6.44E-06,-0.205333333,65.12588334,1.519666667,3.07E-07,20.19839269,-0.8635,-0.941,-1.091,0.518,0.53,0.6155,undefined,9,TRUE,TRUE
0.644,0.722,0.158,0.751,0.8445,0.2805,0.629,0.703,0.1435,P0DOV2,P0DOV2,Ifi204,1,2,4,2,P0DOV2,MOUSE,70178.5,6.6,1780,1780.2,41.48,17.99,NA,619,Interferon-activable protein 204,NA,NA,NA,2,2,77900000,0.029,0.020465884,-0.069666667,21.14938228,0.555666667,0.007674706,3.773822585,-0.4895,-0.548,-0.005,0.167,0.305,0.1525,NC,6,NA,NA
1.699,1.848,1.921,1.405,1.6105,1.6835,1.619,1.764,1.8405,Q9CZT5,Q9CZT5,Vasn,1,6,4,4,Q9CZT5,MOUSE,73401,6.5,1784,1784.1,60.58,60.58,NA,673,Vasorin,extracellular space|mitochondrion|lysosomal membrane|plasma membrane|cell surface|integral component of membrane|extracellular exosome|,negative regulation of epithelial to mesenchymal transition|negative regulation of transforming growth factor beta receptor signaling pathway|cellular response to hypoxia|cellular response to redox state|,protein binding|transforming growth factor beta binding|,4,6,1.01E+09,0.065,2.58E-05,-0.163166667,55.49778491,1.806666667,2.82E-06,14.53318672,-0.9035,-1.04,-1.256,0.91,0.547,0.7635,undefined,9,TRUE,TRUE
2.964,2.819,2.252,2.114,2.2075,1.9395,2.611,2.466,2.0775,Q8R1U2,Q8R1U2,Cgref1,1,21,5,5,E9QPK1|Q8R1U2,MOUSE,30846.9,25.9,1788,1788.1,60.34,60.34,NA,281,Cell growth regulator with EF hand domain protein 1,extracellular region|,cell cycle arrest|cell adhesion|,calcium ion binding|,5,21,1.19E+10,0.259,7.38E-06,-0.315666667,64.22313964,2.531,3.78E-07,19.7973571,-1.4685,-1.756,-1.519,1.166,0.738,0.9455,PC,9,TRUE,NA
0.799,0.727,0.587,0.751,0.4835,0.4455,0.589,0.409,0.4405,G3X924,G3X924,Plvap,1,11,5,5,G3X924|Q91VC4,MOUSE,50473,10.2,1792,1792.1,60.22,60.22,NA,438,Plasmalemma vesicle-associated protein,intracellular|caveola|cell surface|integral component of membrane|extracellular exosome|caveola|,MAPK cascade|positive regulation of cellular extravasation|tumor necrosis factor-mediated signaling pathway|,protein homodimerization activity|,5,11,1.05E+09,0.102,0.001167184,-0.09,35.84138749,0.631666667,0.000260532,7.0448282,-0.5335,-0.349,-0.335,0.364,0.195,0.1185,undefined,8,NA,TRUE
0.999,1.429,1.056,0.669,0.9815,0.7875,1.131,1.309,0.7045,Q61072,Q61072,Adam9,1,9,7,7,A0A140LHU0|Q61072|E9Q638,MOUSE,94588.2,12.3,1797,1797.1,59.82,59.82,NA,845,Disintegrin and metalloproteinase domain-containing protein 9,extracellular space|cytoplasm|plasma membrane|focal adhesion|cell surface|integral component of membrane|intrinsic component of external side of plasma membrane|extracellular exosome|,activation of MAPKK activity|membrane protein ectodomain proteolysis|cell adhesion|cell-matrix adhesion|transforming growth factor beta receptor signaling pathway|response to manganese ion|keratinocyte differentiation|cell adhesion mediated by integrin|positive regulation of cell adhesion mediated by integrin|cell-cell adhesion mediated by integrin|positive regulation of macrophage fusion|response to tumor necrosis factor|monocyte activation|response to hydrogen peroxide|positive regulation of protein secretion|positive regulation of membrane protein ectodomain proteolysis|PMA-inducible membrane protein ectodomain proteolysis|response to glucocorticoid|positive regulation of keratinocyte migration|response to calcium ion|cellular response to lipopolysaccharide|,metalloendopeptidase activity|protein kinase C binding|integrin binding|protein binding|collagen binding|metallopeptidase activity|zinc ion binding|SH3 domain binding|laminin binding|,7,9,5.85E+08,0.123,0.000296719,0.007,42.83617381,1.068333333,5.20E-05,9.180687278,-0.4345,-0.598,-0.549,0.634,0.29,0.6995,undefined,9,TRUE,TRUE
2.07,2.135,2.119,1.896,1.9885,1.9415,1.997,2.067,2.0465,Q80V26,Q80V26,Impad1,1,12,4,4,Q80V26,MOUSE,38729.7,17.9,1803,1803.1,59.58,59.58,NA,356,Inositol monophosphatase 3,Golgi apparatus|membrane|integral component of membrane|,skeletal system development|endochondral ossification|chondrocyte development|inositol biosynthetic process|post-embryonic development|dephosphorylation|chondroitin sulfate metabolic process|embryonic digit morphogenesis|phosphatidylinositol phosphorylation|,"3'-nucleotidase activity|3'(2'),5'-bisphosphate nucleotidase activity|inositol monophosphate 1-phosphatase activity|metal ion binding|inositol monophosphate 3-phosphatase activity|inositol monophosphate 4-phosphatase activity|",4,12,2.15E+09,0.179,2.52E-06,-0.3405,74.36520668,2.062,3.66E-08,27.8673453,-1.2935,-1.321,-1.5,0.727,0.631,0.7135,undefined,9,NA,TRUE
1.918,2.016,1.861,1.63,1.6305,1.5365,1.685,1.899,1.5175,Q04592,Q04592,Pcsk5,1,12,6,6,Q04592|Q04592-2,MOUSE,220321.6,4,1819,1819.1,58.69,58.69,NA,1877,Proprotein convertase subtilisin/kexin type 5,extracellular space|endoplasmic reticulum lumen|Golgi apparatus|integral component of membrane|secretory granule|,kidney development|renin secretion into blood stream|signal peptide processing|heart development|embryo implantation|anterior/posterior pattern specification|protein processing|peptide hormone processing|viral life cycle|respiratory tube development|limb morphogenesis|cytokine biosynthetic process|peptide biosynthetic process|embryonic digestive tract development|embryonic skeletal system development|,endopeptidase activity|serine-type endopeptidase activity|peptidase activity|peptide binding|,6,12,4.79E+08,0.04,7.94E-06,-0.203666667,63.78421326,1.695,4.18E-07,19.49351855,-1.0605,-1,-1.093,0.819,0.577,0.5355,PC,9,TRUE,TRUE
1.866,1.966,2.03,1.732,1.8425,2.0375,2.22,2.311,2.4355,Q99JW5,Q99JW5,Epcam,1,8,5,5,Q99JW5,MOUSE,35703,19.3,1824,1824.1,58.46,58.46,NA,315,Epithelial cell adhesion molecule,plasma membrane|bicellular tight junction|cell surface|integral component of membrane|basolateral plasma membrane|apical plasma membrane|lateral plasma membrane|extracellular exosome|,ureteric bud development|positive regulation of cell proliferation|signal transduction involved in regulation of gene expression|negative regulation of apoptotic process|positive regulation of transcription from RNA polymerase II promoter|stem cell differentiation|cell-cell adhesion|negative regulation of cell-cell adhesion mediated by cadherin|positive regulation of cell motility|positive regulation of stem cell proliferation|,protein complex binding|cadherin binding involved in cell-cell adhesion|,5,8,6.15E+08,0.193,1.37E-05,-0.317666667,59.66228778,2.208333333,1.08E-06,16.85168517,-1.3555,-1.371,-1.539,0.673,0.612,1.0745,NC,9,TRUE,TRUE
2.585,2.698,2.532,1.354,1.6945,2.1615,2.917,3.062,2.9005,P09036,P09036,Spink1,1,11,5,5,P09036,MOUSE,8830.2,57.5,1834,1834.1,57.75,57.75,NA,80,Serine protease inhibitor Kazal-type 1,extracellular space|extracellular exosome|,negative regulation of peptidase activity|negative regulation of nitric oxide mediated signal transduction|negative regulation of peptidyl-tyrosine phosphorylation|regulation of acrosome reaction|negative regulation of calcium ion import|negative regulation of serine-type endopeptidase activity|regulation of store-operated calcium entry|,serine-type endopeptidase inhibitor activity|peptidase inhibitor activity|,5,11,1.87E+09,0.575,0.000642031,-0.008166667,38.82377506,2.355333333,0.000131106,7.898121885,-0.8105,-1.014,-1.733,1.412,0.659,1.4375,PC,9,TRUE,NA
1.769,2.133,1.85,1.262,1.6415,1.4715,1.956,2.145,1.9935,Q8BU25,Q8BU25,Pamr1,1,9,6,6,Q8BU25,MOUSE,82714.5,9,1850,1850.1,57,57,NA,720,Inactive serine protease PAMR1,extracellular region|,NA,NA,6,9,1.07E+09,0.09,0.000107163,-0.072666667,48.01264063,1.829,1.58E-05,11.10183231,-0.7905,-1.033,-1.138,0.952,0.5,1.0735,PC,9,TRUE,NA
1.115,1.019,0.595,0.951,0.7455,0.6825,0.825,0.891,0.7775,Q03146,Q03146,Ddr1,1,8,7,7,Q03146|Q03146-2|E9PW79,MOUSE,102185.9,10.5,1851,1851.1,56.94,56.94,NA,911,Epithelial discoidin domain-containing receptor 1,extracellular space|plasma membrane|integral component of plasma membrane|basolateral plasma membrane|receptor complex|extracellular exosome|,"regulation of cell growth|regulation of cell-matrix adhesion|embryo implantation|lactation|negative regulation of cell proliferation|regulation of extracellular matrix disassembly|smooth muscle cell migration|peptidyl-tyrosine phosphorylation|organ regeneration|collagen-activated tyrosine kinase receptor signaling pathway|peptidyl-tyrosine autophosphorylation|ear development|skin development|wound healing, spreading of cells|protein autophosphorylation|branching involved in mammary gland duct morphogenesis|mammary gland alveolus development|smooth muscle cell-matrix adhesion|",collagen binding|ATP binding|protein tyrosine kinase collagen receptor activity|metal ion binding|,7,8,6.51E+08,0.105,2.99E-05,-0.065666667,54.62030067,0.857666667,3.45E-06,13.90512674,-0.5555,-0.401,-0.527,0.351,0.371,0.3675,undefined,9,TRUE,TRUE
0.746,0.947,0.528,0.266,0.5485,0.0995,0.746,1.021,0.5745,E9QA15,E9QA15,Cald1,1,8,6,6,E9QA15|D3Z6I7|E9QA16|E9Q0M9|Q8VCQ8|S4R1T7,MOUSE,89329,8.5,1854,1854.1,56.73,56.73,NA,768,Caldesmon 1,membrane|actin cap|,muscle contraction|regulation of smooth muscle contraction|,actin binding|calmodulin binding|myosin binding|,6,8,1.02E+09,0.085,0.017138635,0.012666667,22.08999164,0.592333333,0.006180176,3.94758691,-0.2955,-0.487,-0.068,0.4,0.04,0.4865,undefined,7,NA,NA
1.562,2.04,2.067,1.535,1.8145,1.8645,1.39,1.91,1.9645,Q4FZC9-2,Q4FZC9,Syne3,1,10,6,6,Q4FZC9-2|Q4FZC9,MOUSE,102708.6,7.9,1872,1872.1,56.09,56.09,NA,975,Isoform 2 of Nesprin-3,nuclear envelope|nuclear outer membrane|rough endoplasmic reticulum|membrane|integral component of membrane|LINC complex|,cytoskeleton organization|regulation of cell shape|establishment of protein localization to membrane|cytoskeletal anchoring at nuclear membrane|,protein binding|actin filament binding|,6,10,7.38E+08,0.079,1.26E-05,-0.281166667,60.29957883,1.807333333,9.33E-07,17.23628831,-0.9835,-1.176,-1.395,0.61,0.613,0.6445,undefined,9,NA,NA
1.653,1.276,1.607,1.274,1.1365,1.2425,1.514,1.187,1.4675,Q8VEK0,Q8VEK0,Tmem30a,1,5,4,4,Q8VEK0|D3YVV1,MOUSE,41402.5,13.7,1882,1882.1,55.09,55.09,NA,364,Cell cycle control protein 50A,endoplasmic reticulum|Golgi apparatus|membrane|integral component of membrane|apical plasma membrane|transport vesicle membrane|,drug transmembrane transport|positive regulation of neuron projection development|protein localization to endosome|phospholipid translocation|positive regulation of protein exit from endoplasmic reticulum|,protein binding|,4,5,2.07E+08,0.137,1.90E-05,-0.117,57.42703435,1.429666667,1.81E-06,15.56667054,-0.8735,-0.734,-0.888,0.725,0.431,0.6375,undefined,9,NA,TRUE
2.483,2.429,2.653,1.85,2.0425,2.0055,2.426,2.468,2.4595,P35846,P35846,Folr1,1,9,5,5,P35846,MOUSE,30475.8,32.1,1888,1888.1,54.67,54.67,NA,255,Folate receptor alpha,nucleus|endosome|cell surface|membrane|apical plasma membrane|clathrin-coated vesicle|anchored component of external side of plasma membrane|extracellular exosome|,heart looping|neural crest cell migration involved in heart formation|cardiac neural crest cell migration involved in outflow tract morphogenesis|posttranslational protein targeting to membrane|folic acid transport|regulation of transforming growth factor beta receptor signaling pathway|folic acid metabolic process|regulation of canonical Wnt signaling pathway|pharyngeal arch artery morphogenesis|,receptor activity|folic acid binding|folic acid transporter activity|,5,9,1.02E+09,0.321,9.53E-06,-0.259,62.30222716,2.263,5.89E-07,18.50066041,-1.2445,-1.364,-1.563,1.004,0.653,0.9605,PC,9,TRUE,NA
1.955,1.816,2.257,1.931,1.8075,2.2575,2.094,1.951,2.4055,Q8BJT9,Q8BJT9,Edem2,1,9,5,5,Q8BJT9,MOUSE,65122.1,11.4,1890,1890.1,54.56,54.56,NA,577,"alpha-1,2-Mannosidase",endoplasmic reticulum|membrane|,"N-glycan processing|ER-associated ubiquitin-dependent protein catabolic process|endoplasmic reticulum unfolded protein response|glycoprotein ERAD pathway|positive regulation of retrograde protein transport, ER to cytosol|","glycoprotein binding|mannosyl-oligosaccharide 1,2-alpha-mannosidase activity|calcium ion binding|",5,9,1.30E+09,0.114,2.94E-05,-0.356,54.73779335,2.091,3.36E-06,14.14420182,-1.3235,-1.149,-1.732,0.623,0.66,0.7855,undefined,9,TRUE,NA
1.715,1.915,1.968,1.52,1.7355,1.7975,1.89,2.086,2.1515,G3X9Z5,G3X9Z5,Serpina1f,1,14,5,5,G3X9Z5|E9PUC6|Q9DCQ7|Q9DCQ7-2,MOUSE,46862.5,15.3,1892,1892.1,54.51,54.51,NA,411,Alpha-1-antitrypsin 1-6,extracellular space|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,5,14,7.38E+09,0.153,1.86E-05,-0.234333333,57.63152765,1.879666667,1.73E-06,15.68022343,-0.9945,-1.141,-1.387,0.693,0.57,0.8535,PC,9,TRUE,NA
2.628,2.784,2.52,2.465,2.6665,2.3725,2.681,2.703,2.5735,Q921V5,Q921V5,Mgat2,1,9,4,4,Q921V5,MOUSE,51713.5,12.2,1898,1898.1,53.84,53.84,NA,442,"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase",Golgi membrane|Golgi apparatus|Golgi stack|membrane|integral component of membrane|,oligosaccharide biosynthetic process|protein N-linked glycosylation via asparagine|,"alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity|carbohydrate binding|",4,9,1.21E+09,0.122,1.32E-06,-0.523833333,88.25455096,2.604,1.49E-09,44.7942426,-1.7725,-1.839,-1.866,0.835,0.749,0.7505,undefined,9,NA,NA
1.894,1.632,1.97,1.477,1.5245,1.4275,1.609,1.495,1.5485,Q5MJS3,Q5MJS3,Fam20c,1,11,5,5,Q5MJS3|Q8CID3,MOUSE,66392.3,12.4,1905,1905.1,53.42,53.42,NA,579,Extracellular serine/threonine protein kinase FAM20C,extracellular space|Golgi apparatus|extracellular exosome|,skeletal system development|protein phosphorylation|positive regulation of bone mineralization|biomineral tissue development|osteoclast maturation|regulation of fibroblast growth factor receptor signaling pathway|positive regulation of osteoblast differentiation|regulation of phosphorus metabolic process|enamel mineralization|odontoblast differentiation|dentinogenesis|,protein serine/threonine kinase activity|calcium ion binding|manganese ion binding|,5,11,8.74E+08,0.124,1.86E-05,-0.21,57.60379135,1.738333333,1.74E-06,15.66477561,-1.1055,-1.018,-1.114,0.905,0.502,0.5705,PC,9,TRUE,TRUE
0.873,1.16,1.13,0.921,1.1625,0.8065,1.03,1.247,1.0475,Q9QZN4,Q9QZN4,Fbxo6,1,8,5,5,Q9QZN4,MOUSE,35062.4,14.9,1907,1907.1,53.36,53.36,NA,295,F-box only protein 6,cytoplasm|SCF ubiquitin ligase complex|endoplasmic reticulum quality control compartment|,DNA repair|glycoprotein catabolic process|response to unfolded protein|protein ubiquitination|ER-associated ubiquitin-dependent protein catabolic process|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|ERAD pathway|,glycoprotein binding|protein binding|carbohydrate binding|ubiquitin protein ligase activity|ubiquitin protein ligase activity involved in ERAD pathway|,5,8,2.09E+09,0.149,1.96E-05,-0.058166667,57.08476379,1.017333333,1.96E-06,15.17050861,-0.4825,-0.67,-0.548,0.479,0.41,0.4625,undefined,9,NA,NA
0.701,0.591,0.819,0.318,0.5135,0.4515,0.441,0.296,0.5325,O70481,O70481,Ubr1,1,5,4,4,O70481,MOUSE,203602.5,3.6,1908,1908.1,53.01,53.01,NA,1757,E3 ubiquitin-protein ligase UBR1,proteasome complex|cytoplasm|cytosol|,ubiquitin-dependent protein catabolic process|protein ubiquitination|negative regulation of TOR signaling|cellular response to leucine|ubiquitin-dependent protein catabolic process via the N-end rule pathway|,ubiquitin-protein transferase activity|protein binding|zinc ion binding|ligase activity|ubiquitin protein ligase activity|leucine binding|,4,5,2.24E+08,0.036,0.00940437,0.044833333,25.32220746,0.490666667,0.002936157,4.575102905,-0.1715,-0.134,-0.296,0.515,0.191,0.1645,undefined,7,NA,NA
1.208,1.236,1.286,1.025,1.0845,1.0085,1.15,1.173,1.1485,Q8C570,Q8C570,Rae1,1,7,5,5,Q8C570,MOUSE,41592,17.3,1909,1909.1,52.99,52.99,NA,368,mRNA export factor,nucleus|nucleolus|cytoplasm|,cellular response to organic cyclic compound|,NA,5,7,2.47E+08,0.173,8.33E-06,-0.103166667,63.37939275,1.122666667,4.59E-07,18.92026157,-0.6245,-0.718,-0.651,0.519,0.409,0.4465,undefined,9,NA,NA
1.414,1.24,1.426,1.469,1.3015,1.5495,1.503,1.377,1.6405,Q9ER39,Q9ER39,Tor1a,1,10,5,5,Q9ER39,MOUSE,38228.6,13.2,1924,1924.1,51.81,51.81,NA,333,Torsin-1A,nucleus|nuclear envelope|cytoplasm|endoplasmic reticulum|endoplasmic reticulum lumen|cytoskeleton|synaptic vesicle|membrane|cell junction|transport vesicle|secretory granule|growth cone|cytoplasmic vesicle membrane|nuclear membrane|extrinsic component of endoplasmic reticulum membrane|intracellular membrane-bounded organelle|extracellular exosome|,"protein deneddylation|response to oxidative stress|organelle organization|nuclear envelope organization|cell adhesion|neuron projection development|protein localization to nucleus|wound healing, spreading of cells|intermediate filament cytoskeleton organization|synaptic vesicle transport|chaperone mediated protein folding requiring cofactor|protein homooligomerization|regulation of dopamine uptake involved in synaptic transmission|chaperone-mediated protein folding|ER-associated misfolded protein catabolic process|nuclear membrane organization|chaperone-mediated protein transport|positive regulation of synaptic vesicle endocytosis|regulation of protein localization to cell surface|",protein binding|ATP binding|cytoskeletal protein binding|ATPase activity|kinesin binding|unfolded protein binding|misfolded protein binding|,5,10,1.56E+10,0.132,1.92E-05,-0.1495,57.31232738,1.468666667,1.86E-06,15.50331857,-0.9245,-0.712,-1.015,0.492,0.586,0.6765,undefined,9,TRUE,NA
0.761,0.737,0.642,0.641,0.3975,0.6065,0.415,0.348,0.2585,Q9CPU4,Q9CPU4,Mgst3,1,6,3,3,Q9CPU4,MOUSE,17128.6,25.4,1926,1926.1,51.69,51.69,NA,153,Microsomal glutathione S-transferase 3,nuclear envelope|endoplasmic reticulum membrane|membrane|integral component of membrane|extracellular exosome|,response to organonitrogen compound|oxidation-reduction process|,glutathione transferase activity|glutathione peroxidase activity|,3,6,1.88E+09,0.254,0.012495433,0.030333333,23.76013905,0.482333333,0.004207132,4.265633258,-0.3465,-0.091,-0.195,0.44,0.305,0.0695,undefined,5,NA,TRUE
1.069,1.056,1.476,1.109,1.1425,1.5065,1.285,1.076,1.6475,Q9QYK5,Q9QYK5,Hs6st1,1,4,4,4,Q9QYK5,MOUSE,48986,9.9,1928,1928.1,51.67,51.67,NA,411,Heparan-sulfate 6-O-sulfotransferase 1,integral component of membrane|,"angiogenesis|heparan sulfate proteoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process, enzymatic modification|lung alveolus development|neuron development|labyrinthine layer blood vessel development|",heparan sulfate 6-O-sulfotransferase activity|,4,4,3.55E+08,0.099,0.000355708,-0.226166667,41.89743821,1.310666667,6.46E-05,8.865679078,-0.7655,-0.652,-1.227,0.377,0.5,0.4105,undefined,9,NA,TRUE
0.272,0.505,0.667,0.685,1.0685,1.0955,0.53,0.618,0.9245,Q99J94,Q99J94,Slco1a6,1,7,5,5,Q99J94|L7N264|Q9EP96,MOUSE,75855.5,8.5,1929,1929.1,51.65,51.65,NA,670,Solute carrier organic anion transporter family member 1A6,plasma membrane|integral component of membrane|,xenobiotic metabolic process|ion transport|bile acid metabolic process|organ regeneration|multicellular organism growth|heme metabolic process|response to drug|cholesterol homeostasis|triglyceride homeostasis|,transporter activity|,5,7,7.20E+09,0.085,0.01089867,-0.029166667,24.50127759,0.674,0.00354709,4.410948692,-0.1575,-0.364,-0.577,0.131,0.588,0.2045,undefined,8,NA,TRUE
0.364,0.537,0.365,0.322,0.4545,0.3715,0.696,0.842,0.6155,Q9CYN2,Q9CYN2,Spcs2,1,10,6,6,Q9CYN2|A0A140LHG8|A0A140LHR3|A0A140LJG6|A0A140LIK0|A0A140LHW5,MOUSE,25205.4,23.4,1930,1930.1,51.63,51.63,NA,226,Signal peptidase complex subunit 2,signal peptidase complex|integral component of membrane|,signal peptide processing|,peptidase activity|,6,10,2.14E+10,0.234,0.005274359,-0.0035,28.34333008,0.533333333,0.001464425,5.210622359,-0.1995,-0.406,-0.205,0.166,0.173,0.4505,undefined,5,NA,TRUE
0.928,1.139,1.228,0.781,1.0085,1.0965,0.619,0.826,0.9195,Q8R464,Q8R464,Cadm4,1,7,4,4,Q8R464,MOUSE,43178.9,16.2,1937,1937.1,51.32,51.32,NA,388,Cell adhesion molecule 4,integral component of membrane|extracellular exosome|,cell adhesion|,NA,4,7,1.17E+10,0.162,0.000386898,-0.079666667,41.45448275,0.960333333,7.15E-05,8.720313396,-0.3905,-0.573,-0.716,0.525,0.439,0.2375,undefined,9,TRUE,TRUE
1.317,1.392,1.743,1.657,1.4595,1.8335,1.195,1.266,1.5525,Q61526,Q61526,Erbb3,1,8,6,6,Q61526,MOUSE,150919.5,7.4,1950,1950.1,50.93,50.93,NA,1339,Receptor tyrosine-protein kinase erbB-3,extracellular space|intracellular|integral component of membrane|basolateral plasma membrane|apical plasma membrane|lateral plasma membrane|receptor complex|,endocardial cushion development|protein phosphorylation|negative regulation of cell adhesion|signal transduction|transmembrane receptor protein tyrosine kinase signaling pathway|peripheral nervous system development|negative regulation of signal transduction|Schwann cell differentiation|phosphatidylinositol 3-kinase signaling|cranial nerve development|regulation of cell proliferation|negative regulation of neuron apoptotic process|negative regulation of secretion|neuron apoptotic process|positive regulation of protein tyrosine kinase activity|positive regulation of calcineurin-NFAT signaling cascade|extrinsic apoptotic signaling pathway in absence of ligand|,protein binding|ATP binding|growth factor binding|protein tyrosine kinase activator activity|identical protein binding|protein heterodimerization activity|protein tyrosine kinase activity|,6,8,7.64E+08,0.074,3.05E-05,-0.166666667,54.48386114,1.513,3.56E-06,14.01643785,-0.7805,-0.826,-1.163,0.56,0.646,0.5635,undefined,9,TRUE,TRUE
2.192,2.229,2.376,2.039,2.0945,2.2075,2.147,2.304,2.3435,Q8C7V8,Q8C7V8,Ccdc134,1,6,4,4,Q8C7V8|Q8C7V8-2,MOUSE,26551.1,20.5,1956,1956.1,50.46,50.46,NA,229,Coiled-coil domain-containing protein 134,extracellular region|membrane|,NA,NA,4,6,1.32E+09,0.205,5.66E-06,-0.403166667,66.67404581,2.264,2.15E-07,21.58044479,-1.4195,-1.427,-1.759,0.707,0.67,0.8095,PC,9,TRUE,NA
0.349,0.495,0.659,-0.121,0.1715,0.3365,0.531,0.641,0.7435,Q8BGT5,Q8BGT5,Gpt2,1,9,6,6,Q8BGT5|D6RFQ8,MOUSE,58741.5,13.9,1966,1966.1,49.65,49.65,NA,522,Alanine aminotransferase 2,mitochondrion|,2-oxoglutarate metabolic process|biosynthetic process|L-alanine metabolic process|L-alanine catabolic process|,L-alanine:2-oxoglutarate aminotransferase activity|pyridoxal phosphate binding|,6,9,3.55E+08,0.139,0.101548147,0.063833333,12.4276095,0.381333333,0.057179328,2.297882571,0.0765,-0.207,-0.25,0.242,-0.045,0.5665,NC,5,NA,NA
0.963,0.9,0.652,1.224,1.0245,1.1385,1.175,0.864,0.9825,P48725-3,P48725,Pcnt,1,9,6,2,P48725-3|F8VPV0|A0A1W2P737|P48725,MOUSE,286980.1,3.1,1967,1967.1,49.64,10.05,NA,2898,Isoform 3 of Pericentrin,pericentriolar material|centrosome|centriole|microtubule organizing center|microtubule|motile cilium|centriolar satellite|ciliary basal body|intercellular bridge|cis-Golgi network|,microtubule cytoskeleton organization|in utero embryonic development|neuron migration|spindle organization|cerebellar cortex morphogenesis|olfactory bulb development|limb morphogenesis|multicellular organism growth|cilium assembly|negative regulation of apoptotic process|brain morphogenesis|neural precursor cell proliferation|positive regulation of intracellular protein transport|,protein binding|calmodulin binding|,6,9,1.17E+10,0.031,0.000338157,-0.0515,42.17671497,1.177333333,6.06E-05,8.958400395,-0.8605,-0.624,-0.436,0.349,0.678,0.5845,undefined,9,NA,NA
0.672,0.685,0.587,0.506,0.4625,0.3765,0.492,0.612,0.4255,Q9DBC7,Q9DBC7,Prkar1a,1,6,4,4,Q9DBC7|A2AI69,MOUSE,43469.6,12.3,1969,1969.1,49.54,49.54,NA,381,cAMP-dependent protein kinase type I-alpha regulatory subunit,cytoplasm|plasma membrane|cAMP-dependent protein kinase complex|membrane|AMP-activated protein kinase complex|neuromuscular junction|protein complex|,mesoderm formation|protein phosphorylation|negative regulation of protein kinase activity|female meiotic division|heart development|cell proliferation|organ morphogenesis|sarcomere organization|negative regulation of meiotic nuclear division|cardiac muscle cell proliferation|negative regulation of cAMP-dependent protein kinase activity|,cAMP-dependent protein kinase inhibitor activity|protein binding|cAMP-dependent protein kinase regulator activity|cAMP binding|ubiquitin protein ligase binding|protein kinase A catalytic subunit binding|,4,6,87400000,0.123,0.000386096,-0.0395,41.47026148,0.544,7.13E-05,8.647655013,-0.3495,-0.321,-0.264,0.316,0.168,0.2135,undefined,8,NA,NA
0.029,0.557,0.627,-0.119,0.4695,0.6015,0.438,0.96,0.8805,Q924Z4,Q924Z4,Cers2,1,5,3,3,Q924Z4,MOUSE,45194.7,7.3,1970,1970.1,49.44,49.44,NA,380,Ceramide synthase 2,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|nuclear membrane|,sphingolipid biosynthetic process|ceramide biosynthetic process|,DNA binding|sphingosine N-acyltransferase activity|,3,5,1.23E+09,0.073,0.079659416,-0.0715,13.74997094,0.476666667,0.042169933,2.510578791,0.0645,-0.484,-0.51,0.086,-0.032,0.4465,undefined,7,NA,TRUE
0.677,0.518,0.694,0.645,0.5245,0.6385,0.772,0.337,0.5175,Q80VC9,Q80VC9,Camsap3,1,7,5,5,Q80VC9|Q80VC9-2|Q80VC9-9|Q80VC9-5|Q80VC9-4|Q80VC9-3|Q80VC9-8|Q80VC9-7|Q80VC9-6|Q80VC9-10|Q80VC9-13|Q80VC9-14|Q80VC9-11|Q80VC9-12|Q80VC9-17|Q80VC9-16|Q80VC9-15,MOUSE,135971.5,4.8,1972,1972.1,49.28,49.28,NA,1252,Calmodulin-regulated spectrin-associated protein 3,cytoplasm|zonula adherens|microtubule minus-end|centrosome|microtubule minus-end|,microtubule cytoskeleton organization|negative regulation of phosphatase activity|regulation of organelle organization|microtubule anchoring|zonula adherens maintenance|regulation of microtubule cytoskeleton organization|epithelial cell-cell adhesion|,protein binding|microtubule minus-end binding|,5,7,1.93E+09,0.048,0.000814109,-0.023333333,37.66574244,0.559666667,0.000171169,7.514070164,-0.3775,-0.179,-0.353,0.304,0.28,0.1855,NC,8,NA,NA
1.091,1.914,1.718,1.056,1.4365,1.5285,1.294,2.141,2.2375,F6XJP7,F6XJP7,Pcsk6,1,6,5,3,F6XJP7|E9Q4D0,MOUSE,109248.8,4.7,1978,1978.1,49.14,35.13,NA,959,Proprotein convertase subtilisin/kexin type 6,extracellular space|cell surface|extracellular matrix|,"zygotic determination of anterior/posterior axis, embryo|determination of left/right symmetry|glycoprotein metabolic process|protein processing|peptide hormone processing|nerve growth factor production|secretion by cell|",endopeptidase activity|serine-type endopeptidase activity|heparin binding|nerve growth factor binding|,5,6,1.22E+09,0.047,0.000295435,-0.116,42.86213547,1.727,5.17E-05,9.189535569,-0.6915,-1.049,-1.198,0.686,0.473,1.0835,undefined,9,TRUE,NA
0.743,0.691,0.42,0.591,0.4345,0.2825,0.54,0.447,0.2925,Q61937,Q61937,Npm1,1,12,4,4,Q61937|Q5SQB0|Q5SQB5|Q9DAY9,MOUSE,32730.7,13.6,1981,1981.1,48.87,48.87,NA,292,Nucleophosmin,granular component|nucleus|nucleoplasm|nucleolus|cytoplasm|centrosome|cytosol|focal adhesion|large ribosomal subunit|small ribosomal subunit|membrane|nuclear speck|ribonucleoprotein complex|spindle pole centrosome|,"ribosomal large subunit export from nucleus|ribosomal small subunit export from nucleus|DNA repair|nucleosome assembly|rRNA export from nucleus|cell volume homeostasis|nucleocytoplasmic transport|centrosome cycle|cell aging|protein localization|positive regulation of cell proliferation|negative regulation of cell proliferation|regulation of centrosome duplication|positive regulation of centrosome duplication|negative regulation of centrosome duplication|cell growth|positive regulation of cellular biosynthetic process|regulation of endodeoxyribonuclease activity|ribosomal large subunit biogenesis|ribosomal small subunit biogenesis|negative regulation of apoptotic process|regulation of DNA damage response, signal transduction by p53 class mediator|regulation of neuron apoptotic process|negative regulation of protein kinase activity by regulation of protein phosphorylation|positive regulation of translation|positive regulation of DNA replication|positive regulation of protein kinase activity|regulation of centriole replication|negative regulation of mRNA splicing, via spliceosome|positive regulation of NF-kappaB transcription factor activity|protein oligomerization|protein homooligomerization|regulation of cell cycle|regulation of endoribonuclease activity|regulation of eIF2 alpha phosphorylation by dsRNA|negative regulation of cyclin-dependent protein kinase activity|","DNA binding|transcription coactivator activity|RNA binding|protein kinase inhibitor activity|protein binding|phosphatidylinositol-3,4,5-trisphosphate binding|rRNA binding|protein kinase binding|Tat protein binding|histone binding|protein homodimerization activity|ribosomal large subunit binding|ribosomal small subunit binding|poly(A) RNA binding|protein heterodimerization activity|protein N-terminus binding|NF-kappaB binding|unfolded protein binding|",4,12,1.76E+09,0.136,0.004248222,-0.058333333,29.46700537,0.499,0.001130575,5.460699531,-0.4665,-0.289,-0.168,0.276,0.108,0.1895,NC,5,NA,NA
1.039,1.251,1.218,1.076,1.3015,1.2555,1.164,1.212,1.2975,Q8K3B1,Q8K3B1,Fbxo45,1,7,5,5,Q8K3B1,MOUSE,31117.5,17.4,1988,1988.1,48.51,48.51,NA,286,F-box/SPRY domain-containing protein 1,postsynaptic density|cell junction|presynaptic membrane|synapse|postsynaptic membrane|SCF ubiquitin ligase complex|,neuron migration|cellular response to DNA damage stimulus|protein ubiquitination|cerebral cortex radially oriented cell migration|cerebral cortex tangential migration|corticospinal tract morphogenesis|anterior commissure morphogenesis|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|innervation|synapse assembly involved in innervation|,protein binding|,5,7,2.21E+08,0.174,1.58E-05,-0.099166667,58.59798203,1.187333333,1.38E-06,16.06233945,-0.6165,-0.663,-0.799,0.406,0.52,0.5575,undefined,9,NA,NA
0.413,0.506,0.532,0.241,0.2995,0.2425,0.468,0.475,0.4245,Q9WV69,Q9WV69,Dmtn,1,6,5,5,Q9WV69|Q9WV69-3|Q9WV69-2|Q9WV69-4,MOUSE,45638.7,15,1992,1992.1,48.27,48.27,NA,405,Dematin,cytosol|actin filament|plasma membrane|endomembrane system|spectrin-associated cytoskeleton|membrane|cytoplasmic membrane-bounded vesicle|cortical cytoskeleton|platelet dense tubular network membrane|cell projection membrane|perinuclear region of cytoplasm|neuronal postsynaptic density|,protein complex assembly|regulation of cell shape|regulation of lamellipodium assembly|positive regulation of fibroblast migration|negative regulation of peptidyl-threonine phosphorylation|negative regulation of cell-substrate adhesion|actin cytoskeleton organization|positive regulation of blood coagulation|regulation of actin cytoskeleton organization|negative regulation of peptidyl-serine phosphorylation|calcium-mediated signaling using intracellular calcium source|calcium-mediated signaling using extracellular calcium source|erythrocyte development|negative regulation of peptidyl-tyrosine phosphorylation|actin filament bundle assembly|regulation of filopodium assembly|actin filament capping|negative regulation of focal adhesion assembly|protein secretion by platelet|cellular response to calcium ion|cellular response to cAMP|positive regulation of wound healing|negative regulation of protein targeting to membrane|actin filament reorganization|negative regulation of substrate adhesion-dependent cell spreading|positive regulation of substrate adhesion-dependent cell spreading|positive regulation of platelet aggregation|positive regulation of integrin-mediated signaling pathway|calcium-mediated signaling using extracellular calcium source|,actin binding|receptor binding|spectrin binding|protein self-association|,5,6,8.51E+08,0.15,0.005123406,-0.030666667,28.51472546,0.398333333,0.001407756,5.228565536,-0.2135,-0.268,-0.208,0.228,0.024,0.2535,undefined,5,NA,NA
1.196,1.098,1.117,0.764,0.6815,0.7005,1.172,1.07,1.0935,O88325,O88325,Naglu,1,4,4,4,O88325,MOUSE,83165.4,8.2,1997,1997.1,47.93,47.93,NA,739,Alpha-N-acetylglucosaminidase,extracellular exosome|,lysosome organization|cerebellar Purkinje cell layer development|middle ear morphogenesis|locomotor rhythm|retinal rod cell development|inner ear receptor cell development|,NA,4,4,1.08E+08,0.082,0.000474877,0.014166667,40.37276226,1.022,9.18E-05,8.373878079,-0.5995,-0.412,-0.479,0.657,0.259,0.6595,PC,9,TRUE,NA
0.884,0.686,0.375,1.059,0.9275,0.6605,0.978,0.857,0.5695,Q9JHI8-4,Q9JHI8,Nox4,1,8,4,4,Q9JHI8-4|Q9JHI8|Q9JHI8-3,MOUSE,72554.7,8.5,2001,2001.1,47.76,47.76,NA,578,Isoform 4 of NADPH oxidase 4,stress fiber|mitochondrion|endoplasmic reticulum membrane|focal adhesion|apical plasma membrane|NADPH oxidase complex|perinuclear region of cytoplasm|cell periphery|,cell morphogenesis|response to hypoxia|superoxide metabolic process|cell aging|negative regulation of cell proliferation|gene expression|positive regulation of smooth muscle cell migration|superoxide anion generation|positive regulation of apoptotic process|positive regulation of MAP kinase activity|bone resorption|homocysteine metabolic process|positive regulation of stress fiber assembly|positive regulation of protein kinase B signaling|cardiac muscle cell differentiation|oxidation-reduction process|positive regulation of ERK1 and ERK2 cascade|cellular response to cAMP|cellular response to glucose stimulus|cellular response to gamma radiation|cellular response to transforming growth factor beta stimulus|reactive oxygen species metabolic process|positive regulation of reactive oxygen species metabolic process|positive regulation of DNA biosynthetic process|,NAD(P)H oxidase activity|superoxide-generating NADPH oxidase activity|modified amino acid binding|,4,8,5.68E+08,0.085,0.001773381,-0.072166667,33.81153297,0.757333333,0.000415764,6.507362471,-0.6315,-0.474,-0.247,0.154,0.408,0.3575,undefined,8,NA,TRUE
1.205,0.949,1.316,0.917,0.6685,1.0095,1.095,0.885,1.2555,Q3UDR8,Q3UDR8,Yipf3,1,6,4,4,Q3UDR8,MOUSE,38225.9,8.9,2009,2009.1,47.44,47.44,NA,347,Protein YIPF3,nucleoplasm|Golgi apparatus|plasma membrane|integral component of membrane|transport vesicle|intracellular membrane-bounded organelle|,cell differentiation|,NA,4,6,1.49E+09,0.089,0.000346969,-0.014,42.02329661,1.063,6.28E-05,8.9073615,-0.5605,-0.351,-0.725,0.626,0.341,0.5855,undefined,9,NA,TRUE
0.463,0.447,0.577,0.334,0.3835,0.3745,0.495,0.47,0.5955,P59325,P59325,Eif5,1,6,4,4,P59325|Q8BVV6|A0A1Y7VLQ0,MOUSE,49424,10.4,2010,2010.1,47.38,47.38,NA,429,Eukaryotic translation initiation factor 5,cytoplasm|plasma membrane|,translational initiation|regulation of translational initiation|,translation initiation factor activity|GTP binding|poly(A) RNA binding|,4,6,4.98E+08,0.104,0.001751285,0.020166667,33.88202124,0.449333333,0.00040907,6.480797195,-0.2075,-0.156,-0.25,0.283,0.133,0.3185,undefined,5,NA,NA
1.282,1.026,0.949,1.521,1.1305,1.1175,1.271,1.012,1.0615,Q9ES89,Q9ES89,Extl2,1,10,4,4,Q9ES89|Q3TSR0,MOUSE,37618.1,11.5,2026,2026.1,46.54,46.54,NA,330,Exostosin-like 2,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|extracellular exosome|,glycosaminoglycan biosynthetic process|N-acetylglucosamine metabolic process|heparan sulfate proteoglycan biosynthetic process|UDP-N-acetylgalactosamine metabolic process|,"glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|alpha-1,4-N-acetylgalactosaminyltransferase activity|metal ion binding|",4,10,2.23E+08,0.115,0.000109993,-0.11,47.86564015,1.155,1.63E-05,11.04264784,-0.8775,-0.571,-0.614,0.361,0.601,0.4405,undefined,9,NA,TRUE
2.215,2.162,2.223,1.854,1.9805,1.8745,2.351,2.203,2.3865,Q61292,Q61292,Lamb2,1,7,6,6,Q61292,MOUSE,203707.4,3.6,2028,2028.1,46.47,46.47,NA,1799,Laminin subunit beta-2,extracellular region|basement membrane|basal lamina|laminin-3 complex|laminin complex|synapse|extracellular exosome|extracellular matrix|,cell morphogenesis involved in differentiation|cell adhesion|axon guidance|neuromuscular junction development|visual perception|astrocyte development|Schwann cell development|neuron projection development|axon extension involved in regeneration|synapse organization|retina development in camera-type eye|metanephric glomerular visceral epithelial cell development|metanephric glomerular basement membrane development|,integrin binding|,6,7,6.20E+08,0.036,8.08E-06,-0.270166667,63.56562701,2.189333333,4.40E-07,19.34389814,-1.2785,-1.367,-1.449,0.836,0.608,1.0295,PC,9,TRUE,NA
1.245,1.506,1.462,1.17,1.4165,1.3725,1.422,1.522,1.4815,P29416,P29416,Hexa,1,6,3,3,P29416,MOUSE,61182.5,8.1,2033,2033.1,46.24,46.24,NA,528,Beta-hexosaminidase subunit alpha,lysosome|membrane|extracellular exosome|,skeletal system development|carbohydrate metabolic process|ganglioside catabolic process|lysosome organization|sensory perception of sound|locomotory behavior|adult walking behavior|lipid storage|sexual reproduction|glycosaminoglycan metabolic process|myelination|cell morphogenesis involved in neuron differentiation|neuromuscular process controlling posture|neuromuscular process controlling balance|SMAD protein signal transduction|,beta-N-acetylhexosaminidase activity|protein heterodimerization activity|,3,6,1.88E+08,0.081,1.35E-05,-0.12,59.85083798,1.445666667,1.03E-06,16.9226821,-0.6835,-0.892,-0.953,0.626,0.528,0.6545,undefined,9,TRUE,TRUE
1.752,1.892,1.69,1.382,1.5765,1.5065,1.553,1.841,1.5615,Q9DC11,Q9DC11,Plxdc2,1,9,4,4,Q9DC11|B1AY85,MOUSE,60185.7,7.9,2035,2035.1,46.17,46.17,NA,530,Plexin domain-containing protein 2,plasma membrane|integral component of membrane|extracellular exosome|,NA,NA,4,9,5.73E+08,0.079,4.54E-06,-0.184,68.83909584,1.588333333,1.31E-07,22.8853886,-0.8955,-0.996,-1.043,0.695,0.538,0.5975,undefined,9,TRUE,TRUE
0.818,0.849,0.552,0.322,0.4465,0.0325,0.722,0.68,0.4955,Q9DC16,Q9DC16,Ergic1,1,5,4,4,Q9DC16,MOUSE,32961,14.4,2047,2047.1,45.6,45.6,NA,290,Endoplasmic reticulum-Golgi intermediate compartment protein 1,Golgi membrane|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|membrane|integral component of membrane|endoplasmic reticulum-Golgi intermediate compartment membrane|,ER to Golgi vesicle-mediated transport|,NA,4,5,1.92E+08,0.144,0.025502324,0.014,19.99504109,0.482333333,0.010011425,3.565413465,-0.3175,-0.336,-0.028,0.421,0.003,0.3415,undefined,7,NA,TRUE
1.995,2.315,1.97,2.196,2.4485,2.1045,2.093,2.165,1.9155,A0PJK7,A0PJK7,Cdhr5,1,8,5,5,A0PJK7|Q8VHF2|Q8VHF2-2,MOUSE,88624.8,7.9,2055,2055.1,45.14,45.14,NA,831,Cadherin-related family member 5,plasma membrane|coated pit|integral component of membrane|extracellular exosome|,homophilic cell adhesion via plasma membrane adhesion molecules|,calcium ion binding|beta-catenin binding|,5,8,1.46E+09,0.079,2.39E-06,-0.406,75.19693415,2.175,3.02E-08,28.69021536,-1.4685,-1.529,-1.483,0.59,0.824,0.6305,undefined,9,TRUE,TRUE
0.605,0.572,0.145,0.658,0.6415,0.2135,0.676,0.81,0.2165,Q569Z6,Q569Z6,Thrap3,1,7,6,6,Q569Z6|Q8BZN7,MOUSE,108233.3,6.3,2073,2073.1,44.42,44.42,NA,951,Thyroid hormone receptor-associated protein 3,nucleus|nucleoplasm|mediator complex|extracellular exosome|exon-exon junction complex|,"regulation of alternative mRNA splicing, via spliceosome|nuclear-transcribed mRNA catabolic process|transcription from RNA polymerase II promoter|transcription initiation from RNA polymerase II promoter|mRNA processing|circadian rhythm|RNA splicing|intracellular steroid hormone receptor signaling pathway|androgen receptor signaling pathway|positive regulation of circadian rhythm|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of mRNA splicing, via spliceosome|mRNA stabilization|",core promoter sequence-specific DNA binding|RNA polymerase II transcription cofactor activity|transcription cofactor activity|transcription coactivator activity|receptor activity|protein binding|ATP binding|poly(A) RNA binding|thyroid hormone receptor binding|phosphoprotein binding|,6,7,1.88E+09,0.063,0.015947778,-0.107,22.44107746,0.529666667,0.005700228,4.013405819,-0.4445,-0.567,-0.104,0.043,0.13,0.3005,undefined,6,NA,NA
1.284,1.402,1.575,1.588,1.4785,1.8105,1.199,1.396,1.6385,Q9EPQ7,Q9EPQ7,Stard5,1,7,5,5,Q9EPQ7|D3YU00,MOUSE,24378.1,25.3,2093,2093.1,43.64,43.64,NA,213,StAR-related lipid transfer protein 5,NA,lipid transport|,cholesterol binding|bile acid binding|,5,7,7.50E+09,0.253,5.31E-05,-0.182,51.66047437,1.509666667,6.82E-06,12.66698535,-0.7535,-0.91,-1.147,0.515,0.732,0.4715,undefined,9,NA,NA
1.184,0.779,1.012,1.37,0.9525,1.2255,1.159,0.707,0.9945,Q8R0I0,Q8R0I0,Ace2,1,5,5,5,Q8R0I0|Q8R0I0-2,MOUSE,92822.3,6.8,2103,2103.1,43.02,43.02,NA,805,Angiotensin-converting enzyme 2,extracellular region|extracellular space|cytoplasm|plasma membrane|cell surface|integral component of membrane|extracellular exosome|,angiotensin-mediated drinking behavior|regulation of systemic arterial blood pressure by renin-angiotensin|proteolysis|tryptophan transport|receptor biosynthetic process|viral entry into host cell|receptor-mediated virion attachment to host cell|positive regulation of cardiac muscle contraction|positive regulation of gap junction assembly|regulation of cardiac conduction|,virus receptor activity|glycoprotein binding|endopeptidase activity|carboxypeptidase activity|metallopeptidase activity|peptidyl-dipeptidase activity|metal ion binding|,5,5,4.56E+08,0.068,0.000502238,-0.123,40.0653329,1.045,9.85E-05,8.277583985,-0.8375,-0.399,-0.7,0.361,0.545,0.2925,PC,9,TRUE,TRUE
0.594,0.432,0.692,0.58,0.6015,0.6935,0.59,0.417,0.6885,Q91YM2,Q91YM2,Arhgap35,1,7,5,5,Q91YM2,MOUSE,171930.2,3.4,2107,2107.1,42.83,42.83,NA,1499,Rho GTPase-activating protein 35,nucleus|cytoplasm|actin cytoskeleton|,"negative regulation of transcription from RNA polymerase II promoter|neural tube closure|transcription, DNA-templated|integrin-mediated signaling pathway|small GTPase mediated signal transduction|regulation of cell shape|positive regulation of neuron projection development|forebrain development|negative regulation of Rho protein signal transduction|camera-type eye development|negative regulation of vascular permeability|positive regulation of GTPase activity|negative regulation of transcription, DNA-templated|",RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription|GTPase activator activity|GTP binding|,5,7,4.74E+09,0.034,0.000103971,-0.056166667,48.2296195,0.648,1.50E-05,11.06818452,-0.3465,-0.336,-0.458,0.259,0.291,0.2535,undefined,7,NA,NA
0.871,0.69,0.745,0.628,0.7285,0.6505,0.056,0.055,-0.0745,Q61263,Q61263,Soat1,1,5,4,4,Q61263,MOUSE,64368.3,11.2,2108,2108.1,42.78,42.78,NA,540,Sterol O-acyltransferase 1,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|,cholesterol metabolic process|macrophage derived foam cell differentiation|cholesterol storage|cholesterol efflux|very-low-density lipoprotein particle assembly|cholesterol esterification|cholesterol homeostasis|positive regulation of amyloid precursor protein biosynthetic process|,fatty-acyl-CoA binding|sterol O-acyltransferase activity|cholesterol binding|cholesterol O-acyltransferase activity|,4,5,1.37E+09,0.112,0.075915267,0.158,14.00507523,0.526333333,0.039764221,2.55188135,-0.1535,-0.123,-0.039,0.713,0.639,-0.0885,undefined,6,NA,TRUE
1.151,1.439,1.301,1.249,1.2525,1.2985,1.042,1.318,1.2215,Q8CIV2-2,Q8CIV2,Tmem259,1,8,4,4,Q8CIV2-2|Q8CIV2,MOUSE,66004.3,16.5,2111,2111.1,42.42,42.42,NA,574,Isoform 2 of Membralin,integral component of membrane|,NA,NA,4,8,3.70E+08,0.165,1.44E-05,-0.149166667,59.31582276,1.325333333,1.17E-06,16.49676952,-0.6695,-0.83,-0.936,0.554,0.524,0.4625,undefined,9,NA,TRUE
1.274,1.088,1.163,1.502,1.3915,1.4665,1.392,1.207,1.2865,Q8C129,Q8C129,Lnpep,1,6,4,4,Q8C129,MOUSE,117872.3,3.5,2113,2113.1,42.33,42.33,NA,1025,Leucyl-cystinyl aminopeptidase,intracellular|lysosomal membrane|plasma membrane|endomembrane system|membrane|integral component of membrane|cytoplasmic vesicle membrane|perinuclear region of cytoplasm|,proteolysis|protein catabolic process|SMAD protein signal transduction|,aminopeptidase activity|protein binding|metallopeptidase activity|zinc ion binding|,4,6,1.20E+10,0.035,2.65E-05,-0.094,55.34502326,1.328333333,2.92E-06,14.45419619,-0.8215,-0.658,-0.795,0.432,0.729,0.5495,undefined,9,NA,TRUE
0.225,0.491,0.695,-0.209,0.2215,0.4145,0.137,0.549,0.6525,O70439,O70439,Stx7,1,7,5,5,O70439|Q8BH40,MOUSE,29991.3,21.8,2120,2120.1,42.19,42.19,NA,261,Syntaxin-7,immunological synapse|lysosome|lysosomal membrane|endosome|early endosome|late endosome|plasma membrane|endomembrane system|integral component of membrane|endocytic vesicle|SNARE complex|early endosome membrane|vesicle|azurophil granule|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|recycling endosome|extracellular exosome|tertiary granule|,positive regulation of T cell mediated cytotoxicity|intracellular protein transport|vesicle fusion|vesicle docking|organelle localization|organelle assembly|positive regulation of receptor localization to synapse|regulation of protein localization to plasma membrane|,SNARE binding|SNAP receptor activity|protein binding|chloride channel inhibitor activity|syntaxin binding|,5,7,3.74E+08,0.218,0.061959179,0.001333333,15.11181722,0.349,0.030818981,2.732373599,0.0675,-0.238,-0.349,0.302,0.009,0.2165,undefined,5,NA,TRUE
0.762,0.43,0.567,0.841,0.8395,0.9765,0.54,0.519,0.6605,E9Q9B3,E9Q9B3,Spryd3,1,5,4,4,E9Q9B3,MOUSE,50209.6,15.3,2121,2121.1,42.18,42.18,NA,442,SPRY domain-containing 3,NA,NA,NA,4,5,1.78E+08,0.153,0.000239686,0.031,43.94523846,0.725666667,4.03E-05,9.50226799,-0.3515,-0.244,-0.4,0.415,0.485,0.2815,NC,8,NA,NA
0.85,0.87,1.047,0.359,0.6405,0.7765,0.714,0.858,1.0145,E9QMN1,E9QMN1,Ush1c,1,8,5,5,E9QMN1|Q9ES64|E9PY|D6RIM8|Q9ES64-2|Q9ES64-3|A0A0R4J0Z8|H3BLC4|H3BIZ2,MOUSE,102691.1,7.4,2126,2126.1,41.9,41.9,NA,910,Harmonin,photoreceptor outer segment|photoreceptor inner segment|cytoplasm|plasma membrane|brush border|stereocilium|apical part of cell|synapse|,G2/M transition of mitotic cell cycle|sensory perception of sound|parallel actin filament bundle assembly|inner ear morphogenesis|auditory receptor cell differentiation|photoreceptor cell maintenance|neuromuscular process controlling balance|sensory perception of light stimulus|equilibrioception|actin filament bundle assembly|inner ear receptor stereocilium organization|,protein binding|spectrin binding|myosin tail binding|actin filament binding|,5,8,2.52E+09,0.074,0.003745883,0.004166667,30.11818958,0.894666667,0.000973153,5.609290257,-0.2005,-0.444,-0.685,0.648,0.189,0.5175,undefined,8,NA,NA
0.742,1.025,0.513,0.831,1.1025,0.5865,0.829,1.108,0.6005,P16294,P16294,F9,1,4,4,4,P16294,MOUSE,54289.1,7.4,2131,2131.1,41.74,41.74,NA,471,Coagulation factor IX,extracellular space|extracellular exosome|,proteolysis|blood coagulation|zymogen activation|,endopeptidase activity|serine-type endopeptidase activity|calcium ion binding|peptidase activity|,4,4,3.52E+08,0.074,0.001418508,-0.138833333,34.91120914,0.812,0.00032276,6.794408397,-0.5605,-0.774,-0.3,0.216,0.321,0.2645,PC,9,TRUE,NA
2.19,2.172,2.382,1.931,1.9235,2.1325,2.073,2.042,2.2565,Q9Z138,Q9Z138,Ror2,1,4,4,4,Q9Z138|E9PUN5|Q9Z139,MOUSE,106601.1,5.6,2133,2133.1,41.61,41.61,NA,944,Tyrosine-protein kinase transmembrane receptor ROR2,intracellular|plasma membrane|integral component of plasma membrane|,"skeletal system development|cartilage condensation|somitogenesis|transmembrane receptor protein tyrosine kinase signaling pathway|Wnt signaling pathway, calcium modulating pathway|smoothened signaling pathway|JNK cascade|negative regulation of cell proliferation|peptidyl-tyrosine phosphorylation|cell differentiation|positive regulation of cell migration|BMP signaling pathway|embryonic genitalia morphogenesis|inner ear morphogenesis|embryonic digit morphogenesis|cell fate commitment|positive regulation of transcription, DNA-templated|Wnt signaling pathway, planar cell polarity pathway|SMAD protein signal transduction|regulation of canonical Wnt signaling pathway|negative regulation of canonical Wnt signaling pathway|positive regulation of canonical Wnt signaling pathway|",transmembrane receptor protein tyrosine kinase activity|frizzled binding|protein binding|ATP binding|Wnt-protein binding|,4,4,1.30E+09,0.056,1.09E-05,-0.336833333,61.47411201,2.16,7.12E-07,17.96734695,-1.3225,-1.255,-1.673,0.841,0.645,0.7435,undefined,9,TRUE,TRUE
0.172,0.463,0.499,0.207,0.5135,0.5485,0.135,0.422,0.4625,P51906,P51906,Slc1a1,1,5,3,3,P51906,MOUSE,56978,12.2,2144,2144.1,40.98,40.98,NA,523,Excitatory amino acid transporter 3,plasma membrane|integral component of membrane|apical plasma membrane|extracellular exosome|,positive regulation of heart rate|L-glutamate transport|cysteine transport|protein homooligomerization|L-glutamate import|D-aspartate import|L-glutamate transmembrane transport|cysteine transmembrane transport|,L-glutamate transmembrane transporter activity|protein binding|glutamate:sodium symporter activity|glutamate binding|sodium:dicarboxylate symporter activity|cysteine transmembrane transporter activity|,3,5,8.33E+08,0.122,0.012131025,-0.089833333,23.91373745,0.410666667,0.004060937,4.295530552,-0.0955,-0.367,-0.423,0.082,0.177,0.0875,undefined,5,NA,TRUE
1.944,1.946,2.025,1.752,1.7455,1.9025,1.856,1.846,2.0185,P58158,P58158,B3gat3,1,9,5,5,P58158,MOUSE,37237.3,18.5,2145,2145.1,40.9,40.9,NA,335,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,Golgi membrane|Golgi apparatus|cis-Golgi network|membrane|integral component of membrane|extracellular exosome|,glycosaminoglycan biosynthetic process|protein glycosylation|heparan sulfate proteoglycan biosynthetic process|positive regulation of catalytic activity|chondroitin sulfate proteoglycan biosynthetic process|dermatan sulfate proteoglycan biosynthetic process|positive regulation of intracellular protein transport|,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity|glucuronosyltransferase activity|metal ion binding|protein phosphatase activator activity|,5,9,1.90E+08,0.185,6.31E-06,-0.282333333,65.28522621,1.942333333,2.96E-07,20.55171647,-1.1775,-1.137,-1.446,0.755,0.624,0.6875,undefined,9,NA,TRUE
2.321,2.228,2.312,2.161,2.0845,2.1685,2.352,2.255,2.3435,Q9WU60,Q9WU60,Atrn,1,5,3,3,Q9WU60,MOUSE,163133.2,3.7,2146,2146.1,40.9,40.9,NA,1428,Attractin,extracellular space|cytoplasm|plasma membrane|integral component of membrane|extracellular exosome|,inflammatory response|response to oxidative stress|cerebellum development|regulation of multicellular organism growth|myelination|pigmentation|,receptor activity|protein binding|carbohydrate binding|,3,5,53400000,0.037,2.76E-06,-0.329166667,73.58784393,2.371333333,4.38E-08,27.4992616,-1.5125,-1.364,-1.668,0.871,0.807,0.8915,undefined,9,NA,TRUE
1.372,1.65,1.701,1.221,1.5145,1.5655,1.529,1.803,1.8585,Q9QY73,Q9QY73,Tmem59,1,3,3,3,Q9QY73|D3YVM2|D6RI96,MOUSE,36997.5,11.4,2153,2153.1,40.59,40.59,NA,323,Transmembrane protein 59,Golgi cis cisterna|Golgi trans cisterna|Golgi membrane|lysosome|lysosomal membrane|late endosome|Golgi medial cisterna|plasma membrane|integral component of membrane|late endosome membrane|extracellular exosome|,proteolysis|autophagy|positive regulation of autophagy|negative regulation of protein processing|negative regulation of establishment of protein localization to plasma membrane|negative regulation of protein glycosylation in Golgi|,endopeptidase activity|,3,3,1.48E+10,0.114,2.12E-05,-0.23,56.63615929,1.553666667,2.17E-06,15.13483388,-0.8195,-1.004,-1.197,0.522,0.493,0.6255,undefined,9,TRUE,TRUE
0.326,0.703,0.402,0.216,0.4475,0.3935,0.445,0.705,0.5795,Q922E4,Q922E4,Pcyt2,1,9,4,4,Q922E4|A2ABY3,MOUSE,45690.6,11.6,2155,2155.1,40.48,40.48,NA,404,Ethanolamine-phosphate cytidylyltransferase,NA,phosphatidylethanolamine biosynthetic process|,ethanolamine-phosphate cytidylyltransferase activity|,4,9,1.10E+09,0.116,0.004209477,0.003166667,29.51620632,0.507333333,0.001117839,5.471830775,-0.1155,-0.36,-0.276,0.267,0.128,0.3755,undefined,6,NA,NA
0.989,1.189,1.801,1.151,1.6905,1.8355,1.073,1.251,1.8855,E9Q512,E9Q512,Trip11,1,5,4,4,E9Q512,MOUSE,227022.1,1.6,2173,2173.1,39.72,39.72,NA,1976,Thyroid hormone receptor interactor 11,inner acrosomal membrane|acrosomal membrane|outer acrosomal membrane|nucleus|Golgi apparatus|cis-Golgi network|,protein targeting to Golgi|ventricular septum development|,protein binding|,4,5,1.36E+09,0.016,0.001573782,-0.235666667,34.39460805,1.507,0.000363529,6.658369914,-0.5965,-0.86,-1.511,0.39,0.677,0.4865,undefined,9,NA,NA
1.49,1.428,1.297,1.338,1.3645,1.2295,1.422,1.338,1.3435,O88668,O88668,Creg1,1,8,5,5,O88668|K4DI63|J3QP41,MOUSE,24565.5,20.9,2185,2185.1,39.29,39.29,NA,220,Protein CREG1,transcription factor complex|extracellular exosome|,"regulation of transcription, DNA-templated|regulation of growth|oxidation-reduction process|",transcription factor binding|FMN binding|oxidoreductase activity|,5,8,1.48E+08,0.209,2.52E-06,-0.162166667,74.37979312,1.402,3.65E-08,27.73666272,-0.8515,-0.849,-0.889,0.529,0.539,0.5485,PC,9,TRUE,NA
0.738,0.797,0.629,0.524,0.5315,0.4695,0.805,0.793,0.7305,Q9CWE0,Q9CWE0,Mtfr1l,1,4,4,4,Q9CWE0|D6RCX5,MOUSE,32182,14.8,2187,2187.1,39.28,39.28,NA,289,Mitochondrial fission regulator 1-like,mitochondrion|,mitochondrial fission|aerobic respiration|,NA,4,4,7.09E+08,0.148,0.000507908,-0.025833333,40.01010144,0.66,9.98E-05,8.216039786,-0.3905,-0.371,-0.306,0.325,0.16,0.4275,NC,9,NA,NA
0.653,0.646,0.844,0.472,0.4725,0.6425,0.617,0.714,0.9295,O35465-2,O35465,Fkbp8,1,10,3,3,O35465-2|O35465,MOUSE,44071.6,10.1,2190,2190.1,39.12,39.12,NA,402,Isoform 2 of Peptidyl-prolyl cis-trans isomerase FKBP8,cytoplasm|mitochondrion|mitochondrial envelope|endoplasmic reticulum membrane|membrane|integral component of endoplasmic reticulum membrane|mitochondrial membrane|,protein peptidyl-prolyl isomerization|cell fate specification|apoptotic process|smoothened signaling pathway|dorsal/ventral pattern formation|regulation of gene expression|dorsal/ventral neural tube patterning|neural tube development|regulation of BMP signaling pathway|positive regulation of BMP signaling pathway|multicellular organism growth|camera-type eye development|negative regulation of apoptotic process|chaperone-mediated protein folding|,peptidyl-prolyl cis-trans isomerase activity|FK506 binding|identical protein binding|,3,10,5.29E+08,0.101,0.001390471,-0.048166667,35.00891515,0.73,0.000315579,6.820378993,-0.3425,-0.318,-0.579,0.332,0.154,0.4645,undefined,9,NA,TRUE
0.559,0.876,0.726,0.648,0.9865,0.8075,0.852,1.068,0.9615,Q8BG19,Q8BG19,Tmtc4,1,6,4,4,Q8BG19|Q8BG19-3|Q8BG19-2,MOUSE,83816.9,4.1,2191,2191.1,39.11,39.11,NA,741,Transmembrane and TPR repeat-containing protein 4,integral component of membrane|,NA,NA,4,6,1.73E+08,0.041,0.000677953,-0.106333333,38.54467219,0.881,0.000139808,7.814849671,-0.3565,-0.689,-0.595,0.217,0.285,0.5005,undefined,9,NA,TRUE
2.959,2.999,3.031,2.644,2.7385,2.8195,2.853,2.881,2.9165,Q9D1M7,Q9D1M7,Fkbp11,1,11,2,2,Q9D1M7,MOUSE,22307.9,17.9,2194,2194.1,39.08,39.08,NA,201,Peptidyl-prolyl cis-trans isomerase FKBP11,cytoplasm|endoplasmic reticulum membrane|membrane|integral component of membrane|,protein peptidyl-prolyl isomerization|chaperone-mediated protein folding|,peptidyl-prolyl cis-trans isomerase activity|FK506 binding|,2,11,4.81E+09,0.179,5.61E-06,-0.616166667,66.84321376,2.958666667,2.07E-07,21.7091286,-1.9215,-1.962,-2.403,0.966,0.777,0.8465,undefined,9,TRUE,TRUE
0.772,0.461,0.047,0.859,0.6435,0.1015,1.041,0.719,0.3415,Q8BTI8,Q8BTI8,Srrm2,1,5,3,3,Q8BTI8|Q8BTI8-3|Q8BTI8-2,MOUSE,295691.1,1.6,2199,2199.1,38.93,38.93,NA,2703,Serine/arginine repetitive matrix protein 2,Cajal body|nuclear speck|catalytic step 2 spliceosome|,RNA splicing|,poly(A) RNA binding|protein N-terminus binding|C2H2 zinc finger domain binding|,3,5,41900000,0.016,0.045737785,-0.138666667,16.76999667,0.550333333,0.021037801,3.007676377,-0.7835,-0.402,-0.056,0,0.114,0.2955,undefined,6,NA,NA
0.446,0.292,0.505,0.362,0.2235,0.4705,0.431,0.288,0.4345,A2AJ88,A2AJ88,Pnpla7,1,8,3,3,A2AJ88|A2AJ88-2|A2AJ88-3,MOUSE,151860.9,2.5,2210,2210.1,38.57,38.57,NA,1352,Patatin-like phospholipase domain-containing protein 7,lysosomal membrane|endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|nuclear membrane|mitochondrial membrane|,lipid metabolic process|developmental process|,lysophospholipase activity|lysophospholipase activity|,3,8,7.55E+08,0.025,0.009466321,-0.004166667,25.27424811,0.356,0.002968761,4.551925249,-0.2075,-0.042,-0.297,0.214,0.177,0.1305,undefined,5,NA,TRUE
0.583,0.938,0.572,0.379,0.6025,0.4345,0.368,0.719,0.3575,Q7TMR0,Q7TMR0,Prcp,1,4,3,3,Q7TMR0|A0A140LHY2,MOUSE,55653.6,9.1,2212,2212.1,38.36,38.36,NA,491,Lysosomal Pro-X carboxypeptidase,lysosome|basal part of cell|extracellular exosome|,regulation of thyroid hormone mediated signaling pathway|plasma kallikrein-kinin cascade|negative regulation of systemic arterial blood pressure|proteolysis|glucose homeostasis|regulation of blood vessel endothelial cell migration|angiogenesis involved in wound healing|energy homeostasis|regulation of reactive oxygen species metabolic process|,carboxypeptidase activity|serine-type peptidase activity|,3,4,8.06E+08,0.091,0.002138417,-0.047,32.87243374,0.498333333,0.000516127,6.243616948,-0.2265,-0.408,-0.254,0.313,0.178,0.1155,undefined,6,TRUE,NA
0.514,0.516,0.783,0.576,0.5445,0.7785,0.65,0.601,0.8815,O70572,O70572,Smpd2,1,7,3,3,O70572,MOUSE,48435.6,9.7,2214,2214.1,38.16,38.16,NA,419,Sphingomyelin phosphodiesterase 2,intracellular|caveola|integral component of membrane|,response to mechanical stimulus|intracellular signal transduction|positive regulation of apoptotic process|ceramide biosynthetic process|,sphingomyelin phosphodiesterase activity|metal ion binding|,3,7,1.69E+08,0.097,0.001167323,-0.032166667,35.83526891,0.666,0.000260899,7.04315753,-0.2625,-0.271,-0.562,0.256,0.279,0.3675,undefined,9,NA,TRUE
1.03,0.959,1.01,1.063,1.0735,1.2305,1.058,1.17,1.2145,Q91YT2-2,Q91YT2,Rnf185,1,8,5,5,Q91YT2-2|Q91YT2,MOUSE,25534.5,14.4,2215,2215.1,38.11,38.11,NA,192,Isoform 2 of E3 ubiquitin-protein ligase RNF185,mitochondrial outer membrane|endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,autophagy|ER-associated ubiquitin-dependent protein catabolic process|ERAD pathway|protein autoubiquitination|,zinc ion binding|ligase activity|ubiquitin-like protein conjugating enzyme binding|ubiquitin protein ligase activity|,5,8,1.60E+09,0.144,4.45E-05,-0.067666667,52.59932462,1.108333333,5.50E-06,13.07421847,-0.6285,-0.513,-0.724,0.37,0.495,0.5945,undefined,9,NA,TRUE
1.226,1.363,1.185,1.053,0.9555,0.7775,1.121,1.118,0.9445,Q62086,Q62086,Pon2,1,3,3,3,Q62086,MOUSE,39787.8,11.2,2221,2221.1,37.89,37.89,NA,354,Serum paraoxonase/arylesterase 2,extracellular region|nucleus|mitochondrion|lysosome|plasma membrane|,response to oxidative stress|aromatic compound catabolic process|,arylesterase activity|identical protein binding|metal ion binding|,3,3,1.09E+09,0.112,4.68E-05,-0.067333333,52.30452283,1.040333333,5.88E-06,12.86486162,-0.6605,-0.617,-0.485,0.553,0.334,0.4715,NC,9,TRUE,NA
2.046,1.971,2.28,1.713,1.6535,1.9625,1.883,1.804,2.1175,Q9JKF6,Q9JKF6,Nectin1,1,3,3,3,Q9JKF6,MOUSE,57376.4,8.5,2234,2234.1,37.65,37.65,NA,515,Nectin-1,cell-cell adherens junction|integral component of membrane|catenin complex|axon|growth cone membrane|presynaptic membrane|intracellular membrane-bounded organelle|,lens morphogenesis in camera-type eye|desmosome organization|iron ion transport|homophilic cell adhesion via plasma membrane adhesion molecules|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|axon guidance|single organismal cell-cell adhesion|viral entry into host cell|camera-type eye morphogenesis|regulation of synapse assembly|retina development in camera-type eye|enamel mineralization|,receptor activity|protein binding|carbohydrate binding|protein homodimerization activity|virion binding|protein heterodimerization activity|cell adhesion molecule binding|,3,3,1.83E+08,0.085,2.71E-05,-0.237833333,55.24429674,1.973333333,2.99E-06,14.40233449,-1.1425,-1.024,-1.507,0.883,0.614,0.7495,undefined,9,TRUE,TRUE
1.36,1.001,1.025,0.947,0.7045,0.7775,1.263,0.89,0.9685,Q9QZS7,Q9QZS7,Nphs1,1,5,5,5,Q9QZS7|Q9QZS7-2,MOUSE,137531.9,4.6,2235,2235.1,37.64,37.64,NA,1256,Nephrin,intracellular|plasma membrane|integral component of plasma membrane|integral component of membrane|slit diaphragm|cell projection|extracellular exosome|,MAPK cascade|cell adhesion|JNK cascade|skeletal muscle tissue development|myoblast fusion|positive regulation of actin filament polymerization|glomerular basement membrane development|regulation of excretion|glomerular visceral epithelial cell development|,protein binding|myosin binding|,5,5,34200000,0.046,0.000146419,-0.067,46.42589659,0.925666667,2.28E-05,10.47791967,-0.6775,-0.407,-0.505,0.489,0.309,0.3895,undefined,9,TRUE,TRUE
1.555,1.874,2.223,1.308,1.7355,1.9655,1.566,1.918,2.1815,Q8K4T1,Q8K4T1,St8sia6,1,6,5,5,Q8K4T1,MOUSE,45998,16.3,2238,2238.1,37.37,37.37,NA,398,"Alpha-2,8-sialyltransferase 8F",integral component of Golgi membrane|,ganglioside biosynthetic process|protein O-linked glycosylation|glycoprotein metabolic process|glycolipid biosynthetic process|oligosaccharide metabolic process|carbohydrate biosynthetic process|sialylation|,sialyltransferase activity|,5,6,4.42E+08,0.163,0.000111796,-0.224333333,47.78661494,1.899666667,1.66E-05,11.01094988,-0.8405,-1.154,-1.528,0.804,0.572,0.8005,undefined,9,TRUE,TRUE
1.318,1.304,1.367,1.061,1.1445,1.3355,1.191,1.404,1.5675,Q64191,Q64191,Aga,1,7,3,3,Q64191|B7ZNK6,MOUSE,37534.8,8.9,2243,2243.1,37.3,37.3,NA,346,N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase,lysosome|endoplasmic reticulum|extracellular exosome|,proteolysis|protein deglycosylation|protein maturation|,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity|peptidase activity|protein self-association|,3,7,1.81E+08,0.089,2.03E-05,-0.042,56.8591421,1.475666667,2.06E-06,15.25541988,-0.7215,-0.703,-0.915,0.641,0.587,0.8595,undefined,9,TRUE,NA
1.235,1.133,1.598,1.4,1.3135,1.6555,1.344,1.238,1.7075,Q9CYD3,Q9CYD3,Crtap,1,4,3,3,Q9CYD3,MOUSE,46796,6.2,2245,2245.1,37.27,37.27,NA,400,Cartilage-associated protein,proteinaceous extracellular matrix|extracellular space|endoplasmic reticulum|macromolecular complex|,spermatogenesis|peptidyl-proline hydroxylation to 3-hydroxy-L-proline|protein stabilization|chaperone-mediated protein folding|negative regulation of post-translational protein modification|,protein complex binding|,3,4,2.16E+08,0.062,0.00021881,-0.124,44.43875895,1.411666667,3.60E-05,9.741092533,-0.7235,-0.606,-1.16,0.483,0.634,0.6285,PC,9,TRUE,NA
0.851,1.186,1.036,0.484,0.7755,0.6205,0.613,0.756,0.6295,Q61595,Q61595,Ktn1,1,3,3,3,Q61595|F8VQC7|Q61595-11|A0A087WPX0|Q61595-7|A0A087WP14|Q61595-10|A0A087WP85|Q61595-5|A0A087WQQ5|Q61595-15|A0A087WRS1|A0A087WQ25|Q61595-13|A0A087WS23|Q61595-8|A0A087WPW5|Q61595-9|A0A087WQI3|Q61595-4|A0A087WQD0|Q61595-6|A0A087WNW3|Q61595-14|A0A087WQG4|Q61595-3|A0A087WS29|Q61595-16|A0A087WS04|Q61595-12|A0A087WP48|Q61595-2|A0A087WQF8,MOUSE,153160.2,2.6,2253,2253.1,37,37,NA,1327,Kinectin,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,microtubule-based movement|,kinesin binding|,3,3,7.60E+07,0.026,0.001513268,-0.019,34.58742988,0.773666667,0.000347742,6.708896848,-0.2725,-0.515,-0.43,0.594,0.228,0.2815,undefined,9,NA,TRUE
1.404,1.404,1.582,1.31,1.3245,1.5035,1.349,1.397,1.5825,Q6T5E4,Q6T5E4,Gcnt2,1,4,3,3,Q6T5E4|Q7TPQ8|Q9D2A8,MOUSE,46854.9,8.2,2261,2261.1,36.86,36.86,NA,401,"Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme",membrane|,protein glycosylation|transforming growth factor beta receptor signaling pathway|posttranscriptional regulation of gene expression|positive regulation of epithelial to mesenchymal transition|negative regulation of cell-substrate adhesion|positive regulation of cell migration|positive regulation of heterotypic cell-cell adhesion|maintenance of lens transparency|positive regulation of protein kinase B signaling|positive regulation of ERK1 and ERK2 cascade|,"N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity|acetylglucosaminyltransferase activity|",3,4,3.90E+08,0.082,1.58E-05,-0.185166667,58.63907485,1.493333333,1.37E-06,16.25134416,-0.8225,-0.844,-1.129,0.592,0.556,0.5365,PC,9,NA,NA
0.775,0.79,0.843,0.645,0.6665,0.7455,0.721,0.68,0.8875,Q5SUH6,Q5SUH6,Clint1,1,6,5,5,Q5SUH6|Q5SUH7|Q99KN9|Q99KN9-2,MOUSE,69815.1,7.3,2268,2268.1,36.46,36.46,NA,641,Clathrin interactor 1,nucleoplasm|Golgi apparatus|membrane|intracellular membrane-bounded organelle|,vesicle-mediated transport|,clathrin binding|,5,6,4.51E+08,0.073,5.31E-05,-0.049666667,51.67261496,0.741,6.80E-06,12.52195662,-0.3895,-0.37,-0.501,0.331,0.299,0.3325,undefined,9,NA,NA
0.687,0.681,0.699,0.649,0.6585,0.6765,0.531,0.805,0.7025,Q9ER38,Q9ER38,Tor3a,1,6,3,3,Q9ER38|M0QWH2|A0A087WQB9|A0A087WRX4,MOUSE,44440.3,10.3,2273,2273.1,36.36,36.36,NA,385,Torsin-3A,endoplasmic reticulum|endoplasmic reticulum lumen|extracellular exosome|,metabolic process|,3-dehydroquinate dehydratase activity|protein binding|ATP binding|ATPase activity|,3,6,7.62E+08,0.103,2.29E-05,0.0155,56.18529083,0.767333333,2.41E-06,14.69655023,-0.4055,-0.369,-0.33,0.395,0.397,0.4055,undefined,9,TRUE,NA
1.479,1.328,1.355,1.209,1.1565,1.1005,1.628,1.474,1.5045,Q9QYI6,Q9QYI6,Dnajb9,1,8,3,3,Q9QYI6,MOUSE,25787.1,19.8,2275,2275.1,36.33,36.33,NA,222,DnaJ homolog subfamily B member 9,nucleolus|endoplasmic reticulum|endoplasmic reticulum lumen|extracellular exosome|,ER-associated ubiquitin-dependent protein catabolic process|,protein binding|misfolded protein binding|,3,8,5.38E+08,0.198,9.22E-05,0.1105,48.86572555,1.824,1.30E-05,11.45104148,-0.7905,-0.887,-0.727,1.098,0.663,1.3065,undefined,9,TRUE,NA
0.88,0.635,0.411,0.851,0.8015,0.6285,0.534,0.594,0.5135,P14483,P14483,H2-Ab1,1,8,3,3,P14483|P01921|P06342|P06344|P06343,MOUSE,30413,16.9,2276,2276.1,36.31,36.31,NA,265,"H-2 class II histocompatibility antigen, A beta chain",intracellular|early endosome|multivesicular body|Golgi apparatus|plasma membrane|external side of plasma membrane|membrane|integral component of membrane|MHC class II protein complex|,B cell affinity maturation|immunoglobulin production involved in immunoglobulin mediated immune response|humoral immune response mediated by circulating immunoglobulin|positive regulation of antigen processing and presentation|positive regulation of T-helper 1 type immune response|immune response|response to parasitic fungus|antigen processing and presentation|antigen processing and presentation of exogenous peptide antigen via MHC class II|negative regulation of T cell proliferation|positive regulation of alpha-beta T cell activation|antigen processing and presentation of peptide antigen|cellular response to morphine|cellular response to interferon-gamma|cellular response to dexamethasone stimulus|,protein binding|transcription factor binding|toxic substance binding|ubiquitin protein ligase binding|peptide antigen binding|protein heterodimerization activity|repressing transcription factor binding|,3,8,1.91E+08,0.169,0.000907896,-0.020833333,37.08641851,0.731333333,0.000195595,7.391433456,-0.5625,-0.369,-0.228,0.276,0.45,0.3085,NC,8,TRUE,TRUE
1.103,0.969,0.928,1.099,1.0475,0.8155,1.054,0.917,0.8865,P97370,P97370,Atp1b3,1,4,4,4,P97370,MOUSE,32117.4,20.1,2277,2277.1,36.31,36.31,NA,278,Sodium/potassium-transporting ATPase subunit beta-3,cytoplasm|plasma membrane|sodium:potassium-exchanging ATPase complex|caveola|melanosome|extracellular exosome|,cellular sodium ion homeostasis|potassium ion import|cellular potassium ion homeostasis|positive regulation of ATPase activity|sodium ion export from cell|protein stabilization|protein localization to plasma membrane|membrane repolarization|positive regulation of potassium ion transmembrane transporter activity|positive regulation of sodium ion export from cell|positive regulation of potassium ion import|,ATPase activator activity|sodium:potassium-exchanging ATPase activity|protein binding|ATPase binding|sodium:potassium-exchanging ATPase activity|,4,4,2.02E+08,0.201,1.36E-05,-0.116833333,59.76782813,1.018666667,1.05E-06,16.67226631,-0.6965,-0.615,-0.567,0.379,0.445,0.3535,undefined,9,NA,TRUE
0.488,0.35,0.843,0.282,0.1415,0.7115,0.576,0.419,1.1035,Q9DC60,Q9DC60,Ubiad1,1,7,3,3,Q9DC60,MOUSE,37025.7,9.2,2278,2278.1,36.25,36.25,NA,336,UbiA prenyltransferase domain-containing protein 1,nucleus|cytoplasm|mitochondrion|endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of Golgi membrane|,endothelial cell development|ubiquinone biosynthetic process|menaquinone biosynthetic process|vitamin K biosynthetic process|cardiovascular system development|,prenyltransferase activity|antioxidant activity|,3,7,2.39E+09,0.092,0.02544712,0.020833333,20.00763968,0.56,0.009982424,3.567660735,-0.1795,-0.006,-0.592,0.333,0.146,0.4235,undefined,5,NA,TRUE
2.359,2.93,2.127,2.868,3.4535,2.6515,2.71,3.276,2.4775,Q9JJY4,Q9JJY4,Ddx20,1,8,4,4,Q9JJY4|A0A0G2JE88,MOUSE,92621.5,5.3,2289,2289.1,35.75,35.75,NA,825,Probable ATP-dependent RNA helicase DDX20,nucleus|cytoplasm|cytosol|membrane|transcriptional repressor complex|SMN complex|SMN-Sm protein complex|RNA polymerase II transcription repressor complex|Gemini of coiled bodies|,negative regulation of transcription from RNA polymerase II promoter|spliceosomal snRNP assembly|RNA secondary structure unwinding|positive regulation of apoptotic process|oogenesis|regulation of steroid biosynthetic process|,"DNA binding|ATP-dependent RNA helicase activity|protein binding|ATP binding|protein domain specific binding|protein binding, bridging|histone deacetylase binding|repressing transcription factor binding|",4,8,4.36E+09,0.053,1.84E-05,-0.429,57.69456039,2.799,1.70E-06,15.71538376,-1.7005,-2.115,-1.67,0.663,1.239,1.0095,NC,9,NA,NA
1.76,2.17,2.243,1.322,1.4725,1.8645,1.689,2.128,2.2055,P15535,P15535,B4galt1,1,5,3,3,P15535|P15535-2|B1AXY5,MOUSE,44809.7,9.5,2290,2290.1,35.72,35.72,NA,399,"Beta-1,4-galactosyltransferase 1",Golgi trans cisterna|extracellular space|Golgi apparatus|plasma membrane|external side of plasma membrane|cell surface|membrane|integral component of membrane|basolateral plasma membrane|desmosome|glycocalyx|filopodium|brush border membrane|Golgi cisterna membrane|extracellular exosome|,epithelial cell development|acute inflammatory response|lactose biosynthetic process|galactose metabolic process|protein glycosylation|protein N-linked glycosylation|cell adhesion|binding of sperm to zona pellucida|penetration of zona pellucida|negative regulation of cell proliferation|glycoprotein biosynthetic process|oligosaccharide biosynthetic process|extracellular matrix organization|mammary gland development|wound healing|regulation of cell proliferation|positive regulation of apoptotic process|development of secondary sexual characteristics|branching morphogenesis of an epithelial tube|leukocyte migration|regulation of cellular component movement|regulation of acrosome reaction|positive regulation of epithelial cell proliferation involved in wound healing|angiogenesis involved in wound healing|positive regulation of apoptotic process involved in mammary gland involution|,"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity|N-acetyllactosamine synthase activity|lactose synthase activity|protein binding|cytoskeletal protein binding|galactosyltransferase activity|protein kinase binding|manganese ion binding|UDP-galactosyltransferase activity|protein homodimerization activity|alpha-tubulin binding|beta-tubulin binding|",3,5,4.05E+09,0.095,0.000319997,-0.123666667,42.45852637,1.917,5.68E-05,9.052813077,-0.8455,-0.893,-1.508,1.008,0.52,0.9765,PC,9,NA,TRUE
1.18,1.229,1.326,1.019,1.1145,1.1805,0.92,0.853,1.0465,Q9R0Q1,Q9R0Q1,Sytl4,1,4,3,3,Q9R0Q1|Q9R0Q1-2|Q9R0Q1-3,MOUSE,76704.8,4.7,2295,2295.1,35.55,35.55,NA,673,Synaptotagmin-like protein 4,nucleoplasm|cytoplasm|endosome|centrosome|plasma membrane|apical plasma membrane|extrinsic component of membrane|secretory granule|transport vesicle membrane|secretory granule membrane|exocytic vesicle|,intracellular protein transport|exocytosis|synaptic vesicle exocytosis|regulation of calcium ion-dependent exocytosis|positive regulation of exocytosis|negative regulation of insulin secretion|calcium ion-dependent exocytosis of neurotransmitter|positive regulation of protein secretion|multivesicular body sorting pathway|,calcium ion binding|protein binding|phospholipid binding|calcium-dependent phospholipid binding|zinc ion binding|Rab GTPase binding|syntaxin binding|clathrin binding|neurexin family protein binding|,3,4,1.64E+08,0.047,5.31E-05,-0.068666667,51.69416455,1.135,6.77E-06,12.68234609,-0.5855,-0.579,-0.744,0.606,0.548,0.3425,undefined,9,NA,NA
0.673,0.63,0.998,1.645,1.6265,1.9505,1.245,1.113,1.5355,P30412,P30412,Ppic,1,7,4,4,P30412,MOUSE,22907.8,30.1,2297,2297.1,35.43,35.43,NA,212,Peptidyl-prolyl cis-trans isomerase C,cytoplasm|extracellular exosome|,protein peptidyl-prolyl isomerization|protein folding|,peptidyl-prolyl cis-trans isomerase activity|protein binding|cyclosporin A binding|,4,7,1.11E+09,0.301,0.003720611,0.1075,30.15371716,1.347333333,0.000965224,5.617476726,-0.4535,-0.425,-0.82,0.3,1.25,0.7935,undefined,9,TRUE,NA
1.987,1.621,1.675,1.609,1.6955,1.3525,1.753,1.795,1.7165,Q8BGN3,Q8BGN3,Enpp6,1,3,3,3,Q8BGN3|D3YU63|A0A1B0GS66,MOUSE,50959.8,6.1,2300,2300.1,35.31,35.31,NA,440,Ectonucleotide pyrophosphatase/phosphodiesterase family member 6,extracellular region|plasma membrane|anchored component of membrane|extracellular exosome|,lipid metabolic process|lipid catabolic process|choline metabolic process|,phosphoric diester hydrolase activity|glycerophosphodiester phosphodiesterase activity|glycerophosphocholine cholinephosphodiesterase activity|,3,3,3.79E+08,0.061,2.24E-05,-0.124166667,56.31980927,1.744,2.33E-06,14.96530924,-1.0265,-1.038,-0.924,0.982,0.528,0.7335,undefined,9,TRUE,NA
1.371,1.551,1.575,0.382,0.5905,0.6155,0.45,0.58,0.6085,Q58A65,Q58A65,Spag9,1,4,4,4,Q58A65|Q58A65-2|Q58A65-5|Q58A65-4|F8WH31|E9PUD1|Q58A65-3|A0A0R4J196|Q58A65-6,MOUSE,147072.6,3.7,2301,2301.1,35.3,35.3,NA,1321,C-Jun-amino-terminal kinase-interacting protein 4,cytoplasm|cytosol|perinuclear region of cytoplasm|extracellular exosome|,"activation of MAPK activity|activation of JUN kinase activity|vesicle-mediated transport|positive regulation of cell migration|retrograde transport, endosome to Golgi|positive regulation of MAPK cascade|positive regulation of neuron differentiation|striated muscle cell differentiation|protein homooligomerization|negative regulation of protein homodimerization activity|",MAP-kinase scaffold activity|protein binding|JUN kinase binding|kinesin binding|receptor signaling complex scaffold activity|mitogen-activated protein kinase p38 binding|,4,4,1.47E+08,0.037,0.030232232,0.102166667,19.08127116,0.796,0.012355857,3.403941653,-0.1985,-0.309,-0.38,1.079,0.189,0.2325,undefined,8,NA,NA
0.668,0.81,0.823,0.41,0.5335,0.5625,0.66,0.861,0.7925,A2A5Y6,A2A5Y6,Mapt,1,5,3,3,A2A5Y6|A0A0A0MQC7|P10637|P10637-2|B1AQW2|P10637-5|P10637-6|P10637-3|P10637-4,MOUSE,78483.5,5.4,2306,2306.1,35.21,35.21,NA,749,Microtubule-associated protein,nucleus|cytoplasm|microtubule|plasma membrane|axoneme|postsynaptic density|microtubule cytoskeleton|axon|growth cone|nuclear periphery|cytoplasmic ribonucleoprotein granule|tubulin complex|,microtubule cytoskeleton organization|neuron migration|axonogenesis|adult walking behavior|axon cargo transport|regulation of autophagy|positive regulation of microtubule polymerization|negative regulation of intracellular transport|positive regulation of axon extension|mitochondrion transport along microtubule|axon extension|regulation of microtubule-based movement|,protein binding|microtubule binding|SH3 domain binding|enzyme binding|apolipoprotein binding|lipoprotein particle binding|,3,5,1.91E+08,0.054,0.000517306,0.020166667,39.92411859,0.676666667,0.000101763,8.204114489,-0.2305,-0.359,-0.365,0.425,0.212,0.4385,undefined,9,NA,NA
2.957,3.168,3.306,3.084,3.3105,3.4485,2.981,3.188,3.3305,Q64735,Q64735,Cr1l,1,4,3,3,Q64735|Q64735-2|A0A0A6YY75|A0A0A6YXN9,MOUSE,55016.8,4.9,2317,2317.1,34.74,34.74,NA,483,Complement component receptor 1-like protein,external side of plasma membrane|integral component of membrane|receptor complex|,"in utero embryonic development|complement activation, classical pathway|female pregnancy|regulation of complement activation|innate immune response|negative regulation of complement activation|",NA,3,4,6.02E+09,0.049,1.94E-05,-0.814833333,57.17012109,3.327333333,1.92E-06,15.42511983,-2.1805,-2.252,-3.003,0.767,0.973,0.8065,undefined,9,NA,TRUE
0.649,0.519,0.719,0.65,0.5355,0.7345,0.626,0.455,0.6955,Q7TMV3,Q7TMV3,Fastkd5,1,4,4,4,A0A0R4J291|Q7TMV3|F2Z402,MOUSE,87397.4,5.6,2322,2322.1,34.6,34.6,NA,762,"FAST kinase domain-containing protein 5, mitochondrial",mitochondrion|,protein phosphorylation|cellular respiration|,protein kinase activity|poly(A) RNA binding|,4,4,7.50E+07,0.056,0.000432116,-0.036666667,40.86852045,0.633,8.19E-05,8.476813577,-0.3765,-0.222,-0.461,0.285,0.31,0.2445,NC,9,NA,NA
2.754,3.072,3.033,2.57,2.9045,2.8645,2.568,2.882,2.8475,Q9EQU5,Q9EQU5,Set,1,4,4,4,Q9EQU5|Q9EQU5-2|Q9EQU5-3,MOUSE,33377.2,15.9,2324,2324.1,34.48,34.48,NA,289,Protein SET,nucleus|nucleoplasm|cytoplasm|endoplasmic reticulum|cytosol|protein complex|perinuclear region of cytoplasm|,"nucleosome assembly|negative regulation of neuron apoptotic process|endothelial cell differentiation|negative regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|",DNA binding|chromatin binding|,4,4,1.03E+09,0.159,6.44E-06,-0.666166667,65.09544869,2.894,3.09E-07,20.41490542,-1.8655,-2.048,-2.426,0.867,0.765,0.7105,undefined,9,NA,NA
1.315,1.489,1.507,1.284,1.4735,1.4915,1.193,1.363,1.3855,Q3U2C5,Q3U2C5,Rnf149,1,4,2,2,Q3U2C5|Q3U2C5-2,MOUSE,43179.6,6,2328,2328.1,34.3,34.3,NA,394,E3 ubiquitin-protein ligase RNF149,membrane|integral component of membrane|extracellular exosome|,protein ubiquitination|regulation of protein stability|cellular response to drug|negative regulation of MAPK cascade|,protein binding|zinc ion binding|ligase activity|ubiquitin protein ligase activity|,2,4,8.07E+08,0.06,1.26E-05,-0.182666667,60.30603517,1.411666667,9.32E-07,17.13049297,-0.7605,-0.886,-1.019,0.552,0.576,0.4415,undefined,9,TRUE,TRUE
0.745,0.897,0.91,0.745,0.6855,0.8505,0.464,0.959,0.6295,Q9R118,Q9R118,Htra1,1,5,3,3,Q9R118,MOUSE,52125.8,9.3,2330,2330.1,34.2,34.2,NA,480,Serine protease HTRA1,cytosol|extracellular exosome|extracellular matrix|,regulation of cell growth|placenta development|proteolysis|negative regulation of transforming growth factor beta receptor signaling pathway|negative regulation of BMP signaling pathway|positive regulation of epithelial cell proliferation|negative regulation of defense response to virus|chorionic trophoblast cell differentiation|dentinogenesis|,serine-type endopeptidase activity|protein binding|insulin-like growth factor binding|serine-type peptidase activity|,3,5,1.76E+08,0.093,0.000109712,0.039,47.89363821,0.773,1.62E-05,10.93492834,-0.2405,-0.466,-0.336,0.434,0.421,0.4215,PC,9,TRUE,NA
2.456,2.701,2.936,2.301,2.7045,2.7955,2.504,2.763,2.9835,Q62165,Q62165,Dag1,1,8,3,3,Q62165,MOUSE,97245.3,4.8,2343,2343.1,33.8,33.8,NA,893,Dystroglycan,basement membrane|extracellular space|nucleoplasm|cytoplasm|cytoskeleton|plasma membrane|cell-cell junction|cell-cell adherens junction|focal adhesion|cell outer membrane|dystrophin-associated glycoprotein complex|dystroglycan complex|membrane|integral component of membrane|basolateral plasma membrane|lamellipodium|filopodium|node of Ranvier|sarcolemma|costamere|membrane raft|postsynaptic membrane|extracellular exosome|contractile ring|focal adhesion|,morphogenesis of an epithelial sheet|membrane protein ectodomain proteolysis|NLS-bearing protein import into nucleus|cytoskeletal anchoring at plasma membrane|regulation of gastrulation|regulation of epithelial to mesenchymal transition|Schwann cell development|calcium-dependent cell-matrix adhesion|modulation by virus of host morphology or physiology|nerve maturation|myelination in peripheral nervous system|negative regulation of cell migration|microtubule anchoring|negative regulation of MAPK cascade|response to peptide hormone|negative regulation of protein kinase B signaling|epithelial tube branching involved in lung morphogenesis|branching involved in salivary gland morphogenesis|commissural neuron axon guidance|basement membrane organization|positive regulation of basement membrane assembly involved in embryonic body morphogenesis|,dystroglycan binding|actin binding|calcium ion binding|protein binding|structural constituent of muscle|tubulin binding|vinculin binding|protein complex binding|SH2 domain binding|alpha-actinin binding|,3,8,1.60E+09,0.048,2.76E-05,-0.595333333,55.10587413,2.726333333,3.09E-06,14.33135087,-1.6315,-1.828,-2.416,0.736,0.757,0.8105,PC,9,TRUE,TRUE
1.413,1.171,1.28,1.284,1.1135,1.0725,1.203,1.105,1.1975,P59270,P59270,B3gat2,1,3,3,3,P59270|P59270-2,MOUSE,37302.2,8.6,2347,2347.1,33.76,33.76,NA,324,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 2,Golgi membrane|integral component of membrane|,protein glycosylation|,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity|glucuronosyltransferase activity|metal ion binding|,3,3,1.52E+08,0.086,1.43E-05,-0.136,59.38786491,1.188333333,1.15E-06,16.46021636,-0.8625,-0.664,-0.664,0.478,0.471,0.4255,undefined,9,TRUE,TRUE
2.216,2.315,2.106,1.864,1.8455,1.7475,2.113,2.099,2.0485,Q8R4G6,Q8R4G6,Mgat5,1,8,2,2,Q8R4G6,MOUSE,85690.2,3.7,2349,2349.1,33.75,33.75,NA,740,"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A",Golgi membrane|Golgi apparatus|integral component of membrane|extracellular exosome|,protein N-linked glycosylation|,"acetylglucosaminyltransferase activity|alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity|",2,8,1.62E+08,0.037,4.76E-06,-0.248,68.42141028,2.071666667,1.44E-07,22.94630484,-1.3065,-1.25,-1.295,0.909,0.598,0.8565,PC,9,NA,TRUE
0.868,2.338,1.107,0.837,2.4095,1.0915,0.743,2.071,0.9815,Q80X71,Q80X71,Tmem106b,1,5,3,3,Q80X71,MOUSE,31457.1,15.6,2353,2353.1,33.59,33.59,NA,275,Transmembrane protein 106B,lysosomal membrane|integral component of membrane|late endosome membrane|intracellular membrane-bounded organelle|extracellular exosome|,transport|lysosome localization|dendrite morphogenesis|,NA,3,5,3.19E+08,0.156,0.005748474,-0.156333333,27.91909603,1.484333333,0.001614695,5.118221509,-0.4225,-1.583,-0.69,0.619,0.76,0.3785,undefined,9,NA,TRUE
0.77,0.517,0.754,0.909,0.8175,0.9765,0.919,0.97,1.1245,A2AJ15,A2AJ15,Man1b1,1,6,3,3,A2AJ15,MOUSE,75433.8,6.8,2355,2355.1,33.5,33.5,NA,658,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|extracellular vesicle|,N-glycan processing|ER-associated ubiquitin-dependent protein catabolic process|glycoprotein ERAD pathway|,"mannosyl-oligosaccharide 1,2-alpha-mannosidase activity|calcium ion binding|",3,6,1.72E+08,0.068,0.00068677,0.032166667,38.48249323,0.918,0.000141824,7.796397642,-0.4295,-0.284,-0.567,0.282,0.531,0.6605,undefined,9,NA,TRUE
3.083,3.1,3.58,2.855,3.0715,3.0775,2.996,3.213,3.2245,Q8CFG0,Q8CFG0,Sulf2,1,5,3,3,Q8CFG0,MOUSE,101750.8,3.2,2368,2368.1,33.15,33.15,NA,875,Extracellular sulfatase Sulf-2,extracellular space|endoplasmic reticulum|Golgi stack|plasma membrane|cell surface|,kidney development|chondrocyte development|glomerular filtration|sulfur compound metabolic process|positive regulation of vascular endothelial growth factor production|esophagus smooth muscle contraction|positive regulation of Wnt signaling pathway|heparan sulfate proteoglycan metabolic process|glomerular basement membrane development|glial cell-derived neurotrophic factor receptor signaling pathway|negative regulation of fibroblast growth factor receptor signaling pathway|embryonic skeletal system development|cartilage development|bone development|innervation|,arylsulfatase activity|calcium ion binding|N-acetylglucosamine-6-sulfatase activity|,3,5,1.27E+08,0.032,5.30E-06,-0.696833333,67.31820865,3.161333333,1.85E-07,22.07446622,-2.0895,-2.132,-2.611,0.942,0.794,0.9155,undefined,9,TRUE,TRUE
1.338,0.992,1.43,1.724,1.2925,1.7405,1.5,1.094,1.5335,Q8CI85,Q8CI85,Ca12,1,7,3,3,Q8CI85|A0A0R4J0W4|Q8K2J1,MOUSE,39808.8,7.9,2369,2369.1,33.1,33.1,NA,354,Carbonic anhydrase 12,integral component of membrane|,one-carbon metabolic process|regulation of pH|carbon dioxide transport|chloride ion homeostasis|,carbonate dehydratase activity|zinc ion binding|,3,7,3.68E+09,0.079,0.000341179,-0.143666667,42.12412278,1.459,6.13E-05,8.940875711,-0.9415,-0.541,-1.137,0.416,0.752,0.5895,undefined,9,TRUE,TRUE
0.823,0.968,0.997,0.428,0.7605,0.6655,0.658,0.861,0.8505,O88735-2,O88735,Map7,1,4,3,3,O88735-2|D3YWN7|O88735|E9QMU3|A0A1L1SVB6,MOUSE,83057.4,5.1,2380,2380.1,32.89,32.89,NA,730,Isoform 2 of Ensconsin,cytoplasm|microtubule|plasma membrane|microtubule cytoskeleton|basolateral plasma membrane|perinuclear region of cytoplasm|,cell morphogenesis|microtubule bundle formation|glycosphingolipid metabolic process|response to osmotic stress|nucleus organization|germ cell development|spermatogenesis|cell proliferation|fertilization|response to retinoic acid|Leydig cell differentiation|organ growth|homeostasis of number of cells|Sertoli cell development|protein localization to plasma membrane|,receptor binding|structural molecule activity|protein binding|,3,4,2.51E+08,0.051,0.000807391,-0.040166667,37.7076833,0.768666667,0.000169524,7.569463844,-0.2465,-0.541,-0.486,0.45,0.211,0.3715,undefined,9,NA,NA
0.428,0.296,0.824,0.392,0.3765,0.9085,0.441,0.375,0.9155,Q91Y63,Q91Y63,Slc13a3,1,9,3,3,Q91Y63|A2A4U9,MOUSE,66541.4,4.6,2381,2381.1,32.88,32.88,NA,600,Solute carrier family 13 member 3,plasma membrane|membrane|integral component of membrane|extracellular exosome|,sodium ion transport|dicarboxylic acid transport|citrate transport|succinate transmembrane transport|L-aspartate transmembrane transport|,citrate transmembrane transporter activity|succinate transmembrane transporter activity|L-aspartate transmembrane transporter activity|high-affinity sodium:dicarboxylate symporter activity|,3,9,1.70E+09,0.046,0.026787887,-0.01,19.73707314,0.569666667,0.010624113,3.51952628,-0.1355,-0.062,-0.687,0.229,0.309,0.2865,undefined,5,NA,TRUE
1.077,1.437,1.258,1.032,1.3495,1.1025,1.415,1.605,1.4305,Q9CRG1,Q9CRG1,Tm7sf3,1,4,3,3,Q9CRG1|A0A0R4J0K4|D6RI14,MOUSE,63877.6,5.1,2395,2395.1,32.49,32.49,NA,565,Transmembrane 7 superfamily member 3,plasma membrane|integral component of membrane|extracellular exosome|,NA,NA,3,4,1.01E+09,0.051,7.56E-05,-0.116666667,49.91028651,1.279666667,1.02E-05,11.89231645,-0.6095,-0.872,-0.788,0.462,0.396,0.7115,undefined,9,TRUE,TRUE
2.006,2.022,2.173,1.859,1.5335,1.6845,1.949,1.805,1.9605,P98154,P98154,Dgcr2,1,3,2,2,E9Q548|Q6P5A9|E9QNU3|P98154|A0A0R4J1M6|Q8C2R4,MOUSE,62065.2,5.2,2397,2397.1,32.44,32.44,NA,548,Integral membrane protein DGCR2/IDD,membrane|integral component of membrane|,cell adhesion|response to drug|cognition|,carbohydrate binding|,2,3,1.04E+08,0.052,1.22E-05,-0.164,60.64135182,1.953,8.63E-07,17.44600854,-1.2335,-0.94,-1.248,0.958,0.674,0.8055,undefined,9,TRUE,TRUE
0.794,1.334,0.811,-0.064,0.8135,0.3035,0.352,1.159,0.8415,Q501P1,Q501P1,Fbln7,1,3,2,2,Q501P1,MOUSE,49581.1,6.3,2399,2399.1,32.33,32.33,NA,440,Fibulin-7,proteinaceous extracellular matrix|focal adhesion|extracellular exosome|,cell adhesion|,calcium ion binding|heparin binding|,2,3,1.21E+08,0.063,0.020612192,0.082833333,21.11177945,0.728666667,0.007741445,3.766951583,0.0285,-0.646,-0.227,0.611,0.17,0.5605,PC,6,TRUE,NA
0.41,0.539,0.497,0.361,0.3955,0.3535,0.536,0.549,0.5115,Q8R3Q0,Q8R3Q0,Saraf,1,5,3,3,A0A0R4J0D1|Q8R3Q0,MOUSE,36368.9,13.1,2407,2407.1,32.21,32.21,NA,334,Store-operated calcium entry-associated regulatory factor,integral component of endoplasmic reticulum membrane|,calcium ion transport|regulation of store-operated calcium entry|,NA,3,5,1.20E+08,0.131,0.000563862,-0.002333333,39.50558017,0.543,0.000112058,8.036835887,-0.2045,-0.256,-0.361,0.297,0.194,0.3165,undefined,5,TRUE,TRUE
1.347,1.303,1.092,1.084,0.9625,0.8955,1.645,1.552,1.3905,Q9QZS0,Q9QZS0,Col4a3,1,5,3,3,Q9QZS0,MOUSE,163378,1.7,2411,2411.1,32.02,32.02,NA,1669,Collagen alpha-3(IV) chain,collagen type IV trimer|basement membrane|,activation of cysteine-type endopeptidase activity involved in apoptotic process|cell adhesion|cell surface receptor signaling pathway|cell proliferation|negative regulation of angiogenesis|glomerular basement membrane development|endothelial cell apoptotic process|,integrin binding|extracellular matrix structural constituent|,3,5,5.31E+08,0.017,0.000120919,-0.0415,47.37925028,1.12,1.83E-05,10.84885765,-0.6595,-0.569,-0.576,0.43,0.382,0.7435,PC,9,TRUE,TRUE
1.878,1.597,2.201,1.613,1.3475,1.9515,1.753,1.474,2.0765,Q9JHY4,Q9JHY4,Wfdc15b,1,5,3,3,Q9JHY4,MOUSE,9807.6,40,2416,2416.1,31.86,31.86,NA,80,WAP four-disulfide core domain protein 15B,extracellular region|,negative regulation of peptidase activity|defense response to bacterium|,peptidase inhibitor activity|,3,5,1.70E+09,0.4,0.000143493,-0.233666667,46.54583266,1.865666667,2.22E-05,10.5239474,-1.1025,-0.845,-1.552,0.761,0.552,0.7845,PC,9,TRUE,NA
1.537,1.619,1.704,1.755,1.8515,1.9375,1.772,1.849,1.9395,Q8K2B0,Q8K2B0,P3h4,1,5,3,3,Q8K2B0,MOUSE,51587.4,5.1,2417,2417.1,31.85,31.85,NA,443,Endoplasmic reticulum protein SC65,synaptonemal complex|nucleolus|,NA,NA,3,5,1.52E+08,0.051,1.34E-05,-0.1945,59.92565429,1.818666667,1.02E-06,17.00961595,-0.9965,-1.041,-1.274,0.542,0.819,0.7835,undefined,9,TRUE,NA
1.623,2.033,2.404,1.486,1.9735,2.2825,1.651,2.057,2.4315,Q9Z2L6,Q9Z2L6,Minpp1,1,4,3,3,Q9Z2L6,MOUSE,55164,7.4,2420,2420.1,31.73,31.73,NA,481,Multiple inositol polyphosphate phosphatase 1,endoplasmic reticulum lumen|plasma membrane|extracellular exosome|,dephosphorylation|,acid phosphatase activity|bisphosphoglycerate 3-phosphatase activity|inositol hexakisphosphate 2-phosphatase activity|,3,4,5.00E+07,0.074,0.000280277,-0.347,43.17746601,2.079666667,4.81E-05,9.297602694,-0.9095,-1.376,-1.875,0.699,0.628,0.7515,PC,9,TRUE,NA
2.519,3.108,3.817,2.702,2.8515,3.5605,2.609,3.032,3.7455,Q91YY2,Q91YY2,B4galt3,1,6,2,2,Q91YY2|A0A0A6YXE7,MOUSE,44368.6,6,2421,2421.1,31.67,31.67,NA,395,"Beta-1,4-galactosyltransferase 3",cytoplasm|Golgi apparatus|integral component of membrane|Golgi cisterna membrane|extracellular exosome|,protein glycosylation|,"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity|N-acetyllactosamine synthase activity|metal ion binding|",2,6,1.84E+08,0.06,0.000607394,-0.69,39.12011167,3.343,0.000122458,7.987341962,-1.7905,-1.872,-3.422,1.058,0.843,1.0435,undefined,9,NA,TRUE
2.19,2.506,2.393,1.868,2.1995,2.0875,1.971,2.284,2.1755,Q8BW41,Q8BW41,Pomgnt2,1,4,3,3,Q8BW41|Q8BW41-2,MOUSE,70004.6,5.2,2426,2426.1,31.52,31.52,NA,605,"Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2",endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,neuron migration|protein O-linked glycosylation|protein O-linked mannosylation|,acetylglucosaminyltransferase activity|protein O-GlcNAc transferase activity|,3,4,1.67E+08,0.052,7.38E-06,-0.3745,64.22173389,2.216666667,3.78E-07,19.7963767,-1.2885,-1.507,-1.653,0.879,0.63,0.6925,undefined,9,NA,NA
0.714,0.621,0.433,0.815,0.9935,0.5805,0.882,0.718,0.6335,Q80YR5,Q80YR5,Safb2,1,6,4,4,Q80YR5|S4R1M2|D3YXK2,MOUSE,112464,4.8,2429,2429.1,31.48,31.48,NA,991,Scaffold attachment factor B2,nucleoplasm|cytoplasm|intracellular membrane-bounded organelle|extracellular exosome|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",nucleotide binding|DNA binding|identical protein binding|poly(A) RNA binding|,6,6,53200000,0.048,0.001362759,-0.042,35.10598946,0.731666667,0.000308604,6.84625844,-0.5365,-0.521,-0.166,0.295,0.32,0.3565,undefined,8,NA,NA
1.055,0.945,1.432,1.102,1.2285,1.3305,1.306,1.236,1.4625,Q3UUY6,Q3UUY6,Prom2,1,5,3,3,Q3UUY6|Q3UUY6-2,MOUSE,94459.5,3.8,2433,2433.1,31.37,31.37,NA,835,Prominin-2,plasma membrane|integral component of plasma membrane|microvillus|cilium|cell surface|basolateral plasma membrane|apical plasma membrane|cytoplasmic vesicle|microvillus membrane|cell projection|microspike|ciliary membrane|extracellular exosome|prominosome|membrane raft|,positive regulation of protein phosphorylation|positive regulation of cell projection organization|regulation of GTPase activity|negative regulation of pinocytosis|negative regulation of caveolin-mediated endocytosis|,cholesterol binding|,3,5,46900000,0.038,0.000153099,-0.111,46.18413889,1.276333333,2.41E-05,10.38569049,-0.6755,-0.583,-0.989,0.383,0.551,0.6475,undefined,9,TRUE,TRUE
1.099,0.983,1.289,0.709,0.6075,1.0125,0.888,0.775,0.7835,Q6S5C2-2,Q6S5C2,Gnptg,1,4,2,2,Q6S5C2-2|A0A140T8R4|Q6S5C2|A0A0R4J0H5,MOUSE,35349.5,9.8,2434,2434.1,31.36,31.36,NA,307,Isoform 2 of N-acetylglucosamine-1-phosphotransferase subunit gamma,Golgi apparatus|extracellular exosome|,carbohydrate phosphorylation|,protein homodimerization activity|,2,4,1.71E+08,0.098,0.00072258,0.008333333,38.2436116,0.962333333,0.000149844,7.725842506,-0.4325,-0.303,-0.683,0.637,0.308,0.5235,PC,9,TRUE,NA
0.225,2.197,0.862,-0.191,1.7345,0.4615,-0.043,1.925,0.6625,Q5U4D8,Q5U4D8,Slc5a6,1,3,3,3,Q5U4D8,MOUSE,69422.5,7.8,2436,2436.1,31.33,31.33,NA,634,Sodium-dependent multivitamin transporter,vesicle membrane|integral component of membrane|brush border membrane|,sodium ion transport|biotin transport|pantothenate transmembrane transport|,sodium-dependent multivitamin transmembrane transporter activity|,3,3,4.11E+09,0.078,0.084350999,-0.169666667,13.4583197,0.754333333,0.045099116,2.463478614,0.0865,-1.175,-0.552,0.268,-0.055,0.4095,undefined,6,NA,TRUE
0.655,0.685,0.912,0.796,0.8415,1.0685,0.681,0.707,0.9385,P21995,P21995,Emb,1,9,3,3,P21995,MOUSE,37577.2,7.8,2437,2437.1,31.29,31.29,NA,330,Embigin,integral component of plasma membrane|cell junction|synapse|,plasma membrane lactate transport|,NA,3,9,1.12E+11,0.078,0.000413823,-0.068166667,41.10851944,0.834,7.75E-05,8.608206872,-0.3845,-0.403,-0.668,0.28,0.461,0.3055,undefined,9,TRUE,TRUE
2.803,2.965,2.992,2.457,2.6345,2.6615,2.938,3.096,3.1275,Q9DAU7,Q9DAU7,Wfdc2,1,5,4,4,Q9DAU7|A2A5G5|A2A5G4,MOUSE,19058.3,27,2440,2440.1,31.24,31.24,NA,174,WAP four-disulfide core domain protein 2,extracellular exosome|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|cysteine-type endopeptidase inhibitor activity|aspartic-type endopeptidase inhibitor activity|,4,5,1.19E+08,0.27,1.26E-05,-0.539,60.33758282,2.810333333,9.25E-07,17.25948811,-1.7555,-1.803,-2.274,0.762,0.746,1.0905,PC,9,TRUE,NA
2.199,2.921,1.941,1.976,2.7135,1.7335,2.71,3.288,2.4515,Q80T14,Q80T14,Fras1,1,5,4,4,Q80T14,MOUSE,453771.9,1.2,2451,2451.1,30.97,30.97,NA,4010,Extracellular matrix protein FRAS1,basement membrane|plasma membrane|integral component of membrane|sublamina densa|,morphogenesis of an epithelium|metanephros morphogenesis|cell communication|protein transport|embryonic limb morphogenesis|skin development|palate development|,metal ion binding|,4,5,2.50E+08,0.012,7.56E-05,-0.349333333,49.90885967,2.389,1.02E-05,11.89170316,-1.3815,-1.962,-1.288,0.796,0.638,1.1015,undefined,9,TRUE,TRUE
0.566,0.489,0.505,0.542,0.4815,0.4975,0.571,0.44,0.5405,P51859,P51859,Hdgf,1,6,3,3,P51859,MOUSE,26382.3,10.9,2456,2456.1,30.85,30.85,NA,237,Hepatoma-derived growth factor,extracellular space|nucleus|nucleoplasm|cytoplasm|transcriptional repressor complex|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|cellular process|",nucleotide binding|RNA polymerase II transcription corepressor activity|transcription corepressor binding|DNA binding|protein binding|growth factor activity|heparin binding|poly(A) RNA binding|,3,6,1.10E+09,0.109,0.000237896,-0.031333333,43.99038178,0.510333333,3.99E-05,9.489062894,-0.3305,-0.237,-0.292,0.227,0.231,0.2135,PC,8,NA,NA
2.078,2.274,2.194,1.478,1.6905,1.6105,2.191,2.383,2.3075,Q9Z0J1,Q9Z0J1,Reck,1,7,4,4,Q9Z0J1,MOUSE,111101,4.2,2457,2457.1,30.85,30.85,NA,971,Reversion-inducing cysteine-rich protein with Kazal motifs,plasma membrane|anchored component of membrane|,blood vessel maturation|embryo implantation|negative regulation of endopeptidase activity|extracellular matrix organization|embryonic forelimb morphogenesis|positive regulation of Notch signaling pathway|,endopeptidase inhibitor activity|serine-type endopeptidase inhibitor activity|,4,7,1.04E+10,0.042,4.43E-05,-0.1115,52.62497068,1.930666667,5.46E-06,13.11366531,-0.9475,-1.074,-1.209,0.892,0.556,1.1135,undefined,9,TRUE,NA
1.705,1.72,2.21,1.883,1.9135,2.4655,1.875,1.886,2.4365,O70443,O70443,Gnaz,1,4,3,3,O70443,MOUSE,41362.4,7.8,2458,2458.1,30.82,30.82,NA,355,Guanine nucleotide-binding protein G(z) subunit alpha,cytosol|heterotrimeric G-protein complex|membrane|extracellular exosome|,G-protein coupled receptor signaling pathway|adenylate cyclase-modulating G-protein coupled receptor signaling pathway|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway|metabolic process|,GTPase activity|signal transducer activity|GTP binding|G-protein beta/gamma-subunit complex binding|G-protein coupled serotonin receptor binding|metal ion binding|,3,4,4.34E+08,0.078,0.000757156,-0.471166667,38.01655783,2.170666667,0.000157886,7.659269638,-1.2305,-1.177,-2.262,0.483,0.707,0.6525,undefined,9,NA,NA
2.41,2.46,2.94,2.205,2.4515,3.0585,2.685,2.86,3.5275,Q8K273,Q8K273,Mmgt1,1,8,2,2,Q8K273,MOUSE,14733.6,22.9,2467,2467.1,30.47,30.47,NA,131,Membrane magnesium transporter 1,Golgi membrane|cytoplasm|early endosome|Golgi apparatus|plasma membrane|membrane|integral component of membrane|early endosome membrane|ER membrane protein complex|,cation transport|cobalt ion transport|copper ion transport|ferrous iron transport|magnesium ion transport|cation transmembrane transport|ferrous iron transmembrane transport|,cobalt ion transmembrane transporter activity|ferrous iron transmembrane transporter activity|magnesium ion transmembrane transporter activity|inorganic cation transmembrane transporter activity|,2,8,4.40E+09,0.229,7.26E-05,-0.488166667,50.12887117,2.78,9.71E-06,11.98661335,-1.5615,-1.672,-2.401,0.738,0.818,1.1495,undefined,9,TRUE,TRUE
0.474,0.71,0.774,0.384,0.6345,0.6995,0.352,0.583,0.6515,P48410,P48410,Abcd1,1,3,3,3,P48410|A2ALN0,MOUSE,82370.9,4.6,2473,2473.1,30.38,30.38,NA,736,ATP-binding cassette sub-family D member 1,cytoplasm|mitochondrion|peroxisome|peroxisomal membrane|integral component of peroxisomal membrane|membrane|perinuclear region of cytoplasm|,fatty acid beta-oxidation|peroxisome organization|peroxisomal long-chain fatty acid import|long-chain fatty acid catabolic process|very long-chain fatty acid catabolic process|transmembrane transport|,"peroxisomal fatty-acyl-CoA transporter activity|protein binding|ATP binding|ATPase activity|enzyme binding|ATPase activity, coupled to transmembrane movement of substances|identical protein binding|protein homodimerization activity|",3,3,1.47E+09,0.046,0.00161664,-0.096833333,34.2671038,0.595333333,0.00037436,6.625120584,-0.2195,-0.434,-0.53,0.253,0.205,0.1445,PC,7,NA,NA
0.443,0.594,0.324,0.563,0.8385,0.5745,0.246,0.188,-0.0175,Q6PE54,Q6PE54,Dhx40,1,3,2,2,Q6PE54,MOUSE,89783.8,4.2,2479,2479.1,30.13,30.13,NA,779,Probable ATP-dependent RNA helicase DHX40,cytoplasm|,RNA processing|,ATP-dependent RNA helicase activity|ATP binding|poly(A) RNA binding|,2,3,95800000,0.042,0.053671985,0.013166667,15.85781364,0.38,0.025954857,2.855425879,-0.1935,-0.287,-0.05,0.255,0.422,-0.0675,undefined,5,NA,NA
1.366,1.573,0.992,1.029,1.2515,0.6705,1.4,1.603,1.0265,Q9Z0J0,Q9Z0J0,Npc2,1,5,3,3,Q9Z0J0,MOUSE,16784.1,28.1,2483,2483.1,29.99,29.99,NA,149,Epididymal secretory protein E1,lysosome|endoplasmic reticulum|extracellular exosome|,cholesterol metabolic process|response to virus|cholesterol transport|intracellular sterol transport|intracellular cholesterol transport|cholesterol efflux|cholesterol homeostasis|,cholesterol binding|enzyme binding|,3,5,2.32E+08,0.281,0.00062567,-0.0965,38.96045023,1.222666667,0.000127044,7.939167899,-0.7685,-0.934,-0.421,0.58,0.297,0.6675,PC,9,TRUE,NA
0.204,0.729,0.437,0.332,0.7045,0.6075,0.369,0.913,0.6325,O88876,O88876,Dhrs3,1,4,3,3,O88876|G5E8W9|O88876-2|H7BX54,MOUSE,34051.3,9.6,2493,2493.1,29.73,29.73,NA,302,Short-chain dehydrogenase/reductase 3,integral component of membrane|,retinoid metabolic process|outflow tract morphogenesis|regulation of ossification|retinol metabolic process|negative regulation of retinoic acid receptor signaling pathway|oxidation-reduction process|palate development|bone morphogenesis|cardiac septum morphogenesis|,retinol dehydrogenase activity|NADP-retinol dehydrogenase activity|,3,4,9.80E+07,0.096,0.00502389,-0.0225,28.60902632,0.535333333,0.001377518,5.269047177,-0.1155,-0.392,-0.363,0.098,0.31,0.3275,undefined,5,NA,TRUE
0.5,0.43,0.789,0.393,0.2595,0.5165,0.549,0.287,0.5385,Q9Z2A7,Q9Z2A7,Dgat1,1,4,2,2,Q9Z2A7,MOUSE,57245.5,7.2,2496,2496.1,29.67,29.67,NA,498,Diacylglycerol O-acyltransferase 1,endoplasmic reticulum membrane|membrane|integral component of membrane|intracellular membrane-bounded organelle|,triglyceride biosynthetic process|lipid storage|very-low-density lipoprotein particle assembly|long-chain fatty-acyl-CoA metabolic process|retinol metabolic process|diacylglycerol metabolic process|fatty acid homeostasis|,2-acylglycerol O-acyltransferase activity|diacylglycerol O-acyltransferase activity|retinol O-fatty-acyltransferase activity|,2,4,9.94E+08,0.072,0.001871564,-0.009833333,33.54561236,0.457333333,0.000442017,6.39584878,-0.2425,-0.129,-0.344,0.265,0.179,0.2125,undefined,5,NA,TRUE
0.603,0.522,0.491,0.554,0.4885,0.4585,0.419,0.334,0.3075,Q6P9Q4,Q6P9Q4,Fhod1,1,2,2,2,Q6P9Q4,MOUSE,130853.3,3,2501,2501.1,29.52,29.52,NA,1197,FH1/FH2 domain-containing protein 1,stress fiber|nucleus|cytosol|membrane|bleb|,positive regulation of transcription from RNA polymerase II promoter|positive regulation of stress fiber assembly|,actin binding|identical protein binding|,2,2,1.68E+08,0.03,0.001456541,-0.046666667,34.78865327,0.478333333,0.000331997,6.714020693,-0.3515,-0.266,-0.24,0.26,0.239,0.0785,NC,6,NA,NA
0.632,0.57,0.723,0.504,0.4645,0.6185,0.556,0.586,0.6915,Q3UXS0,Q3UXS0,Scamp3,1,11,2,2,Q3UXS0|O35609|E9Q855,MOUSE,38984.9,4.2,2504,2504.1,29.4,29.4,NA,350,Secretory carrier-associated membrane protein,Golgi membrane|integral component of membrane|extracellular exosome|,intracellular protein transport|response to organic substance|response to retinoic acid|,ubiquitin protein ligase binding|,2,11,4.58E+08,0.042,0.000495487,-0.021833333,40.1431746,0.620666667,9.68E-05,8.250213378,-0.3085,-0.271,-0.417,0.406,0.22,0.2395,undefined,9,NA,TRUE
0.809,1.112,0.618,0.501,0.8195,0.3255,0.68,0.979,0.4895,Q56A08,Q56A08,Gpkow,1,3,3,3,Q56A08,MOUSE,54116,8.4,2506,2506.1,29.39,29.39,NA,488,G-patch domain and KOW motifs-containing protein,nucleoplasm|,NA,nucleic acid binding|,3,3,1.70E+08,0.084,0.004711828,-0.071166667,28.96058233,0.687333333,0.001270404,5.347019305,-0.3885,-0.658,-0.198,0.407,0.148,0.2625,undefined,8,NA,NA
0.464,0.628,1.128,0.397,0.7625,1.0765,0.299,0.66,0.9635,Q6P1H4,Q6P1H4,Extl3,1,3,3,3,Q6P1H4|Q9WVL6,MOUSE,105564,3.6,2507,2507.1,29.32,29.32,NA,919,Exostoses (Multiple)-like 3,endoplasmic reticulum|integral component of membrane|,glycosaminoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process|positive regulation of cell growth|,receptor activity|,3,3,12600000,0.036,0.009057109,-0.180166667,25.51777853,0.778,0.002806869,4.614721089,-0.1955,-0.624,-0.888,0.279,0.234,0.1135,undefined,7,NA,TRUE
0.459,0.637,0.548,0.381,0.5755,0.4855,0.418,0.593,0.5085,F7AA26,F7AA26,Pakap,1,2,2,2,F7AA26|A2API8|O54931|O54931-2|O54931-3|O54931-4|O54931-5,MOUSE,126773,2.4,2510,2510.1,29.28,29.28,NA,1137,Paralemmin A kinase anchor protein (Fragment),membrane|,regulation of cell shape|,NA,2,2,55700000,0.024,0.000432116,-0.040833333,40.86753108,0.521333333,8.19E-05,8.456224883,-0.2175,-0.377,-0.31,0.243,0.202,0.2145,undefined,7,NA,NA
0.486,0.114,0.579,0.557,0.1685,0.6335,0.567,0.29,0.5375,Q4VBD2,Q4VBD2,Tapt1,1,4,2,2,Q4VBD2,MOUSE,64520.5,2.4,2521,2521.1,28.99,28.99,NA,564,Transmembrane anterior posterior transformation protein 1,integral component of membrane|,in utero embryonic development|post-embryonic development|embryonic skeletal system development|,NA,2,4,48200000,0.024,0.017693732,-0.0085,21.90909206,0.46,0.006443039,3.913880591,-0.3485,0.03,-0.397,0.174,0.266,0.2245,undefined,6,NA,TRUE
1.091,1.226,1.38,1.342,1.3145,1.4685,1.212,1.248,1.4075,H3BJN3,H3BJN3,Cux1,1,3,2,2,H3BJN3|P70403|H3BKT0|H3BJQ9|P53564|H3BK24|P53564-3|H3BLS0|E9QKE9|P53564-2|P53564-4|H3BJ26,MOUSE,77646,2.9,2529,2529.1,28.66,28.66,NA,678,Protein CASP,nucleus|cytoplasm|integral component of Golgi membrane|,negative regulation of transcription from RNA polymerase II promoter|kidney development|transcription from RNA polymerase II promoter|intra-Golgi vesicle-mediated transport|lung development|auditory receptor cell differentiation|positive regulation of transcription from RNA polymerase II promoter|,RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|DNA binding|chromatin binding|,2,3,82200000,0.029,3.81E-05,-0.166166667,53.38524557,1.337333333,4.59E-06,13.47609062,-0.6845,-0.789,-1.031,0.418,0.555,0.5345,undefined,9,NA,TRUE
1.729,2.263,2.442,1.63,2.0815,2.2595,1.72,2.185,2.3675,A0A0A6YX40,A0A0A6YX40,Igsf3,1,3,2,2,A0A0A6YX40|Q6ZQA6,MOUSE,138169.5,2.2,2533,2533.1,28.58,28.58,NA,1214,Immunoglobulin superfamily member 3,cell surface|,lacrimal gland development|,NA,2,3,1.43E+08,0.022,3.83E-05,-0.338166667,53.32866071,2.174,4.65E-06,13.44879661,-1.1155,-1.375,-1.785,0.807,0.68,0.7595,undefined,9,TRUE,TRUE
0.676,0.639,0.499,0.53,0.5725,0.4005,0.387,0.289,0.2575,G3X9J1,G3X9J1,Slc8a1,1,6,3,3,G3X9J1|P70414|G5E8Y0|Q68FL0,MOUSE,108835.1,3.6,2534,2534.1,28.55,28.55,NA,970,Sodium/calcium exchanger 1,mitochondrion|cytosol|microtubule|plasma membrane|integral component of plasma membrane|intercalated disc|membrane|integral component of membrane|basolateral plasma membrane|Z disc|T-tubule|sarcolemma|dendritic spine|dendritic shaft|,embryonic placenta development|regulation of the force of heart contraction|regulation of sodium ion transport|heart morphogenesis|sodium ion transport|calcium ion transport|cellular sodium ion homeostasis|response to nutrient|response to glucose|post-embryonic development|positive regulation of fibroblast migration|regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion|telencephalon development|positive regulation of bone mineralization|response to ATP|cellular response to reactive oxygen species|embryonic heart tube development|sodium ion transmembrane transport|response to immobilization stress|response to muscle stretch|response to drug|response to hydrogen peroxide|muscle fiber development|cardiac muscle cell development|cardiac muscle contraction|calcium ion transport into cytosol|calcium ion import|calcium ion transmembrane transport|cellular response to cAMP|sodium ion export|cellular response to hypoxia|cell communication by electrical coupling involved in cardiac conduction|sodium ion import|positive regulation of the force of heart contraction|calcium ion export|,calcium:sodium antiporter activity|protein binding|cytoskeletal protein binding|ankyrin binding|,3,6,84400000,0.036,0.002798769,-0.0345,31.52598369,0.482,0.000703723,5.919445123,-0.3485,-0.289,-0.189,0.297,0.253,0.0695,undefined,6,TRUE,TRUE
0.637,0.631,0.499,0.59,0.3045,0.3665,0.535,0.516,0.3875,Q91WL8,Q91WL8,Wwox,1,3,3,3,Q91WL8,MOUSE,46968.1,7,2535,2535.1,28.55,28.55,NA,414,WW domain-containing oxidoreductase,nucleus|cytoplasm|mitochondrion|Golgi apparatus|cytosol|RNA polymerase II transcription factor complex|plasma membrane|microvillus|,osteoblast differentiation|Wnt signaling pathway|negative regulation of Wnt signaling pathway|positive regulation of transcription from RNA polymerase II promoter|skeletal system morphogenesis|oxidation-reduction process|cellular response to transforming growth factor beta stimulus|intrinsic apoptotic signaling pathway by p53 class mediator|extrinsic apoptotic signaling pathway|positive regulation of extrinsic apoptotic signaling pathway|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand|,protein binding|oxidoreductase activity|enzyme binding|RNA polymerase II transcription coactivator activity|,3,3,1.20E+08,0.07,0.002030851,-0.023666667,33.12256708,0.572333333,0.00048724,6.332312352,-0.4635,-0.242,-0.224,0.361,0.153,0.2735,undefined,6,NA,NA
0.466,0.464,0.666,0.06,0.2585,0.2225,0.283,0.452,0.4335,Q921H9,Q921H9,Coa7,1,3,2,2,Q921H9,MOUSE,26358.2,13.4,2545,2545.1,28.11,28.11,NA,231,Cytochrome c oxidase assembly factor 7,mitochondrial intermembrane space|,NA,NA,2,3,1.89E+08,0.134,0.021896264,0.049166667,20.77011623,0.344,0.008375069,3.704779004,-0.0275,-0.122,-0.219,0.337,0.055,0.2715,NC,5,NA,NA
0.667,0.903,0.447,0.758,1.0095,0.5545,0.793,1.025,0.5745,Q62217,Q62217,Sema5a,1,3,3,3,Q62217|Q3UPZ0,MOUSE,124304.5,3.8,2547,2547.1,28.01,28.01,NA,1077,Semaphorin-5A,membrane|integral component of membrane|extracellular exosome|,patterning of blood vessels|positive regulation of endothelial cell proliferation|blood vessel endothelial cell proliferation involved in sprouting angiogenesis|negative regulation of cell adhesion|axon guidance|axonal fasciculation|diencephalon development|positive regulation of actin filament depolymerization|positive regulation of catenin import into nucleus|positive regulation of angiogenesis|branching morphogenesis of an epithelial tube|positive regulation of axon extension involved in axon guidance|negative regulation of axon extension involved in axon guidance|positive chemotaxis|positive regulation of protein kinase B signaling|cell chemotaxis|semaphorin-plexin signaling pathway|positive regulation of extracellular matrix disassembly|signal clustering|negative regulation of endothelial cell apoptotic process|positive regulation of endothelial cell chemotaxis|,axon guidance receptor activity|semaphorin receptor binding|chondroitin sulfate proteoglycan binding|heparan sulfate proteoglycan binding|syndecan binding|,3,3,2.23E+08,0.038,0.001533015,-0.1005,34.52486424,0.781333333,0.000352788,6.692469776,-0.4925,-0.703,-0.278,0.177,0.38,0.3135,undefined,8,TRUE,TRUE
0.987,1.034,1.105,0.664,0.7255,0.7975,0.936,0.978,1.0545,Q80WJ7,Q80WJ7,Mtdh,1,2,2,2,Q80WJ7,MOUSE,63958.9,4.8,2549,2549.1,27.99,27.99,NA,579,Protein LYRIC,nucleus|nucleolus|cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|bicellular tight junction|integral component of membrane|apical plasma membrane|nuclear body|nuclear membrane|intercellular canaliculus|perinuclear region of cytoplasm|,negative regulation of transcription from RNA polymerase II promoter|positive regulation of autophagy|lipopolysaccharide-mediated signaling pathway|negative regulation of apoptotic process|positive regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of angiogenesis|positive regulation of NF-kappaB transcription factor activity|positive regulation of protein kinase B signaling|bicellular tight junction assembly|,RNA polymerase II transcription factor binding|transcription coactivator activity|double-stranded RNA binding|protein binding|poly(A) RNA binding|NF-kappaB binding|,2,2,53200000,0.048,0.00017849,-0.004333333,45.40778553,0.931666667,2.88E-05,10.09441773,-0.4115,-0.438,-0.561,0.564,0.283,0.5375,undefined,9,NA,TRUE
0.663,0.937,0.331,0.575,0.8645,0.2585,0.634,0.903,0.3025,Q61103,Q61103,Dpf2,1,2,2,2,D3Z5N6|Q61103,MOUSE,45369.9,5.3,2551,2551.1,27.95,27.95,NA,391,Zinc finger protein ubi-d4,nuclear chromatin|nucleus|nucleoplasm|cytoplasm|centrosome|intracellular membrane-bounded organelle|BAF-type complex|,"transcription, DNA-templated|regulation of transcription, DNA-templated|apoptotic process|",RNA polymerase II core promoter proximal region sequence-specific DNA binding|zinc ion binding|,2,2,1.16E+09,0.053,0.010998823,-0.089333333,24.45003609,0.611666667,0.00358919,4.400815134,-0.4255,-0.668,-0.092,0.236,0.191,0.2225,NC,6,NA,NA
0.42,0.787,0.604,0.323,0.4585,0.2535,0.564,0.728,0.5265,P62858,P62858,Rps28,1,4,3,3,P62858,MOUSE,7898,40.5,2553,2553.1,27.87,27.87,NA,69,40S ribosomal protein S28,cytoplasm|small ribosomal subunit|cytosolic small ribosomal subunit|extracellular exosome|,rRNA processing|rRNA export from nucleus|translation|ribosome biogenesis|ribosomal small subunit biogenesis|,structural constituent of ribosome|poly(A) RNA binding|,3,4,1.21E+10,0.405,0.005346629,-0.000833333,28.27522558,0.474666667,0.00148757,5.195715794,-0.1845,-0.353,-0.177,0.239,0.095,0.3755,undefined,6,NA,NA
1.162,1.167,1.223,1.162,1.1465,1.4555,1.14,1.08,1.2375,Q6P9J9,Q6P9J9,Ano6,1,4,2,2,Q6P9J9,MOUSE,107451.2,3,2554,2554.1,27.86,27.86,NA,911,Anoctamin-6,intracellular|plasma membrane|cell surface|membrane|chloride channel complex|extracellular exosome|,"dendritic cell chemotaxis|activation of blood coagulation via clotting cascade|cation transport|chloride transport|lipid transport|blood coagulation|phospholipid scrambling|positive regulation of bone mineralization|bleb assembly|positive regulation of ion transmembrane transport|purinergic nucleotide receptor signaling pathway|bone mineralization involved in bone maturation|sodium ion transmembrane transport|positive regulation of apoptotic process|negative regulation of cell volume|pore complex assembly|positive regulation of phagocytosis, engulfment|calcium activated phospholipid scrambling|calcium activated phosphatidylserine scrambling|calcium activated phosphatidylcholine scrambling|calcium activated galactosylceramide scrambling|calcium ion transmembrane transport|positive regulation of monocyte chemotaxis|phosphatidylserine exposure on blood platelet|chloride transmembrane transport|regulation of anion transmembrane transport|positive regulation of endothelial cell apoptotic process|",calcium activated cation channel activity|intracellular calcium activated chloride channel activity|voltage-gated ion channel activity|voltage-gated chloride channel activity|phospholipid scramblase activity|protein homodimerization activity|intracellular calcium activated chloride channel activity|,2,4,66300000,0.03,1.24E-05,-0.111166667,60.53613662,1.184,8.84E-07,17.12784331,-0.7045,-0.599,-0.806,0.491,0.507,0.4445,undefined,9,NA,TRUE
0.686,1.008,0.84,0.614,0.7435,0.9045,0.697,1.015,0.8965,Q6ZQB6,Q6ZQB6,Ppip5k2,1,4,4,4,E9Q9J4|Q6ZQB6|Q6ZQB6-3|Q6ZQB6-2|A2ARP1|A2ARP1-2|A2ARP1-3|A2ARP1-7|A2ARP1-6,MOUSE,129565.5,3.5,2556,2556.1,27.78,27.78,NA,1129,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2,cytosol|,inositol metabolic process|phosphorylation|dephosphorylation|,"inositol-1,3,4,5,6-pentakisphosphate kinase activity|inositol hexakisphosphate 5-kinase activity|acid phosphatase activity|ATP binding|diphosphoinositol-pentakisphosphate kinase activity|inositol hexakisphosphate 1-kinase activity|inositol hexakisphosphate 3-kinase activity|",4,4,82900000,0.035,0.000183508,-0.068166667,45.25646375,0.900666667,2.98E-05,10.03850278,-0.3465,-0.564,-0.645,0.399,0.31,0.4375,undefined,9,NA,NA
0.558,0.273,0.765,0.473,0.2025,0.6955,0.319,0.029,0.5255,P70158,P70158,Smpdl3a,1,2,2,2,P70158,MOUSE,50370.4,11,2561,2561.1,27.54,27.54,NA,445,Acid sphingomyelinase-like phosphodiesterase 3a,extracellular space|extracellular exosome|,sphingomyelin catabolic process|,"sphingomyelin phosphodiesterase activity|hydrolase activity, acting on glycosyl bonds|",2,2,10100000,0.11,0.031818446,-0.026166667,18.76832365,0.448,0.013279069,3.34930694,-0.2705,0.007,-0.487,0.302,0.233,0.0585,PC,5,TRUE,NA
1.975,2.307,2.11,2.371,2.7545,2.5215,2.269,2.574,2.4045,P17047-2,P17047,Lamp2,1,3,2,2,P17047-2|P17047|P17047-3,MOUSE,46309.9,4.3,2562,2562.1,27.43,27.43,NA,415,Isoform LAMP-2B of Lysosome-associated membrane glycoprotein 2,lysosome|lysosomal membrane|late endosome|plasma membrane|membrane|integral component of membrane|phagocytic vesicle membrane|platelet dense granule membrane|late endosome membrane|extracellular exosome|,protein stabilization|,enzyme binding|protein domain specific binding|,2,3,2.57E+08,0.043,1.20E-05,-0.316666667,60.82444666,2.413666667,8.27E-07,17.55936778,-1.3425,-1.569,-1.659,0.636,1.101,0.9335,undefined,9,TRUE,TRUE
1.217,0.99,1.116,0.599,0.4195,0.5335,1.101,0.84,1.0155,Q3USG4,Q3USG4,Scnn1a,1,4,3,3,Q3USG4|Q61180|H3BJC3|H3BLI2|H3BKW1,MOUSE,80278.4,4.4,2563,2563.1,27.41,27.41,NA,700,Amiloride-sensitive sodium channel subunit alpha,cytosol|integral component of plasma membrane|external side of plasma membrane|membrane|integral component of membrane|apical plasma membrane|cortical actin cytoskeleton|motile cilium|sodium channel complex|ciliary membrane|extracellular exosome|,sodium ion transport|sodium ion transmembrane transport|multicellular organismal water homeostasis|sodium ion homeostasis|,actin binding|ligand-gated sodium channel activity|WW domain binding|sodium channel activity|ligand-gated sodium channel activity|,3,4,1.04E+08,0.044,0.003720611,0.132,30.15240681,0.902333333,0.000965516,5.617174639,-0.4325,-0.192,-0.333,0.802,0.217,0.7305,undefined,8,NA,TRUE
1.387,1.21,1.165,1.413,1.2515,1.2635,1.407,1.226,1.2425,O08800,O08800,Serpinb8,1,5,3,3,O08800,MOUSE,42777.2,11.2,2564,2564.1,27.38,27.38,NA,374,Serpin B8,extracellular space|cytoplasm|cytosol|extracellular exosome|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,3,5,1.50E+08,0.112,8.33E-06,-0.161,63.32682102,1.306333333,4.65E-07,18.88553409,-0.9295,-0.739,-0.774,0.457,0.534,0.4855,undefined,9,NA,NA
0.733,1.418,1.136,0.431,1.1325,0.8505,0.822,1.503,1.2255,P22437,P22437,Ptgs1,1,3,3,3,P22437,MOUSE,69782.8,5.3,2575,2575.1,27.23,27.23,NA,602,Prostaglandin G/H synthase 1,photoreceptor outer segment|nuclear envelope|cytoplasm|endoplasmic reticulum membrane|extracellular exosome|,prostaglandin biosynthetic process|prostaglandin metabolic process|inflammatory response|response to oxidative stress|aging|learning|memory|regulation of blood pressure|response to organonitrogen compound|negative regulation of norepinephrine secretion|sensory perception of pain|cyclooxygenase pathway|keratinocyte differentiation|negative regulation of epinephrine secretion|maintenance of blood-brain barrier|regulation of cell proliferation|positive regulation of vasoconstriction|positive regulation of smooth muscle contraction|response to corticosterone|oxidation-reduction process|response to fatty acid|,peroxidase activity|prostaglandin-endoperoxide synthase activity|lipid binding|heme binding|metal ion binding|dioxygenase activity|,3,3,6.65E+08,0.053,0.002392742,-0.080666667,32.3152438,1.039,0.00058678,6.131717613,-0.2455,-0.869,-0.686,0.466,0.259,0.5915,undefined,9,TRUE,NA
1.037,0.989,0.986,0.896,0.8225,1.0855,0.946,0.894,0.8955,Q6DVA0,Q6DVA0,Lemd2,1,3,3,3,Q6DVA0,MOUSE,57962,6.2,2585,2585.1,26.99,26.99,NA,511,LEM domain-containing protein 2,integral component of nuclear inner membrane|membrane|nuclear membrane|,nuclear envelope organization|neurogenesis|skeletal muscle cell differentiation|negative regulation of MAPK cascade|negative regulation of protein kinase B signaling|heart formation|,NA,3,3,5.06E+08,0.062,1.48E-05,-0.03,59.15293238,1.021666667,1.22E-06,16.31604816,-0.5425,-0.481,-0.599,0.488,0.54,0.4145,undefined,9,NA,TRUE
0.799,0.376,0.64,0.821,0.5595,0.8235,0.76,0.479,0.7475,Q8C3X8,Q8C3X8,Lmf2,1,4,2,2,Q8C3X8,MOUSE,80166.8,4.5,2588,2588.1,26.88,26.88,NA,702,Lipase maturation factor 2,endoplasmic reticulum membrane|membrane|integral component of membrane|,NA,NA,2,4,1.44E+09,0.045,0.002226738,-0.041,32.66568122,0.727,0.000541292,6.218200028,-0.6055,-0.166,-0.442,0.236,0.399,0.3325,undefined,8,NA,TRUE
1.919,1.883,1.936,1.741,1.8435,1.8415,2.043,1.937,1.8865,Q61112,Q61112,Sdf4,1,3,2,2,Q61112|Q61112-2,MOUSE,42120.4,5.5,2593,2593.1,26.71,26.71,NA,361,45 kDa calcium-binding protein,late endosome|Golgi apparatus|Golgi lumen|membrane|extracellular exosome|,UV protection|cerebellum development|fat cell differentiation|response to ethanol|,calcium ion binding|,2,3,1.29E+08,0.055,5.70E-06,-0.3145,66.60618123,1.926,2.18E-07,21.52903045,-1.1585,-1.229,-1.445,0.593,0.619,0.7335,PC,9,TRUE,NA
0.944,0.724,0.873,1.034,0.8505,0.7625,1.048,0.824,0.7725,Q4VAA7,Q4VAA7,Snx33,1,5,4,4,Q4VAA7,MOUSE,65598.7,9.5,2606,2606.1,26.34,26.34,NA,574,Sorting nexin-33,endosome|cytosol|membrane|cytoplasmic membrane-bounded vesicle|extrinsic component of membrane|cytoplasmic vesicle membrane|,mitotic cytokinesis|intracellular protein transport|endocytosis|endosome organization|mitotic nuclear division|vesicle organization|endosomal transport|protein import|cleavage furrow formation|macropinocytosis|negative regulation of endocytosis|positive regulation of membrane protein ectodomain proteolysis|membrane tubulation|negative regulation of protein localization to cell surface|positive regulation of protein localization to cell surface|,phosphatidylinositol binding|identical protein binding|,4,5,1.20E+08,0.095,9.53E-05,-0.083666667,48.66922821,0.809,1.36E-05,11.24854097,-0.6025,-0.381,-0.481,0.352,0.332,0.2785,undefined,9,NA,NA
0.504,0.475,0.788,0.461,0.3305,0.7405,0.488,0.377,0.7525,Q8VIB3,Q8VIB3,St3gal6,1,4,2,2,Q8VIB3,MOUSE,38252.8,9.1,2607,2607.1,26.29,26.29,NA,329,"Type 2 lactosamine alpha-2,3-sialyltransferase",integral component of Golgi membrane|extracellular exosome|,cellular protein modification process|protein glycosylation|glycolipid metabolic process|oligosaccharide metabolic process|cellular response to interleukin-6|sialylation|,"sialyltransferase activity|beta-galactoside alpha-2,3-sialyltransferase activity|",2,4,2.00E+08,0.091,0.00395916,-0.028333333,29.84412768,0.566333333,0.001036543,5.546417729,-0.2525,-0.149,-0.533,0.279,0.239,0.2465,undefined,7,NA,TRUE
1.363,1.424,1.696,1.447,1.5235,1.8305,1.678,1.736,1.9525,Q3UPY5-2,Q3UPY5,Glb1l2,1,5,3,3,Q3UPY5-2|A0A0R4J0L1|Q3UPY5|E0CYE1|E0CY86|Q8BZW3,MOUSE,74147.1,6.1,2608,2608.1,26.28,26.28,NA,636,Isoform 2 of Beta-galactosidase-1-like protein 2,extracellular region|,carbohydrate metabolic process|,beta-galactosidase activity|,3,5,4.81E+09,0.061,6.15E-05,-0.199,50.94376728,1.668333333,8.05E-06,12.34427505,-0.8775,-0.907,-1.315,0.484,0.666,0.7555,PC,9,NA,TRUE
2.208,2.18,2.189,1.718,1.8575,1.7835,2.308,2.46,2.3065,Q9JI33,Q9JI33,Ntn4,1,5,3,3,Q9JI33,MOUSE,72604.3,6.3,2612,2612.1,26.2,26.2,NA,628,Netrin-4,basement membrane|plasma membrane|,neuron remodeling|regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling|,laminin-1 binding|,3,5,3.23E+08,0.063,5.24E-05,-0.141666667,51.75751169,2.194333333,6.67E-06,12.71127561,-1.0765,-1.181,-1.459,0.997,0.625,1.2445,PC,9,TRUE,NA
1.526,1.699,1.609,1.131,1.3195,1.2295,1.163,1.333,1.2465,Q9JLQ0,Q9JLQ0,Cd2ap,1,4,3,3,Q9JLQ0,MOUSE,70619.8,4.5,2616,2616.1,26.11,26.11,NA,637,CD2-associated protein,ruffle|nucleolus|cytoplasm|cytosol|plasma membrane|cell-cell junction|cell cortex|endocytic vesicle|filamentous actin|perinuclear region of cytoplasm|extracellular exosome|,mitotic nuclear division|vesicle organization|single organismal cell-cell adhesion|cell migration|negative regulation of transforming growth factor beta1 production|proteasome-mediated ubiquitin-dependent protein catabolic process|regulation of receptor-mediated endocytosis|cell division|positive regulation of protein localization to nucleus|regulation of actin cytoskeleton reorganization|,vascular endothelial growth factor receptor binding|protein binding|beta-catenin binding|protein C-terminus binding|SH3 domain binding|protein complex binding|cadherin binding|,3,4,1.54E+09,0.045,2.74E-05,-0.093333333,55.19277653,1.397666667,3.02E-06,14.37587601,-0.7065,-0.836,-0.834,0.798,0.467,0.5515,undefined,9,NA,NA
1.803,1.955,2.197,1.4,1.5675,2.1345,2.221,2.369,2.4965,Q9R0M0,Q9R0M0,Celsr2,1,3,3,3,Q9R0M0|A2AEE7|Q9R0M0-2,MOUSE,322437.2,1.2,2620,2620.1,26,26,NA,2920,Cadherin EGF LAG seven-pass G-type receptor 2,cytoplasm|plasma membrane|integral component of membrane|,"neuron migration|cilium movement|regulation of transcription, DNA-templated|homophilic cell adhesion via plasma membrane adhesion molecules|G-protein coupled receptor signaling pathway|Wnt signaling pathway|ventricular system development|neural plate anterior/posterior regionalization|regulation of protein localization|cerebrospinal fluid secretion|cilium assembly|",G-protein coupled receptor activity|calcium ion binding|protein binding|,3,3,1.04E+08,0.012,0.000724549,-0.181333333,38.22130413,2.017,0.000150615,7.719280855,-0.8895,-0.989,-1.691,0.702,0.536,1.2435,undefined,9,TRUE,TRUE
0.686,1.153,0.95,0.564,1.0465,0.8435,0.364,0.827,0.6285,Q80YE7,Q80YE7,Dapk1,1,2,2,2,Q80YE7|Q80YE7-2,MOUSE,163321.4,1.7,2623,2623.1,25.95,25.95,NA,1442,Death-associated protein kinase 1,cytoplasm|cytosol|plasma membrane|actin cytoskeleton|,protein phosphorylation|apoptotic process|extrinsic apoptotic signaling pathway via death domain receptors|negative regulation of translation|intracellular signal transduction|negative regulation of apoptotic process|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|protein autophosphorylation|cellular response to interferon-gamma|apoptotic signaling pathway|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|regulation of N-methyl-D-aspartate selective glutamate receptor activity|,protein kinase activity|calmodulin-dependent protein kinase activity|protein binding|calmodulin binding|ATP binding|GTP binding|syntaxin-1 binding|identical protein binding|,2,2,81400000,0.017,0.002506633,-0.0355,32.0800164,0.788,0.000619439,6.074167716,-0.1965,-0.62,-0.472,0.481,0.417,0.1775,undefined,8,NA,NA
0.497,0.821,0.717,0.706,0.9435,0.7645,0.786,1.047,0.9465,Q8K2W3,Q8K2W3,Txndc11,1,4,4,4,Q8K2W3|Q3TWZ5|D6RHA0|D3YU69|Q8K2W3-2|D6RDR0|D6REU4,MOUSE,107212.3,5.9,2625,2625.1,25.84,25.84,NA,948,Thioredoxin domain-containing protein 11,endoplasmic reticulum membrane|integral component of membrane|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|,protein disulfide isomerase activity|,4,4,4.90E+07,0.059,0.000872889,-0.006,37.29047181,0.833,0.000186618,7.449527326,-0.2535,-0.55,-0.464,0.244,0.415,0.5725,undefined,9,NA,NA
1.3,1.192,1.125,1.026,0.9435,0.8765,1.302,1.154,1.0905,Q80T21,Q80T21,Adamtsl4,1,4,3,3,Q80T21,MOUSE,116646.6,4.3,2626,2626.1,25.83,25.83,NA,1036,ADAMTS-like protein 4,proteinaceous extracellular matrix|interstitial matrix|,proteolysis|apoptotic process|extracellular matrix organization|positive regulation of apoptotic process|,protease binding|metalloendopeptidase activity|,3,4,1.15E+08,0.043,2.39E-05,-0.017666667,55.95253754,1.141,2.54E-06,14.64790004,-0.6295,-0.578,-0.557,0.624,0.403,0.6315,PC,9,TRUE,NA
0.512,0.56,0.535,0.431,0.4945,0.4705,0.15,0.194,0.1745,Q6VH22,Q6VH22,Ift172,1,2,2,2,Q6VH22,MOUSE,199313.5,2.1,2627,2627.1,25.8,25.8,NA,1749,Intraflagellar transport protein 172 homolog,cilium|axoneme|intraciliary transport particle B|motile cilium|ciliary basal body|primary cilium|sperm midpiece|sperm principal piece|sperm cytoplasmic droplet|extracellular vesicle|,neural tube formation|neural tube closure|heart looping|Notch signaling pathway|smoothened signaling pathway|determination of left/right symmetry|brain development|heart development|epidermis development|regulation of smoothened signaling pathway|dorsal/ventral pattern formation|protein processing|spinal cord motor neuron differentiation|neural tube development|cytoplasmic microtubule organization|cilium assembly|positive regulation of smoothened signaling pathway|negative regulation of epithelial cell proliferation|palate development|limb development|cilium morphogenesis|bone development|hindgut development|left/right axis specification|,protein binding|,2,2,89300000,0.021,0.01596599,0.053,22.42912735,0.401,0.005715935,4.01115667,-0.1295,-0.167,-0.146,0.386,0.343,0.0315,NC,6,NA,NA
2.531,2.656,2.798,2.396,2.5355,2.7495,2.482,2.603,2.7515,Q8C2L6,Q8C2L6,Tmem161b,1,4,2,2,Q8C2L6|A0A286YE14|A0A286YDI6,MOUSE,55922.2,4.7,2637,2637.1,25.62,25.62,NA,487,Transmembrane protein 161B,integral component of membrane|,NA,NA,2,4,2.75E+09,0.047,1.37E-05,-0.602333333,59.69540587,2.665,1.07E-06,16.87146716,-1.7275,-1.756,-2.321,0.744,0.725,0.7215,undefined,9,NA,TRUE
2.953,3.488,3.719,2.363,2.9135,3.4425,2.673,3.204,3.6385,O35632,O35632,Hyal2,1,5,3,3,O35632|Q8C309|A0A0A6YX37,MOUSE,54244.2,5.2,2638,2638.1,25.61,25.61,NA,473,Hyaluronidase-2,Golgi membrane|cytoplasm|lysosome|cytosol|microvillus|cell surface|cytoplasmic membrane-bounded vesicle|apical plasma membrane|endocytic vesicle|cytoplasmic vesicle|membrane raft|anchored component of plasma membrane|perinuclear region of cytoplasm|RNA polymerase II transcription factor complex|anchored component of external side of plasma membrane|,response to reactive oxygen species|hematopoietic progenitor cell differentiation|carbohydrate metabolic process|glycosaminoglycan catabolic process|response to virus|multicellular organismal aging|negative regulation of fibroblast migration|fusion of virus membrane with host plasma membrane|transformation of host cell by virus|hyaluronan catabolic process|negative regulation of cell growth|positive regulation of urine volume|monocyte activation|positive regulation of protein import into nucleus|negative regulation of MAP kinase activity|cellular response to fibroblast growth factor stimulus|positive regulation of transcription from RNA polymerase II promoter|response to antibiotic|viral entry into host cell|skeletal system morphogenesis|positive regulation of inflammatory response|cartilage development|defense response to virus|negative regulation of protein kinase B signaling|multicellular organismal iron ion homeostasis|negative regulation of protein tyrosine kinase activity|renal water absorption|cellular response to interleukin-1|cellular response to tumor necrosis factor|cellular response to UV-B|cellular response to transforming growth factor beta stimulus|positive regulation of interleukin-8 secretion|positive regulation of interleukin-6 secretion|positive regulation of extrinsic apoptotic signaling pathway|,virus receptor activity|hyalurononglucosaminidase activity|hyaluronic acid binding|enzyme binding|receptor signaling protein tyrosine kinase inhibitor activity|receptor tyrosine kinase binding|hyaluronoglucuronidase activity|transforming growth factor beta binding|virus receptor activity|RNA polymerase II transcription coactivator activity|,3,5,3.86E+08,0.052,0.000519849,-0.720166667,39.89011693,3.23,0.000102562,8.223122276,-1.6755,-2.026,-3.304,0.943,0.732,1.0095,undefined,9,TRUE,NA
1.093,1.099,0.729,1.037,1.0585,0.6895,1.13,1.132,0.7675,A6H6E2,A6H6E2,Mmrn2,1,2,2,2,A6H6E2,MOUSE,105832,2.3,2646,2646.1,25.45,25.45,NA,943,Multimerin-2,basement membrane|extracellular space|extracellular exosome|,negative regulation of vascular endothelial growth factor receptor signaling pathway|negative regulation of cell migration involved in sprouting angiogenesis|,NA,2,2,3.18E+09,0.023,0.00022511,-0.168833333,44.28900101,0.984,3.72E-05,9.687478328,-0.7815,-0.766,-0.435,0.31,0.299,0.3605,PC,9,TRUE,NA
0.83,1.02,0.429,0.672,0.7145,0.2865,1.281,1.315,0.7715,Q9EQQ2,Q9EQQ2,Yipf5,1,4,2,2,Q9EQQ2,MOUSE,28329,8.1,2647,2647.1,25.43,25.43,NA,257,Protein YIPF5,endoplasmic reticulum membrane|integral component of membrane|ER to Golgi transport vesicle|Golgi cisterna membrane|nuclear outer membrane-endoplasmic reticulum membrane network|endoplasmic reticulum exit site|,protein transport|vesicle-mediated transport|regulation of ER to Golgi vesicle-mediated transport|,NA,2,4,6.65E+08,0.081,0.007771662,-0.059666667,26.3428704,0.813666667,0.002321202,4.784105408,-0.5495,-0.695,-0.155,0.287,0.151,0.6035,undefined,7,NA,TRUE
0.528,0.508,0.629,0.406,0.3995,0.1555,0.502,0.42,0.4825,Q9JLJ1,Q9JLJ1,Selenok,1,4,2,2,Q9JLJ1,MOUSE,10628.1,14.8,2652,2652.1,25.31,25.31,NA,94,Selenoprotein K,endoplasmic reticulum|endoplasmic reticulum membrane|plasma membrane|integral component of membrane|,positive regulation of defense response to virus by host|calcium ion transport|response to oxidative stress|macrophage derived foam cell differentiation|protein palmitoylation|positive regulation of cell migration|positive regulation of tumor necrosis factor production|positive regulation of T cell proliferation|respiratory burst after phagocytosis|regulation of calcium-mediated signaling|regulation of protein transport|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress|positive regulation of monocyte chemotactic protein-1 production|positive regulation of chemokine secretion|positive regulation of T cell migration|positive regulation of interleukin-6 secretion|regulation of store-operated calcium entry|,identical protein binding|,2,4,3.74E+08,0.148,0.008969096,-0.0365,25.56422576,0.475333333,0.00277701,4.624159712,-0.3775,-0.335,-0.11,0.337,0.055,0.2115,undefined,6,NA,TRUE
0.143,0.601,0.559,0.063,0.5065,0.3005,0.087,0.541,0.4825,P97855,P97855,G3bp1,1,4,2,2,P97855,MOUSE,51884.9,5.8,2654,2654.1,25.29,25.29,NA,465,Ras GTPase-activating protein-binding protein 1,nucleus|cytoplasm|cytosol|plasma membrane|focal adhesion|cytoplasmic stress granule|,transport|negative regulation of canonical Wnt signaling pathway|nucleic acid phosphodiester bond hydrolysis|,DNA binding|mRNA binding|helicase activity|endonuclease activity|protein binding|ATP binding|poly(A) RNA binding|,2,4,2.79E+08,0.058,0.044396254,-0.084833333,16.9320412,0.353333333,0.020267299,3.034947198,0.0015,-0.449,-0.337,0.117,0.078,0.0805,NC,5,NA,NA
0.503,-0.121,0.603,0.508,-0.1055,0.6855,0.398,-0.23,0.5645,Q0KL02-4,Q0KL02-4,Trio,1,5,2,2,Q0KL02-4|Q0KL02|Q0KL02-3|Q0KL02-2,MOUSE,351137,0.5,2658,2658.1,25.23,25.23,NA,3102,Isoform 4 of Triple functional domain protein,cytoplasm|,protein phosphorylation|regulation of Rho protein signal transduction|positive regulation of GTPase activity|,protein serine/threonine kinase activity|Rho guanyl-nucleotide exchange factor activity|ATP binding|enzyme binding|,2,5,2.06E+09,0.005,0.190439175,-0.148166667,9.053719043,0.335333333,0.124344934,1.758952252,-0.4565,0.142,-0.633,0.04,0.069,-0.0505,undefined,5,NA,NA
1.34,1.757,1.494,1.372,1.8055,1.5425,1.376,1.79,1.5315,Q6DFV7,Q6DFV7,Ncoa7,1,2,2,2,Q6DFV7|B9EIW5|A0A1L1SSS4|Q6DFV7-3,MOUSE,106983.2,3.1,2664,2664.1,25.06,25.06,NA,943,Nuclear receptor coactivator 7,intracellular|nucleus|,"transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|",ligand-dependent nuclear receptor transcription coactivator activity|nuclear hormone receptor binding|,2,2,39400000,0.031,1.58E-05,-0.172,58.63029398,1.576333333,1.37E-06,16.24628199,-0.7675,-1.125,-0.988,0.566,0.663,0.6195,undefined,9,NA,NA
1.113,1.239,1.096,1.05,1.0715,1.0405,1.181,1.303,1.0295,Q8VC04,Q8VC04,Tmem106a,1,5,2,2,Q8VC04,MOUSE,29508.3,13.7,2666,2666.1,25.06,25.06,NA,261,Transmembrane protein 106A,integral component of membrane|extracellular exosome|,NA,NA,2,5,66700000,0.137,7.54E-06,-0.128833333,64.05340957,1.166666667,3.93E-07,19.37101273,-0.6815,-0.779,-0.676,0.421,0.429,0.5135,undefined,9,NA,TRUE
1.34,1.181,1.155,1.09,0.9485,0.8885,1.373,1.211,1.4665,Q3UQN2,Q3UQN2,Fcho2,1,3,3,3,Q3UQN2|J3QPQ1|Q3UQN2-3|A0A286YDL7|Q3UQN2-2|F6RG68,MOUSE,89246.1,3.3,2674,2674.1,24.85,24.85,NA,809,F-BAR domain only protein 2,plasma membrane|coated pit|clathrin-coated vesicle|clathrin-coated vesicle|,membrane invagination|clathrin coat assembly|clathrin-mediated endocytosis|protein localization to plasma membrane|,"phosphatidylserine binding|protein binding|phosphatidylinositol-4,5-bisphosphate binding|phosphatidylinositol binding|",3,3,1.20E+08,0.033,6.30E-05,-0.0825,50.80464323,1.141333333,8.31E-06,12.28252252,-0.7385,-0.645,-0.576,0.574,0.308,0.5825,undefined,9,NA,NA
0.942,1.156,0.991,0.938,1.1675,1.0025,0.988,1.199,1.0385,Q8QZW3,Q8QZW3,Fam151a,1,4,3,3,Q8QZW3,MOUSE,67022.5,4.9,2681,2681.1,24.75,24.75,NA,608,Protein FAM151A,integral component of membrane|extracellular exosome|,NA,NA,3,4,4.14E+09,0.049,1.53E-05,-0.094333333,58.82910015,1.063,1.31E-06,16.13138698,-0.5375,-0.722,-0.618,0.401,0.449,0.4615,undefined,9,NA,TRUE
0.723,0.562,0.517,0.813,0.6685,0.6225,0.758,0.593,0.5525,Q04646-2,Q04646-2,Fxyd2,1,7,3,3,Q04646-2|Q04646-3|Q04646,MOUSE,7265.2,26.5,2688,2688.1,24.59,24.59,NA,70,Isoform 2 of Sodium/potassium-transporting ATPase subunit gamma,integral component of plasma membrane|sodium:potassium-exchanging ATPase complex|membrane|basolateral plasma membrane|intracellular membrane-bounded organelle|extracellular exosome|,regulation of cell growth|potassium ion transport|sodium ion transmembrane transport|regulation of cell proliferation|regulation of sodium ion transmembrane transporter activity|,ion channel activity|sodium:potassium-exchanging ATPase activity|sodium channel regulator activity|,3,7,1.56E+10,0.265,0.000243019,-0.067333333,43.87782964,0.660333333,4.09E-05,9.450018564,-0.5015,-0.364,-0.327,0.21,0.331,0.2475,undefined,9,NA,NA
1.323,0.957,1.354,1.328,0.9785,1.3745,1.567,1.197,1.5975,Q69ZN6,Q69ZN6,Gnptab,1,3,3,3,Q69ZN6|Q69ZN6-2,MOUSE,142236.4,2.1,2691,2691.1,24.53,24.53,NA,1235,N-acetylglucosamine-1-phosphotransferase subunits alpha/beta,Golgi membrane|nucleus|Golgi apparatus|integral component of membrane|,lysosome organization|protein secretion|N-glycan processing to lysosome|cell differentiation|carbohydrate phosphorylation|,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity|calcium ion binding|transcription factor binding|,3,3,4.70E+09,0.021,0.000153751,-0.136833333,46.14980151,1.356,2.43E-05,10.37265031,-0.9025,-0.536,-1.006,0.423,0.56,0.6405,undefined,9,NA,TRUE
1.42,1.238,1.283,1.367,1.2005,1.2455,1.461,1.276,1.3245,Q99LJ1,Q99LJ1,Fuca1,1,2,2,2,Q99LJ1,MOUSE,52564.9,6.1,2695,2695.1,24.45,24.45,NA,452,Tissue alpha-L-fucosidase,lysosome|extracellular exosome|,fucose metabolic process|glycoside catabolic process|,alpha-L-fucosidase activity|,2,2,2.20E+08,0.061,6.90E-06,-0.126,64.6638879,1.340333333,3.42E-07,19.78823945,-0.8885,-0.692,-0.808,0.528,0.523,0.5815,undefined,9,TRUE,NA
1.25,1.522,1.453,1.719,1.5665,1.6625,1.566,1.583,1.6835,Q571E4,Q571E4,Galns,1,3,3,3,Q571E4|Q8CC47,MOUSE,58185.9,5.3,2701,2701.1,24.37,24.37,NA,520,N-acetylgalactosamine-6-sulfatase,lysosome|extracellular exosome|,metabolic process|,sulfuric ester hydrolase activity|N-acetylgalactosamine-6-sulfatase activity|metal ion binding|,3,3,17700000,0.053,1.60E-05,-0.174166667,58.49466543,1.524,1.41E-06,16.16828346,-0.7905,-0.931,-1.087,0.471,0.651,0.6415,undefined,9,TRUE,NA
0.847,0.606,0.555,0.786,0.5395,0.4165,0.901,0.851,0.8155,Q80X80,Q80X80,C2cd2l,1,6,2,2,Q80X80|Q8CAA2,MOUSE,76784.2,5.8,2712,2712.1,24.03,24.03,NA,706,Phospholipid transfer protein C2CD2L,integral component of membrane|,positive regulation of insulin secretion involved in cellular response to glucose stimulus|,insulin binding|,2,6,3.87E+08,0.058,0.00025091,0.038166667,43.70947133,0.657333333,4.26E-05,9.391878071,-0.3195,-0.332,-0.22,0.378,0.269,0.4535,undefined,9,NA,TRUE
2.086,2.177,2.561,2.003,2.1095,2.4565,2.44,2.527,2.8785,Q91XQ0,Q91XQ0,Dnah8,1,8,3,3,Q91XQ0|Q91XQ0-2,MOUSE,545108,0.6,2715,2715.1,23.95,23.95,NA,4731,"Dynein heavy chain 8, axonemal",microtubule|dynein complex|outer dynein arm|sperm principal piece|,microtubule-based movement|metabolic process|,microtubule motor activity|ATP binding|ATPase activity|,3,8,6.29E+09,0.006,0.000102221,-0.3945,48.31203305,2.496666667,1.48E-05,11.22326581,-1.3825,-1.411,-2.135,0.784,0.668,1.1095,NC,9,NA,NA
0.411,0.333,0.124,0.612,0.5505,0.3405,0.825,0.744,0.5385,Q3TQN1,Q3TQN1,Tpst2,1,2,2,2,Q3TQN1|O88856,MOUSE,44156.7,5.8,2730,2730.1,23.67,23.67,NA,390,Protein-tyrosine sulfotransferase 2,endoplasmic reticulum|extracellular exosome|,peptidyl-tyrosine sulfation|fusion of sperm to egg plasma membrane|prevention of polyspermy|,protein-tyrosine sulfotransferase activity|,2,2,14900000,0.058,0.011128284,-0.007666667,24.387732,0.523666667,0.003641051,4.388511371,-0.3875,-0.304,-0.117,0.053,0.258,0.4515,undefined,5,NA,NA
0.817,0.988,1.013,0.515,0.7015,0.7265,0.687,0.854,0.8835,B1AR74,B1AR74,Bcas3,1,2,2,2,B1AR74|Q8CCN5|Q0VF62|Q8CCN5-2,MOUSE,104310.2,2.6,2742,2742.1,23.41,23.41,NA,943,Breast carcinoma-amplified sequence 3 homolog,nucleus|cytoplasm|transcriptionally active chromatin|cell periphery|,response to starvation|positive regulation of catalytic activity|positive regulation of transcription from RNA polymerase II promoter|cellular response to estrogen stimulus|,chromatin binding|transcription factor binding|acetyltransferase activator activity|histone acetyltransferase binding|nuclear hormone receptor binding|histone binding|beta-tubulin binding|,2,2,1.31E+08,0.026,0.000355708,-0.034833333,41.89456887,0.807333333,6.46E-05,8.864730763,-0.3165,-0.463,-0.536,0.49,0.232,0.3845,undefined,9,NA,NA
0.53,0.277,0.955,-0.118,0.1685,0.8615,0.552,0.689,1.1605,Q8BJU0,Q8BJU0,Sgta,1,3,3,3,Q8BJU0|Q8BJU0-2,MOUSE,34550,8.5,2743,2743.1,23.39,23.39,NA,315,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,cytoplasm|cytosol|membrane|,positive regulation of ER-associated ubiquitin-dependent protein catabolic process|,protein complex binding|protein homodimerization activity|protein heterodimerization activity|,3,3,33100000,0.085,0.021517528,-0.072833333,20.85899356,0.595333333,0.008205417,3.720907616,-0.3275,-0.189,-0.595,0.204,-0.034,0.5045,undefined,6,NA,NA
0.998,1.262,0.782,0.614,0.6995,0.6215,0.705,0.97,0.5455,Q8C0D9,Q8C0D9,Cep68,1,5,3,3,Q8C0D9|Q8C0D9-2|Q3TRP8,MOUSE,79660.4,5.1,2746,2746.1,23.32,23.32,NA,733,Centrosomal protein of 68 kDa,nucleus|nucleoplasm|cytoplasm|centrosome|microtubule organizing center|cell junction|,centriole-centriole cohesion|protein localization to organelle|centrosome organization|,protein kinase binding|protein domain specific binding|,3,5,1.76E+08,0.051,0.000224027,-0.061166667,44.32124157,0.792666667,3.70E-05,9.648075856,-0.4455,-0.557,-0.37,0.465,0.283,0.2575,NC,9,NA,NA
1.305,1.163,0.989,1.284,1.1575,0.8275,1.005,0.859,0.9155,P23188,P23188,Furin,1,3,3,3,P23188,MOUSE,88082.8,3.5,2748,2748.1,23.3,23.3,NA,793,Furin,extracellular region|extracellular space|early endosome|endoplasmic reticulum lumen|endoplasmic reticulum membrane|trans-Golgi network|plasma membrane|cell surface|trans-Golgi network transport vesicle membrane|membrane|integral component of membrane|trans-Golgi network transport vesicle|Golgi cisterna|membrane raft|extracellular exosome|,signal peptide processing|aging|cell proliferation|regulation of signal transduction|negative regulation of endopeptidase activity|protein processing|peptide hormone processing|viral life cycle|positive regulation of cell migration|positive regulation of transforming growth factor beta receptor signaling pathway|negative regulation of low-density lipoprotein particle receptor catabolic process|nerve growth factor production|negative regulation of transforming growth factor beta1 production|secretion by cell|regulation of protein catabolic process|peptide biosynthetic process|regulation of low-density lipoprotein particle receptor biosynthetic process|regulation of endopeptidase activity|,protease binding|endopeptidase activity|serine-type endopeptidase activity|serine-type endopeptidase inhibitor activity|protein binding|peptidase activity|peptide binding|metal ion binding|nerve growth factor binding|,3,3,1.46E+08,0.035,0.000502238,-0.2605,40.06522959,1.312,9.85E-05,8.277551784,-1.1795,-1.023,-0.547,0.459,0.325,0.4025,PC,9,TRUE,TRUE
0.506,0.6,0.652,0.107,0.3335,0.4165,0.771,0.9,0.9565,P97315,P97315,Csrp1,1,3,2,2,P97315,MOUSE,21438.8,13.9,2749,2749.1,23.29,23.29,NA,193,Cysteine and glycine-rich protein 1,nucleus|focal adhesion|actin cytoskeleton|extracellular exosome|,actin cytoskeleton organization|platelet aggregation|,protein binding|zinc ion binding|poly(A) RNA binding|,2,3,6.62E+08,0.139,0.027163264,0.112666667,19.66718683,0.567,0.010796458,3.507136492,-0.0465,-0.192,-0.274,0.399,0.071,0.7185,undefined,7,NA,NA
0.682,0.418,1.01,0.708,0.4595,1.0515,0.853,0.585,1.1815,Q1W617,Q1W617,Shroom4,1,4,3,3,Q1W617|Q1W617-2,MOUSE,165574.7,4,2752,2752.1,23.24,23.24,NA,1475,Protein Shroom4,cytoplasm|cytoplasmic side of plasma membrane|basal plasma membrane|apical plasma membrane|stress fiber|actin cytoskeleton|myosin II complex|cortical actin cytoskeleton|filamentous actin|,actin filament organization|brain development|cognition|cell morphogenesis|,actin filament binding|,3,4,23900000,0.04,0.005326058,-0.0845,28.2964649,0.803333333,0.001480313,5.200361597,-0.4495,-0.191,-0.818,0.246,0.292,0.4135,NC,8,NA,NA
1.544,1.7,1.846,1.223,1.3945,1.6145,1.775,1.927,2.1515,J3QMW5,J3QMW5,Gm2075,1,5,2,2,Q3UT53|J3QMW5|Q8BX20|Q3TQZ4|A0A1Y7VLT7|A0A1Y7VJE9|J3QQ02|Q3UTA4|A0A1Y7VK80|A0A1Y7VNG9|J3QP87|J3QPI8|J3QNT6|Q60872|Q8BMJ3,MOUSE,16762.6,11.1,2755,2755.1,23.21,23.21,NA,144,Predicted gene 2075,NA,translational initiation|,translation initiation factor activity|,2,5,8.06E+09,0.111,0.000209904,-0.152333333,44.63446547,1.637666667,3.44E-05,9.811552387,-0.7665,-0.879,-1.268,0.569,0.491,0.9395,undefined,9,NA,NA
2.523,2.737,3.342,2.187,2.4165,3.0215,2.47,2.68,3.2895,Q8BZT5,Q8BZT5,Lrrc19,1,3,2,2,Q8BZT5,MOUSE,42028.8,5.2,2764,2764.1,22.97,22.97,NA,364,Leucine-rich repeat-containing protein 19,integral component of membrane|,NA,NA,2,3,1.11E+09,0.052,0.000301891,-0.548833333,42.75399559,2.846666667,5.30E-05,9.152728112,-1.5305,-1.644,-2.742,0.968,0.705,0.9505,undefined,9,TRUE,TRUE
0.517,0.557,0.796,1.499,1.5085,1.7935,1.005,1.089,1.2835,Q9D868,Q9D868,Ppih,1,7,3,3,Q9D868|Q9D868-2|A2BGI9,MOUSE,20748.6,12.7,2767,2767.1,22.94,22.94,NA,188,Peptidyl-prolyl cis-trans isomerase H,spliceosomal complex|cytoplasm|nuclear speck|U4/U6 x U5 tri-snRNP complex|U4/U6 snRNP|,protein peptidyl-prolyl isomerization|mRNA processing|protein folding|RNA splicing|positive regulation of viral genome replication|,peptidyl-prolyl cis-trans isomerase activity|ribonucleoprotein complex binding|,3,7,4.91E+08,0.127,0.008716394,0.148333333,25.70859063,1.154333333,0.002686216,4.653569101,-0.3255,-0.301,-0.66,0.245,1.25,0.6815,undefined,9,NA,NA
0.124,0.539,0.306,0.601,0.9245,0.7985,0.643,0.812,0.6925,Q61687,Q61687,Atrx,1,3,2,2,Q61687,MOUSE,281206.5,0.8,2778,2778.1,22.63,22.63,NA,2476,Transcriptional regulator ATRX,nuclear chromosome|heterochromatin|nucleus|nucleoplasm|PML body|telomeric heterochromatin|SWI/SNF superfamily-type complex|,"DNA repair|nucleosome assembly|DNA replication-independent nucleosome assembly|chromatin remodeling|transcription, DNA-templated|spermatogenesis|positive regulation of nuclear cell cycle DNA replication|DNA damage response, signal transduction by p53 class mediator|forebrain development|replication fork processing|positive regulation of telomere maintenance|post-embryonic forelimb morphogenesis|multicellular organism growth|positive regulation of transcription from RNA polymerase II promoter|Sertoli cell development|seminiferous tubule development|cellular response to hydroxyurea|negative regulation of telomeric RNA transcription from RNA pol II promoter|",DNA binding|chromatin binding|helicase activity|protein binding|ATP binding|zinc ion binding|DNA translocase activity|methylated histone binding|histone binding|chromo shadow domain binding|,2,3,1.11E+09,0.008,0.013456659,0.033166667,23.37924115,0.586666667,0.004592783,4.191976007,-0.0775,-0.427,-0.276,0.068,0.524,0.3875,NC,7,NA,NA
1.234,1.055,1.106,1.037,0.8745,0.9255,1.026,0.844,0.8995,Q9CZE3,Q9CZE3,Rab32,1,2,3,2,Q9CZE3,MOUSE,25296.2,13.4,2785,2785.2,15.44,10.44,NA,223,Ras-related protein Rab-32,mitochondrion|early endosome|trans-Golgi network|membrane|phagocytic vesicle membrane|melanosome|phagocytic vesicle|,intracellular protein transport|metabolic process|antigen processing and presentation|melanosome organization|Rab protein signal transduction|endosome to melanosome transport|phagosome maturation|melanosome assembly|,GTPase activity|protein binding|GTP binding|GTP-dependent protein binding|AP-1 adaptor complex binding|AP-3 adaptor complex binding|BLOC-2 complex binding|,2,2,2.76E+08,0.085,4.81E-05,-0.151166667,52.17620166,1.02,6.06E-06,12.8060093,-0.7545,-0.562,-0.667,0.474,0.321,0.2815,undefined,9,NA,NA
0.203,0.611,0.517,0.371,0.7365,0.6885,0.253,0.726,0.6835,Q9Z127,Q9Z127,Slc7a5,1,3,2,2,Q9Z127,MOUSE,56555.9,5.8,2786,2786.1,22.38,22.38,NA,512,Large neutral amino acids transporter small subunit 1,nucleus|nucleolus|cytoplasm|cytosol|plasma membrane|integral component of plasma membrane|membrane|apical plasma membrane|intracellular membrane-bounded organelle|extracellular exosome|,amino acid transmembrane transport|nervous system development|L-amino acid transport|leucine transport|phenylalanine transport|tryptophan transport|cell differentiation|cation transmembrane transport|L-alpha-amino acid transmembrane transport|,L-amino acid transmembrane transporter activity|L-leucine transmembrane transporter activity|L-phenylalanine transmembrane transporter activity|L-tryptophan transmembrane transporter activity|antiporter activity|,2,3,51700000,0.058,0.011533865,-0.066166667,24.19420236,0.560666667,0.003806973,4.350415332,-0.0405,-0.506,-0.493,0.194,0.235,0.2135,undefined,6,NA,TRUE
0.649,0.383,0.44,0.669,0.4185,0.4755,0.838,0.567,0.6295,A7TU71,A7TU71,Shroom2,1,2,2,2,A7TU71|A2ALU4,MOUSE,166630.3,2,2798,2798.1,22.21,22.21,NA,1487,Protein Shroom2,cytoplasm|cell-cell junction|cell cortex|neuronal cell body|apical junction complex|extracellular exosome|cortical actin cytoskeleton|filamentous actin|,negative regulation of actin filament depolymerization|establishment of melanosome localization|apical protein localization|cell-cell junction maintenance|,protein binding|protein domain specific binding|actin filament binding|,2,2,52500000,0.02,0.001775325,-0.016,33.80144247,0.585,0.000416731,6.504772497,-0.4615,-0.2,-0.264,0.203,0.238,0.3885,NC,6,NA,NA
0.605,0.802,0.763,0.371,0.5845,0.5445,0.783,0.976,0.9415,Q62523,Q62523,Zyx,1,3,3,3,Q62523|Q7TQE2,MOUSE,61857,6.3,2802,2802.1,22.14,22.14,NA,564,Zyxin,stress fiber|nucleus|cytoplasm|cell-cell adherens junction|focal adhesion|,cell-matrix adhesion|transforming growth factor beta receptor signaling pathway|integrin-mediated signaling pathway|stress fiber assembly|regulation of inflammatory response|,protein binding|zinc ion binding|poly(A) RNA binding|,3,3,1.49E+08,0.063,0.001929606,0.035333333,33.38657079,0.716333333,0.000458504,6.3989627,-0.2045,-0.381,-0.383,0.393,0.194,0.5935,undefined,8,NA,NA
2.226,2.143,2.702,3.162,3.0945,3.6535,2.518,2.431,2.9945,P70313,P70313,Nos3,1,4,2,2,P70313|E9Q9X4,MOUSE,134568.4,2.4,2807,2807.1,22.05,22.05,NA,1202,"Nitric oxide synthase, endothelial",nucleus|cytoplasm|Golgi apparatus|cytosol|cytoskeleton|caveola|,angiogenesis|ovulation from ovarian follicle|in utero embryonic development|blood vessel remodeling|regulation of sodium ion transport|regulation of the force of heart contraction by chemical signal|regulation of systemic arterial blood pressure by endothelin|arginine catabolic process|nitric oxide biosynthetic process|nitric oxide mediated signal transduction|negative regulation of cell proliferation|negative regulation of muscle hyperplasia|smooth muscle hyperplasia|lung development|positive regulation of guanylate cyclase activity|lipopolysaccharide-mediated signaling pathway|response to fluid shear stress|negative regulation of potassium ion transport|endothelial cell migration|positive regulation of angiogenesis|negative regulation of blood pressure|positive regulation of vasodilation|regulation of blood vessel size|negative regulation of hydrolase activity|negative regulation of calcium ion transport|oxidation-reduction process|,actin monomer binding|NADPH-hemoprotein reductase activity|nitric-oxide synthase activity|iron ion binding|calmodulin binding|FMN binding|heme binding|tetrahydrobiopterin binding|arginine binding|flavin adenine dinucleotide binding|NADP binding|scaffold protein binding|,2,4,7.99E+08,0.024,0.000388467,-0.366166667,41.43014571,2.911333333,7.19E-05,8.712386442,-1.5845,-1.451,-2.43,0.677,1.662,0.9295,undefined,9,NA,NA
0.013,0.493,0.38,0.063,0.5585,0.4445,0.143,0.619,0.5105,Q9WUK2,Q9WUK2,Eif4h,1,2,2,2,Q9WUK2|Q9WUK2-2,MOUSE,27397.6,4,2812,2812.1,21.93,21.93,NA,248,Eukaryotic translation initiation factor 4H,membrane|perinuclear region of cytoplasm|,translational initiation|sexual reproduction|developmental growth|,nucleotide binding|translation initiation factor activity|poly(A) RNA binding|,2,2,6490000,0.04,0.046605671,-0.058,16.63968426,0.365666667,0.021678617,2.985796639,0.0325,-0.417,-0.338,0.049,0.135,0.1905,undefined,5,NA,NA
0.365,0.431,0.736,0.418,0.4065,0.7595,0.542,0.66,0.9665,F8VQ23,F8VQ23,Adra2b,1,4,2,2,F8VQ23|P30545|Q925K6,MOUSE,51183.3,3,2814,2814.1,21.9,21.9,NA,453,Alpha-2B adrenergic receptor,intracellular|integral component of plasma membrane|,MAPK cascade|angiogenesis|regulation of vascular smooth muscle contraction|G-protein coupled receptor signaling pathway|negative regulation of adenylate cyclase activity|cell-cell signaling|female pregnancy|negative regulation of norepinephrine secretion|platelet activation|activation of protein kinase B activity|epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway|positive regulation of neuron differentiation|positive regulation of blood pressure|negative regulation of insulin secretion involved in cellular response to glucose stimulus|positive regulation of uterine smooth muscle contraction|adenylate cyclase-inhibiting adrenergic receptor signaling pathway|activation of MAPK activity by adrenergic receptor signaling pathway|,adrenergic receptor activity|alpha2-adrenergic receptor activity|epinephrine binding|,2,4,85500000,0.03,0.006510651,0.066333333,27.26521247,0.555,0.001877063,4.977888491,-0.1655,-0.054,-0.414,0.256,0.287,0.4885,undefined,6,NA,TRUE
0.592,0.743,1.417,0.816,0.9825,1.6565,0.497,0.643,1.3215,Q8BMQ2,Q8BMQ2,Gtf3c4,1,2,2,2,Q8BMQ2|Q8BMQ2-3|E9Q2B0,MOUSE,92923.6,3.7,2817,2817.1,21.89,21.89,NA,817,General transcription factor 3C polypeptide 4,transcription factor TFIIIC complex|,"transcription, DNA-templated|histone acetylation|",DNA binding|histone acetyltransferase activity|,2,2,76700000,0.037,0.013342995,-0.162833333,23.42341653,1.001333333,0.004546303,4.200483605,-0.3225,-0.45,-1.218,0.284,0.549,0.1805,NC,9,NA,NA
0.732,0.8,0.923,0.53,0.6125,0.8275,0.611,0.674,0.7475,Q9DCB8,Q9DCB8,Isca2,1,3,2,2,Q9DCB8,MOUSE,16945.8,20.7,2825,2825.1,21.73,21.73,NA,154,"Iron-sulfur cluster assembly 2 homolog, mitochondrial",mitochondrion|,iron-sulfur cluster assembly|,structural molecule activity|metal ion binding|iron-sulfur cluster binding|,2,3,2.45E+08,0.207,8.95E-05,-0.014333333,49.03114324,0.777,1.25E-05,11.39206871,-0.3265,-0.379,-0.503,0.431,0.368,0.3235,NC,9,NA,NA
0.386,0.453,0.444,0.379,0.4615,0.4515,0.547,0.61,0.6055,Q61070,Q61070,Ei24,1,3,2,2,A0A0R4J250|Q61070,MOUSE,39217.2,6.4,2827,2827.1,21.71,21.71,NA,340,Etoposide-induced protein 2.4,cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|Golgi apparatus|membrane|integral component of membrane|nuclear membrane|,autophagy|intrinsic apoptotic signaling pathway in response to DNA damage|negative regulation of cell growth|response to drug|neuromuscular process controlling balance|cellular response to UV-C|positive regulation of intrinsic apoptotic signaling pathway|,NA,2,3,5.64E+08,0.064,0.00078649,-0.0055,37.8275504,0.496666667,0.000164909,7.544092162,-0.2135,-0.271,-0.277,0.181,0.2,0.3475,undefined,6,NA,TRUE
1.993,2.654,2.104,2.497,2.7075,2.7835,2.567,3.07,2.6785,Q62181,Q62181,Sema3c,1,3,3,3,Q62181,MOUSE,86599.7,3.4,2837,2837.1,21.45,21.45,NA,751,Semaphorin-3C,extracellular space|extracellular exosome|,neural crest cell migration|somitogenesis|blood vessel remodeling|outflow tract morphogenesis|cardiac right ventricle morphogenesis|pulmonary myocardium development|axon guidance|heart development|post-embryonic development|neural tube development|limb bud formation|dichotomous subdivision of terminal units involved in salivary gland branching|,semaphorin receptor binding|,3,3,7.35E+08,0.034,2.24E-05,-0.4135,56.3231859,2.485333333,2.33E-06,14.96710914,-1.3675,-1.888,-1.713,0.642,0.753,1.0925,PC,9,TRUE,NA
0.413,0.355,0.349,0.558,0.5565,0.5095,0.62,0.476,0.4335,Q8BR70,Q8BR70,Yipf6,1,3,2,2,Q8BR70,MOUSE,26315.5,6.3,2840,2840.1,21.32,21.32,NA,236,Protein YIPF6,endoplasmic reticulum|cis-Golgi network|trans-Golgi network|integral component of membrane|ER to Golgi transport vesicle|,intestinal epithelial cell development|,identical protein binding|,2,3,21800000,0.063,0.000926743,-0.010833333,36.95098465,0.471333333,0.000201791,7.296698712,-0.2885,-0.225,-0.226,0.14,0.312,0.2225,undefined,6,NA,TRUE
1.736,1.961,1.944,1.342,1.4905,1.4735,1.691,1.912,1.8995,P15947,P15947,Klk1,1,3,2,2,P15947|P00756|P15946|Q61759,MOUSE,29344.8,6.8,2846,2846.1,21.19,21.19,NA,261,Kallikrein-1,nucleus|extracellular exosome|,proteolysis|,serine-type endopeptidase activity|,2,3,3.09E+08,0.068,2.95E-05,-0.1075,54.69559817,1.776,3.39E-06,14.12289584,-0.9425,-0.953,-1.091,0.925,0.498,0.9185,undefined,9,TRUE,NA
0.984,0.77,0.311,0.514,0.3675,-0.2915,1.295,1.23,0.6355,Q4VAE3,Q4VAE3,Tmem65,1,3,2,2,Q4VAE3,MOUSE,25203,9.4,2853,2853.1,21.09,21.09,NA,234,Transmembrane protein 65,mitochondrion|integral component of membrane|,NA,NA,2,3,2.34E+08,0.094,0.094873288,0.009,12.81266984,0.654333333,0.052327865,2.359608869,-0.5685,-0.518,0.132,0.42,-0.167,0.7555,NC,6,NA,TRUE
1.181,0.6,1.031,1.201,0.6515,1.0815,1.205,0.423,0.9935,Q6ZWR6,Q6ZWR6,Syne1,1,4,2,2,Q6ZWR6|A0A1L1STC6|Q6ZWR6-4|Q6ZWR6-2|Q6ZWR6-3,MOUSE,1017267.9,0.2,2859,2859.1,20.96,20.96,NA,8799,Nesprin-1,nucleus|nuclear envelope|nuclear outer membrane|nucleoplasm|cytoplasm|Golgi apparatus|cytoskeleton|integral component of membrane|sarcomere|nuclear membrane|LINC complex|postsynaptic membrane|,Golgi organization|establishment of nucleus localization|muscle cell differentiation|cytoskeletal anchoring at nuclear membrane|nuclear matrix anchoring at nuclear membrane|,actin binding|protein binding|lamin binding|identical protein binding|protein homodimerization activity|poly(A) RNA binding|actin filament binding|,2,4,17100000,0.002,0.000494124,-0.132166667,40.16155041,1.038666667,9.63E-05,8.307620275,-0.8725,-0.38,-0.702,0.37,0.451,0.3405,undefined,8,NA,TRUE
1.827,2.319,2.396,1.552,2.0405,2.1375,1.66,2.129,2.2995,B2RQY6,B2RQY6,BC035947,1,4,2,2,B2RQY6,MOUSE,78024.9,3.1,2860,2860.1,20.96,20.96,NA,695,BC035947 protein,viral capsid|,viral life cycle|,NA,2,4,2.14E+08,0.031,8.53E-05,-0.3745,49.2836931,2.064666667,1.18E-05,11.62577577,-1.0345,-1.418,-1.768,0.769,0.569,0.6355,undefined,9,NA,TRUE
0.597,0.414,0.798,0.563,0.4275,0.8115,0.734,0.579,0.9775,Q8BGC3,Q8BGC3,Slc16a12,1,4,2,2,Q8BGC3,MOUSE,54348.8,4.5,2861,2861.1,20.96,20.96,NA,486,Monocarboxylate transporter 12,integral component of plasma membrane|,plasma membrane lactate transport|creatine transmembrane transport|,creatine transmembrane transporter activity|lactate transmembrane transporter activity|symporter activity|,2,4,6.43E+08,0.045,0.002494653,-0.013833333,32.10588769,0.670666667,0.00061576,6.080477775,-0.3125,-0.165,-0.57,0.266,0.284,0.4145,undefined,8,NA,TRUE
0.689,0.504,0.568,0.837,0.6485,0.5635,0.78,0.591,0.5585,O35988,O35988,Sdc4,1,3,2,2,O35988,MOUSE,21539.1,9.5,2864,2864.1,20.92,20.92,NA,198,Syndecan-4,Golgi lumen|focal adhesion|cell surface|integral component of membrane|costamere|membrane raft|extracellular exosome|,ureteric bud development|neural tube closure|signal transduction|regulation of fibroblast migration|cell migration|wound healing|positive regulation of protein kinase activity|positive regulation of stress fiber assembly|positive regulation of focal adhesion assembly|inner ear receptor stereocilium organization|positive regulation of exosomal secretion|positive regulation of extracellular exosome assembly|,fibronectin binding|protein kinase C binding|thrombospondin receptor activity|,2,3,3.69E+08,0.095,0.000386096,-0.053,41.47306965,0.586333333,7.12E-05,8.648555482,-0.4505,-0.243,-0.345,0.239,0.25,0.2315,PC,9,TRUE,TRUE
0.393,0.622,0.759,0.376,0.6195,0.7565,0.422,0.646,0.7875,Q9R269,Q9R269,Ppl,1,3,3,3,Q9R269|G5E898,MOUSE,204628,1.5,2876,2876.1,20.71,20.71,NA,1755,Periplakin,nucleus|mitochondrion|cytoskeleton|extrinsic component of plasma membrane|desmosome|extracellular exosome|,keratinization|,protein binding|,3,3,6.41E+08,0.015,0.00257985,-0.019166667,31.9247147,0.618,0.00064199,6.036390174,-0.1265,-0.332,-0.526,0.275,0.286,0.3085,NC,7,NA,NA
0.51,0.534,0.086,0.434,0.5345,0.0855,0.801,0.831,0.5395,P63158,P63158,Hmgb1,1,3,2,2,P63158|A0A0J9YUD8|P30681,MOUSE,25064.5,11.1,2878,2878.1,20.7,20.7,NA,215,High mobility group protein B1,condensed chromosome|extracellular region|extracellular space|nucleus|cytoplasm|cell surface|transcriptional repressor complex|,"inflammatory response to antigenic stimulus|base-excision repair, DNA ligation|inflammatory response|negative regulation of RNA polymerase II transcriptional preinitiation complex assembly|DNA geometric change|V(D)J recombination|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of DNA binding|negative regulation of blood vessel endothelial cell migration|positive regulation of transcription from RNA polymerase II promoter|negative regulation of apoptotic cell clearance|","four-way junction DNA binding|bubble DNA binding|phosphatidylserine binding|sequence-specific DNA binding transcription factor activity|cytokine activity|protein binding|heparin binding|DNA binding, bending|poly(A) RNA binding|repressing transcription factor binding|supercoiled DNA binding|",2,3,2.04E+08,0.111,0.025969683,-0.069833333,19.89709613,0.487333333,0.010239774,3.547962473,-0.4245,-0.451,-0.065,0.096,0.037,0.3885,PC,7,NA,NA
2.403,2.681,2.918,2.375,2.6695,2.9065,2.585,2.859,3.1015,Q7TT36,Q7TT36,Adgra3,1,4,2,2,Q7TT36,MOUSE,146805.8,2,2882,2882.1,20.66,20.66,NA,1310,Adhesion G protein-coupled receptor A3,external side of plasma membrane|integral component of membrane|,G-protein coupled receptor signaling pathway|,G-protein coupled receptor activity|,2,4,43600000,0.02,3.78E-05,-0.597666667,53.43981182,2.857666667,4.53E-06,13.50246014,-1.6835,-1.864,-2.532,0.779,0.762,0.9525,undefined,9,TRUE,TRUE
1.735,2.025,1.876,1.226,1.5395,1.5815,1.654,1.94,1.7625,Q8C7K6,Q8C7K6,Pcyox1l,1,3,2,2,Q8C7K6,MOUSE,55044.8,3.6,2888,2888.1,20.5,20.5,NA,495,Prenylcysteine oxidase-like,extracellular region|vacuolar membrane|membrane|,prenylated protein catabolic process|prenylcysteine catabolic process|oxidation-reduction process|,prenylcysteine oxidase activity|,2,3,87900000,0.036,9.48E-05,-0.110333333,48.70087338,1.775,1.35E-05,11.38278764,-0.7685,-1.022,-1.203,0.94,0.492,0.8995,PC,9,TRUE,NA
0.537,0.267,0.428,0.516,0.3445,0.3605,0.532,0.656,0.6755,Q920L1,Q920L1,Fads1,1,3,3,3,Q920L1,MOUSE,52550,8.9,2891,2891.1,20.33,20.33,NA,447,Fatty acid desaturase 1,nucleus|mitochondrion|endoplasmic reticulum membrane|membrane|integral component of membrane|,unsaturated fatty acid biosynthetic process|aging|cellular response to starvation|response to sucrose|response to organic cyclic compound|arachidonic acid metabolic process|response to insulin|response to vitamin A|response to isolation stress|long-chain fatty acid biosynthetic process|oxidation-reduction process|,linoleoyl-CoA desaturase activity|oxidoreductase activity|,3,3,3.63E+08,0.089,0.001082297,-0.014166667,36.18616092,0.446,0.000240649,7.086212132,-0.3325,-0.173,-0.206,0.235,0.188,0.2035,undefined,5,NA,TRUE
1.768,1.445,1.731,2.018,1.8045,2.0915,1.703,1.395,1.6855,P49183,P49183,Dnase1,1,5,2,2,P49183|H3BKL7,MOUSE,32255,5.6,2898,2898.1,20.13,20.13,NA,284,Deoxyribonuclease-1,nucleus|nuclear envelope|extracellular exosome|,"DNA catabolic process, endonucleolytic|apoptotic process|",actin binding|endodeoxyribonuclease activity|deoxyribonuclease I activity|,2,5,1.44E+09,0.056,8.41E-05,-0.3065,49.35766984,1.828,1.16E-05,11.65695571,-1.3505,-0.886,-1.425,0.543,0.788,0.4915,PC,9,TRUE,NA
1.848,2.266,2.039,1.106,1.5395,1.3125,1.707,2.12,1.8975,E9Q718,E9Q718,Plod2,1,2,2,2,E9Q718|Q9R0B9,MOUSE,87527.1,3,2903,2903.1,20.02,20.02,NA,758,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2",endoplasmic reticulum|extracellular exosome|,response to hypoxia|cellular response to hormone stimulus|oxidation-reduction process|activation of mitophagy in response to mitochondrial depolarization|,iron ion binding|procollagen-lysine 5-dioxygenase activity|L-ascorbic acid binding|,2,2,41900000,0.03,0.000302211,-0.017666667,42.74228706,1.766333333,5.32E-05,9.148750611,-0.6895,-1.015,-0.998,1.127,0.437,1.0325,undefined,9,TRUE,NA
0.308,0.592,0.657,0.394,0.6935,0.7585,0.62,0.9,0.9695,Q8VHE6,Q8VHE6,Dnah5,1,3,3,3,Q8VHE6,MOUSE,531485.4,0.9,2915,2915.1,19.73,19.73,NA,4621,"Dynein heavy chain 5, axonemal",axonemal dynein complex|microtubule|axoneme|outer dynein arm|,cilium movement|determination of left/right symmetry|metabolic process|lateral ventricle development|sperm motility|outer dynein arm assembly|cilium assembly|left/right axis specification|,microtubule motor activity|ATP binding|ATPase activity|,3,3,14600000,0.009,0.004602128,-0.043833333,29.08205125,0.677333333,0.001235364,5.374138833,-0.1645,-0.419,-0.564,0.15,0.265,0.4695,NC,7,NA,NA
1.659,1.783,2.153,1.539,1.6785,2.0485,1.844,1.963,2.3385,Q925P2,Q925P2,Ceacam2,1,3,2,2,Q925P2|Q925P2-2|Q925P2-3,MOUSE,57600.7,5.1,2917,2917.1,19.69,19.69,NA,520,Carcinoembryonic antigen-related cell adhesion molecule 2,cell surface|integral component of membrane|extracellular exosome|,viral process|negative regulation of brown fat cell proliferation|negative regulation of feeding behavior|regulation of energy homeostasis|homophilic cell adhesion via plasma membrane adhesion molecules|,protein homodimerization activity|,2,3,1.14E+08,0.051,0.000106517,-0.253333333,48.07298009,2.001666667,1.56E-05,11.12620926,-1.0105,-1.089,-1.663,0.822,0.576,0.8445,undefined,9,TRUE,TRUE
1.958,1.98,2.057,1.944,1.9825,2.0585,2.17,2.188,2.2695,Q3UHN9,Q3UHN9,Ndst1,1,3,3,3,Q3UHN9,MOUSE,101408.4,3.2,2922,2922.1,19.57,19.57,NA,882,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,Golgi membrane|integral component of membrane|,MAPK cascade|polysaccharide biosynthetic process|protein deacetylation|protein sulfation|inflammatory response|smoothened signaling pathway|respiratory gaseous exchange|fibroblast growth factor receptor signaling pathway|organ morphogenesis|heparan sulfate proteoglycan biosynthetic process|glycosaminoglycan metabolic process|heparin biosynthetic process|forebrain development|midbrain development|embryonic neurocranium morphogenesis|embryonic viscerocranium morphogenesis|,sulfotransferase activity|[heparan sulfate]-glucosamine N-sulfotransferase activity|deacetylase activity|,3,3,7.60E+08,0.032,6.03E-06,-0.334,66.04718319,2.115666667,2.48E-07,21.11005039,-1.3175,-1.291,-1.567,0.63,0.68,0.8615,undefined,9,NA,TRUE
0.262,0.51,0.669,0.179,0.4425,0.5765,0.156,0.401,0.5945,O08786,O08786,Cckar,1,4,2,2,O08786|Q3TPL0,MOUSE,49234.6,5.9,2924,2924.1,19.49,19.49,NA,436,Cholecystokinin receptor type A,lysosome|endosome|endoplasmic reticulum|cytosol|integral component of plasma membrane|terminal bouton|,temperature homeostasis|gastric acid secretion|neuron migration|reduction of food intake in response to dietary excess|positive regulation of cytosolic calcium ion concentration|axonogenesis|response to nutrient|digestion|feeding behavior|response to radiation|response to heat|insulin secretion|pancreatic juice secretion|forebrain development|pancreas development|organ regeneration|actin cytoskeleton reorganization|response to lipopolysaccharide|cellular response to hormone stimulus|cholecystokinin signaling pathway|response to starvation|regulation of potassium ion transport|regulation of hormone secretion|response to glucocorticoid|regulation of calcium ion transport|positive regulation of somatostatin secretion|response to peptide|,cholecystokinin receptor activity|peptide binding|,2,4,2.53E+08,0.059,0.015284776,-0.092833333,22.69960803,0.434666667,0.005370803,4.062218674,-0.0925,-0.323,-0.515,0.142,0.122,0.1095,undefined,5,NA,TRUE
0.766,0.585,0.634,0.565,0.3985,0.4475,0.361,0.176,0.2295,Q3UFK1,Q3UFK1,Ccdc28a,1,2,2,2,Q3UFK1|G3UZ16|G3UX80|Q8CEI3,MOUSE,20357.5,14.6,2930,2930.1,19.38,19.38,NA,184,Coiled-coil domain-containing 28A,NA,NA,NA,2,2,1.00E+07,0.146,0.012131025,0.027333333,23.91419418,0.473666667,0.00406051,4.295619622,-0.3155,-0.133,-0.18,0.453,0.283,0.0565,undefined,5,NA,NA
0.577,0.392,0.535,0.377,0.4325,0.3965,0.551,0.504,0.5555,Q9JM51,Q9JM51,Ptges,1,3,2,2,Q9JM51,MOUSE,17456.4,7.1,2936,2936.1,19.29,19.29,NA,153,Prostaglandin E synthase,nuclear envelope lumen|cytoplasm|integral component of membrane|perinuclear region of cytoplasm|,prostaglandin biosynthetic process|acute inflammatory response|chronic inflammatory response|prostaglandin metabolic process|negative regulation of cell proliferation|response to organic cyclic compound|response to lipopolysaccharide|response to retinoic acid|response to cytokine|response to calcium ion|,prostaglandin-D synthase activity|glutathione binding|prostaglandin-E synthase activity|,2,3,6.11E+09,0.071,0.000822395,0.0115,37.61582111,0.462666667,0.000173148,7.483722209,-0.2295,-0.191,-0.239,0.219,0.178,0.3315,undefined,7,NA,TRUE
0.564,0.354,0.508,0.583,0.3895,0.5425,0.594,0.381,0.5385,P21460,P21460,Cst3,1,2,2,2,P21460,MOUSE,15758.8,17.1,2944,2944.1,19.09,19.09,NA,140,Cystatin-C,extracellular region|basement membrane|extracellular space|lysosome|multivesicular body|endoplasmic reticulum|axon|nuclear membrane|neuronal cell body|contractile fiber|perinuclear region of cytoplasm|extracellular exosome|,"eye development|response to hypoxia|cell activation|apoptotic process|defense response|brain development|salivary gland development|embryo implantation|positive regulation of cell proliferation|response to toxic substance|response to carbohydrate|negative regulation of peptidase activity|negative regulation of collagen catabolic process|negative regulation of extracellular matrix disassembly|negative regulation of endopeptidase activity|response to nutrient levels|response to estradiol|response to drug|circadian sleep/wake cycle, REM sleep|regulation of programmed cell death|extracellular fibril organization|positive regulation of DNA replication|negative regulation of proteolysis|response to axon injury|Sertoli cell development|negative regulation of elastin catabolic process|negative regulation of blood vessel remodeling|negative regulation of cell death|cellular response to hydrogen peroxide|",beta-amyloid binding|protease binding|endopeptidase inhibitor activity|cysteine-type endopeptidase inhibitor activity|identical protein binding|,2,2,74100000,0.171,0.00085779,-0.008666667,37.38554506,0.515666667,0.000182577,7.4185102,-0.3515,-0.145,-0.303,0.228,0.266,0.2535,PC,6,TRUE,NA
1.022,0.669,1.099,0.689,1.0925,0.9355,0.652,1.043,0.8905,P97333,P97333,Nrp1,1,3,3,3,P97333,MOUSE,104253.4,4.2,2946,2946.1,19.07,19.07,NA,923,Neuropilin-1,extracellular space|early endosome|cytosol|neurofilament|plasma membrane|focal adhesion|integral component of membrane|axon|sorting endosome|,angiogenesis|patterning of blood vessels|neuron migration|sprouting angiogenesis|cell migration involved in sprouting angiogenesis|axon guidance|axonal fasciculation|heart development|motor neuron axon guidance|dendrite development|cell migration|facial nerve structural organization|trigeminal nerve morphogenesis|trigeminal nerve structural organization|vestibulocochlear nerve structural organization|nerve development|branchiomotor neuron axon guidance|gonadotrophin-releasing hormone neuronal migration to the hypothalamus|negative regulation of axon extension|retinal ganglion cell axon guidance|cellular response to hepatocyte growth factor stimulus|endothelial cell chemotaxis|cellular response to vascular endothelial growth factor stimulus|ventral trunk neural crest cell migration|VEGF-activated neuropilin signaling pathway|otic placode formation|negative regulation of neuron apoptotic process|platelet-derived growth factor receptor signaling pathway|vascular endothelial growth factor receptor signaling pathway|hepatocyte growth factor receptor signaling pathway|sympathetic nervous system development|neuron development|regulation of axon extension involved in axon guidance|positive regulation of axon extension involved in axon guidance|negative regulation of axon extension involved in axon guidance|artery morphogenesis|axon extension involved in axon guidance|positive regulation of peptidyl-tyrosine phosphorylation|positive chemotaxis|axonogenesis involved in innervation|dichotomous subdivision of terminal units involved in salivary gland branching|angiogenesis involved in coronary vascular morphogenesis|cell migration involved in coronary vasculogenesis|coronary artery morphogenesis|retina vasculature morphogenesis in camera-type eye|renal artery morphogenesis|sympathetic ganglion development|trigeminal ganglion development|ganglion morphogenesis|positive regulation of ERK1 and ERK2 cascade|semaphorin-plexin signaling pathway|commissural neuron axon guidance|regulation of retinal ganglion cell axon guidance|sensory neuron axon guidance|sympathetic neuron projection extension|sympathetic neuron projection guidance|neural crest cell migration involved in autonomic nervous system development|toxin transport|semaphorin-plexin signaling pathway involved in neuron projection guidance|semaphorin-plexin signaling pathway involved in axon guidance|positive regulation of retinal ganglion cell axon guidance|VEGF-activated neuropilin signaling pathway involved in axon guidance|protein localization to early endosome|facioacoustic ganglion development|negative regulation of extrinsic apoptotic signaling pathway|,vascular endothelial growth factor-activated receptor activity|protein binding|heparin binding|semaphorin receptor activity|growth factor binding|vascular endothelial growth factor binding|metal ion binding|,3,3,2.90E+08,0.042,1.10E-05,-0.026833333,61.41433436,0.98,7.22E-07,17.66322893,-0.5215,-0.532,-0.497,0.401,0.492,0.4965,PC,9,TRUE,TRUE
2.294,1.479,2.2,2.039,1.2385,1.9595,2.261,1.441,2.1675,Q61088,Q61088,Fzd4,1,3,2,2,Q61088,MOUSE,61340.4,3.1,2950,2950.1,18.95,18.95,NA,537,Frizzled-4,plasma membrane|cell-cell junction|cell surface|integral component of membrane|extracellular exosome|,"luteinization|blood vessel development|vasculogenesis|G-protein coupled receptor signaling pathway|Wnt signaling pathway, calcium modulating pathway|sensory perception of sound|negative regulation of cell-substrate adhesion|Wnt signaling pathway|regulation of vascular endothelial growth factor receptor signaling pathway|locomotion involved in locomotory behavior|substrate adhesion-dependent cell spreading|extracellular matrix-cell signaling|non-canonical Wnt signaling pathway|progesterone secretion|positive regulation of JUN kinase activity|positive regulation of transcription, DNA-templated|positive regulation of sequence-specific DNA binding transcription factor activity|canonical Wnt signaling pathway|retina vasculature morphogenesis in camera-type eye|cerebellum vasculature morphogenesis|retinal blood vessel morphogenesis|",G-protein coupled receptor activity|protein binding|Wnt-protein binding|cytokine binding|PDZ domain binding|ubiquitin protein ligase binding|protein homodimerization activity|Wnt-activated receptor activity|protein heterodimerization activity|,2,3,70500000,0.031,0.000463038,-0.295166667,40.50836991,1.988,8.90E-05,8.416654369,-1.5455,-0.73,-1.592,0.691,0.528,0.8775,undefined,9,TRUE,TRUE
1.098,0.83,1.076,1.039,0.7865,1.0325,1.22,0.949,1.1995,Q8K209,Q8K209,Adgrg1,1,2,2,2,Q8K209,MOUSE,78052.4,2.4,2952,2952.1,18.89,18.89,NA,687,Adhesion G-protein coupled receptor G1,intracellular|plasma membrane|integral component of membrane|extracellular exosome|glial limiting end-foot|,angiogenesis|cell adhesion|G-protein coupled receptor signaling pathway|Rho protein signal transduction|brain development|negative regulation of cell proliferation|vascular endothelial growth factor production|cerebral cortex regionalization|cerebral cortex radial glia guided migration|layer formation in cerebral cortex|positive regulation of Rho protein signal transduction|positive regulation of cell adhesion|protein kinase C signaling|positive regulation of neural precursor cell proliferation|negative regulation of neuron migration|,G-protein coupled receptor activity|collagen binding|extracellular matrix binding|,2,2,1.47E+08,0.024,0.000112316,-0.1175,47.7497116,1.052,1.68E-05,10.99617585,-0.7275,-0.455,-0.748,0.376,0.347,0.5025,PC,9,TRUE,TRUE
0.449,0.602,0.739,0.405,0.5735,0.7105,0.563,0.712,0.8535,O88952,O88952,Lin7c,1,2,2,2,O88952,MOUSE,21947.7,9.1,2964,2964.1,18.74,18.74,NA,197,Protein lin-7 homolog C,cytoplasm|plasma membrane|cell-cell junction|bicellular tight junction|postsynaptic density|basolateral plasma membrane|neuron projection|synapse|postsynaptic membrane|extracellular exosome|MPP7-DLG1-LIN7 complex|,morphogenesis of an epithelial sheet|exocytosis|neurotransmitter secretion|asymmetric protein localization|protein transport|maintenance of epithelial cell apical/basal polarity|protein localization to basolateral plasma membrane|,protein binding|cytoskeletal protein binding|protein domain specific binding|PDZ domain binding|L27 domain binding|,2,2,1.89E+08,0.091,0.001222122,-0.042,35.60813987,0.637666667,0.000274907,6.981361987,-0.2125,-0.349,-0.521,0.239,0.228,0.3635,undefined,9,NA,NA
0.309,0.535,0.528,-0.244,-0.0015,-0.0095,0.558,0.78,0.7775,A0A087WQH8,A0A087WQH8,Slc35a4,1,2,2,2,A0A087WQH8,MOUSE,11213.7,16.5,2969,2969.1,18.67,18.67,NA,103,Probable UDP-sugar transporter protein SLC35A4,NA,NA,NA,2,2,1.45E+08,0.165,0.19510759,0.090333333,8.915354188,0.353,0.128370307,1.736716374,0.0595,-0.148,-0.17,0.356,-0.192,0.6365,undefined,5,NA,TRUE
0.778,0.884,0.67,0.633,0.7035,0.6785,0.551,0.735,0.4435,Q9R022,Q9R022,Dnajc12,1,3,2,2,Q9R022,MOUSE,23080.4,14.6,2973,2973.1,18.59,18.59,NA,198,DnaJ homolog subfamily C member 12,NA,NA,NA,2,3,82500000,0.146,0.000261617,-0.053,43.52061184,0.659666667,4.45E-05,9.327030732,-0.4045,-0.385,-0.359,0.36,0.32,0.1505,undefined,9,NA,NA
2.634,2.51,3.446,2.251,2.1425,2.9365,2.436,2.308,3.1385,Q9EPU5,Q9EPU5,Tnfrsf21,1,4,2,2,Q9EPU5,MOUSE,73350.9,3.3,2975,2975.1,18.54,18.54,NA,655,Tumor necrosis factor receptor superfamily member 21,integral component of plasma membrane|axon|intrinsic component of plasma membrane|,B cell apoptotic process|adaptive immune response|apoptotic process|humoral immune response|negative regulation of B cell proliferation|negative regulation of myelination|negative regulation of T cell proliferation|myelination|regulation of oligodendrocyte differentiation|T cell receptor signaling pathway|neuron apoptotic process|cellular response to tumor necrosis factor|oligodendrocyte apoptotic process|negative regulation of interleukin-5 secretion|negative regulation of interleukin-13 secretion|negative regulation of interleukin-10 secretion|,NA,2,4,1.40E+08,0.033,0.00043047,-0.518,40.90533945,2.748333333,8.12E-05,8.542944956,-1.5945,-1.399,-2.683,1.015,0.703,0.8505,undefined,9,TRUE,TRUE
1.261,0.928,0.749,1.236,0.9195,0.7405,1.178,0.842,0.6675,Q9Z2A0,Q9Z2A0,Pdpk1,1,2,2,2,Q9Z2A0|F2Z3X6|F2Z3Z9|Q3TRL2,MOUSE,64213.8,5.3,2976,2976.1,18.53,18.53,NA,559,3-phosphoinositide-dependent protein kinase 1,nucleus|cytoplasm|cytosol|plasma membrane|focal adhesion|cytoplasmic membrane-bounded vesicle|cell projection|neuronal postsynaptic density|,"type B pancreatic cell development|transcription, DNA-templated|regulation of transcription, DNA-templated|protein phosphorylation|negative regulation of protein kinase activity|hyperosmotic response|signal transduction|epidermal growth factor receptor signaling pathway|positive regulation of phospholipase activity|regulation of endothelial cell migration|negative regulation of cardiac muscle cell apoptotic process|cell migration|peptidyl-threonine phosphorylation|calcium-mediated signaling|negative regulation of transforming growth factor beta receptor signaling pathway|activation of protein kinase B activity|cellular response to insulin stimulus|negative regulation of toll-like receptor signaling pathway|regulation of I-kappaB kinase/NF-kappaB signaling|regulation of mast cell degranulation|focal adhesion assembly|positive regulation of release of sequestered calcium ion into cytosol|cellular response to epidermal growth factor stimulus|positive regulation of establishment of protein localization to plasma membrane|extrinsic apoptotic signaling pathway|",protein serine/threonine kinase activity|3-phosphoinositide-dependent protein kinase activity|insulin receptor binding|ATP binding|phospholipase activator activity|kinase activity|protein kinase binding|phospholipase binding|,2,2,2.84E+08,0.053,0.000724549,-0.161833333,38.21974516,0.966666667,0.00015067,7.718822462,-0.9225,-0.584,-0.429,0.343,0.356,0.2655,undefined,9,NA,NA
0.55,0.639,0.677,0.391,0.4955,0.5335,0.694,0.779,0.8215,P33587,P33587,Proc,1,2,2,2,P33587,MOUSE,53186.4,5.8,3001,3001.1,18.21,18.21,NA,460,Vitamin K-dependent protein C,extracellular space|,proteolysis|blood coagulation|negative regulation of blood coagulation|negative regulation of apoptotic process|,calcium ion binding|peptidase activity|,2,2,16400000,0.058,0.001028696,0.009,36.42366202,0.631666667,0.000227842,7.205267375,-0.2335,-0.308,-0.379,0.317,0.184,0.4735,PC,8,TRUE,NA
3.181,4.105,3.356,4.331,5.2705,4.3885,3.668,4.588,3.8455,Q80ZX8,Q80ZX8,Spag1,1,10,2,2,Q80ZX8|Q80ZX8-3,MOUSE,101923.3,2.2,3005,3005.1,18.11,18.11,NA,901,Sperm-associated antigen 1,nucleoplasm|cytoplasm|microtubule cytoskeleton|,single fertilization|metabolic process|axonemal dynein complex assembly|,GTP binding|hydrolase activity|,2,10,4.95E+10,0.022,0.014340042,-0.257333333,23.04848059,3.153,0.004956236,4.12856304,-2.4305,-3.051,-0.02,0.797,1.929,1.2315,undefined,9,NA,NA
1.077,1.375,1.285,0.909,1.2225,1.1325,1.032,1.326,1.2415,Q9CWS1,Q9CWS1,Rnf135,1,2,2,2,Q9CWS1,MOUSE,47259.6,6.9,3006,3006.1,18.1,18.1,NA,417,E3 ubiquitin-protein ligase RNF135,cytoplasm|,protein ubiquitination|positive regulation of interferon-beta production|innate immune response|regulation of innate immune response|,ubiquitin-protein transferase activity|protein binding|zinc ion binding|ligase activity|ribonucleoprotein complex binding|,2,2,2.73E+08,0.069,3.39E-05,-0.144333333,53.98780201,1.191,3.99E-06,13.76997976,-0.5695,-0.827,-0.823,0.496,0.384,0.4735,undefined,9,NA,NA
1.057,1.288,0.645,0.826,1.0725,0.4285,0.809,1.036,0.3975,Q8CIR4,Q8CIR4,Trpm6,1,2,2,2,Q8CIR4,MOUSE,235223.4,1,3011,3011.1,18.03,18.03,NA,2028,Transient receptor potential cation channel subfamily M member 6,integral component of membrane|apical plasma membrane|brush border membrane|,protein phosphorylation|response to toxic substance|metal ion transport|calcium ion transmembrane transport|,protein serine/threonine kinase activity|cation channel activity|calcium channel activity|ATP binding|metal ion binding|,2,2,3.65E+08,0.01,0.002675183,-0.057833333,31.74706538,0.852,0.000668796,5.993387402,-0.5435,-0.723,-0.185,0.501,0.32,0.2835,undefined,8,NA,TRUE
0.687,1.2,0.733,0.7,1.2285,0.7615,0.578,1.087,0.6255,Q91Z92,Q91Z92,B3galt6,1,3,2,2,Q91Z92,MOUSE,37419.9,8,3013,3013.1,17.99,17.99,NA,325,"Beta-1,3-galactosyltransferase 6",Golgi membrane|Golgi medial cisterna|membrane|integral component of membrane|,glycosaminoglycan biosynthetic process|protein glycosylation|heparan sulfate proteoglycan biosynthetic process|chondroitin sulfate biosynthetic process|,"UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity|UDP-galactosyltransferase activity|galactosylxylosylprotein 3-beta-galactosyltransferase activity|",2,3,80700000,0.08,0.001620011,-0.069,34.25265917,0.846333333,0.000375607,6.621361939,-0.3205,-0.78,-0.376,0.364,0.429,0.2695,undefined,9,NA,TRUE
1.632,1.733,1.542,1.518,1.5955,1.4435,1.088,0.951,0.7645,Q66PY1,Q66PY1,Scube3,1,3,2,2,Q66PY1|Q66PY1-2,MOUSE,114174.5,2.1,3017,3017.1,17.91,17.91,NA,993,"Signal peptide, CUB and EGF-like domain-containing protein 3",extracellular region|cell surface|,protein homooligomerization|protein heterooligomerization|,calcium ion binding|,2,3,2.14E+08,0.021,0.000483375,-0.036833333,40.28280404,1.227333333,9.37E-05,8.345603392,-0.7965,-0.64,-0.515,0.853,0.575,0.3025,PC,9,TRUE,NA
0.574,0.659,0.665,0.626,0.7275,0.7325,0.583,0.664,0.6745,Q3U2I3,Q3U2I3,Fam160a2,1,2,2,2,A0A1C7CYU5|Q3U2I3|Q3U2I3-2|F8WHJ1|Q3U2I3-3,MOUSE,107509.4,2.6,3034,3034.1,17.61,17.61,NA,975,FTS and Hook-interacting protein,FHF complex|,endosome organization|lysosome organization|endosome to lysosome transport|protein transport|early endosome to late endosome transport|,NA,2,2,4.84E+08,0.026,8.93E-05,-0.045333333,49.0489749,0.674333333,1.24E-05,11.39937149,-0.3225,-0.395,-0.43,0.257,0.347,0.2715,undefined,9,NA,NA
0.564,0.361,0.323,0.472,0.2845,0.2465,0.699,0.492,0.4585,Q9D4J7,Q9D4J7,Phf6,1,2,2,2,Q9D4J7|E9QAG2|Q9D4J7-2,MOUSE,42279.7,6.3,3035,3035.1,17.6,17.6,NA,364,PHD finger protein 6,condensed chromosome kinetochore|nucleus|nucleoplasm|nucleolus|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",DNA binding|zinc ion binding|tubulin binding|enzyme binding|histone binding|histone deacetylase binding|ribonucleoprotein complex binding|poly(A) RNA binding|phosphoprotein binding|scaffold protein binding|,2,2,9.50E+07,0.063,0.006407855,-0.016166667,27.35171854,0.448666667,0.001840044,4.996310995,-0.3865,-0.187,-0.148,0.188,0.111,0.3255,NC,5,NA,NA
1.339,1.986,1.016,2.266,2.5465,2.1185,2.167,2.583,1.8445,Q08501,Q08501,Prlr,1,4,2,2,Q08501,MOUSE,69038.2,2.6,3037,3037.1,17.55,17.55,NA,608,Prolactin receptor,intracellular|cell surface|integral component of membrane|,activation of transmembrane receptor protein tyrosine kinase activity|JAK-STAT cascade|lactation|regulation of cell adhesion|regulation of epithelial cell differentiation|prolactin signaling pathway|mammary gland epithelial cell differentiation|prostate gland growth|mammary gland alveolus development|mammary gland epithelium development|,prolactin receptor activity|protein binding|peptide hormone binding|metal ion binding|,2,4,7.45E+08,0.026,0.001065441,0.0025,36.25995938,2.058666667,0.000236594,7.159869328,-0.9645,-1.368,-0.748,0.429,1.5,1.1665,undefined,9,TRUE,TRUE
0.484,0.289,0.759,0.283,0.0765,0.4905,0.426,0.212,0.6395,J3QMP3,J3QMP3,Adgb,1,7,3,3,J3QMP3|G3UZ78|A0A140LI36|G3UZ78-2,MOUSE,189945.5,2.5,3042,3042.1,17.44,17.44,NA,1660,Androglobin,cytoplasm|,proteolysis|oxygen transport|,calcium-dependent cysteine-type endopeptidase activity|iron ion binding|heme binding|,3,7,8.91E+09,0.025,0.029040517,0.010666667,19.31757652,0.443666667,0.011701522,3.445416835,-0.2015,0.016,-0.448,0.354,0.097,0.2465,undefined,5,NA,NA
1.65,1.904,1.897,1.162,1.3405,1.4475,1.739,1.989,1.9865,Q8BGW9,Q8BGW9,Defb29,1,4,2,2,Q8BGW9,MOUSE,9408.9,33.3,3046,3046.1,17.41,17.41,NA,78,Beta-defensin 29,extracellular region|cell surface|,defense response to bacterium|innate immune response|,NA,2,4,28300000,0.333,0.00016565,-0.044833333,45.76312437,1.664666667,2.65E-05,10.22681381,-0.7145,-0.824,-1.093,0.886,0.465,1.0115,PC,9,TRUE,NA
0.827,0.872,0.612,0.685,0.7465,0.4865,0.735,0.777,0.5215,Q02384,Q02384,Sos2,1,2,2,2,Q02384|A0A0A0MQ87|S4R2C4|Q62245,MOUSE,154493,2.4,3061,3061.1,17.31,17.31,NA,1333,Son of sevenless homolog 2,intracellular|,B cell homeostasis|lymphocyte homeostasis|small GTPase mediated signal transduction|regulation of T cell differentiation in thymus|regulation of Rho protein signal transduction|regulation of T cell proliferation|positive regulation of GTPase activity|regulation of pro-B cell differentiation|,DNA binding|guanyl-nucleotide exchange factor activity|Ras guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|protein binding|protein heterodimerization activity|,2,2,54200000,0.024,0.000315705,-0.1165,42.52422748,0.707333333,5.59E-05,9.022180924,-0.5285,-0.556,-0.326,0.297,0.194,0.2205,NC,9,NA,NA
1.842,2.072,2.142,1.527,1.7715,1.8415,1.615,1.84,1.9145,Q6P9S7,Q6P9S7,Galnt10,1,2,2,2,Q6P9S7,MOUSE,69856.5,2.9,3067,3067.1,17.21,17.21,NA,603,Polypeptide N-acetylgalactosaminyltransferase 10,Golgi membrane|integral component of membrane|,protein O-linked glycosylation|O-glycan processing|,polypeptide N-acetylgalactosaminyltransferase activity|carbohydrate binding|metal ion binding|,2,2,5540000,0.029,1.90E-05,-0.1445,57.42581158,1.863333333,1.81E-06,15.56599391,-0.8865,-1.05,-1.292,0.938,0.686,0.7375,undefined,9,NA,TRUE
1.739,1.745,1.919,1.427,1.4485,1.6225,1.691,1.693,1.8715,Q9Z0L8,Q9Z0L8,Ggh,1,2,2,2,Q9Z0L8|Q9Z0L8-2,MOUSE,35697.1,8.2,3080,3080.1,17.06,17.06,NA,317,Gamma-glutamyl hydrolase,extracellular space|nucleus|lysosome|cytosol|melanosome|extracellular exosome|,proteolysis|glutamine metabolic process|response to zinc ion|response to insulin|response to drug|response to ethanol|,gamma-glutamyl-peptidase activity|,2,2,22300000,0.082,1.94E-05,-0.171166667,57.1752191,1.712,1.92E-06,15.4279167,-0.9455,-0.912,-1.224,0.776,0.522,0.7565,PC,9,TRUE,NA
1.889,1.614,1.995,1.462,1.2905,1.5835,1.832,1.597,1.9375,O88839,O88839,Adam15,1,4,2,2,O88839|O88839-2|O88839-3,MOUSE,95400.9,2.6,3087,3087.1,16.88,16.88,NA,864,Disintegrin and metalloproteinase domain-containing protein 15,acrosomal vesicle|adherens junction|cell surface|integral component of membrane|cell projection|extracellular exosome|,angiogenesis|negative regulation of cell-matrix adhesion|proteolysis|cell adhesion|integrin-mediated signaling pathway|negative regulation of cell growth|negative regulation of cell migration|collagen catabolic process|tissue regeneration|innate immune response|cardiac epithelial to mesenchymal transition|protein kinase C signaling|negative regulation of receptor binding|,metalloendopeptidase activity|integrin binding|protein binding|metallopeptidase activity|zinc ion binding|SH3 domain binding|,2,4,3.90E+07,0.026,5.74E-05,-0.163833333,51.2746891,1.704,7.46E-06,12.49231825,-1.0025,-0.796,-1.249,0.781,0.491,0.7925,undefined,9,TRUE,TRUE
1.087,1.187,1.047,0.546,0.6615,0.5205,0.289,0.385,0.2495,Q8CI11,Q8CI11,Gnl3,1,2,2,2,Q8CI11|Q8CI11-2,MOUSE,61413,5.2,3090,3090.1,16.85,16.85,NA,538,Guanine nucleotide-binding protein-like 3,extracellular space|nucleus|nucleoplasm|nucleolus|membrane|,cell proliferation|regulation of cell proliferation|ribosome biogenesis|positive regulation of pri-miRNA transcription from RNA polymerase II promoter|,GTPase activity|protein binding|GTP binding|poly(A) RNA binding|,2,2,44100000,0.052,0.024689939,0.0825,20.16441032,0.658666667,0.009628507,3.595673799,-0.2375,-0.31,-0.193,0.832,0.34,0.0635,NC,6,NA,NA
2.878,2.994,2.892,3.025,3.1565,2.9535,2.873,2.986,2.8555,P49070,P49070,Camlg,1,5,2,2,P49070,MOUSE,32826.8,6.1,3091,3091.1,16.84,16.84,NA,294,Calcium signal-modulating cyclophilin ligand,endoplasmic reticulum|membrane|integral component of membrane|,receptor recycling|epidermal growth factor receptor signaling pathway|,protein binding|,2,5,9.03E+09,0.061,1.94E-06,-0.649333333,82.12094699,2.989,6.14E-09,36.59765566,-2.1015,-2.104,-2.226,0.767,0.992,0.7765,undefined,9,NA,NA
0.878,1.092,0.842,0.765,0.9955,0.7455,0.863,1.073,0.8275,Q9R1S7,Q9R1S7,Abcc6,1,2,2,2,Q9R1S7,MOUSE,166566,1.8,3104,3104.1,16.58,16.58,NA,1498,Multidrug resistance-associated protein 6,nucleus|plasma membrane|integral component of membrane|basolateral plasma membrane|apical plasma membrane|lateral plasma membrane|,metabolic process|transmembrane transport|,"ATP binding|ATPase activity, coupled to transmembrane movement of substances|",2,2,15300000,0.018,5.14E-05,-0.175166667,51.85914166,0.906666667,6.52E-06,12.61012382,-0.5735,-0.756,-0.556,0.299,0.234,0.3015,undefined,9,NA,TRUE
2.534,2.576,2.278,1.713,1.7705,1.4725,2.234,2.272,1.9785,Q7TSK7,Q7TSK7,Adamtsl2,1,2,2,2,Q7TSK7,MOUSE,109068.3,3.6,3105,3105.1,16.52,16.52,NA,957,ADAMTS-like protein 2,extracellular region|proteinaceous extracellular matrix|,proteolysis|negative regulation of transforming growth factor beta receptor signaling pathway|,metalloendopeptidase activity|zinc ion binding|,2,2,1.89E+08,0.036,9.36E-05,-0.064,48.76603674,2.098333333,1.33E-05,11.40972266,-1.1745,-1.135,-1.03,1.323,0.561,1.0715,PC,9,TRUE,NA
0.522,0.501,0.425,0.589,0.5835,0.5085,0.746,0.599,0.6495,Q9CWS4,Q9CWS4,Ints11,1,3,2,2,Q9CWS4|A8Y5J3|D6RH69,MOUSE,68584.2,3.3,3107,3107.1,16.5,16.5,NA,600,Integrator complex subunit 11,cytoplasm|integrator complex|blood microparticle|,snRNA processing|,hydrolase activity|,2,3,33500000,0.033,0.000442489,-0.019,40.74050857,0.561,8.43E-05,8.416345417,-0.3595,-0.267,-0.272,0.173,0.267,0.3445,NC,8,NA,NA
1.938,2.471,2.417,2.156,2.7045,2.6495,0.97,1.499,1.4495,Q2EMV9,Q2EMV9,Parp14,1,3,2,2,Q2EMV9|Q2EMV9-2,MOUSE,205737.6,1,3110,3110.1,16.43,16.43,NA,1817,Poly [ADP-ribose] polymerase 14,nucleus|cytoplasm|plasma membrane|membrane|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",nucleic acid binding|NAD+ ADP-ribosyltransferase activity|protein binding|,2,3,3.41E+08,0.01,0.002297296,0.077666667,32.51479336,2.044333333,0.000560429,6.18085322,-0.6105,-1.046,-1.177,1.322,1.627,0.3505,NC,9,NA,NA
1.103,1.238,0.708,0.837,0.9875,0.4575,1.005,1.136,0.6105,Q9D8T0,Q9D8T0,Fam3a,1,2,2,2,I7HJS7|Q9D8T0|I7HPY1|J3JS95,MOUSE,25621.3,11.3,3126,3126.1,16.25,16.25,NA,230,Protein FAM3A,extracellular region|,NA,NA,2,2,14800000,0.113,0.001572041,-0.128,34.41025873,0.901666667,0.000362221,6.662460002,-0.6725,-0.778,-0.286,0.419,0.203,0.3465,PC,9,NA,TRUE
2.651,2.968,3.658,2.514,2.8525,3.5425,3.061,3.359,4.0535,Q3UVD5,Q3UVD5,Lgr6,1,7,2,2,Q3UVD5,MOUSE,105806,1.6,3130,3130.1,16.19,16.19,NA,967,Leucine-rich repeat-containing G-protein coupled receptor 6,nucleoplasm|cytoplasm|plasma membrane|integral component of membrane|vesicle|,G-protein coupled receptor signaling pathway|Wnt signaling pathway|positive regulation of Wnt signaling pathway|positive regulation of cell migration|,protein-hormone receptor activity|,2,7,6.21E+09,0.016,0.001191457,-0.787666667,35.72915286,3.457,0.000267353,7.014232612,-1.8095,-2.003,-3.736,0.822,0.754,1.2465,undefined,9,TRUE,TRUE
1.398,1.681,1.341,1.189,1.2615,1.3635,1.341,1.404,1.3885,Q8BRK9,Q8BRK9,Man2a2,1,3,2,2,Q8BRK9|Q8BRK9-2|Q3TSU5,MOUSE,131331,2.1,3131,3131.1,16.19,16.19,NA,1152,Alpha-mannosidase 2x,Golgi membrane|integral component of membrane|,mannose metabolic process|protein glycosylation|,"mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity|zinc ion binding|mannosidase activity|hydrolase activity, hydrolyzing N-glycosyl compounds|carbohydrate binding|",2,3,25600000,0.021,5.20E-06,-0.157333333,67.7562974,1.330333333,1.68E-07,22.03955975,-0.7735,-0.796,-0.898,0.49,0.479,0.5545,undefined,9,NA,TRUE
0.739,1.738,0.591,0.701,1.1555,0.5685,0.483,1.464,0.3225,Q71FD7,Q71FD7,Fblim1,1,3,2,2,Q71FD7,MOUSE,42565.7,6.9,3132,3132.1,16.18,16.18,NA,375,Filamin-binding LIM protein 1,stress fiber|focal adhesion|cell cortex|,regulation of cell shape|single organismal cell-cell adhesion|regulation of integrin activation|,zinc ion binding|filamin binding|,2,3,51400000,0.069,0.001801464,-0.055,33.72732059,0.733,0.000423904,6.485771399,-0.3835,-0.649,-0.232,0.338,0.379,0.2175,NC,8,NA,NA
0.416,0.466,0.281,0.422,0.4885,0.3035,0.699,0.746,0.5445,Q8K3Z9,Q8K3Z9,Pom121,1,4,2,2,Q8K3Z9,MOUSE,121476.1,1.6,3137,3137.1,16.07,16.07,NA,1200,Nuclear envelope pore membrane protein POM 121,nuclear pore|endoplasmic reticulum membrane|nuclear membrane|,protein transport|mRNA transport|,NA,2,4,5.59E+08,0.016,0.003635631,-0.0545,30.26723564,0.484,0.000940322,5.640390999,-0.3255,-0.368,-0.196,0.098,0.129,0.3355,undefined,6,NA,TRUE
2.418,2.714,3.222,2.467,2.7785,3.3145,2.494,2.804,3.4175,Q62179,Q62179,Sema4b,1,3,2,2,Q62179,MOUSE,92702.9,2.6,3142,3142.1,15.97,15.97,NA,823,Semaphorin-4B,plasma membrane|membrane|integral component of membrane|synapse|,nervous system development|cell differentiation|,protein binding|,2,3,5.07E+09,0.026,0.000272902,-0.704666667,43.30786526,2.983,4.67E-05,9.342615539,-1.6985,-1.893,-2.997,0.707,0.832,0.8215,undefined,9,TRUE,TRUE
1.323,1.804,1.441,1.255,1.7515,1.3885,1.426,1.902,1.5445,Q9JHU9,Q9JHU9,Isyna1,1,2,2,2,Q9JHU9,MOUSE,61558.1,2.8,3143,3143.1,15.97,15.97,NA,557,Inositol-3-phosphate synthase 1,cytoplasm|,inositol biosynthetic process|phospholipid biosynthetic process|,inositol-3-phosphate synthase activity|,2,2,39700000,0.028,2.43E-05,-0.395,55.84101229,1.571,2.61E-06,14.71215681,-0.9615,-1.344,-1.236,0.356,0.337,0.4785,undefined,9,NA,NA
1.062,1.311,1.246,0.932,1.1965,1.1315,1.108,1.354,1.2935,Q562G0,Q562G0,Pigo,1,2,2,2,Q562G0|Q9JJI6|A2AG36,MOUSE,120811.1,2.4,3152,3152.1,15.86,15.86,NA,1101,GPI ethanolamine phosphate transferase 3,membrane|,metabolic process|,"protein binding|phosphotransferase activity, for other substituted phosphate groups|mannose-ethanolamine phosphotransferase activity|",2,2,14700000,0.024,2.58E-05,-0.084,55.50221158,1.199666667,2.82E-06,14.4859643,-0.5345,-0.746,-0.771,0.52,0.441,0.5865,undefined,9,NA,TRUE
3,3.564,3.125,2.358,3.0765,2.8925,2.752,3.169,3.3015,Q80U12-2,Q80U12-2,Sgsm2,1,9,2,2,Q80U12-2|Q80U12,MOUSE,119580.4,2,3156,3156.1,15.81,15.81,NA,1005,Isoform 2 of Small G protein signaling modulator 2,cytoplasm|,late endosome to Golgi transport|positive regulation of GTPase activity|,GTPase activator activity|Rab GTPase binding|,2,9,1.30E+10,0.02,2.34E-05,-0.535166667,56.06364347,3.086,2.48E-06,14.82935832,-1.6635,-2.165,-2.406,1.193,0.73,1.1005,undefined,9,NA,NA
0.853,0.842,0.679,0.639,0.6315,0.5875,0.866,0.851,0.6405,Q9D8,Q9D8,Cutc,1,4,2,2,Q9D8|F8WHX2,MOUSE,29402.5,7.7,3178,3178.1,15.51,15.51,NA,272,Copper homeostasis protein cutC homolog,nucleus|nucleoplasm|nucleolus|cytoplasm|,protein tetramerization|copper ion homeostasis|,copper ion binding|,2,4,32400000,0.077,7.62E-05,-0.032166667,49.86722557,0.774,1.03E-05,11.73912321,-0.4735,-0.451,-0.333,0.374,0.285,0.4055,undefined,9,NA,NA
1.176,0.886,1.109,1.219,0.9455,1.1675,1.204,0.91,1.1375,Q61712,Q61712,Dnajc1,1,2,2,2,Q61712,MOUSE,64096.8,4.1,3184,3184.1,15.37,15.37,NA,552,DnaJ homolog subfamily C member 1,nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum membrane|plasma membrane|membrane|integral component of membrane|nuclear membrane|,regulation of translation|protein folding|regulation of protein secretion|,DNA binding|protein binding|ribosome binding|chaperone binding|,2,2,2.84E+10,0.041,6.28E-05,-0.163166667,50.8247609,1.116,8.27E-06,12.29143436,-0.8245,-0.53,-0.809,0.359,0.438,0.3875,undefined,9,TRUE,TRUE
0.651,0.878,0.516,0.288,0.5305,0.1685,0.686,0.909,0.5515,P13808-5,P13808-5,Slc4a2,1,3,3,3,P13808-5|P13808|A0A0R4J101|P13808-3|A0A0R4J1K9|P13808-2|A0A0R4J1K4|P13808-4,MOUSE,119387.4,3.3,3186,3186.1,15.36,15.36,NA,1237,Isoform C2 of Anion exchange protein 2,integral component of plasma membrane|focal adhesion|membrane|basolateral plasma membrane|,chloride transport|bicarbonate transport|regulation of intracellular pH|chloride transmembrane transport|,inorganic anion exchanger activity|chloride transmembrane transporter activity|,3,3,2.82E+08,0.033,0.010899877,0.021833333,24.49695524,0.574,0.003550622,4.410093397,-0.2435,-0.439,-0.113,0.402,0.065,0.4595,undefined,7,NA,NA
0.636,0.289,0.463,0.75,0.4195,0.5925,0.574,0.224,0.4015,Q8CIW5,Q8CIW5,Twnk,1,2,2,2,Q8CIW5,MOUSE,77505.3,3.6,3189,3189.1,15.35,15.35,NA,685,"Twinkle protein, mitochondrial",mitochondrion|mitochondrial nucleoid|,mitochondrial DNA replication|DNA unwinding involved in DNA replication|transcription from mitochondrial promoter|protein hexamerization|protein homooligomerization|cellular response to glucose stimulus|,protease binding|DNA helicase activity|single-stranded DNA binding|ATP binding|5'-3' DNA helicase activity|,2,2,96900000,0.036,0.006470567,0.008333333,27.30071865,0.507,0.001861779,4.985444736,-0.4145,-0.075,-0.246,0.244,0.373,0.1685,NC,6,NA,NA
0.49,0.582,0.558,0.127,0.2385,0.1645,0.601,0.525,0.5335,A2AKX3,A2AKX3,Setx,1,8,2,2,A2AKX3|A2AKX3-2|Q91ZU0,MOUSE,301805.8,0.5,3205,3205.1,15.22,15.22,NA,2646,Probable helicase senataxin,"nuclear chromosome|chromosome, telomeric region|nucleus|nucleoplasm|nucleolus|cytoplasm|axon|growth cone|","MAPK cascade|double-strand break repair|DNA recombination|termination of RNA polymerase II transcription|mRNA splice site selection|cellular response to DNA damage stimulus|spermatogenesis|circadian rhythm|fibroblast growth factor receptor signaling pathway|positive regulation of neuron projection development|positive regulation of RNA splicing|cellular response to oxidative stress|negative regulation of apoptotic process|protein kinase B signaling|cellular response to fibroblast growth factor stimulus|positive regulation of transcription from RNA polymerase II promoter|positive regulation of DNA-templated transcription, termination|cellular response to hydrogen peroxide|cellular response to retinoic acid|positive regulation of DNA-templated transcription, initiation|positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled|",transcription termination site sequence-specific DNA binding|helicase activity|protein binding|ATP binding|identical protein binding|,2,8,4.80E+09,0.005,0.01994332,0.088833333,21.28847977,0.379333333,0.007432793,3.79928883,-0.0775,-0.123,-0.102,0.388,0.056,0.3915,undefined,6,NA,NA
0.608,1.211,1.027,0.434,1.0535,0.8695,0.745,1.344,1.1645,Q9ET54,Q9ET54,Palld,1,2,2,2,Q9ET54|Q9ET54-6|Q9ET54-2|Q9ET54-4|Q9ET54-5|Q9ET54-3,MOUSE,153668.9,1.4,3209,3209.1,15.19,15.19,NA,1408,Palladin,ruffle|nucleus|cytoplasm|mitochondrion|actin filament|plasma membrane|focal adhesion|actin cytoskeleton|Z disc|lamellipodium|,keratinocyte development|epithelial cell morphogenesis|actin cytoskeleton organization|,actin binding|,2,2,1.54E+08,0.014,0.002433139,-0.119333333,32.22954847,0.942333333,0.000598474,6.110705434,-0.2565,-0.805,-0.71,0.335,0.218,0.5025,undefined,9,NA,NA
0.584,0.636,1.176,0.04,0.0935,0.9535,0.649,0.504,1.2415,Q61247,Q61247,Serpinf2,1,3,2,2,Q61247,MOUSE,55199.1,4.4,3210,3210.1,15.17,15.17,NA,491,Alpha-2-antiplasmin,fibrinogen complex|extracellular space|cell surface|extracellular exosome|blood microparticle|,regulation of blood vessel size by renin-angiotensin|acute-phase response|response to organic substance|negative regulation of plasminogen activation|negative regulation of endopeptidase activity|collagen fibril organization|positive regulation of collagen biosynthetic process|positive regulation of cell differentiation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of JNK cascade|blood vessel morphogenesis|positive regulation of smooth muscle cell proliferation|positive regulation of stress fiber assembly|negative regulation of fibrinolysis|positive regulation of ERK1 and ERK2 cascade|positive regulation of transforming growth factor beta production|,protease binding|serine-type endopeptidase inhibitor activity|protein homodimerization activity|,2,3,1.22E+08,0.044,0.076373123,-0.098666667,13.9756778,0.601666667,0.040034298,2.547116548,-0.0375,-0.221,-0.94,0.27,-0.018,0.3545,PC,7,TRUE,NA
1.252,1.29,2.093,0.937,0.9905,1.7935,1.467,1.502,2.3085,P47878,P47878,Igfbp3,1,2,2,2,P47878,MOUSE,32713.3,7.8,3229,3229.1,15.01,15.01,NA,292,Insulin-like growth factor-binding protein 3,extracellular space|nucleus|insulin-like growth factor ternary complex|extracellular exosome|,regulation of cell growth|osteoblast differentiation|negative regulation of protein phosphorylation|protein phosphorylation|negative regulation of cell proliferation|regulation of glucose metabolic process|negative regulation of smooth muscle cell migration|regulation of growth|positive regulation of apoptotic process|positive regulation of catalytic activity|positive regulation of MAPK cascade|positive regulation of insulin-like growth factor receptor signaling pathway|type B pancreatic cell proliferation|positive regulation of myoblast differentiation|negative regulation of smooth muscle cell proliferation|,fibronectin binding|insulin-like growth factor binding|protein tyrosine phosphatase activator activity|insulin-like growth factor I binding|insulin-like growth factor II binding|,2,2,24900000,0.078,0.004209477,-0.120833333,29.52062161,1.560666667,0.001116703,5.472830449,-0.5685,-0.575,-1.56,0.673,0.394,0.9115,PC,9,TRUE,NA
0.673,1.342,0.751,0.344,1.0285,0.4375,0.727,1.392,0.8065,P97927,P97927,Lama4,1,2,2,2,P97927,MOUSE,204497.2,1.6,3254,3254.1,14.72,14.72,NA,1816,Laminin subunit alpha-4,extracellular region|basement membrane|basal lamina|extracellular exosome|,blood vessel development|cell adhesion|regulation of cell adhesion|regulation of cell migration|regulation of embryonic development|brown fat cell differentiation|,receptor binding|,2,2,5490000,0.016,0.009436626,0.181,25.29533444,0.819666667,0.002954381,4.569674656,0.0045,-0.602,-0.089,0.667,0.36,0.7455,PC,8,TRUE,NA
1.405,1.437,1.586,1.186,1.2325,1.3825,1.35,1.378,1.5315,Q8R418,Q8R418,Dicer1,1,2,2,2,Q8R418|F8VQ54|Q8R418-2,MOUSE,219555.4,1.7,3259,3259.1,14.61,14.61,NA,1916,Endoribonuclease Dicer,nucleus|cytoplasm|RISC complex|micro-ribonucleoprotein complex|RISC-loading complex|,"negative regulation of transcription from RNA polymerase II promoter|meiotic spindle organization|angiogenesis|regulation of protein phosphorylation|hair follicle development|apoptotic DNA fragmentation|RNA processing|cell proliferation|regulation of Notch signaling pathway|post-embryonic development|zygote asymmetric cell division|regulation of gene expression|negative regulation of Schwann cell proliferation|positive regulation of gene expression|regulation of muscle cell apoptotic process|positive regulation of Schwann cell differentiation|myoblast differentiation involved in skeletal muscle regeneration|rRNA catabolic process|stem cell maintenance|spinal cord motor neuron differentiation|nerve development|olfactory bulb interneuron differentiation|cerebral cortex development|lung development|embryonic limb morphogenesis|production of siRNA involved in RNA interference|targeting of mRNA for destruction involved in RNA interference|pre-miRNA processing|hair follicle morphogenesis|regulation of myelination|positive regulation of myelination|peripheral nervous system myelin formation|conversion of ds siRNA to ss siRNA involved in RNA interference|siRNA loading onto RISC involved in RNA interference|embryonic hindlimb morphogenesis|production of miRNAs involved in gene silencing by miRNA|multicellular organism growth|miRNA loading onto RISC involved in gene silencing by miRNA|conversion of ds siRNA to ss siRNA|regulation of odontogenesis of dentin-containing tooth|regulation of viral genome replication|regulation of cell differentiation|regulation of neuron differentiation|positive regulation of transcription from RNA polymerase II promoter|mRNA stabilization|spleen development|digestive tract development|reproductive structure development|regulation of oligodendrocyte differentiation|epidermis morphogenesis|branching morphogenesis of an epithelial tube|neuron projection morphogenesis|anatomical structure development|regulation of neurogenesis|cartilage development|spindle assembly|regulation of RNA metabolic process|defense response to virus|regulation of cell cycle|cardiac muscle cell development|inner ear receptor cell development|negative regulation of glial cell proliferation|intestinal epithelial cell development|cardiac neural crest cell development involved in outflow tract morphogenesis|ganglion development|regulation of enamel mineralization|hair follicle cell proliferation|RNA phosphodiester bond hydrolysis|RNA phosphodiester bond hydrolysis, endonucleolytic|regulation of miRNA metabolic process|positive regulation of miRNA metabolic process|",double-stranded RNA binding|helicase activity|endoribonuclease activity|ribonuclease III activity|deoxyribonuclease I activity|protein binding|ATP binding|protein domain specific binding|siRNA binding|miRNA binding|metal ion binding|pre-miRNA binding|pre-miRNA binding|,2,2,5.18E+08,0.017,0.000151217,-0.3005,46.26180317,1.472666667,2.36E-05,10.41523911,-0.8935,-0.86,-1.357,0.515,0.321,0.4715,undefined,9,NA,NA
0.401,0.866,0.74,0.412,0.8925,0.7665,0.427,0.889,0.7665,Q4U2R1,Q4U2R1,Herc2,1,2,2,2,Q4U2R1|Q4U2R1-2,MOUSE,534293.3,0.3,3274,3274.1,14.46,14.46,NA,4836,E3 ubiquitin-protein ligase HERC2,nucleus|cytoplasm|mitochondrial inner membrane|centriole|membrane|,DNA repair|cellular response to DNA damage stimulus|spermatogenesis|protein ubiquitination|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|,ubiquitin-protein transferase activity|zinc ion binding|ligase activity|ubiquitin protein ligase binding|SUMO binding|,2,2,3920000,0.003,0.002392742,-0.151833333,32.31244163,0.69,0.000587159,6.131029691,-0.2395,-0.654,-0.597,0.166,0.213,0.2005,undefined,8,NA,NA
2.099,2.122,2.459,3.026,3.0655,3.4185,2.433,2.408,2.7085,Q6NZQ4,Q6NZQ4,Paxip1,1,5,2,2,Q6NZQ4,MOUSE,120578.8,2.2,3285,3285.1,14.36,14.36,NA,1056,PAX-interacting protein 1,nucleus|nuclear matrix|histone methyltransferase complex|,"positive regulation of histone H3-K36 methylation|vasculogenesis|DNA repair|DNA recombination|transcription, DNA-templated|cellular response to DNA damage stimulus|response to ionizing radiation|DNA damage response, signal transduction by p53 class mediator|positive regulation of protein ubiquitination|positive regulation of histone acetylation|endothelial cell migration|positive regulation of isotype switching|histone H3-K4 methylation|positive regulation of histone H3-K4 methylation|positive regulation of transcription initiation from RNA polymerase II promoter|adipose tissue development|chorion development|",protein binding|,2,5,8.78E+08,0.022,0.000237896,-0.298166667,43.98523773,2.732666667,3.99E-05,9.579529335,-1.4695,-1.44,-2.084,0.664,1.642,0.8985,NC,9,NA,NA
0.598,0.374,0.611,0.552,0.3355,0.5805,0.172,0.121,0.5275,Q9DBT4,Q9DBT4,Entpd4,1,3,3,3,Q9DBT4|Q9DBT4-2,MOUSE,70429.2,5,3313,3313.1,14.14,14.14,NA,613,Ectonucleoside triphosphate diphosphohydrolase 4,Golgi membrane|autophagosome membrane|integral component of membrane|cytoplasmic vesicle|,metabolic process|,uridine-diphosphatase activity|,3,3,1.46E+08,0.05,0.014002037,0.045,23.17384161,0.325,0.004815217,4.141550618,-0.1235,-0.074,-0.155,0.306,0.257,0.0595,undefined,5,NA,TRUE
1.902,2.297,2.365,1.458,1.8685,1.9365,1.736,2.127,2.1995,P59729,P59729,Rin3,1,2,2,2,P59729|Q3U332,MOUSE,108188.4,1.7,3317,3317.1,14.12,14.12,NA,980,Ras and Rab interactor 3,early endosome|cytoplasmic membrane-bounded vesicle|cytoplasmic vesicle|,signal transduction|positive regulation of GTPase activity|,GTPase activator activity|Rab guanyl-nucleotide exchange factor activity|Rab GTPase binding|,2,2,2.66E+09,0.017,0.000341443,-0.382666667,42.11380946,2.091,6.15E-05,8.937442606,-1.0465,-1.286,-1.952,0.84,0.445,0.7035,undefined,9,NA,NA
0.974,1.354,1.05,0.476,0.8715,0.5675,0.487,0.863,0.5635,Q8C5P7,Q8C5P7,Tdrp,1,2,2,2,Q8C5P7,MOUSE,20300.1,12,3354,3354.1,13.7,13.7,NA,182,Testis development-related protein,nucleus|cytoplasm|,spermatogenesis|,NA,2,2,2.10E+07,0.12,0.00462859,-0.059666667,29.04319358,0.793666667,0.001246467,5.365453294,-0.3175,-0.652,-0.4,0.635,0.193,0.1835,NC,9,NA,NA
0.974,0.892,0.958,0.627,0.5605,0.6275,0.632,0.546,0.6175,P49817,P49817,Cav1,1,2,2,2,P49817|P49817-2|H3BKG0|P51637,MOUSE,20709.4,10.1,3359,3359.1,13.61,13.61,NA,178,Caveolin-1,Golgi membrane|acrosomal membrane|intracellular|mitochondrion|endosome|peroxisomal membrane|endoplasmic reticulum|Golgi apparatus|lipid particle|cytosol|plasma membrane|integral component of plasma membrane|caveola|focal adhesion|cilium|cell cortex|basal plasma membrane|cell surface|membrane|integral component of membrane|basolateral plasma membrane|apical plasma membrane|cytoplasmic vesicle|protein complex|membrane raft|perinuclear region of cytoplasm|focal adhesion|VCP-NPL4-UFD1 AAA ATPase complex|,negative regulation of transcription from RNA polymerase II promoter|MAPK cascade|inactivation of MAPK activity|angiogenesis|vasculogenesis|response to hypoxia|negative regulation of endothelial cell proliferation|positive regulation of endothelial cell proliferation|negative regulation of cytokine-mediated signaling pathway|regulation of the force of heart contraction|response to ischemia|regulation of the force of heart contraction by chemical signal|triglyceride metabolic process|calcium ion transport|cellular calcium ion homeostasis|endocytosis|regulation of smooth muscle contraction|skeletal muscle tissue development|response to nutrient|lactation|protein localization|negative regulation of cell proliferation|cellular response to starvation|negative regulation of signal transduction|response to gamma radiation|positive regulation of calcium ion transport into cytosol|posttranscriptional regulation of gene expression|positive regulation of gene expression|negative regulation of muscle cell apoptotic process|positive regulation of peptidase activity|receptor-mediated endocytosis of virus by host cell|regulation of fatty acid metabolic process|lipid storage|regulation of blood coagulation|negative regulation of BMP signaling pathway|negative regulation of epithelial cell differentiation|mammary gland development|organ regeneration|positive regulation of microtubule polymerization|T cell costimulation|negative regulation of protein ubiquitination|positive regulation of protein ubiquitination|negative regulation of protein binding|positive regulation of protein binding|response to progesterone|negative regulation of peptidyl-serine phosphorylation|positive regulation of peptidyl-serine phosphorylation|cholesterol efflux|nitric oxide homeostasis|positive regulation of toll-like receptor 3 signaling pathway|wound healing|vasoconstriction|response to drug|negative regulation of tyrosine phosphorylation of Stat5 protein|cholesterol homeostasis|negative regulation of MAP kinase activity|negative regulation of MAPK cascade|response to estrogen|negative regulation of nitric oxide biosynthetic process|negative regulation of neuron differentiation|positive regulation of endocytosis|positive regulation of vasoconstriction|negative regulation of JAK-STAT cascade|microtubule polymerization|negative regulation of pinocytosis|positive regulation of metalloenzyme activity|negative regulation of smooth muscle cell proliferation|negative regulation of nitric-oxide synthase activity|protein oligomerization|protein homooligomerization|response to glucocorticoid|cytosolic calcium ion homeostasis|response to calcium ion|membrane depolarization|regulation of peptidase activity|calcium ion homeostasis|mammary gland involution|positive regulation of cell adhesion molecule production|negative regulation of necroptotic process|negative regulation of protein tyrosine kinase activity|negative regulation of ERK1 and ERK2 cascade|caveola assembly|cellular response to mechanical stimulus|cellular response to exogenous dsRNA|cellular response to peptide hormone stimulus|cellular response to hyperoxia|cellular response to transforming growth factor beta stimulus|caveolin-mediated endocytosis|regulation of heart rate by cardiac conduction|angiotensin-activated signaling pathway involved in heart process|negative regulation of canonical Wnt signaling pathway|positive regulation of canonical Wnt signaling pathway|cellular senescence|apoptotic signaling pathway|regulation of membrane repolarization during action potential|regulation of ventricular cardiac muscle cell action potential|negative regulation of peptidyl-tyrosine autophosphorylation|negative regulation of potassium ion transmembrane transport|regulation of cell communication by electrical coupling involved in cardiac conduction|regulation of inward rectifier potassium channel activity|positive regulation of gap junction assembly|receptor internalization involved in canonical Wnt signaling pathway|negative regulation of anoikis|positive regulation of extrinsic apoptotic signaling pathway|positive regulation of intrinsic apoptotic signaling pathway|negative regulation of cation channel activity|,"RNA polymerase I transcription factor binding|receptor binding|structural molecule activity|protein binding|peptidase activator activity|enzyme binding|protein kinase binding|syntaxin binding|protein binding, bridging|protein complex scaffold|identical protein binding|ion channel binding|protein heterodimerization activity|nitric-oxide synthase binding|ATPase binding|inward rectifier potassium channel inhibitor activity|MDM2/MDM4 family protein binding|",2,2,24600000,0.101,0.000918802,0.019833333,37.00562628,0.722666667,0.000199268,7.368533691,-0.3745,-0.28,-0.37,0.591,0.283,0.2695,PC,9,NA,TRUE
3.44,3.759,4.119,2.679,3.0135,3.5545,3.232,3.547,4.0085,D3YZW1,D3YZW1,Srgap1,1,4,2,2,D3YZW1|Q91Z69|F8VPQ4|Q812A2|E9QN14,MOUSE,125010.8,1.8,3367,3367.1,13.53,13.53,NA,1085,SLIT-ROBO Rho GTPase-activating protein 1,cytoplasm|,Rho protein signal transduction|cell migration|negative regulation of cell migration|positive regulation of GTPase activity|,GTPase activator activity|protein binding|Rho GTPase binding|Rac GTPase binding|,2,4,3.44E+10,0.018,0.000635384,-0.753666667,38.87510405,3.609,0.000129566,7.91351615,-1.9375,-2.047,-3.69,1.224,0.773,1.1555,undefined,9,NA,NA
1.019,1.078,1.217,1.314,1.3875,1.5265,1.377,1.432,1.5755,Q99PL7,Q99PL7,Scd3,1,2,2,2,Q99PL7|P13516|P13011,MOUSE,41716.3,4.4,3370,3370.1,13.52,13.52,NA,359,Acyl-CoA desaturase 3,integral component of membrane|,oxidation-reduction process|monounsaturated fatty acid biosynthetic process|,palmitoyl-CoA 9-desaturase activity|stearoyl-CoA 9-desaturase activity|,2,2,1.01E+08,0.044,0.000104799,-0.1545,48.18653812,1.365333333,1.52E-05,11.17221856,-0.7335,-0.757,-1.021,0.307,0.625,0.6525,undefined,9,NA,TRUE
0.686,0.569,0.749,0.547,0.4465,0.6255,0.67,0.55,0.7345,O70496,O70496,Clcn7,1,2,2,2,O70496|E9PYL4,MOUSE,89224.8,2.7,3374,3374.1,13.5,13.5,NA,803,H(+)/Cl(-) exchange transporter 7,lysosomal membrane|membrane|integral component of membrane|cytoplasmic vesicle|,chloride transport|response to pH|ion transmembrane transport|regulation of anion transmembrane transport|,voltage-gated chloride channel activity|protein binding|ATP binding|antiporter activity|,2,2,2.31E+08,0.027,0.000346084,-0.016666667,42.04130255,0.635666667,6.25E-05,8.834871733,-0.3485,-0.229,-0.426,0.341,0.229,0.3335,undefined,9,NA,TRUE
1.048,0.96,0.775,1.108,1.0365,0.8515,1.235,1.143,0.9625,Q8BZW2,Q8BZW2,Sowahb,1,2,2,2,Q8BZW2,MOUSE,84167.7,1.8,3375,3375.1,13.48,13.48,NA,760,Ankyrin repeat domain-containing protein SOWAHB,NA,NA,NA,2,2,1.01E+08,0.018,4.86E-05,-0.193,52.12188997,1.041666667,6.13E-06,12.79210441,-0.8235,-0.716,-0.602,0.235,0.326,0.4225,undefined,9,NA,NA
1.04,1.819,1.534,1.977,2.8055,2.4145,2.479,3.206,2.8705,Q8K2H2,Q8K2H2,Otud6b,1,6,2,2,A0A0A0MQF5|Q8K2H2,MOUSE,33985.8,6.4,3423,3423.1,12.84,12.84,NA,294,OTU domain-containing protein 6B,NA,proteolysis|,cysteine-type peptidase activity|,2,6,3.68E+09,0.064,0.001984996,0.020666667,33.2426548,2.312333333,0.000473952,6.362564457,-0.6595,-1.369,-1.378,0.418,1.348,1.7645,undefined,9,NA,NA
1.006,1.094,1.295,0.869,0.9735,1.1735,1.099,1.184,1.3885,Q6DID7,Q6DID7,Wls,1,2,2,2,Q6DID7|Q6DID7-2,MOUSE,62871.7,4.8,3430,3430.1,12.69,12.69,NA,541,Protein wntless homolog,Golgi membrane|Golgi apparatus|integral component of membrane|cytoplasmic vesicle membrane|cytoplasmic vesicle|dendrite membrane|dendrite cytoplasm|,mesoderm formation|anterior/posterior axis specification|Wnt signaling pathway|positive regulation of canonical Wnt signaling pathway|,protein binding|Wnt-protein binding|mu-type opioid receptor binding|,2,2,1.98E+08,0.048,0.00013978,-0.068166667,46.67592016,1.145333333,2.15E-05,10.5740767,-0.5025,-0.563,-0.857,0.501,0.404,0.6085,undefined,9,NA,TRUE
1.963,1.982,1.998,2.12,2.2295,2.2295,1.504,1.565,1.5985,E9Q0Y4,E9Q0Y4,Sipa1,1,6,2,2,E9Q0Y4|P46062,MOUSE,112964,3.5,3437,3437.1,12.62,12.62,NA,1038,Signal-induced proliferation-associated protein 1,nucleus|nucleolus|Golgi apparatus|plasma membrane|transport vesicle|protein complex|,cellular response to water deprivation|positive regulation of GTPase activity|regulation of small GTPase mediated signal transduction|regulation of cell cycle|,GTPase activator activity|protein C-terminus binding|,2,6,2.88E+10,0.035,0.000100329,-0.118,48.41051522,1.897666667,1.44E-05,11.26347399,-1.0055,-1.009,-1.186,0.806,1.187,0.4995,undefined,9,NA,NA
1.36,1.418,1.483,1.073,1.1755,1.1855,1.347,1.402,1.5415,D6RG59,D6RG59,Psmg1,1,4,2,2,D6RG59|Q9JK23|D3Z795,MOUSE,7460.2,51.5,3449,3449.1,12.54,12.54,NA,64,Proteasome assembly chaperone 1,nucleus|cytoplasm|endoplasmic reticulum|,cerebellar granule cell precursor proliferation|proteasome assembly|proteasome core complex assembly|,proteasome binding|,2,4,4.91E+08,0.515,1.44E-05,-0.0995,59.32233465,1.335333333,1.17E-06,16.50055633,-0.7205,-0.734,-0.847,0.636,0.423,0.6455,undefined,9,NA,NA
1.439,1.388,1.438,1.343,1.3075,1.3575,1.511,1.456,1.5105,Q91WK0,Q91WK0,Lrrfip2,1,3,2,2,A0A0G2JFV5|A0A0G2JEP4|Q91WK0|E9QN52|A0A1L1SQW1|Q91WK0-2|A0A0R4J169|A0A1L1SVG1|A0A1L1SSC0,MOUSE,47261,3.8,3465,3465.1,12.42,12.42,NA,415,Leucine-rich repeat flightless-interacting protein 2,NA,Wnt signaling pathway|,NA,2,3,1.37E+09,0.038,2.29E-05,-0.310666667,56.19591368,1.503,2.40E-06,14.89940906,-1.0085,-0.912,-1.266,0.433,0.373,0.5165,undefined,9,NA,NA
2.029,2.716,3.3,1.592,2.2945,2.8795,2.006,2.69,3.2785,Q9JJN5,Q9JJN5,Cpn1,1,2,2,2,Q9JJN5,MOUSE,52129.7,4.3,3470,3470.1,12.38,12.38,NA,457,Carboxypeptidase N catalytic chain,extracellular space|,proteolysis|bradykinin catabolic process|response to glucocorticoid|,carboxypeptidase activity|metallocarboxypeptidase activity|zinc ion binding|,2,2,25600000,0.043,0.004394839,-0.503166667,29.29621067,2.793333333,0.001175923,5.422178748,-0.9905,-1.554,-3.155,1.01,0.642,1.0285,PC,9,TRUE,NA
0.945,1.401,1.09,0.675,1.1455,0.8355,1.016,1.468,1.1615,Q8K0T2,Q8K0T2,Dync2li1,1,2,2,2,Q8K0T2,MOUSE,39696.9,15,3485,3485.1,12.24,12.24,NA,351,Cytoplasmic dynein 2 light intermediate chain 1,microtubule|axoneme|dynein complex|motile primary cilium|apical part of cell|intraciliary transport particle|,determination of left/right symmetry|metabolic process|cilium assembly|,motor activity|,2,2,2.12E+09,0.15,0.000420662,-0.008333333,41.03065424,1.083666667,7.89E-05,8.583146202,-0.3565,-0.757,-0.537,0.575,0.352,0.6735,NC,9,NA,NA
2.029,2.189,1.996,1.812,1.9875,1.7935,2,2.156,1.9665,Q7TPE5,Q7TPE5,Slc7a6os,1,2,2,2,Q7TPE5,MOUSE,35325.6,7.5,3492,3492.1,12.17,12.17,NA,306,Probable RNA polymerase II nuclear localization protein SLC7A6OS,nucleus|cytoplasm|,hematopoietic progenitor cell differentiation|protein transport|,NA,2,2,72700000,0.075,2.36E-06,-0.349333333,76.05042405,2.032333333,2.48E-08,29.38848058,-1.2935,-1.385,-1.418,0.718,0.566,0.7165,NC,9,NA,NA